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General introduction

3 
1Traumatic brain injury (TBI) is one of the leading causes of death and disability worldwide. In 
Europe, approximately 2.5 million people sustain a TBI annually, of whom 75,000 die.1,2 Survivors 
are challenged with a range of disabilities and symptoms that may drastically reduce quality of 
life and result in huge societal costs.3-5
 
TBI is often referred to as “the most complex disease in our most complex organ”. Our brain 
is an extremely complex structure and a TBI may damage one or more of its areas resulting 
in various symptoms. The severity of TBI ranges from mild concussion to persistent coma and 
death, with the large majority of patients at the mild end of the spectrum. The word ‘mild’ might 
however be misleading because a substantial part of these patients report cognitive, somatic, 
and emotional symptoms that may last for months or even years after sustaining a TBI.6-8 This 
was already acknowledged by Hippocrates (460-377BC). His famous aphorism “No head injury is 
too severe to despair of, nor too trivial to ignore” indicates that even mild TBI (mTBI) might have 
serious consequences. Notwithstanding, millennia later, it is still unknown why some patients 
develop prolonged sequelae following mTBI whereas others recover within a few weeks. 
Since TBI is recognized as a serious public health concern, it has emerged as an important topic 
in medical research. In the year 2016, more than 1,500 papers have been published in English 
language journals studying TBI in humans, which is a fourfold of the number of papers that 
was published in the year 1990 (Figure 1). In comparison, the total number of papers in English 
language journals about human subjects has only doubled since 1990. Nevertheless, all these 
research endeavors have not yet resulted in major advances in our understanding of TBI, nor in 
an improvement of patient outcomes.9-11
Figure 1. Number of published papers from 1990 to 2016 on TBI in human subjects 
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The following EMBASE search was employed: [article]/lim AND [english]/lim AND [humans]/lim AND [xxxx-xxxx]/py AND (‘traumatic 
brain injury’:ab,ti OR ‘head injury’:ab,ti OR tbi:ab,ti OR concuss*:ab,ti). The total number of papers has increased from 327 in 1990 to 
665 (103%) in 2000, to 1233 (277%) in 2010 and to 1631 (400%) in 2016. In comparison, the total number of papers with the search 
strategy: [article]/lim AND [english]/lim AND [humans]/lim AND [xxxx-xxxx]/py has increased from 146,545 in 1990 to 212,278 (45%) in 
2000 to 363,573 (148%) in 2010 and 396,607 (171%) in 2016.
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Research in TBI is hampered by the heterogeneity of the patient population, the lack of 
standardized outcome instruments, and the fact that secondary insults and complications are 
common and may interact with the effects of a possibly beneficial treatment.10,12 Moreover, 
many randomized controlled trials (RCTs) have methodological shortcomings, including a lack 
of statistical power and focus on isolated disease mechanisms.10 In addition, prognostic studies 
often include too many predictors and do not use internal or external validation approaches.13,14 
As a consequence, the evidence derived from many studies is modest.
 
In this thesis we address two important and emerging topics in TBI research. First, we focus on 
outcome following TBI, with an emphasis on prevalence, predictors, and prediction modeling. 
Second, we focus on whether comparative effectiveness research (CER) could contribute to 
evidence generation in TBI, by analyzing current guideline adherence, treatment variation, and 
analytical methods. For both purposes, we follow a methodological perspective. This chapter will 
introduce some concepts related to outcome and CER in TBI. In addition, the research questions 
will be explained and an outline for this thesis will be provided. 
1.1 Traumatic Brain Injury
Traumatic Brain Injury (TBI) is generally defined as “an alteration in brain function or other 
evidence of brain pathology, caused by an external force”15 (Box 1). TBI was historically considered 
a single event. However, it is now recognized as a progressive disease in which both primary and 
secondary damage might be detrimental,16 and where final outcome is determined based on 
complex interactions between genetic make-up, pre-injury characteristics, injury mechanism, 
secondary complications, and psycho(social) characteristics.8,17,18
The incidence of TBI is increasing substantially all over the globe as a consequence of an increase 
in motor vehicle crashes in low- and middle-income countries and an increase in fall incidents 
in high-income countries.5,19 Consistent epidemiological data are however lacking because of 
heterogeneity in TBI definitions and data collection methods.11 Consequently, reported annual 
incidence rates vary from 47 to 849 per 100,000 in the European population.11 
The severity of TBI is most often indicated by the Glasgow Coma Scale (GCS) score; a score ranging 
from 3 to 15 based on eye reactivity (e.g. being able to open the eyes), verbal activity (e.g. being 
confused) and motor activity (e.g. obeying commands).20 Based on the GCS score, TBI severity 
is often trichotomized into mild (GCS score 13-15; in some studies 14-15), moderate (GCS score 
9-12) and severe (GCS score 3-8). The large majority of TBI patients (70-90%) sustained a mTBI 
according to this classification.21 In addition to the GCS score, studies in mTBI patients frequently 
use additional diagnostic criteria as recommended by the American Congress of Rehabilitation 
Medicine22 (Box 1). 
5 
1Box 1. Definitions for Traumatic Brain Injury
Traumatic Brain Injury (Menon et al. 2010)15
• An alteration in brain function or other evidence of brain pathology, caused by an external force.
• An alteration in brain functioning includes at least one of the following: 
○ Any period of loss or decreased consciousness
○ Any loss of memory before or after the injury
○ Neurologic deficits
○ Any alteration in mental state at time of injury
Mild Traumatic Brain Injury (American Congress of Rehabilitation Medicine)23
Same criteria but with the following restrictions: 
• Loss of consciousness between 0-30 minutes
• A Glasgow Coma Scale (GCS) of 13-15 after 30 minutes
• Loss of memory no longer than 24 hours
1.2 Outcome following TBI
Studying outcome following TBI aims to identify the objective and subjective burden experienced 
after sustaining a TBI. Subsequently, factors influencing outcome can be studied to identify 
patients at enhanced risk for persistent sequelae, which can be defined as the experience of 
residual symptoms (e.g. fatigue, headache, depression). Outcome research is also critically 
important in the evaluation of treatment effectiveness; e.g. we can compare outcome in patients 
receiving and not receiving a particular treatment. Outcome following TBI is however complex 
and multidimensional and there is no consensus on how and when outcome should be assessed. 
As a consequence, comparing results of different studies is challenging.
 
Some studies examining outcome focus on mortality, which is a hard endpoint. Since 
approximately 40% of patients with severe TBI die,9 it is considered important in this subgroup 
of patients. However, mortality rates in mild and moderate TBI are much lower and survivors 
of TBI are frequently challenged with cognitive, somatic, and emotional symptoms that may 
drastically influence functioning and quality of life. Therefore, the emphasis of outcome research 
had shifted towards other outcome measurements including clinical outcome, post-concussion 
symptoms, psychiatric disorders, and health-related quality of life (HRQoL).9,24 
1.2.1 Clinical outcome
Clinical outcome refers to the degree to which TBI survivors are able to function independently, 
fulfill occupational and social roles, and have returned to daily functioning (definition based on 
Wilson et al.25). It is usually measured with either the Glasgow Outcome Scale (GOS; 5-point 
scale)26 or the Glasgow Outcome Scale Extended (GOSE; 8-point scale).25 Both scales divide 
patients who sustained TBI into groups that allow for a standardized description of recovery. 
General introduction
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Scales range from death to good recovery (GOS) or upper good recovery (GOSE). In research 
practice, both the GOS and GOSE are commonly collapsed into a binary scale (favorable outcome 
vs. unfavorable outcome). It should however be noted that this results in loss of information and 
statistical power,27,28 and should therefore be discouraged. A proportional odds model in which 
the GOS/GOSE is used as an ordinal outcome variable has been proposed as an alternative.27,29 In 
such a model, a summary odds ratio is calculated based on all possible transitions on the scale.27 
As a consequence, all patients who improved with at least one point on the GOS or GOSE can 
contribute towards demonstrating a beneficial treatment effect, rather than only those patients 
who shifted from having an unfavorable outcome towards having a favorable outcome. Although 
the GOSE is recommended as standard end-point measurement for outcome following TBI,24,30 its 
ability to detect burden following mTBI can be debated since the large majority of mTBI patients 
function in the upper levels.31 
1.2.2 Post-concussion symptoms
Post-concussion symptoms refer to physical (e.g. headache, dizziness), cognitive (e.g. memory 
deficits, concentration problems), and emotional (e.g. depression, irritability) problems that can 
be experienced after sustaining a TBI. It has been assumed that post-concussion symptoms are 
relatively common following injury but resolve within weeks to months in the large majority of 
patients.32-34 This assumption has however been challenged by recent prognostic studies reporting 
that up to 50% of mTBI patients experience persistent post-concussion symptoms.7,35 Persistence 
of post-concussion symptoms can be diagnosed according to the International Classification of 
Diseases Tenth Edition (ICD-10) as Post-Concussion Syndrome (PCS). This diagnosis is however 
highly controversial, because post-concussion symptoms are neither unique to TBI nor do they 
cluster together in a predictable manner.36,37
 
Despite controversy on diagnostic criteria, persistent post-concussion symptoms represent 
a substantial burden to patients and relatives and are associated with reduced HRQoL, lower 
functioning, and work absentism.38-40 Therefore, they are currently the topic of active research 
investigation. Post-concussion symptoms are commonly measured using self-reported 
questionnaires, among which the Rivermead Post-concussion Questionnaire (RPQ)41 is the 
most frequently used. The RPQ is a 16-item questionnaire that measures the prevalence and 
severity of post-concussion symptoms in comparison to before the injury. There has however 
been substantial variability among studies in the use of the RPQ; e.g. the scale can be used as a 
linear total scale41,42 or can be divided into two (RPQ3 and RPQ13),43 or three (cognitive, somatic 
and emotional)44 subscales. In addition, many studies dichotomize the RPQ into ‘PCS’ vs. ‘no 
PCS’ using different symptoms (all RPQ symptoms vs. only those RPQ symptoms described in the 
ICD-10 criteria) and different cut-off points (including symptoms that are indicated to be mild or 
worse or symptoms that are indicated to be moderate or worse).12 This substantial variation in 
study design and analysis hampers comparability of studies on post-concussion symptoms, and 
subsequently slows down evidence generation.
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11.2.3 Psychiatric disorders 
Psychiatric disorders such as depression and post-traumatic stress disorder (PTSD) are relatively 
common following TBI.24,45 They are also more common following TBI than following other 
injuries.46 Psychiatric disorders are associated with adverse outcomes, such as lower quality of 
life,45 lower societal and occupational participation,47,48 and less life satisfaction.47 In addition, 
they may interfere with rehabilitation interventions49 and are consequently considered important 
in outcome assessment following TBI. Psychiatric disorders can be assessed with either self-
reported questionnaires or diagnostic interviews. Self-reported questionnaires are relatively 
efficient in terms of costs and labor intensity, but cannot confirm the presence of a psychiatric 
disorder. In addition, they might not be reliable in a TBI population as a consequence of memory 
deficits, attention problems and because of overlap between TBI symptoms and symptoms of a 
psychiatric disorder.50-54 Therefore, the use of diagnostic interviews is recommended to reliably 
assess psychiatric disorders following TBI.
1.2.4. Health-related quality of life (HRQoL)
HRQoL reflects a patient’s perspective on how an illness and its treatment affect physical, 
affective, cognitive, and social daily life aspects.55-57 HRQoL can be measured with generic (e.g. 
SF-36) or disease specific measurements (e.g. QOLIBRI). The SF-36 is a frequently used generic 
HRQoL instrument and yields a profile of eight domains relevant to quality of life, including: 
physical functioning, role limitations related to physical health problems, role limitations related 
to emotional health problems, bodily pain, general health perceptions, social role functioning, 
vitality, and mental health. From these subscales, a physical and mental health summary score 
can be calculated, which is often performed in studies assessing HRQoL following TBI.57 However, 
no convincing validation, such as confirmatory factor analysis, has been performed for the 
adequacy of this two-dimensional structure in TBI patients. 
1.2.5 Outcome prediction following TBI
The identification of prognostic factors for TBI outcome is relevant for both clinical practice 
and research.13,18 It might be especially relevant to combine various prognostic factors into a 
prediction model, which can be defined as a mathematical formula estimating prognosis in 
individual patients. 
For moderate and severe TBI, prognostic modeling is relatively advanced with two well-established 
models predicting mortality and clinical outcome.58,59 For mTBI patients, however, prognostic 
modeling has received relatively limited attention. Information on prognostic factors and the 
development of a prognostic model can however be used to identify patients at increased risk of 
long-term sequelae who may benefit from additional monitoring or (preventive) treatment, and 
thereby has the potential to reduce mTBI burden. 
General introduction
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Applying prediction modeling to mTBI patients is challenging because there is lack of standardized 
outcomes and unequivocal predictors. Next to these challenges, prior prediction modeling 
studies can be criticized for methodological shortcomings. For example, studies often included 
too many candidate predictors given the number of patients in their sample.14 Also, only a limited 
number of studies used internal validation techniques and more advanced statistical techniques 
such as shrinkage. This may result in statistical overfitting, meaning that a model performs well 
in the developmental set but poorly in new patients.13,60 Furthermore, none of the developed 
prognostic models for post-concussion symptoms or psychiatric disorders has been externally 
validated in an independent dataset,14,61 whereas this is a prerequisite for implementation in 
clinical practice.9,60
1.3 Comparative effectiveness research in TBI
1.3.1 Evidence generation in TBI
The scientific evidence underpinning international guideline recommendations for the medical 
and surgical management of TBI is weak.62 Although there have been major advances in the 
understanding of molecular and cellular mechanisms of TBI,63 this has not yet resulted in an 
increase in evidence-based treatment,5,64 nor has it changed patient outcomes.10
Randomized Controlled Trials (RCTs) are regarded the cornerstone of evidence-based medicine. 
The contribution of RCTs to the field of TBI is however relatively disappointing. According to a 
2016 state-of-the-science overview, nearly three-quarters of all RCTs in TBI failed to detect a 
statistically significant difference between treatment and comparison groups.10 This might be 
caused by the limited effectiveness of new interventions, but also by the heterogeneity of TBI,65 
as well as by methodological shortcomings such as small sample sizes and focus on isolated 
disease mechanisms.65,66
Observational studies constitute the main alternative for RCTs. They have the potential 
to contribute to the evaluation of treatment effectiveness in a real-world setting. A major 
methodological challenge in observational studies is confounding by indication, referring to a 
situation where the treatment indication is a confounder in the association between treatment 
and outcome. For example, aggressive, risky treatments might be more often performed in 
patients with a relatively unfavorable prognosis compared to patients with a relatively favorable 
prognosis.67,68 As a consequence, it remains uncertain whether differences in outcome among 
treated and non-treated patients are caused by the treatment under study or by differences in 
patient characteristics between treated and non-treated patients (Figure 2).
9 
1Figure 2. The influence of patient characteristics on treatment allocation in RCTs and observational 
studies
RCT: random treatment alloca!on Observa!onal study: treatment 
alloca!on pa!ent dependent
Treatment Outcome
Pa!ent characteris!cs
Treatment Outcome
Pa!ent characteris!cs
1.3.2 Variation in structures and processes of care
Since the current body of evidence underpinning the management of TBI is inconclusive, large 
between-center variation in both structures and processes of care are expected, which may 
arise from local traditions, personal preferences, and resource availability.69-71 Structures refer 
to the conditions under which patient care is provided (e.g. the number of beds, nurse-to-
patient ratio) and processes refer to activities that constitute patient care (e.g. treatment policy). 
Previous studies investigating structures and processes of TBI care indeed reported substantial 
heterogeneity among centers.70,72-76 One might argue that large variation is worrisome since this 
may imply that some patients are not receiving the best care and are therefore at risk for a 
less favorable outcome. On the other hand, since we do not know the effectiveness of current 
structures and processes of care, one might also regard variation as an opportunity to study the 
comparative effectiveness of interventions that all have the potential to be best practices. 
1.3.3 Comparative Effectiveness Research 
Comparative Effectiveness Research (CER) refers to “the generation and synthesis of evidence 
that compares the benefits and harms of alternative methods to prevent, diagnose, treat 
and monitor a clinical condition or improve the delivery of care.”77 CER provides a promising 
framework to identify best practices for the treatment of TBI.78 While traditional RCTs are often 
conducted in rather selected patient populations, CER aims to demonstrate effectiveness of real-
life interventions and thereby may directly inform consumers, clinicians and policy makers.77 
It has been recognized that the methodological quality underpinning CER studies is critically 
important for its success. Therefore the Good Research for Comparative Effectiveness (GRACE) 
checklist has been proposed.79,80 This checklist consists of 11 items with quality criteria about 
both the data and the methods used in CER studies, including items on adequate recording 
of treatment, the use of validated outcome measurements, and adjustment for confounding 
factors. For confounding factors, the GRACE checklist recommends considering restriction, 
stratification, multivariable analysis, propensity score matching, instrumental variables or other 
approaches.79 Some of these methods, however, do not take into account the role of unmeasured 
General introduction
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confounders (e.g. factors related to clinical intuition), while these factors may comprise important 
determinants of both treatment indication and patient outcome.
A method that may adjust for unmeasured confounders is instrumental variable analysis. 
In instrumental variable analysis, the association between an ‘instrument’ and outcome is 
analyzed.81 This instrument should be associated with the treatment under study, should cause 
the outcome only through the treatment under study and its effect should not be associated 
with the confounders (Figure 3).81 Treatment preference may potentially serve as an instrument 
in multicenter observational CER studies, for example, by comparing patient outcomes in centers 
with a high preference for a particular intervention to patient outcomes in centers with a lower 
preference for the intervention. This strategy was recently used in two observational multicenter 
studies on ICP monitoring.82,83 
In order to obtain valid estimates of the treatment effect in instrumental variable analyses, it is 
crucial that the underlying assumptions are met (i.e. instrument is associated with treatment, 
causes outcome only through the treatment and is not associated with confounders). However, 
a 2014 systematic review found that these assumptions are often violated.84 For example, 
the instrument treatment preference could be associated with geographic location, patient 
characteristics, facility characteristics and the provision of co-occurring treatments,84 which may 
influence the validity of the effect estimate. 
Figure 3. Instrumental variable analysis with treatment preference as instrument 
Instrument
Treatment preference 
of a center (e.g. the 
extent to which 
centers generally 
place ICP monitors 
in pa!ents with severe TBI)
Treatment
Treatment on pa!ent 
level (e.g. pa!ent received 
an ICP monitor yes/no)
Outcome
Outcome measurement 
on pa!ent level 
(e.g. mortality, 
clinical outcome)
Confounders
Factors influencing
treatment choice and
outcome (e.g. age, 
TBI severity, 
clinical intui!on)
11
 
11.3.4 Valorization of scientific knowledge
Valorization refers to the utilization of research findings in clinical practice. Valorization of 
research might be accomplished by the conduct of systematic reviews and the development of 
guidelines. Systematic reviews summarize and weight scientific information on the same topic 
and provide recommendations that may directly inform doctors and policy-makers. Nevertheless, 
a recent evidence-mapping approach found that only half of the systematic reviews in the acute 
management of TBI were current (i.e. included the most recent RCTs) and only two-thirds were 
complete (i.e. including all available RCTs that met the inclusion criteria of the review, taking into 
account when the review was conducted). Also, for some topics, there were multiple systematic 
reviews available with sometimes conflicting conclusions.85 Hence, current information from 
systematic reviews might be outdated, incomplete and contradictory, which may decrease the 
translation of research endeavors to clinical practice. 
Guidelines are developed to improve quality of care, reduce practice variation and ensure that 
evidence-based care is optimally implemented.86 The use of guidelines might be associated 
with more favorable outcomes in TBI patients.87 However, guidelines can only improve patient 
outcomes if they are based on high-quality evidence, properly implemented and adhered to. 
1.4 Aims and outline of this thesis
The aim of this thesis is to expand our knowledge on outcome and opportunities for CER in 
patients with TBI. We maintain an integrative approach by using a wide range of methodologies, 
including systematic reviews of the literature, analysis of patient data, survey data and a 
simulation study to address methodological challenges. 
The aim of this thesis was operationalized in the following two main research questions:
1. What is the prevalence and what are predictors of outcome following TBI? 
a. What is the prevalence of TBI outcome in terms of persistent post-concussion symptoms, 
psychiatric disorders and HRQoL? 
b. What are predictors of TBI outcome? 
c. Can we identify patients at greatest risk for suffering post-concussion symptoms? 
2. To what extent can CER contribute to evidence generation in TBI?
a. To what extent do clinicians adhere to current evidence from guidelines? 
b. To what extent does variation in structure and process characteristics exist among centers 
treating patients with TBI? 
c. What is the influence of analytical methods on the estimate of treatment effectiveness 
in observational studies? And which method may provide a valid estimate in case of 
confounding by indication? 
General introduction
12
This thesis consists of two parts. In Part I (Chapter 2-8) prevalence and predictors of TBI sequelae 
are described and the possibility of identifying patients at greatest risk for post-concussion 
symptoms is examined. Specifically, Chapter 2 provides an overview of current knowledge on 
prevalence, predictors, assessment and treatment of post-concussion symptoms. Chapter 
3 examines the influence of definition of post-concussion syndrome on prevalence rates and 
predictors. Chapter 4 and 5 study the prevalence and predictors of psychiatric disorders following 
TBI. Prediction models for six-month post-concussion symptoms were developed and externally 
validated in Chapter 6 and 7. Chapter 8 assesses HRQoL of Dutch and Chinese TBI patients and 
examines psychometric properties of the SF-36.
In Part II (Chapter 9-16) of this thesis we examine how CER could contribute to evidence 
generation in TBI. We start with an overview of current guideline adherence in Chapter 9. 
In the Chapters 10 to 13 we describe variation in structures and processes of care, which is 
a prerequisite for CER. Specifically we focus on general characteristics (Chapter 10), structures 
and processes during emergency department and hospital admission (Chapter 11), intracranial 
pressure monitoring and treatment policy (Chapter 12) and rehabilitation (Chapter 13). Chapter 
14 describes variation of ICU management across five neurotrauma centers in the Netherlands 
and uses instrumental variable analysis to analyze the effect of intracranial pressure monitoring. 
The influence of analytical techniques on effect estimates is further examined in Chapter 15 and 
16.
The results of the studies included in this thesis are further discussed in Chapter 17, together 
with their interpretation and recommendations for future research, policy and clinical practice. 
This thesis is part of the Collaborative European NeuroTrauma Effectiveness Research in Traumatic 
Brain Injury (CENTER-TBI; European Union FP 7th Framework program; grant 602150) project; 
a prospective longitudinal observational study that is currently recruiting patients from 68 
European neurotrauma centers. CENTER-TBI aims to improve characterization and classification 
of TBI and to identify best clinical care, by using a comparative effectiveness approach. One of the 
tasks within CENTER-TBI is the characterization of center characteristics by sending out a survey 
(‘the provider profiling questionnaires’) to the participating neurotrauma centers addressing 
structural and process characteristics of different phases of care. The development of this survey 
is described in chapter 10 and the results are presented in chapters 10-13. How the results of 
this survey can be used for the CENTER-TBI CER analyses, will subsequently be described in the 
discussion section (Chapter 17).
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Abstract 
Mild traumatic brain injury (mTBI) can present a substantial burden to patients, relatives, and 
health systems. Whereas recovery is expected in the majority of patients, a subset continues 
to report persisting somatic, cognitive, emotional, and/or behavioral problems, referred to 
as post-concussion syndrome (PCS). However, this term has been subject of debate since the 
mechanisms underlying post-concussion symptoms and the role of pre- and post-injury-related 
factors are still poorly understood. 
Current evidence and controversies concerning the use of the terms post-concussion symptoms 
versus syndrome, its diagnosis, etiology, prevalence, assessment and treatment in both adults 
and children are reviewed. Post-concussion symptoms are dependent on complex interactions 
between somatic, psychological, and social factors. Progress in understanding has been hampered 
by inconsistent classification and variable assessment procedures. There are substantial 
limitations in research to date, resulting in gaps in our understanding, leading to uncertainty 
regarding epidemiology, etiology, prognosis, and treatment. 
Future directions concerning the identification of potential mechanisms, new imaging 
techniques, comprehensive, multidisciplinary assessment and treatment options are discussed. 
Longitudinal studies applying standardized assessment strategies, diagnoses, and evidence-
based interventions are required in adult and pediatric mTBI populations to optimize recovery 
and reduce burden of post-concussion symptoms. 

25
 
2
Introduction
Mild traumatic brain injuries (mTBI) are among the most common neurologic conditions, 
representing a substantial burden worldwide.1,2 A subset of mTBI patients suffers from acute 
post-concussion symptoms that may manifest as somatic, cognitive, emotional, and/or 
behavioral problems. In a small portion of mTBI patients, post-concussion symptoms persist over 
time,3,4 which is often referred to as post-concussion syndrome (PCS). PCS is usually diagnosed 
according to the International Classification of Diseases (ICD)-105, or following Diagnostic and 
Statistical Manual of Mental Disorders (DSM)-IV criteria.6 However, over the last 15 years the 
concept of PCS as a reliably identifiable, unique syndrome has been questioned.7,8 Therefore, we 
will use the term post-concussion symptoms to describe symptoms following mTBI and will refer 
to persistent post-concussion symptoms when these persist for at least three months after TBI. 
This narrative review (based on a systematic literature search till April 5th 2017, see search strategy 
and selection criteria and appendix) adds to the literature by summarizing current knowledge 
on epidemiology, etiology, assessment and treatment of post-concussion symptoms, using a 
multidimensional comprehensive coverage of topics, both in adults and children. Understanding 
the various factors leading to post-concussion symptoms (Figure 1), and the complex 
interactions between temporal onset, biological, psychological and social factors, as well as the 
relative influence of injury-related and non-injury related factors may contribute towards the 
understanding, diagnosis and classification of post-concussion symptoms. In addition, an insight 
into the wide range of assessment methods and possible treatments may provide guidance for 
both physicians and policy-makers. Furthermore, this review will provide directions for future 
research and clinical services, including recommendations on the investigation of etiological 
factors, assessment and treatment of post-concussion symptoms.
Definitions and epidemiology
Mild Traumatic Brain Injury (mTBI)
The American Congress of Rehabilitation Medicine (ACRM)10 defines mTBI as an “acute brain 
injury resulting from mechanical energy to the head from external physical forces”, with any of 
the following symptoms: loss of consciousness (LOC) not exceeding 30 minutes, post-traumatic 
amnesia (PTA) of no more than 24 hours, a score of no less than 13 on the Glasgow Coma Scale 
(GCS) after 30 minutes post injury (or upon presentation),11 and an (unspecified) period of 
confusion (feeling dazed, disoriented, confused), or other transient neurologic abnormalities 
such as focal signs or seizures. 
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Figure 1. A model for the study of post-concussion symptoms after mTBI 
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Literature on mTBI frequently distinguishes between complicated and uncomplicated mTBI. Most 
mTBI patients do not show trauma-related abnormalities on computed tomography (CT) scans. 
However, the term “complicated mTBI” can be used to refer to the, e.g. 5-10% of emergency 
department (ED) patients12 showing abnormalities, such as subarachnoid hemorrhage, 
intracranial contusions, or small extra-axial hematomas. 
Controversies related to definitions
Post-concussion symptoms following mTBI refer to somatic symptoms of brain injury (nausea, 
dizziness, headache, blurred vision, auditory disturbance, fatigue), cognitive deficits involving 
memory and executive function, or emotional/behavioral changes (disinhibition and emotional 
lability).5,6,10 The literature on mTBI frequently uses the term “symptom” to refer to all changes 
experienced after a concussion, regardless of whether they refer to the patient’s subjective 
report, for which the term “complaints” might be more appropriate. In this review, the term 
“symptoms” will be applied to remain consistent with the literature. 
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Post-concussion symptoms do not always cluster in a consistent and predictable manner, and it 
is controversial whether they truly represent a specific, cohesive, and predictable syndrome.8,13 
Although the term post-concussion symptoms might suggest otherwise, these symptoms are not 
specific to TBI but are also frequently reported in non-brain injured trauma patients14, including 
patients with whiplash injuries15 and even in healthy adults and children.16-18
PCS is usually defined according to DSM-IV or ICD-10 criteria, with both focusing on symptom 
presentation.13 These manuals agree on the prerequisite history of brain trauma for the diagnosis 
of post-concussional disorder (DSM-IV6) or PCS (ICD-105). Differences between diagnostic systems 
are presented in Table 1. An important difference is that DSM-IV requires immediate symptom 
onset and persistence for at least three months whereas ICD-10 does not. In addition, DSM-IV 
requires objective evidence of memory or attention deficits (criterion B), but ICD-10 explicitly 
precludes such evidence (criterion C-3). The variability in terminology and associated criteria 
of the DSM-IV and ICD-10 hampers accurate identification and diagnosis of patients with PCS.9 
Different classification methods may result in overestimation or underestimation of symptoms, 
particularly when relying on subjective endorsement of symptoms by patients. This was shown in 
a cross-sectional study in which 61 patients were referred to a concussion clinic following mTBI.19 
Table 1. Comparison of three definitions of post-concussion symptoms
ICD-10 DSM-IV DSM-5
Headache ✓ ✓
Dizziness ✓ ✓
Fatigue ✓ ✓
Noise intolerance ✓ ✓
Irritability/lability/anxiety/depression ✓ ✓
Sleep problems ✓ ✓
Concentration problems ✓ A ✓ B ✓ B 
Memory deficit ✓ A ✓ B ✓ B 
Intolerance of alcohol ✓
Preoccupation with symptoms ✓
Personality change ✓
Apathy ✓
Perceptual-motor ✓ B 
Social cognition ✓ B 
Table shows symptoms presented in the International Classification of Diseases (ICD)-10 definition of PCS (diagnosis code F07.02), the 
Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV definition of postconcussional disorder and the DSM-V definition of 
neurocognitive disorder. A Subjective report; B Objective test.
Post-concussional disorder was not included in the last DSM-5 edition.20 Instead, DSM-5 includes 
“mild neurocognitive disorder due to TBI”, a neurocognitive disorder, which strongly suggests 
– but not formally requires- performance-based, quantifiable evidence of acquired cognitive 
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deficits after mTBI (Table 1). Importantly, in DSM-5 the most frequently reported post-concussion 
symptoms are reduced to the status of “associated features”. In addition, DSM-5 emphasizes the 
broad differential diagnoses, especially when symptom severity “appears to be inconsistent with 
the severity of the TBI”.21
Prevalence of post-concussion symptoms
Prevalence of post-concussion symptoms varies and depends on pre-injury factors,14,22 patient 
population (see panel 1),23 assessment,23 analysis strategies, and diagnostic criteria.23,24 Overall, 
single symptoms (e.g. headache or depression) are very common25 (Figure 2), whereas multiple 
concurrent symptoms are less frequent.23 
Neuropsychological testing consistently shows minor cognitive deficits within the first two weeks 
after injury, with some exploratory evidence suggestion deficits lasting up to six months.26 It has 
been suggested that self-reported somatic symptoms (headaches, dizziness) are more prevalent 
immediately after the injury (1-2 weeks)27, whereas cognitive and emotional symptoms resolve 
more slowly and may still be above baseline levels at three months post injury.28 However, as 
these are cross-sectional analyses, which do not track the evolution of symptoms in single 
patients, evidence supporting a differential trajectory between self-reported somatic and 
cognitive/emotional subacute symptoms is limited. 
ICD-10 prevalence rates at three months post-injury vary between 6%,29 22%30 and 64%.24 DSM-
IV diagnostic criteria appear to be stricter than ICD-10 criteria leading to lower estimates when 
using DSM-IV: a cohort study of patients after mTBI found a prevalence of PCS at three months of 
64% based on ICD-10 criteria, but only a prevalence of 11% when using DSM-IV.24
Only few pediatric studies report prevalence of post-concussion symptoms based on ICD-10 
or DSM-IV diagnostic criteria; one-month prevalence for children recruited from ED based on 
ICD-10 reach 52%18 and three-month prevalence based on DSM-IV constitutes 29.3%.31 Some 
studies define symptomatic children as having an increase at least in one symptom and arrive 
at estimates between 24.5-52.5% at one month post injury,18,32 11-39% after three months, 
and 2.3% at 12 months,18 which makes comparison of symptom development trends between 
children and adults challenging. An additional complication in capturing prevalence rates in 
children is that younger children may not be able to describe their symptoms reliably. Therefore, 
such prevalence estimates should be treated with caution. 
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Figure 2. The prevalence of post-concussion symptoms over time
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Figure is based on data presented in Hartvigsen et al.25
Etiology
Acute and persistent post-concussion symptoms 
Acute symptoms post-injury, such as headache, dizziness, sensitivity to light or noise, double 
vision or tinnitus, are associated with the development of persistent symptoms.13,33,34 A clinical 
risk score in children has identified headache, sensitivity to noise, fatigue and answering 
questions slowly as predictive of post-concussion symptoms at 28 days post-injury.35 In addition, 
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the experience of post-concussion symptoms early post-injury (1 week – 1 month) is consistently 
associated with a higher odds of persistent post-concussion symptoms.14,36 A 2015 study in 103 
patients found that 82% of patients experiencing post-concussion symptoms one year after mTBI 
had already reported these after one month.37
Biological factors and persistent post-concussion symptoms
Several predominantly biological factors, such as diffuse axonal injury, neuro-inflammation, and 
altered cerebral blood flow have been implicated in the genesis of post-concussion symptoms 
after mTBI.38-40 However, these factors have not yet been analyzed in high-quality prognostic 
studies. The role of biological factors is underlined by findings that repetitive mTBIs is associated 
with increased symptom prevalence,41,42 longer time to symptom resolution, 42,43 and (limited) 
neurocognitive deficits.44 Similarly, repetitive sub-concussive impacts, e.g. in contact sports, 
have also been associated with minor long-term neuropsychological sequelae, abnormalities 
in both neuroimaging and in neuropsychological tests,45 and even with the development of 
neurodegenerative conditions such as chronic traumatic encephalopathy (CTE).45 Although many 
symptoms of CTE bear similarity with post-concussion symptoms (e.g. irritability, impulsivity, 
depression, (short-term) memory loss), current evidence on the association of repetitive sub-
concussive impacts with CTE is limited and should be considered preliminary.46
A major controversy in attempting to identify the role of biological factors in the development of 
post-concussion symptoms is their weak relationship with injury severity and the high prevalence 
of PCS-like symptoms in non-brain injured patients, as well as in healthy participants.14-18,32,36,47
Even though most studies find higher symptom endorsement in brain-injured patients,29,37,48-50 
the high rate of false-positives needs to be taken into account when validating biological factors. 
It should be acknowledged that biological factors do not exist in isolation but need to be 
interpreted in the context of potentially confounding factors, e.g. pre- and post-injury physical 
and mental health, trauma, and psychosocial factors.14,49-51 
Psychiatric, psychological, (psycho)-social factors and post-concussion symptoms
Psychiatric factors
Many post-concussion symptoms (e.g. sleep difficulties, irritability and concentration problems) 
are similar to symptoms of the hyperarousal dimension of posttraumatic stress disorder (PTSD),50 
which may occur following exposure to severe, often life-threatening events. PTSD following TBIs 
of all severity grades has a pooled prevalence rate of 13.8% (10.2% to 17.4%)52 and appears to 
follow TBI more frequently than other traumatic injuries not involving the brain.38,53 
Given the overlap between post-concussion and PTSD symptoms,50,53,54 careful differential 
diagnosis is required. Nevertheless, a prospective study including 534 brain-injured patients and 
827 controls found that mTBI was a significant predictor for PTSD but not for post-concussion 
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symptoms.50 However, it is unclear, whether these results also hold true for pediatric samples. 
A smaller prospective study comparing parent-reported post-concussion symptoms and PTSD 
symptoms in 186 children with mTBI and 99 children with non-head orthopedic injuries reported 
higher rates of post-concussion symptoms after mTBI but comparable rates of PTSD symptoms.54 
Almost half of patients with persistent post-concussion symptoms suffer from premorbid 
depression and anxiety.38,55 Pre-injury mental health status has repeatedly been shown to predict 
persistent post-concussion symptoms in adult36,38,39,56 and pediatric populations.9,18 However, the 
question of causality remains unclear, as psychiatric symptoms might be a reaction to experiencing 
persistent post-concussion symptoms, and/or mental health problems might increase the risk of 
reporting persisting symptoms.
Psychological factors
Recall biases have been shown to influence reports of post-concussion symptoms after mTBI. 
Patients after mTBI expecting to experience post-concussion symptoms show higher symptoms 
rates than patients with lower levels of expectation.57 Similarly, in some patients the “good-old-
days” bias may lead them to underestimate pre-injury symptoms.39,48
Malingering, exaggeration, and misattribution of common symptoms may also influence the 
persistence and worsening of post-concussion symptoms following mTBI. Involvement in 
litigation and compensation processes may lead to stress, exaggeration, and attribution.7,58 
Malingering is a multidimensional construct defined by the DSM-IV as “intentional production 
of false or grossly exaggerated physical or psychological symptoms, motivated by the external 
incentives”. This diagnosis has been criticized for poor classification accuracy. Although removed 
from the index in the DSM-5, codes to identify conditions and criteria for when to consider 
malingering remain unchanged. Neuropsychological performance based outcomes (PERBOS) 
have also become an established practice in litigation cases despite the presence potential for 
bias and possible misinterpretation.58 
Finally, symptoms commonly occurring in everyday life, such as headache, irritability, sleep 
disturbance and forgetfulness may be misattributed to brain trauma.7,30 Extensive assessments 
for putative somatic origins of such common symptoms may further beliefs that these symptoms 
are indicative of serious brain damage, leading to hypervigilance and catastrophic attributions, 
comparable to behaviors seen in patients with somatoform disorders or hypochondriasis.7,30,53,58 ,59
Socio-demographic, social and personality factors 
Female sex is consistently associated with greater reporting of persistent post-concussion 
symptoms.36 Sex effects appear to be smaller in children.18,32 ,47 Some studies found that post-
concussion symptoms are associated with lower education in adults36 and pre-injury learning 
difficulties in children.32 Community integration, social support, lifestyle, and family dynamics 
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may contribute to the development and persistence of post-concussion symptoms in adults39,60 
and children9 However, conclusive evidence has not yet been established.
Basic personality traits as captured in the five-factor model do not appear to be associated 
with persistent post-concussion symptoms.14 However, more specific traits such as high anxiety 
sensitivity,61 low resilience,62 coping styles30,63 or alexithymia61 may be associated with persistence 
of symptoms. However, the cross-sectional design and small sample sizes in these studies hamper 
the establishment of firm conclusions in this area. 
Predicting persistent post-concussion symptoms
The identification of risk factors might be especially useful for clinical practice when combined 
into a prognostic model predicting patients at risk of poor outcome. However, current models 
are often based on small samples64 and lack internal and external validation.14,36,64 In addition, no 
model is able to reliably predict outcomes at the individual patient level.36 Therefore, identification 
of high-risk patients might best be accomplished by careful and dense follow-up data collection. 
However, advances in study and modeling methodology and, possibly, the incorporation of 
advanced imaging and biochemical biomarkers (see Panel 2 for recommendations) may improve 
the ability to identify at-risk patients in the first week post-injury in the future. 
Clinical assessment of post-concussion symptoms
Providing optimal care depends on the early and reliable identification of patients at risk of 
developing persistent post-concussion symptoms,8,65 by a multidisciplinary team. Medical 
examination should include a history of previous TBIs, head and neck injuries, and a detailed 
description of the number and extent of acute concussion symptoms, preferably using 
standardized instruments (see Table 2). Special emphasis should also be placed on the assessment 
of co-morbid injuries and disorders, such as chronic headache, and other pain, cervical-disorders, 
chronic fatigue, sleep and somatoform disorders.18,56,65,66 However, checklists should not be 
solely administered to “diagnose” persistent post-concussion symptoms as a disorder in the 
absence of a comprehensive multidimensional medical, neurological, and psychiatric and (neuro)
psychological evaluation.55,67
Since persistence of post-concussion symptoms has been associated with pre-, peri-, and 
post-injury psychological distress and risk of psychiatric disorders (PTSD, depression, anxiety, 
substance abuse, somatoform disorders), anamnesis should also include an assessment of pre-
injury and current mental health difficulties (see table 2).14,26,52,55 Finally, information on social 
and legal factors, such as availability of social support, life stressors, and involvement in legal 
proceedings needs to be collected.66
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Table 2. Selection of Post-Concussion Symptoms Assessments (Adults and Children) based on CDE 
Recommendations and Frequent Clinical Use
Assessments Examinations and instruments Population
Clinical Examination 
and History
Standardized medical history and history of injury event, neurological and physical 
examination including orientation, speech fluency, memory, concentration, 
dyslexia, dizziness, vertigo, sleep, cranial nerves, motor, sensory and gait 
assessment; balance and vestibular testing; respiratory and heart rate, blood 
pressure; Cervical spine range of motion and tenderness; comprehensive headache 
assessment; neuroimaging (if mandated by neurological deficits)
 
Standardized pre- and post-injury anamnesis of depression, anxiety, stress, 
dissociation, behavior, and other mental health problems retro- and prospective 
assessment: e. g. Structured Clinical Interview-DSM, Mini International 
Neuropsychiatric Interview (v 5.5),
Diagnostic Interview Schedule for Children-IV, Neuropsychiatric Rating Schedule 
(NPRS), Clinician-administered PTSD Scale (CAPS)
A/P
Self-reported Post-
Concussion Symptoms
Health and Behavior Inventory* 
Neurobehavioral Symptom Inventory ** 
Post-concussion Symptom Inventory** 
Rivermead Post-Concussion Symptom Questionnaire*
P 
A 
P 
A
Neuropsychological 
Impairments
Behavior Rating Inventory of Executive Function**  
Rey Auditory Verbal Learning Test* 
California Verbal Learning Test for Children* 
Delis-Kaplan Executive Function System - Verbal Fluency* 
Immediate Post-Concussion Assessment and Cognitive Testing ** 
Trail making test (TMT)* 
TRAILS-PRESCHOOL** 
Cognitive Battery-NIH Toolbox** 
Wechsler Abbreviated Scale of Intelligence* 
Wechsler Adult Intelligence Scale* 
Wechsler Intelligence Scale for Children-IV*/Wechsler Preschool and Primary Scale 
of Intelligence -III
P 
A/P 
P 
P 
A/P 
A 
P 
A/P 
P 
A 
P
Psychological and 
Psychiatric Status
Brief-Symptom-Inventory-18* 
Beck-Depression Inventory II** 
Child Behavior Checklist** 
Patient Health Questionnaire -9** 
Screen for Child Anxiety Related Emotional Disorders (SCARED)** 
Minnesota Multiphasic Personality Inventory (MMPI)** 
Posttraumatic Stress Disorder Checklist (PCL)** 
Short Mood and Feelings Questionnaire (SMFQ)** 
Alcohol Use Disorders Identification Test: Self-Report Version (AUDIT)**
A 
A/P 
P 
A/P 
P 
A 
A 
A/P 
A
Symptom Validity Test of memory malingering (TOMM)** 
Medical Symptom Validity Test**
A/P 
A/P
Family and 
Environment
Family Assessment Device (FAD)** 
Child and Adolescent Scale of Environment (CASE) ** 
Family Burden of Injury Interview (FBII) **
A/P 
P 
P
* Common Data Elements (CDEs) recommended as basic measure; ** CDEs recommended as supplemental measure; 
Abbreviations: A = Adult TBI; P = Pediatric TBI
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A variety of symptom checklists exist to assess somatic, emotional, and cognitive post-concussion 
symptomatology, and require patients to indicate presence, absence, frequency, and intensity of 
symptoms. Neuropsychological PERBOS include measures of attention, memory, concentration, 
orientation and executive function and can provide performance-based evidence of symptoms 
indicating impaired cognition. Standard neuropsychological procedures should be followed to 
ensure that test results are not unduly influenced by comorbid disorders (e.g., attention deficit 
hyperactivity disorder, and dyslexia68,69), or inadequate understanding of test and questionnaire 
requirements, or low effort.70 Until now, only in the field of sport concussion, short reliable and 
sensitive screening instruments (7-10 minutes) are implemented to identify possible symptoms.71 
A comprehensive overview of instruments suitable for clinical assessment is presented in table 2.
Neuroimaging and persistent post-concussion symptoms
No consensus has been reached on the relevance of imaging indicators of brain abnormalities 
for prognosis and outcome after mTBI. Several studies have shown that measures derived from 
magnetic resonance imaging (MRI)65,72-74 or magnetic resonance spectroscopy (MRS) can reveal 
structural or functional abnormalities in adults and children with an otherwise normal CT.18 Thus, 
for some patients, persistence of post-concussion symptoms may be explained by yet unknown 
brain abnormalities. However, current evidence is equivocal and the few large-scale, prognostic 
studies available suggest only small effects,75 if at all. 
Health-related quality of life and post-concussion symptoms 
Health-related quality of life (HRQoL) measures supplement functional and mental health 
outcomes with information on how health conditions influence patients’ subjective perspectives 
on their wellbeing. Post-concussion symptoms have been linked to lower levels of satisfaction 
with life60 and HRQoL in adults76 and children.77 However, given the association of pre-injury 
physical and mental health status with persistent post-concussion symptoms, the specificity of 
these findings is unclear. Further research is needed to isolate the specific effects of persistent 
symptoms on HRQoL.11
Management of patients with post-concussion symptoms
Treatment of post-concussion symptoms is primarily symptom-oriented, and, given the 
limitations of current treatment guidelines,78 highly variable. 
Pharmacological interventions
The evidence for pharmacological treatment of depression, anxiety, and mood lability after mTBI 
is limited and conflicting. A meta-analysis evaluating the effectiveness of depression treatment 
after mTBI found that studies using a pre-post design suggested treatment benefits from selective 
serotonin reuptake inhibitors.79 In contrast, the overall effects of controlled trials included in 
this meta-analysis did not reveal significant differences between treatment and control groups, 
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with some evidence favoring the control condition.79 However, a recently published RCT found 
sertraline to be effective in preventing depression following TBI when administered early after 
injury.80 These findings may have considerable therapeutic implications for patients with TBI, but 
future studies are needed to replicate results before a change in the treatment guidelines could 
be recommended.
Non-pharmacological interventions
Evidence concerning the benefits of non-pharmacological interventions targeting post-concussion 
symptoms is limited. Early educational interventions in ED patients after mTBI have received 
very limited evidence in reducing the incidence and severity of post-concussion symptoms.81 
However, successful interventions may be economical, as a single center RCT focusing on 
symptom management delivered via telephone counseling demonstrated reduced chronification 
of post-concussion symptoms during the first three months post injury.82 However, this finding 
could not be replicated in a multi-center study of patients with mixed severity TBIs.83 A recent 
Cochrane review concluded that most unselected mTBI patients make good recovery and do 
not necessarily benefit from interventions such as telephone counseling or patient information 
brochures.84 
Evidence for beneficial effects of neuropsychological rehabilitation on post-concussion symptoms 
is still limited. A systematic review found evidence that, particularly when applied early, such 
approaches may be efficient in reducing self-reported post-concussion symptoms, anxiety and 
depression, but do not result in a clear reduction of cognitive impairment.85 
A recent study suggests that cognitive behavioral therapy (CBT) can improve HRQoL in patients 
with persistent post-concussion symptoms in the context of outpatient rehabilitation services.86 
However, the effect of CBT on post-concussion symptoms was only marginal.86 Problem 
orientation and problem-solving skills seem to improve by neuropsychological rehabilitation 
addressing self-regulation of cognitive and emotional processes,87 but evidence is limited.
Intervention studies in children and adolescents are highly variable, of limited methodological 
quality, and evidence to support any particular intervention for post-concussion symptoms in 
pediatric samples is absent.88 In adults, as in pediatric populations, well-designed prospective 
studies focusing on non-pharmacological multidimensional intervention that show improvement 
on variables such as HRQoL and return to play and work are still lacking.
Rest and post-concussion symptoms
Concerns have been raised regarding the expert-based consensus recommendation for rest 
after acute concussion, as studies in adults89 and children90 indicate that prolonged rest may 
contribute to prolonged symptomatology,91 and no reduction in post-concussion symptoms was 
found in a study on rest interventions.81 
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Vestibular rehabilitation therapy
The traumatic event resulting in mTBI might also have resulted in concomitant cervical soft 
tissue damage, resulting in “whiplash-related” symptoms such as headache, dizziness and 
balance dysfunction as well as cognitive and visual dysfunction.15 A 2014 RCT comparing cervical 
spine physiotherapy and vestibular rehabilitation therapy (VRT) with a control condition in 58 
athletes found that among the intervention group a significantly higher proportion of individuals 
were medically cleared after eight weeks of treatment.92 However, a recent systematic review 
concluded that current evidence for optimal prescription and efficacy of VRT in patients with mTBI 
is still limited.93 Thus, further high-level studies evaluating the effects and optimal intervention 
window of VRT are required 
Headaches
Headaches are among the most disabling symptoms after mTBI. Most post-traumatic headaches 
show clinical features of a recognized primary headache, such as migraine headaches or tension 
headaches. Post-traumatic migraines may respond to the same abortive and prophylactic 
treatments as sporadic migraines.94 In addition, non-pharmacological approaches such as 
biofeedback, physical therapy, cognitive behavioral therapy, either as primary or adjunctive 
treatments, have also been successfully applied to persistent post-concussion headaches.56,95 
Methodological considerations
In this narrative review, we only included prospective cohort studies with at least 100 participants, 
and reviews, with some exceptions (supplemental material). A total of ten included studies did 
not meet these criteria.16,17,19,27,28,48,61,68,69,96 For these topics, there was no prospective study with 
at least 100 participants available. Therefore, prospective, multicenter research with larger 
patient samples is needed. In addition, it should be noted that studies fulfilling our quality criteria 
might still be at risk of bias. Attrition is a recurrent problem,36,64 that may have influenced the 
reported prevalence rates, the relevance of etiological factors and also treatment effectiveness. 
In addition, some studies of etiological factors were based only on univariable analyses, while 
multivariable assessment is highly recommended because of the multifactorial nature of post-
concussion symptoms.
Conclusions and future directions
Despite a sharp increase in studies investigating post-concussion symptoms, controversies and 
debates still exists pertaining to etiology, diagnosis, pathophysiology, natural history, prevalence, 
and terminology. The subjective nature of post-concussion symptoms, their low specificity, and 
the significant overlap with other physical, neurological and psychiatric conditions add additional 
challenges to these discussions.8,13,14,16,35,36,47,50,67 The frequent overlap and very individual interplay 
of post-concussion symptoms with especially pre- and post-injury psychiatric, psychological 
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and social factors are still under-investigated and necessitates a standardized comprehensive 
differential diagnosis of comorbid mental conditions, in particular depression, anxiety disorders 
and PTSD. 
In this review, we described possible factors contributing to post-concussion symptoms from a 
bio-psychosocial perspective. This provides insight into its complex nature and can be used by 
physicians to estimate risk of persistent symptoms in individual patients. In addition, it may provide 
targets for prediction modeling in which the explanatory value of different factors contributing to 
post-concussion symptoms are combined. Currently, no valid model is available to predict post-
concussion symptoms.36,64 Future prediction modeling studies can be improved by using solid 
methodology (see panel 2). However, the feasibility of prediction modeling can be debated given 
the complex, controversial and multifactorial nature of post-concussion symptoms. Therefore, 
investing in routine and economic follow-up methods (e.g. the development of a mobile phone 
applications) might be prioritized over prediction models. 
The frequent reliance on simple symptom questionnaires for diagnosis ignores possible biases14 
and the fact that the major classification systems require several other criteria to be fulfilled, 
such as performance-based evidence of cognitive impairment.20 Most questionnaires were 
developed in and for patients with more severe deficits, thus their sensitivity and specificity in 
mTBI may be challenged. More refined neuropsychological tests, especially sensitive to assess 
cognition after mTBI, may support the diagnosis of post-concussion symptoms. Moreover, 
short screening batteries (computerized and paper and pencil) are required for use in EDs and 
at general practitioners practices. This is line with international attempts at developing and 
implementing standards for clinical research (e.g. CDEs),97 terminology and diagnosis criteria for 
post-concussion symptoms. 
The heterogeneous nature of mTBI and post-concussion symptoms and the lack of reliable 
biological predictors and clinically useful gold-standard biomarkers still limit the development 
of disease-modifying therapies. A first step may be the identification of specific biochemical98 
and imaging biomarkers that can complement clinical diagnosis, inform prognosis by identifying 
patients at risk for post-concussion symptom persistence, and predict treatment response.72,99
Large-scale multidimensional, prospective longitudinal studies with several measurement points 
are strongly required to tackle current challenges in studying post-concussion symptoms. Such 
designs would allow stratified subgroup analyses to identify patients at risk for developing 
persistent symptoms, and might help to further early and personalized treatment. Depending 
on the research question, improved designs should include control groups, to receive insight 
into spontaneous recovery, and progression, injury severity, frequency, intensity and fluctuation 
(trauma controls and healthy participants) of post-concussion symptoms. 
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Due to normal variation in developmental trajectories, outcomes in children after mTBI may 
be particularly variable. Longitudinal large sample studies (>100) that investigate predictors of 
post-concussion symptoms in pediatric populations with multiple endpoints, adequate controls 
are especially important since high neuro- and cognitive plasticity is present here.
Although evidence for effective treatments is limited, a multi-disciplinary approach corresponding 
to the complex etiology of post-concussion symptoms may be most promising. Such an approach 
would combine in-depth comprehensive medical and neurological diagnosis with an emphasis 
on psychiatric differential diagnostics and psychosocial und neuropsychological outcome 
assessment. Also health management, medical monitoring, and proactive health maintenance 
interventions require further investigation. Future treatment directions (repetitive transcranial 
magnetic stimulation, vestibular and vision rehabilitation therapy and aerobic exercise) may offer 
a solution for the basic pathological processes associated with post-concussion symptoms.56
Standardization of treatment and interventions, outcome measures,97 and follow-up assessment 
time-points would also enhance reliability and validity of research comparisons and individualized 
treatment. One might speculate as to whether post-concussion symptoms represent the most 
valid endpoint for treatment/study after mTBI. Given their low specificity, it may well be that 
other outcomes (e.g. functional outcome and HRQoL) prove to be more useful.
To summarize, standardization of multidimensional comprehensive diagnostics, treatment and 
interventions, and follow-up assessment time-points may enhance reliability and validity of 
research comparisons and refine personalized treatment and care.
This review documents the need for future directions concerning the identification of potential 
mechanisms, new imaging techniques, comprehensive multidisciplinary assessment and 
treatment options. Longitudinal-well controlled studies applying standardized, diagnoses, 
assessment strategies and evidence-based interventions are required in adult and pediatric mTBI 
populations to optimize recovery and reduce burden of post-concussion symptoms.
Supplemental material is available at www.marysecnossen.nl
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Panel 1. Cohort descriptions: Emergency Department patients versus sports related 
injuries and military blast injuries
Patients presenting for care with mTBI represent a diverse group with differing mechanisms of 
injury and presentations to different points of care within the medical system. Characteristics 
of these subpopulations differ in terms of injury characteristics as well as patient demographics 
and likely affect outcomes. Important differences also exist with regard to risk of repeat injury 
and return to activities which influences clinical management. A broad understanding of these 
issues is essential to the care of these differing populations of mTBI. A brief comparison of such 
differences is presented in the table below. 
Table: Cohort Descriptions: Emergency Department vs. Sports-related vs. Military Blast Injuries
Emergency department mTBI Sports mTBI Military blast mTBI
Mechanism of 
injury
Higher energy (motor vehicle 
crashes, falls, direct impact) 
Lower energy102
Angular acceleration
Overpressure104
Hospitalization High rate of hospitalization100 Low rate of hospitalization Unknown
LOC High incidence LOC Low incidence LOC (< 10%) Unknown
Repetitive injury Uncommon Common Possible
Visual deficits Unknown, but likely101 Common (smooth pursuit, 
saccadic deficits,  
convergence insufficiency103)
Common (smooth 
pursuit, saccadic deficits, 
convergence insufficiency105)
Duration Symptoms may persist for  
months59
Symptoms resolve in 
80-90% in 8-10 days64
High incidence of PTSD106
Summary: In short, mTBI patients are a heterogeneous population with differing pre-injury, injury 
and post-injury characteristics, all of which likely influence clinical care and recovery. Accounting 
for these differences in management of patients is paramount to optimize care and ultimate 
outcomes.
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Panel 2. Methodological recommendations for studies on post-concussion symptoms 
after mTBI
Well-designed confirmatory studies with the following characteristics have been called for to 
better understand post-concussion symptoms and its consequences:
• Study design: Prospective inception cohort studies with appropriate control group (e.g. non-
brain injured patients, general population) and appropriate follow-up period to differentiate 
persistent deficits and symptoms due to post-concussion symptoms from the effects of 
pre-injury (neuro)psychiatric disorders and other non-mTBI factors. Longitudinal analyses 
strategies to monitor evolution of post-concussion symptoms in single patients.
• Instruments: Use crosswalk analysis to compare incidence rates between studies using 
different post-concussion symptom assessment procedures. At least include anchor items.
• Studies on predictors / prediction models (based on Mushkudiani et al.107 and Steyerberg 108:
• Sample size: N > 500 
• Predictors should be based on theory, clinical knowledge or previous research
• For every predictor considered there should be at least ten cases (i.e. patients classified 
as having PCS) 
• A liberal p-value (e.g. p < 0.157)109 should be used when applying selection procedures
• Results should be internally validated (e.g. bootstrap validation)
• Both discrimination and calibration statistics should be mentioned; a score chart is 
warranted for implementation in clinical practice 
• External validation: external validation in an independent dataset is a prerequisite before 
implementation in clinical practice. External validation and updating of an existing model 
should be prioritized against the development of a new model.
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Abstract 
Background: Mild Traumatic Brian Injury (mTBI) is a common diagnosis and approximately one-
third of mTBI patients experience a variety of cognitive, emotional, psychosocial and behavioral 
post-concussion symptoms. When a cluster of these symptoms persists for more than three 
months they are often classified as post-concussion syndrome (PCS). The objective of this study 
was to determine prevalence rates, risk factors and functional outcome associated with PCS six 
months after mTBI applying divergent classification methods. 
Methods: We performed a post-hoc analysis of 731 mTBI patients recruited in the Radboud 
University Brain Injury Cohort Study (RUBICS). Follow-up questionnaires at six months after 
mTBI included the Rivermead Post-Concussion Symptoms Questionnaire (RPQ) and the Glasgow 
Outcome Scale Extended (GOSE). The RPQ was analyzed according to different classification 
methods: the mapped International Classification of Diseases (ICD-10)/Diagnostic and Statistical 
Manual of Mental Disorders (DSM-IV), the RPQ total score, the RPQ3 and the three-factor model 
using two different cut-off points (mild or worse and moderate or worse). 
Findings: Prevalence rates of PCS ranged from 11.4% to 38.7% using divergent classification 
methods. Six percent of patients experienced PCS according to all eight methods. Applying 
the divergent classification methods resulted in a different set of predictors being statistically 
significantly associated with PCS and a different percentage of overlap with functional 
impairment, measured with the GOSE. 
Conclusions: Depending on the classification method and rating score used, prevalence rates 
of PCS deviated considerably. For future research, consensus regarding the diagnostic criteria 
for PCS and the analysis of the RPQ should be reached, to enhance comparability of studies 
regarding PCS after mTBI. 
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Introduction
Traumatic brain injury (TBI) is a leading cause of death and disability worldwide with an annual 
incidence of 262 per 100,000 admitted TBI patients in Europe.1 The large majority (70-80%) of 
all TBI cases are evaluated as mild TBI (mTBI). In the first weeks following mTBI many patients 
suffer from post-concussion symptoms comprising physical symptoms (e.g. headaches, dizziness, 
blurred vision, fatigue and sleep disturbances), cognitive deficits (e.g. poor memory, attention 
and executive difficulties), and behavioral/emotional symptoms (e.g. depression, irritability, 
anxiety, emotional lability).2 For most patients these symptoms will diminish spontaneously,3 
but for a subset of patients (estimated between 5-43%4-9) symptoms last for over months and 
sometimes even longer. When a set of symptoms persists for over three months, it is often 
referred to as post-concussion syndrome (PCS).
 
It is challenging to define PCS because there is no consensus with regards to the criteria for 
diagnosis.10 The most used criteria for diagnosis are those specified in the International 
Classification of Diseases (ICD-10)11 and the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-IV).2 Even though the ICD-10 and DSM-IV classifications deviate, they both include a head 
injury with potential loss or alteration of consciousness and the existence of certain symptoms. 
A frequently used instrument to assess the presence and severity of post-concussion symptoms 
is the Rivermead Post-Concussion Symptoms Questionnaire (RPQ).12 The RPQ was developed 
by King (1995), who proposed to use the total scale score for analyses.12 Subsequently, other 
evaluation methods have been applied. Potter et al. (2006) proposed a ≥ 12 cut-off for the 
total scale score.13 Eyres et al. (2005) suggested the use of a two subscale version, one scale 
containing three items (RPQ3) and one containing 13 items (RPQ13), because of a possible lack 
of unidimensionality for the RPQ total scale.14 Smith-Seemiller et al. (2003) recommended a 
modified scoring system with three subscales (cognitive, emotional and somatic symptoms) or 
two subscales (collapsing somatic and emotional symptoms versus cognitive symptoms) to be 
more sensitive.13,15 The majority of studies however mapped the ICD-10 or DSM-IV criteria to 
the RPQ.16-18 Patients are subsequently classified with PCS if they report at least three out of 
the following symptoms: headaches, dizziness, fatigue, irritability, impaired memory, impaired 
concentration, and insomnia. Next to heterogeneity in classification methods, there is also no 
consensus on whether symptoms should be incorporated in the rating for PCS if they are rated as 
2 (mild problem) or worse or only if they are rated as 3 (moderate problem) or worse.19,20
The application of different classification methods and cut-offs may lead to incomparability of 
studies assessing PCS. The main objective of this study was to assess the prevalence rate of 
PCS among patients six months after mTBI, using four divergent classification methods and two 
different rating scores as cut-off to analyze the RPQ. In addition, we examined the association 
between PCS, predictors and functional outcome using the divergent classification methods.
Divergent classification methods of post-concussion syndrome
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Methods
Study design 
Data were obtained from the prospective observational Radboud University Brain Injury Cohort 
Study (RUBICS).21-24 All patients with mild, moderate or severe TBI admitted between January 
1998 and December 2010 to the emergency department (ED) of the Radboud University Medical 
Center (RUNMC), a level I trauma center in the Netherlands, were included in the database. The 
ethical standards committee of the RUNMC had approved this study. 
Study participants
The RUBICS database contains information on 2286 patients with mild, moderate and severe 
TBI. In the current study, 797 patients were selected from the RUBICS database based on the 
following inclusion criteria: patients’ age was 16 years and older, written informed consent 
given by patients (or guardians), patients suffering from mTBI (GCS 13-15) and admitted to the 
emergency department of RUNMC between January 2003 and June 2010. Diagnosis of mTBI was 
based on a Glasgow Coma Scale (GCS, 13-15) after initial resuscitation or followed by sedation 
and intubation during resuscitation for a non-neurological cause. Exclusion criteria were alcohol 
or drug abuse or dementia, unknown address, and not able to speak or write Dutch. 
Measurements 
Clinical data was registered in the ED by a neurologist and/or neurosurgeon and entered by a 
research nurse into the RUBICS databank. Demographic data (age, sex and educational level), 
trauma mechanisms, hospitalization, clinical variables and comorbidities were collected with a 
postal questionnaire which was self-rated by patients or guardians at six months after the trauma. 
Assessment of persistent post-concussion symptoms and diagnosis of PCS 
The prevalence rates and severity of persistent post-concussion symptoms were assessed with 
the postal RPQ at six-month follow-up. Patients were asked to rate the severity of 16 different 
symptoms, commonly found after TBI, over the past 24 hours. In each case, the symptoms were 
compared with how severe they were before the injury occurred (pre-morbid). The patient was 
asked to rate the symptoms on a 5-point Likert scale: 0 (not experienced at all), 1 (no more of 
a problem), 2 (mild problem), 3 (moderate problem) and 4 (severe problem). In the literature, 
there is not a gold standard concerning the use of the RPQ. Therefore, we used the following 
classification methods: Mapped ICD-10/DSM-IV, RPQ total score,12 RPQ 314 and three-factor 
model.15 Because no clear cut-off was found in the literature for the RPQ13, this scale was not 
taken into consideration. For each classification method, we used two different rating scores as 
cut-off (≥ 2 and ≥ 3), resulting in eight different classification methods in total (Panel 1). 
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Functional outcome
Functional outcome was assessed using the six-month Glasgow Outcome Scale Extended (GOSE), 
which was completed as a postal questionnaire. The GOSE is a functional measurement scale 
specifically designed for TBI.25,26 The instrument evaluates functional outcome through eight 
categories encompassing consciousness, independence at home and outside the home, work, 
social and leisure activities, family and friendship and return to normal life.27 After accumulating 
these categories an 8-point scale ranging from 1 (dead) to 8 (complete recovery) is established, 
which has the ability to distinguish between functional outcomes. When there was no available 
outcome at exactly six months, outcomes measured within a two-month range were also 
approved. Functional impairment was classified as a GOSE score of ≤ 6.28
Statistical analysis
For demographic data (age, sex and educational level), trauma mechanisms, hospitalization, 
clinical injury variables and comorbidities descriptive analyses were performed. Patients included 
in current study were compared to those having incomplete RPQ data on demographic variables 
using Chi-Square tests (categorical variables) and student’s t-tests (continuous variables).
Prevalence of PCS using the eight divergent classification methods was determined by computing 
the percentage of patients meeting the specific criteria of each classification method. We 
subsequently determined overlap between classification methods by calculating the number and 
percentage of patients diagnosed with PCS according to multiple classification methods.
The univariable associations between predictors and PCS according to multiple classification 
methods were explored by using Chi-Square tests (categorical variables) and the student’s t-test 
(continuous variables). The variables age, gender, education, injury mechanism, injury severity 
scale (ISS), abbreviated injury score of the head (AISH), comorbidity, traumatic abnormalities on 
the head computed tomography (CT) scan and hospitalization were considered as risk factors. 
All characteristics that were significant at p < 0.20 in the univariable analyses were included in a 
stepwise backwards multivariable logistic regression to identify significant risk factors (p < 0.05) 
of PCS. The association between PCS and functional impairment (GOSE ≤ 6) was determined by 
calculating the percentage of patients for each classification method of PCS that was functionally 
impaired. Multiple imputation technique with 5 datasets was used to impute missing predictor 
variables.
All statistical analyses were performed using SPSS version 21 for Windows (IBM SPSS Statistics, 
SPSS Inc, Chicago, IL). 
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Results
Study population 
In total 797 mTBI patients were included in this study. The six-month follow-up questionnaire 
was completed by 92% (N = 731) of mTBI patients, who filled in all the items of the RPQ. Patients 
with a missing six-month RPQ (n = 66) did not differ from those included in this study, except that 
there was a slight significant difference in age (54 vs. 44) and ISS (7.9 vs. 9.7). The characteristics 
of our study sample are shown in Table 1. The median age of the respondents was 44 years and 
63% were male. Almost half (48%) of the patients were injured due to road traffic accidents and 
a third due to falls. Approximately 50% of the respondents were admitted to the hospital and 
they were hospitalized for an average of three days. A total of 35 patients were admitted to the 
intensive care unit (ICU). 
Six-month persistent post-concussion symptoms 
The three most frequently reported symptoms on the six-month RPQ were fatigue, forgetfulness/
poor memory and poor concentration (Online Supplement A). Fatigue was endorsed by 308 
patients (42.1%) and 32 (4.4%) patients evaluated this as a severe problem. Nausea and/or 
vomiting was the least reported symptom (n = 42, 5.7%). Approximately one-third of the patients 
(N = 242) endorsed none of the symptoms (total RPQ score of 0), whereas three patients had 
an RPQ score of 59, which means they experience severe problems six months after the injury 
on almost every item. The median score on the RPQ for the study population was 4 (IQR, 4-15). 
Prevalence rates of PCS according to the different classification methods
The use of divergent classification methods resulted in prevalence rates for six-month PCS 
ranging from 11.4% (three-factor model with rating score 3) to 38.7% (mapped ICD-10/DSM-IV 
with rating score 2; Figure 1.1 and 1.2). Classification methods overlapped substantially; e.g. 
95.6% (n = 108) of patients who met the criteria for PCS according to the mapped ICD-10/DSM-IV 
with rating score 2 also met the criteria for PCS according to the RPQ total score with rating score 
2. The lowest amount of overlap was found for the classification methods RPQ3 and three-factor 
model with rating score 3 (n = 49, 51%) A total of 46 (6.3%) patients met the criteria for PCS 
according to all classification methods. 
Divergent classification methods of post-concussion syndrome
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Table 1. Characteristics of the study population
N 731
Gender (male) 463 (63.3%)
Age1 (years) 44 (27-57)
Education
Primary education 21 (2.9%)
Secondary education 336 (46.0%)
Higher professional education 108 (14.8%)
Academic education 84 (11.5%)
Unknown 182 (24.9%)
Injury Mechanism
Road traffic accident 351 (48.0%)
Fall 240 (32.8%)
Sports 77 (10.5%)
Assault 41 (5.6%)
Other/Unknown 22 (3.0%)
Injury characteristics
ISS1 6 (4-14)
AISH1 2 (2-2)
Head AIS 3 93 (12.7%)
Head AIS 4 57 (7.8%)
Head AIS 5 11 (1.5%)
Comorbidity2
No pre-existing disease 329 (45.0%)
1 comorbid disease 92 (12.6%)
2 comorbid disease 33 (4.5%)
3 or more comorbidities 40 (5.5%)
Unknown 237 (32.4%)
CT scan
No CT scan 45 (6.2%)
CT scan, no abnormalities 591 (81.0%)
CT scan, abnormalities 94 (12.9%)
Hospitalization3
Hospital admission 373 (51.0%)
Number of days hospitalized1 3 (1-8)
ICU admission 35 (4.8%)
1 Data are displayed as median, with the first and third quartile given within brackets. 2 Comorbidity is defined as the presence of any 
co-existing diseases or disease processes additional to injury that the injury patients sustained. The following diseases were assessed as 
comorbid disease: asthma, chronic bronchitis, chronic non-specific lung disease (not questioned), heart disease, diabetes, back hernia 
or chronic backache, osteoarthritis, rheumatoid arthritis, and cancer. 3 Hospital or IC admission for one day or more after arrival at 
emergency department.
Abbreviations: mTBI = mild Traumatic Brain Injury; RPQ = Rivermead Post-Concussion Symptoms Questionnaire; PCS = Post-Concussion 
Syndrome; ISS = Injury Severity Score; AISH = Abbreviated Injury Scale of the Head; AIS = Abbreviated Injury Scale; CT = computed 
tomography; IC = intensive care.
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Figure 1. Number of mTBI patients with persistent post-concussion symptoms at six months and the 
overlap between classification methods 
Figure 1.1 Rating score 2
Post-Concussion
Syndrome
Mapped ICD-10/
DSM-IV
RPQ Total Score
RPQ3
Three-factor
model
283 pa!ents
234 pa!ents
261 pa!ents
231 pa!ents
RPQ3: 172 (73.5%)
ICD-10/DSM-IV: 222 (94.9%)
Three-factor model: 197 (84.2%)
RPQ 3: 206 (72.8%)
RPQ Total score: 222 (78.4%) 
Three-factor model: 214 (75.6%)
RPQ Total Score: 197 (85.3%)
ICD-10/DSM-IV: 214 (92.6%) 
RPQ3: 154 (66.7%)
RPQ Total score: 172 (65.9%)
ICD-10/DSM-IV: 206 (78.9%)
Three-factor model: 154 (59.0%)
Figure 1.2 Rating score 3
Post-Concussion
Syndrome
Mapped ICD-10/
DSM-IV
RPQ Total Score
RPQ3
Three-factor
model
113 pa!ents
125 pa!ents
96 pa!ents
83 pa!ents
RPQ3: 66 (52.8%)
ICD-10/DSM-IV: 108 (86.4%)
Three-factor model: 79 (63.2%)
RPQ 3: 63 (55.8%)
RPQ Total score: 108 (95.6%) 
Three-factor model: 77 (68.1%)
RPQ Total Score: 79 (95.2%)
ICD-10/DSM-IV: 77 (92.8%)  
RPQ3: 49 (59.0%)
RPQ Total score: 63 (65.6%)
ICD-10/DSM-IV: 63 (65.6%)
Three-factor model: 49 (51.0%)
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Risk factors for PCS 
Female gender, lower education and assault were significantly associated with six-month PCS 
according to all classification methods, whereas traumatic abnormalities on the head CT scan 
was not statistically significantly associated with PCS according to any of the classification 
methods (Table 2, Online Supplements B and C). The significance of the predictors ISS, AISH, 
comorbidity and hospital admission however depended on the classification method used; 
e.g. hospital admission was a significant predictor for PCS using six out of eight classification 
methods. Multivariable prediction models explained 8-16% (Nagelkerke R2) of the variation in 
PCS according to the different classification methods.
PCS and functional outcome
A total of 198 (27.1%) patients were functionally impaired (GOSE ≤ 6) six months post-injury. 
There was a significant association between PCS according to all classification methods and 
functional impairment (p < .01). The highest percentage of functional impairment for patients 
with PCS was found for the RPQ total scale with rating score 3 (72.8%, n = 91), whereas the RPQ3 
with rating score 2 recorded the lowest percentage (46.0%, n = 120; Table 3).
Table 2. Significant predictors in multivariable model of six-month PCS using divergent classification 
methods on a p < 0.05 level
 Mapped  
ICD-10/DSM-IV
RPQ  
total score
RPQ3 Three-factor  
model
Predictor ≥ 2 ≥ 3 ≥ 2 ≥ 3 ≥ 2 ≥ 3 ≥ 2 ≥ 3
Gender ● ● ● ● ● ● ● ◌
Education ● ● ● ● ● ◌ ● ●
Injury mechanism (Assault) ● ● ● ● ● ● ● ●
CT abnormalities ◌ ◌ ◌ ◌ ◌ ◌ ◌ ◌
ISS ◌ ◌ ● ◌ ◌ ◌ ◌ ◌
AISH ● ◌ ● ◌ ◌ ◌ ● ●
Comorbidity ● ◌ ● ◌ ◌ ● ● ◌
Hospital admission ● ● ● ● ◌ ◌ ● ●
Nagelkerke R2 0.15 0.08 0.16 0.10 0.11 0.11 0.13 0.08
● predictor is statistically significantly (p < .05) associated with PCS in multivariable logistic regression analysis.
◌ predictor is not statistically significantly (p < .05) associated with PCS in multivariable logistic regression analysis.
≥ 2 = rating score 2, indicating mild or worse;  ≥ 3 = rating score 3, indicating moderate or worse 
Abbreviations: AISH = abbreviated injury severity scale head; CT = computed tomography; DSM = Diagnostic and Statistical Manual; 
ICD = International Classification of Diseases; ISS = injury severity scale; PCS = post-concussion syndrome; RPQ = Rivermead post-
concussion questionnaire
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Table 3. MTBI patients with PCS and functionally impaired (GOSE ≤ 6)
Mapped ICD-10/DSM-IV RPQ total score RPQ3 Three-factor model
Rating score 2* 51.6% (146) 58.1% (136) 46.0% (120) 54.5% (126)
Rating score 3** 71.7% (81) 72.8% (91) 67.7% (65) 71.7% (59)
* mild or worse; ** moderate or worse 
Discussion
The prevalence of PCS six months following mTBI ranged from 11.4% to 38.7%, depending on 
the classification method and rating score applied. The divergent classification methods in this 
study additionally influenced the statistical significance of predictors and the association with 
functional outcome, as measured with the GOSE.
The prevalence rates of PCS in our study are in line with preceding studies, which reported that 
prevalence rates of PCS after mTBI fluctuate and are estimated to range from 5% to 43%.4-9 The 
prevalence rates that were found in the literature were dependent on many aspects, such as 
case-mix of the sample and setting, but also on the rating score applied and classification method 
used to identify mTBI patients with PCS. Yeates et al. have pointed out that the inconsistency in 
definition and classification criteria interferes with the righteous classification and identification 
of patients with PCS,29 which ultimately leads to incommensurable prevalence rates and 
outcomes. Additionally, Waljas et al. have also stated that the rate of PCS diagnosis varies greatly 
based on which rating scale is being used,19 which substantiates the decision during this paper to 
study two different rating scores as cut-off points. Recently, the DSM criteria for PCS have been 
revised substantially. Since this definition deviates significantly from the DSM-IV (e.g. the term 
mild neurocognitive impairment (MNI) due to TBI was introduced instead of PCS),30 it is likely 
that this will result in even more heterogeneity in prevalence rates. Tator et al. have recently 
emphasized “a refinement of the definition of PCS”31 and also the lack of consensus with regard 
to the definitions of PCS has previously been identified as a problem.8 This problem presented 
itself as an opportunity in our study to explore and compare prevalence rates, risk factors and 
functional outcome when divergent cut-off rating scores and classification methods of the RPQ 
are applied. 
When comparing divergent classification methods, different patients were identified as suffering 
from PCS. There was a difference of almost 30% in prevalence rates between the classification 
method with the highest (mapped ICD-10/DSM-IV with rating score 2; 38.7%) and lowest (three-
factor model with rating score 3; 11.4%) percentage. Forty-six patients experienced PCS according 
to all classification methods. The most overlap in identifying the same patients experiencing 
PCS was found between the mapped ICD-10/DSM-IV and the RPQ total score (95.6%), both 
with rating score 3. This can be explained by the overlap between symptoms included in both 
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classification methods and by the fact that six out of seven eligible symptoms from the RPQ 
enclosed in the mapped ICD-10/DSM-IV are in the top eight most reported symptoms in this 
population. The lowest percentage of overlap was found between the RPQ3 and the three-factor 
model (51.0%) when a rating score of 3 was used as a cut-off. This can be explained by the fact 
that the RPQ3 only defines three somatic symptoms, while four out of the five most reported 
symptoms (forgetfulness/poor memory, poor concentration, taking longer to think, feeling 
frustrated or impatient) in this study population are cognitive or emotional, which are captured 
in the three-factor model. This also is in line with the thought that the RPQ3 measures symptoms 
that occur more often in the acute phase after a mTBI.18
 
In this study, we found that the classification method used influenced the statistical significance 
of predictors; i.e. several predictors were statistically significantly associated with PCS using some 
classification methods but not using others. This might be one of the reasons for the substantial 
heterogeneity in studies on predictors and prediction modeling for PCS, 32,33 hampering prognostic 
research. 
Although PCS was statistically significantly associated with functional impairment (GOSE ≤ 6), 
there was variation in the amount of overlap between PCS and functional impairment dependent 
on the classification methods applied, ranging from 46.0% to 72.8%. Restricting PCS to only those 
symptoms that are endorsed as ‘moderate or worse’ resulted in higher overlap between PCS and 
functional impairment. This may indicate that symptoms endorsed as moderate or worse are 
more likely to represent clinical relevant symptomatology than symptoms endorsed as mild. This 
is in line with the findings by Waljas et al (2015),19 who reported that when using rating score 
3 as a cut-off, patients with head injury were successfully distinguished from healthy controls, 
whereas when rating score 2 was used as cut-off, this resulted in a substantial proportion of 
healthy controls being diagnosed with PCS. 
The present study is unique because eight divergent classification methods concerning PCS were 
applied and the statistical effect this might have had on predictors associating with PCS and the 
different percentages seen as functionally impaired, measured by the GOSE were assessed.
Our study had several limitations. Firstly, Ruff et al. have declared that PCS concerns a complex 
interplay of biological, psychological and social factors, which include prior health, life stressors 
and compensation/litigation issues.8 This implies that an overview of many aspects of a patients’ 
current, but also previous life before the trauma, is required for correct assessment. Our study 
was a post-hoc analysis of prospectively collected data of individuals after mTBI, and there was 
no pre-injury data available except for pre-existing comorbidity. Additionally, post-concussion 
symptoms in our study were self-reported, which might have led to more or less reported 
symptoms on the questionnaire than if the respondents were interviewed by a physician.34 
Response bias might also have played a role during our study. Respondents with symptoms may 
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have been more likely to participate in the six-month follow-up questionnaires than patients who 
were currently not experiencing/or had never experienced any symptoms. Furthermore, the RPQ 
has been argued to not be the most ideal instrument to use in a mTBI population,35 but there is 
currently no consensus on what would be a better instrument to use either. Looking at the RPQ 
total scale, one should keep in mind that even though the total RPQ score has been proposed by 
the developer of the instrument and is used in most papers till now, Eyres et al. have revalidated 
the RPQ, and have pointed out that the various items of the RPQ have very low construct validity 
and in consequence of this should not be computed into a sum score,14 but into two subscales. 
A final limitation of our study is that data were collected in one academic hospital, which limits 
the generalizability of the results, because of differences in case-mix and because patients with 
severe trauma are more likely to be admitted to the ED of an academic hospital.
During the last decade, a shift from identifying PCS and interpreting it as an exclusive syndrome 
to recognizing it as being a highly complex and ever changing condition in different settings/
populations can be observed. This development leads to more and more specific research in 
the area of PCS or as now suggested persistent post-concussive symptoms. This debate and 
inconsistency concerning definitions, diagnostic criteria, assessment and evaluation of PCS 
hampers its research and therapy. Standardizing and improving diagnosis and assessment of PCS 
will facilitate to identify opportunities for intervention when patients suffer from the disabling 
PCS symptoms or even prevent mTBI patients to develop PCS. In addition, it is recommended to 
perform sensitivity and specificity analyses on the different classification methods for the RPQ to 
evaluate their classification accuracy.18
Conclusion
Our study showed that prevalence rates of PCS six months after mTBI deviate considerably 
dependent on the classification method and rating score used. In addition, applying divergent 
classification methods resulted in a different set of predictors being statistically significantly 
associated with PCS and a different percentage of overlap with functional impairment, measured 
with the GOSE. These findings highlight the need for a universal guideline with respect to 
diagnostic criteria for PCS and a gold standard for analysis of the RPQ to enhance comparability 
of studies regarding PCS after mTBI.
Supplemental material is available at www.marysecnossen.nl
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Abstract
This review examined the pre- and post-injury prevalence of and risk factors for anxiety disorders 
and depressive disorders following traumatic brain injury (TBI), based on evidence from studies 
using structured diagnostic interviews. 
A systematic literature search was conducted in EMBASE, MEDLINE, Cochrane Central, PubMed, 
PsycINFO, and Google Scholar. We identified studies in civilian adults with TBI reporting on the 
prevalence of anxiety and depressive disorders using structured diagnostic interviews, and 
assessed their quality. Pooled pre- and post-injury prevalence estimates of anxiety and depressive 
disorders were computed. 
A total of 34 studies described in 68 publications were identified, often assessing anxiety disorders 
(n = 9), depressive disorders (n = 7), or a combination of disorders (n = 6). Prevalence rates 
of psychiatric disorders varied widely. Pooled prevalence estimates of anxiety and depressive 
disorders were 19% and 13% prior to TBI, and 21% and 17% in the first year after TBI. Pooled 
prevalence estimates increased over time, and indicated high long-term prevalence of Axis I 
disorders (54%), including anxiety disorders (36%) or depressive disorders (43%). Females, those 
without employment, and those with a psychiatric history were at higher risk for anxiety and 
depressive disorders following TBI. 
We conclude that a substantial number of patients encounter anxiety and depressive disorders 
following TBI, and that these problems persist over time. All healthcare settings should pay 
attention to the occurrence of psychiatric symptoms in the aftermath of TBI to enable early 
identification and treatment of these disorders and to enhance the recovery and quality of life 
of TBI survivors.
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Introduction
Traumatic brain injury (TBI) often imposes long-term consequences that complicate recovery and 
rehabilitation.1 A significant proportion of TBI survivors is diagnosed with psychiatric disorders, 
with post-traumatic stress disorder (PTSD) and major depression (MD) being the most commonly 
diagnosed and studied disorders.1-3
Anxiety disorders and depressive disorders have a major impact on functional outcome of 
patients with TBI, and drastically reduce their health-related quality of life (HRQL).4-9 Due to the 
high incidence of TBI and the common diagnosis of anxiety and depressive disorders following 
TBI, this pathology imposes substantial disease burden and economic consequences to both 
individuals and society. Early identification and treatment of psychiatric disorders in patients with 
TBI may improve their outcome, psychosocial functioning, and HRQL.10,11 For early prevention 
and treatment, insight in the prevalence of and risk factors for anxiety and depressive disorders 
is needed.
Anxiety and depressive disorders can be diagnosed with use of standard criteria like the Diagnostic 
and Statistical Manual of Mental Disorders (DSM)12 or the International Statistical Classification 
of Diseases and Related Health Problems (ICD).13 These criteria specify clinical disorders (so 
called Axis I disorders in DSM) that represent acute symptoms that need treatment. Axis I 
disorders include a wide range of psychological diagnostic categories, for example substance 
use, schizophrenia, psychotic disorders, dementia, etc. Common Axis I disorders include anxiety 
disorders (generalized anxiety disorder (GAD), acute stress disorder (ASD), panic disorder, 
agoraphobia, specific phobia, social phobia, obsessive-compulsive disorder (OCD), and PTSD), 
and depressive disorders (dysthymia, bipolar disorder, and major depression).
Previous reviews on psychiatric outcomes after TBI reported a wide range of anxiety and 
depressive disorders among TBI survivors,3,14-17 and large variation in prevalence rates.3,15,17 These 
reviews found prevalence rates of anxiety as high as 70%,15 and rates of depressive disorders 
varying from 25% to 50%.3,18 The existing reviews, however, focused solely on post-TBI prevalence 
rates of PTSD,17,19,20 anxiety disorders,15 or depressive disorders,18,21 or included studies with 
prevalence rates based on both self-report measures and structured diagnostic interviews.18,22 
Research, however, indicated that self-reports from TBI patients may be unreliable due to the 
overlap between psychiatric symptoms and disorders, memory deficits associated with TBI, and 
evidence that TBI patients tend to underestimate their functional problems.10,15 In contrast to 
self-reports, the use of structured diagnostic interviews enables the clinical examination for the 
presence of psychiatric disorders according to standard criteria like the DSM or ICD.23 Use of 
these criteria in structured diagnostic interviews leads to more accurate prevalence estimates 
compared to self-report measures.18,24 Self-report measures may provide an overestimation of 
psychiatric disorders after TBI, as they do not take into account the pre-existing or co-morbid 
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conditions of TBI patients, and enable patients to report more symptoms by prompting them 
with specific questions.25,26
The current review was conducted to improve our knowledge on psychiatric outcomes following 
TBI, which may enable early identification and treatment of these psychiatric disorders and may 
enhance the recovery and HRQL of patients with TBI. This review provides a full oversight of the 
prevalence of and risk factors for anxiety and depressive disorders in civilian adults with TBI, 
based on evidence from structured diagnostic interviews. The current study therefore analyzed 
existing research that has examined the pre-injury and/or post-injury prevalence of clinically 
diagnosed anxiety and depressive disorders following TBI, and/or the risk factors influencing the 
development of anxiety and depressive disorders following TBI.
Methods
Relevant studies were identified through systematic literature searches in the databases EMBASE, 
MEDLINE, Cochrane Central, PubMed, and PsycINFO. Grey literature was examined via Google 
Scholar. Search strategies were developed in consultation with a search expert, and included a 
combination of subheadings and text words (Online Supplement A). Reference lists and citation 
indices of the included papers and relevant reviews were inspected to identify additional relevant 
citations. We restricted searches to English-language papers, published in peer-reviewed journals 
until November 2nd 2015.
Study selection
Study design – We included retrospective and prospective cohort studies, cross-sectional 
studies, and case-control studies. Reviews, case reports, editorials, and intervention studies were 
excluded.
Participants – Studies were included if they were conducted in civilian adults (≥ 16 years) with 
TBI. Studies including a mixed population (e.g. all trauma patients) were only included if they 
analyzed their results for TBI patients separately. TBI was defined as an alteration in brain function 
or other evidence of brain pathology, caused by an external cause.27 There was no restriction in 
the diagnosis of TBI (e.g. self-reported) or severity of TBI. There was also no restriction in the 
methods of patient selection (e.g. samples drawn from to the ED or hospital, referral clinics, or 
outpatient programs).
Psychiatric disorders – We included studies that examined all Axis I disorders or reported on 
the prevalence of at least one of the underlying anxiety disorders (including generalized anxiety 
disorder, acute stress disorder, panic disorder, agoraphobia, specific phobia, social phobia, 
obsessive-compulsive disorder, and posttraumatic stress disorder) or depressive disorders 
(dysthymia, bipolar disorder, and major depression) – see Box 1. All information on risk factors 
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for anxiety or depressive disorders (from univariable or multivariable analysis) were extracted 
from the included studies.
Structured diagnostic interviews – We included studies that used structured diagnostic interviews 
for the diagnosis of disorders (see Online Supplement B). Studies solely using self-report measures 
(e.g. checklist or rating scales) or other measures to determine disorders (e.g. own classification 
system) were excluded.
Multiple publications – To avoid double counting of prevalence rates, we identified publications 
that were related to the same sample of patients. For studies using data from an overlapping 
sample, one study was chosen as reference study by giving priority to the largest sample size 
(e.g. whole sample instead of specific age group or injury mechanism), the assessment of most 
disorders (e.g. Axis I over solely PTSD), and the focus on reporting prevalence rates (instead of 
predictors of disorders, or their impact on outcome). Information from all articles was used for 
analyzing the risk factors for psychiatric disorders following TBI.
Data extraction and risk of bias assessment 
The first review author (AS) screened all titles and abstracts and deleted obvious irrelevant 
citations. After initial selection, the reviewer (AS) screened the remaining citations on title and 
abstract, and full-text. Any doubt on inclusion was resolved by consulting a second author (JH). 
Two reviewers (AS and MC) extracted data and assessed the risk of bias of the included studies. 
Any discrepancies were resolved by discussion or consulting a third author (SP). 
We extracted information on the participants (age, gender, injury severity, and injury mechanism), 
and the assessment (interview, procedure, and timing), prevalence (before and/or after TBI), 
and risk factors (assessed and significant variables) for the studied psychiatric disorders. For 
each study the risk of bias was assessed using items on attrition bias (management of loss to 
follow-up) and reporting bias (primary outcomes missing) from the Research Triangle Institute 
item bank for observational studies,28 complemented by items on the assessment of psychiatric 
disorders (e.g. inter-rater reliability, or assessor blinded to psychiatric history, medical file history, 
and/or hospitalization variables of participants), study limitations, and statements on causality.
Statistical analysis
TBI severity was assessed and categorized into severity levels (mild / minor, moderate, severe) with 
use of the classification methods reported in the studies. TBI severity can be classified with use of 
the Glasgow Coma Scale,29 which is often categorized into mild or minor (GCS 13-15), moderate 
(GCS 9-12), and severe TBI (GCS 3-8).30 Additionally, the American Congress of Rehabilitation 
Medicine (ACRM) defined mild TBI as a traumatically induced physiological disruption of brain 
function with a loss of consciousness (LOC) of approximately 30 minutes or less, an initial GCS of 
13-15 after 30 minutes, and posttraumatic amnesia (PTA) not greater than 24 hours.31
Prevalence of and risk factors for anxiety and depressive disorders after traumatic brain injury
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Pooled prevalence estimates per disorder were determined for three time points: before TBI 
(pre-injury), during the first year (first year), and after one year (> 1 year). A step-by-step guide 
was followed to perform a meta-analysis using a random-effects model in a Microsoft Excel 
spreadsheet.32 This meta-analysis using Microsoft Excel showed to achieve results comparable 
with that of using Comprehensive Meta-Analysis Software (CMA), a commercial software package 
specifically developed to conduct meta-analyses.32 If studies reported prevalence rates equal to 
0%, a prevalence rate of 0.1% was used in our calculations. Studies with a sample size of fewer 
than 30 patients were excluded from the calculation of pooled prevalence estimates to minimize 
outlier estimates resulting from small sample sizes. Additionaly, studies that used a sample with 
self-reported TBI33,34 or retrospective recall over decades after injury to assess the prevalence 
of disorders prior to TBI (pre-injury)35 or the year after injury (first year)35 were excluded from 
the calculation of pooled prevalence estimates, as suggested by the Cochrane Collaboration.36 
When only a small number of studies (N ≤ 2) reported on the prevalence of a disorder, no pooled 
prevalence estimates were calculated for that disorder. 
Heterogeneity was assessed with the Q-statistic and I2-statistic. The Q-statistic is a Chi2-test for 
heterogeneity, which assesses whether observed differences in results are compatible with 
chance alone. A significant Q (low p-value) provides evidence of heterogeneity among the effect 
sizes, and indicates that the variation in effect sizes is beyond chance.37 The I²-statistic describes 
the percentage of variation across studies that is due to heterogeneity rather than chance.38 An 
I2 value of 25% or lower is associated with low heterogeneity, 50% is associated with moderate 
heterogeneity, and 75% or higher is associated with high heterogeneity.38
Results
Literature search
In January 2015, a total of 4,800 unique titles of potentially relevant articles were identified 
through the extensive search strategy (Online Supplement C). In November, the search 
strategy was updated and an additional 539 new, unique titles of potentially relevant articles 
were identified. Screening of the titles and abstracts resulted in a selection of 291 articles that 
appeared to meet all selection criteria. After screening and selection of the full text papers, we 
retrieved 34 studies described in 68 publications. The main reasons for exclusion were not using 
a structured interview, not reporting about TBI patients (separately), or not reporting prevalence 
rates. Twelve out of the 34 included studies were multiple publications on the same sample of 
patients, with the number of related studies ranging from 1 (n = 5)2,33,34,39,40 to 7 (n = 1; Online 
Supplement D).41 The 34 studies formed the basis of our review.
Study characteristics
Of the 34 studies, most were conducted in Australia (n = 9),2,5,42-48 followed by the US 
(n = 8),33,34,41,49-53 the UK (n = 4),24,39,54,55 and Canada (n = 3)11,56,57 (Table 1). Sample sizes varied 
75
 
4
widely, ranging between 1658 and 47646 participants. The majority of the participants were males 
(except in 3 studies with 40-46% males),54,56,59 with an average age of 29 to 42 years (in 27 out 
of the 34 studies). Traffic accidents comprised over half of all causes in 16 of the 22 studies that 
reported on injury mechanism.
TBI severity was often classified using the Glasgow Coma Scale (GCS, n = 15),5,34,39-41,43,44,49-51,56,58,61,64,66 
the definition of mild TBI by the American Congress of Rehabilitation Medicine (ACRM, 
n = 8),11,45-48,53,57,65 or the duration of Post Traumatic Amnesia (PTA, n = 3).24,42,54 Fifteen studies 
included all TBI severity levels, and twelve only mild TBI.
Axis I disorders (n = 11),2,5,33-35,39,40,44,48,60,61 acute stress disorder (ASD) and/or post-traumatic stress 
disorder (PTSD) (n = 9),24,42,43,45,46,54,55,59,63 (major) depression (n = 7),11,41,50-52,57,65 and a combination 
of anxiety disorders and depressive disorders (n = 6)47,49,53,56,58,64 were the most frequently studied 
disorders per sample. The three studies on ASD also assessed PTSD, and only included patients 
with mild TBI (n = 3).42,46,54 In contrast, 15 of the remaining 31 studies included all TBI severity 
levels in their assessment of Axis I disorders, PTSD, (major) depression, or both anxiety disorders 
and depressive disorders.
The most frequently used structured interview was the Structured Clinical Interview for DSM 
Disorders (SCID, n = 15),5,11,33,34,40,44,49-52,57,58,60,62,65 followed by the Clinical Assessment PTSD 
(CAPS, n = 6),2,24,45,46,48,55 Schedules for Clinical Assessment in Neuropsychiatry / Present State 
Examination (SCAN/PSE, n = 5),35,39,41,50,61 and/or Mini International Neuropsychiatric Interview 
(MINI, n = 3).2,47,48 Axis I disorders were often assessed with the SCID (n = 6),5,33,34,40,44,60 or SCAN/
PSE (n = 3).35,39,61 ASD and/or PTSD were diagnosed with use of a range of interviews, including 
the CAPS (n = 4),24,45,46,55 Acute Stress Disorder Interview (ASDI, n = 2),42,54 and Posttraumatic 
Symptom Scale (PSS, n = 2),54,59 whereas depressive disorders were commonly assessed with 
use of the SCID (n = 8).11,49-52,57,58,65 Five studies used multiple instruments in their assessment of 
Axis I disorders (MINI and CAPS),2,48 ASD and PTSD (ASDI and PSS54 or Composite International 
Diagnostic Interview, CIDI42), and major depression (SCAN/PSE and SCID).50 Eleven studies 
reported that the interviews were conducted by one trained (neuro) psychiatrist or psychologist.
Risk of bias
Overall, 21 of the 34 studies reported on attrition, and faced problems of patients who refused to 
participate (n = 17, 8-58% of study sample),2,35,40,42-48,54,58,60-63,65 patients who could not be contacted 
(n = 11, 2-58%),2,5,35,40,42,43,54,55,61,63,65 and patients who deceased or did not attend appointments 
(n = 6, 3-36%).35,39,40,50,62,65 According to these studies, participants often did not differ from 
those who did not participate. A few studies, however, showed differences in age (participants 
were older2,47,50 or younger59,63 compared to non-responders), and TBI severity (participants had 
higher2,63 or lower43 TBI severity level compared to non-responders).
Prevalence of and risk factors for anxiety and depressive disorders after traumatic brain injury
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With respect to patient selection, two of the 34 studies included patients with self-reported 
TBI (not medically documented),33,34 and in another 16 studies participants were drawn from 
a variety of settings like specialty referral clinics or outpatient programs. Only 6 out of the 34 
studies provided information on the inter-rater reliability of the structured diagnostic interviews, 
which ranged between 80% (n = 2)34,51 and 100% (n = 4).2,44-46
Prevalence rates
Prevalence rates of anxiety and depressive disorders were assessed retrospectively (pre-
injury, n = 15),5,33-35,41,44,47,48,51,53,56,60-62,65 and at approximately 3 months (n = 8),2,47-50,52,54,58 6 
months (n = 8),42,43,50,55,57-60 1 year (n = 10),2,5,34,35,39,45,50,52,61,63 or more than one year after TBI 
(n = 12)24,33-35,40,44,51,53,56,62,64,65 (Figure 1). Of the 12 studies with long-term follow-up, 6 studies had 
follow-up periods between 1 and 3 years,34,40,44,53,62,64 5 studies comprised periods of 5 to 8 years 
after TBI,24,33,51,56,65 and one study 31 years after TBI.35 Overall, a wide range of prevalence rates 
was reported for Axis I disorders, anxiety disorders and depressive disorders (Table 2).
Figure 1. Time points at which prevalence of psychiatric disorders was assessed
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Table 2. Prevalence rates of psychiatric disorders before and after TBI
Disorder Study Severity Pre-
injury
< 3  
months
3-6 
months
1  
year
> 1  
year
Follow-up 
(mean, (SD), range)
Axis I Bryant, 2010 Mild 34.3 1y
Meares, 2011 Mild 44.6* 32.1 ~106.2d (14.9)
Gil, 2005 Mild 40.8* 10.0 6mo
Gomez-Hernandez, 1997 Mild to severe 13.8* [1mo-1y]
Gould, 2011A Compl mild to 
severe
54.1* 45.9c 1y (1mo)
Whelan-Goodinson, 2009 Minor to severe 65.0 3.0y (1.5); 0.5-5.5y
Deb, 2007 Minor to severe 27.6 1y (1mo)
Koponen, 2002 Mild to severe 21.7* 40.0 > 10y
Koponen, 2011 Mild to severe 39.5** 47.4 1y
Hibbard, 1998 Mild to severe 51.0* [7.6y (7.1); 1-37y]
Ashman, 2004 Mild to severe 5.0* 9.0 5.0 0.0 Base, 1, 2y; 3mo-4y
Diaz, 2014 Severe 56.0 17.8mo (5.7)
Anxiety Meares, 2011 Mild 41.1* 32.1 ~106.2d (14.9)
Ponsford, 2011 Mild 16.1* 12.5b 3mo
Caspi, 2005 Mild to moderate 19.0* [2.9y (3.7); 1mo-5y]
Gould, 2011A Compl mild to 
severe
22.1* 13.9 24.6 28.7c 6w67, 6mo68, 6mo-1y
Whelan-Goodinson, 2009 Minor to severe 13.0* 38.0 3.0y (1.5); 0.5-5.5y
Ashman, 2004 Mild to severe 16.0* 27.0 19.0 9.0 Base, 1, 2y; 3mo-4y
Al-Adawi, 2007 Mild to severe 50.0 18.2mo (12.2); 
0mo-5y
Van Reekum, 1996 Mild to severe 16.7* 38.9 4.9y; 2-9y
Diaz, 2014 Severe 20.9 17.8mo (5.7)
GAD Bryant, 2010 Mild 9.8 13.4 3mo, 1y
Meares, 2011 Mild 14.3* 10.7 ~106.2d (14.9)
Gould, 2011C Compl mild to 
severe
1.0* 2.0 1y
Whelan-Goodinson, 2009 Minor to severe 5.0* 17.0 3.0y (1.5); 0.5-5.5y
Deb, 1999 Minor to severe 1.8 ~1y (4w)
Koponen, 2002 Mild to severe 0.0* 0.0 1.7 < 1y, > 10y
Hibbard, 1998 Mild to severe 1.0* 8.0 7.6y (7.1); 1-37y
Fann, 1995 Mild to severe 24.0 32.5mo (35.1); 
1-128mo
Van Reekum, 1996 Mild to severe 5.6* 27.8 4.9y; 2-9y
Jorge, 1993D Mild to severe 10.6 3.0 1.5 31d (IQR 32), 3mo, 1y
Jorge, 2004 Mild to severe 15.4d 1y
Diaz, 2012 Severe 0.0* 15.1 18.4mo (6)
Fann, 1995 Mild to severe 24.0 32.5mo (35.1); 
1-128mo
Van Reekum, 1996 Mild to severe 5.6* 27.8 4.9y; 2-9y
Jorge, 1993D Mild to severe 10.6 3.0 1.5 31d (IQR 32), 3mo, 1y
Jorge, 2004 Mild to severe 15.4d 1y
Diaz, 2012 Severe 0.0* 15.1 18.4mo (6)
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Table 2. Continued
Disorder Study Severity Pre-
injury
< 3  
months
3-6 
months
1  
year
> 1  
year
Follow-up 
(mean, (SD), range)
ASD Jones, 2005 Mild 21.2 6.0d (1.9)
Bryant, 1999C Mild 13.9 7.2d (5.3); 2-25d
Harvey, 2000 Mild 13.9 1mo
Broomhall, 2009 Mild 4.6 6.7d (6.9)
Gould, 2011C Compl mild to 
severe
0.0* 1.0 1y
Whelan-Goodinson, 2008 Minor to severe 11.0 3.0y (1.5); 0.5-5.5y
Panic Bryant, 2010 Mild 7.4 7.5 3mo, 1y
Meares, 2011 Mild 10.7* 10.7 ~106.2d (14.9)
Gould, 2011C Compl mild to 
severe
2.0* 2.0 1y
Whelan-Goodinson, 2009 Minor to severe 1.0* 6.0 3.0y (1.5); 0.5-5.5y
Deb, 1999 Minor to severe 6.7 ~1y (4w)
Koponen, 2002 Mild to severe 0.0* 1.7 6.7 < 1y, > 10y
Hibbard, 1998 Mild to severe 4.0* 4.0 7.6y (7.1); 1-37y
Fann, 1995 Mild to severe 4.0 32.5mo (35.1); 
1-128mo
Van Reekum, 1996 Mild to severe 5.6 4.9y; 2-9y
Jorge, 2004 Mild to severe 2.2d 9.4mo (4.2)
Diaz, 2012 Severe 3.0* 3.0 18.4mo (6)
Agora-phobia Bryant, 2010 Mild 14.8 12.8 7.2d (9.6), 3mo, 1y
Meares, 2011 Mild 12.5* 7.1 ~106.2d (14.9)
Gould, 2011C Compl mild to 
severe
0.0* 2.0 1y
Whelan-Goodinson, 2009 Minor to severe 1.0* 1.0 3.0y (1.5); 0.5-5.5y
Hibbard, 1998 Mild to severe 4.0* 5.0 7.6y (7.1); 1-37y
Fann, 1995 Mild to severe 2.0 32.5mo (35.1); 
1-128mo
Specific phobia Gould, 2011C Compl mild to 
severe
5.9* 6.9 1y
Whelan-Goodinson, 2009 Minor to severe 0.0* 7.0 3.0y (1.5); 0.5-5.5y
Koponen, 2002 Mild to severe 8.3* 5.0 13.3 < 1y, > 10y
Koponen, 2011 Mild to severe 5.3** [1y]
Hibbard, 1998 Mild to severe 4.0* 5.0 7.6y (7.1); 1-37y
Social phobia Bryant, 2010 Mild 6.1 9.0 7.2d (9.6), 3mo, 1y
Meares, 2011 Mild 10.7* 3.6 ~106.2d (14.9)
Gould, 2011C Compl mild to 
severe
7.8* 2.9 1y
Whelan-Goodinson, 2009 Minor to severe 2.0* 6.0 3.0y (1.5); 0.5-5.5y
Koponen, 2002 Mild to severe 5.0* 0.0 5.0 < 1y, > 10y
Koponen, 2011 Mild to severe 5.3** 1y
Hibbard, 1998 Mild to severe 4.0* 5.0 7.6y (7.1); 1-37y
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Table 2. Continued
Disorder Study Severity Pre-
injury
< 3  
months
3-6 
months
1  
year
> 1  
year
Follow-up 
(mean, (SD), range)
OCD Bryant, 2010 Mild 3.2 4.0 3mo, 1y
Meares, 2011 Mild 10.7* 7.1 ~106.2d (14.9)
Gould, 2011C Compl mild to 
severe
0.0* 1.0 1y
Whelan-Goodinson, 2009 Minor to severe 1.0* 1.0 3.0y (1.5); 0.5-5.5y
Deb, 1999 Minor to severe 1.2 ~1y (4w)
Hibbard, 1998 Mild to severe 1.0* 9.0 7.6y (7.1); 1-37y
Van Reekum, 1996 Mild to severe 5.6 4.9y; 2-9y
PTSD Bryant, 2010 Mild 12.7 13.0 3mo, 1y
Meares, 2011 Mild 17.9* 19.6 ~106.2d (14.9)
Jones, 2005 Mild 30.4 17.2 44.0d (2.6), 94.3d 
(2.9)
Bryant, 1999C Mild 23.8 6mo
Creamer, 2005 Mild 15.0 1y
Gil, 2005 Mild 14.2 6mo
Roitman, 2013 Mild 31.6a 224.9d (39.1)
Caspi, 2005 Mild to moderate 1.7* 18.3 2.9y (3.7); 1mo-5y
McCauley, 2005 Mild to moderate 11.5 86.4d (17.4)
Whelan-Goodinson, 2009 Minor to severe 4.0* 14.0 3.0y (1.5); 0.5-5.5y
Deb, 1999 Minor to severe 2.4 ~1y (4w)
Koponen, 2002 Mild to severe 0.0 31.4y (4.4); 27-48y
Koponen, 2011 Mild to severe 0.0** 2.6 1y
Hibbard, 1998 Mild to severe 6.0* 10.0 7.6y (7.1); 1-37y
Ashman, 2004 Mild to severe 10.0* 30.0 18.0 21.0 Base, 1, 2y; 3mo-4y
Barker-Collo, 2013 Mild to severe 17.9 1y
Turnbull, 2001 Mild to severe 17.1 5mo (3)
Mauri, 2014 Mild to severe 6.3 6.3 1mo, 3mo
0.0 6mo
Jorge, 2004 Mild to severe 7.7d 1y
Alway, 2015A Moderate to 
severe
0.5 1.9 4.3 9.4 8.9 56.4d (39.9), Initial-
3mo,
3-6mo, 6mo-1y, 1-2y
8.7 2-3y
5.6 3-4y
5.0 4-5y
Diaz, 2012 Severe 3.0* 3.0 18.4mo (6)
Sumpter, 2005 Severe 2.9 6y (7); 0.6-34y
Bryant, 2000 Severe 27.1 6.3mo (1.3); 5-7mo
Depression Meares, 2011 Mild 25.0* 10.7 ~106.2d (14.9)
Ponsford, 2011 Mild 27.0* 13.5b 3mo
Rao, 2010 Mild 16.3 9.3 3mo, 1y
Kennedy, 2005 Mild to  
moderate
50.0* [76mo (94); 3mo-36y]
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Table 2. Continued
Disorder Study Severity Pre-
injury
< 3  
months
3-6 
months
1  
year
> 1  
year
Follow-up 
(mean, (SD), range)
Caspi, 2005 Mild to  
moderate
8.0* [2.9y (3.7); 1mo-5y]
Gould, 2011A 23.0* 8.2 18.0c 32.8 6w67, 6mo68, 6mo-1y
Whelan-Goodinson, 2009 Compl mild to 
severee
17.0* 46.0 3.0y (1.5); 0.5-5.5y
Deb, 1999 Minor to severe 12.8 ~1y (4w)
Koponen, 2011 Minor to severe 0.0** 5.3 1y
Ashman, 2004 Mild to severe 20.0* 35.0 24.0 21.0 Base, 1, 2y; 3mo-4y
Al-Adawi, 2007 Mild to severe 57.4 18.2mo (12.2); 
0mo-5y
Jorge, 2004 Mild to severe 51.6d 1y
Gomez-Hernandez, 1997 Mild to severe 0.0* [1mo-1y]
Diaz, 2014 Mild to severe 27.9 17.8mo (5.7)
Dysthymia Meares, 2011 Severe 0.02* 0.0 ~106.2d (14.9)
Gould, 2011C Mild 3.9* 1.0 1y
Whelan-Goodinson, 2009 Compl mild to 
severe
0.0* 1.0 3.0y (1.5); 0.5-5.5y
Koponen, 2002 Minor to severe 0.0 31.4y (4.4); 27-48y
Hibbard, 1998 Mild to severe* 1.0* 3.0 7.6y (7.1); 1-37y
Fann, 1995 Mild to severe 14.0 32.5mo (35.1); 
1-128mo
Meares, 2011 Severe 0.02* 0.0 ~106.2d (14.9)
Fedoroff, 1992 Mild to severe 0.0* 3.0 7.7 7.0 ~36.6d (15.8), 3mo69, 
1y69
Mild to severe 2.3 6mo69
Jorge, 2004 9.9d 1y
Bipolar disorder Gould, 2011C Mild to severe 0.0* 2.0 1y
Koponen, 2002 Mild to severe 0.0* 0.0 1.7 31.4y (4.4); 27-48y
Koponen, 2011 Mild to severe 5.3** [1y]
Hibbard, 1998 Mild to severe 0.0* 2.0 7.6y (7.1); 1-37y
Fann, 1995 Mild to severe 0.0 32.5mo (35.1); 
1-128mo
Van Reekum, 1996 Mild to severe 0.0* 16.7 4.9y; 2-9y
Jorge, 1994 Mild to severe 1.9 31d (IQR 32)
Diaz, 2012 Severe 3.0* 6.1 18.4mo (6)
MD Bryant, 2010 Mild 17.9 17.4 7.2d (9.6), 3mo, 1y
Meares, 2011 Mild 23.2* 10.7 ~106.2d (14.9)
Konrad, 2011 Mild 3.0* 9.1 6.0y; 4.8-7.3y
Rapoport, 2003A Mild 16.7 49.0d (30.0)
McCauley, 2005 Mild to moderate 15.0 86.4d (17.4)
Kennedy, 2005 Mild to moderate 14.0* 30.0 76mo (94); 3mo-36y
Chamelian, 2006 Mild to moderate 7.9 6mo
Gould, 2011C Compl mild to 
severe
13.7* 29.4 1y
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Table 2. Continued
Disorder Study Severity Pre-
injury
< 3  
months
3-6 
months
1  
year
> 1  
year
Follow-up 
(mean, (SD), range)
Whelan-Goodinson, 2009 Minor to severe 17.0* 45.0 3.0y (1.5); 0.5-5.5y
Koponen, 2002 Mild to severe 0.0* 10.0 10.0 31.4y (4.4); 27-48y
Koponen, 2011 Mild to severe 10.5** 7.9 1y
Hibbard, 1998 Mild to severe 17.0* 61.0 7.6y (7.1); 1-37y
Fann, 1995 Mild to severe 12.0* 26.0 32.5mo (35.1); 
1-128mo
Van Reekum, 1996 Mild to severe 22.2* 61.1 4.9y; 2-9y
Mauri, 2014 Mild to severe 62.5 50.0 1mo, 3mo
43.8 6mo
Fedoroff, 1992 Mild to severe 0.0* 25.8 ~36.6d (15.8)
Jorge, 2004 Mild to severe 16.5 9.9 Initial, 3mo
6.6 6mo
Diaz, 2012 Severe 6.1* 30.3 18.4mo (6)
Axis I also includes disorders other than anxiety or depressive disorders (e.g. substance use, schizophrenia, psychotic disorders, 
dementia, etc.) * Lifetime pre-injury prevalence; ** Prevalence in 12-month period before TBI a Assessed at on average 7 months after TBI 
b-d Prevalence measured over a period of time: last 3 monthsb; 6 to 12 monthsc; during 1st yeard
d=day; w=week; mo=month; y=year. Abbreviations: ASD = acute stress disorder; GAD = Generalized Anxiety Disorder; HI = head injury; 
IQR = interquartile range; MD = major depression; OCD = Obsessive Compulsive Disorder; PTSD = post-traumatic stress disorder
Pre-injury
In total, 14 of the 15 studies that assessed the history of psychiatric disorders before TBI used 
the same diagnostic interview to assess the pre-injury and post-injury disorders, while 1 study 
used questions to assess the personal history of psychiatric disorders.70 The 15 studies showed 
widely varying prevalence rates of pre-injury Axis I disorders (5-54%, with 40-54% in 5 out of 
8 studies),5,33,48,60,61 anxiety disorders (13-41%), and depressive disorders (0-50%, with 17-27% 
in 5 of the 9 studies reporting on pre-injury rates),5,34,44,47,48 irrespective of TBI severity. The 15 
studies also reported varying pre-injury rates of the other disorders: GAD 0-14%, panic 0-11%, 
agoraphobia 0-13%, specific phobia 0-8%, social phobia 2-11%, OCD 0-11%, PTSD 0-18%, 
dysthymia 0-4%, bipolar disorder 0-5%, major depression 0-23%, and absence of ASD (0%, n = 1).71 
A history of dysthymia or bipolar disorders prior to TBI was rarely reported. A few studies reported 
absence of disorders (a prevalence rate of 0%), which may be explained due to the assessment of 
disorders after a long period of time,6,35,44 the measure used for diagnosis of disorders (PSE),41,70 
or inclusion of only patients with severe TBI,6 with causes other than MVA,61 or those admitted to 
a rehabilitation hospital.71 Additionally, two studies that assessed Axis I disorders in patients with 
mild TBI generally reported relatively high prevalence rates of all disorders, which may be related 
to their measures used for diagnosis of the disorders (MINI/CAPS).2,48
Post-injury
In the first year after TBI, prevalence rates of Axis I disorders ranged from 10-34% in mild 
TBI, to 5-47% in studies with all TBI severity levels. Additionally, substantial prevalence rates 
were reported of post-injury anxiety disorders (13-32%), especially ASD (14-21% in 3 of the 
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5 studies)42,54,72 and PTSD (12-32% in 12 of the 17 studies),2,34,42,43,45,48,49,54,55,59,60,63 or depressive 
disorders (5-52%, 11-35% in 6 of the 8 studies),5,34,39,47,48,52 especially major depression (7-63%, 
15-29% in 6 of the 11 studies).2,11,41,49,50,71 Major depression tended to be more frequently 
diagnosed in patients with more severe TBI, as 8-18% of the patients with mild TBI received this 
diagnosis versus 7-63% in patients with all TBI severity levels.
Even years after TBI, patients were diagnosed with psychiatric disorders, with prevalence rates 
of Axis I disorders as high as 40% (more than 10 years after TBI)35 and 65% (3 years after TBI).44 
Prevalence of anxiety ranged from 9-50% after on average 1.5 to 5 years of follow-up,34,40,44,56,64 
and rates for depressive disorders were up to 21-57% after follow-up periods of on average 1.5 
to 3 years.34,40,44,64 Long-term prevalence rates were almost all higher than (or equal to) the rates 
before TBI, in all studies that measured both pre-injury and long-term prevalence of psychiatric 
disorders.6,33-35,44,51,53,56,62,65
Although the prevalence of dysthymia after TBI was generally low (0-3% in 5 of the 8 
studies),33,35,44,48,71 a few studies also reported a prevalence rate of 0% (absence of disorder) for 
GAD, social phobia, PTSD, and bipolar disorder. These studies, however, had a long follow-up 
period (more than 30 years after TBI),35 a small sample size (n = 16),58 or included solely patients 
admitted to neurosurgery,58 or a TBI rehabilitation clinic.53 
Pooled prevalence estimates
Figure 2 provides an overview of the overall pooled prevalence estimates per disorder by time 
point (also see Online Supplement E). Highest variation in prevalence rates across studies was 
seen prior to TBI in agoraphobia (moderate heterogeneity: I2 = 66%, p = 0.05), and depressive 
Figure 2. Forest plot of pooled prevalence rates per psychiatric disorder
Axis I also includes disorders other than anxiety or depressive disorders (e.g. substance use, schizophrenia, psychotic disorders, 
dementia, etc.)
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disorders (high heterogeneity: I2 = 82%, p < 0.01). Highest pooled prevalence rates were retrieved 
for Axis I disorders (n = 5, 38% before TBI; n = 6, 32% in the first year; n = 3, 54% after one year), 
including anxiety disorders (n = 6, 19%; n = 5, 21%; n = 3, 36%), and depressive disorders (n = 8, 
13%; n = 10, 17%; n = 3, 43%). Overall, the pooled prevalence rates increased over time in all 
disorders, except panic disorder, PTSD, and dysthymia (slight decrease).
Table 3. Risk factors associated with psychiatric disorders after TBI*
Disorder Patient-related Injury-related Follow-up related
Axis I Younger age (18-64 year)39,78 (2|8)
Less education39,78 (2|6)
Pre-injury unemployment5 (1|3)
History of psychiatric disorders33,39,71,78 (4|5)
History of alcohol consumption39,78 (2|2)
More severe TBI33 (1|7) Shorter34, longer71 time 
post-injury (2|2)
Poorer GOS39,78 (2|2)
Lower MMSE score39,78 (2|2)
Anxiety Older age5,76,86 (3|6)
Female gender33,34 (2|6)
Pre-injury unemployment76 (1|2)
Pre-injury anxiety disorders5,75,76 (3|4)
Less56, more (symptoms)58 
severe TBI (1|4)
ASD History of psychiatric disorders79 (1|2) Shorter79, longer46 
hospitalization (2|2)
PTSD Older age60 (1|9)
Female gender34 (PTSD severity)63 (2|5)
History of psychiatric disorders60,74 (PTSD 
severity)63 (3|4)
Higher LOC59 (PTSD severity)63 
(2|2)
Shorter PTA duration74 (1|8)
Shorter time post-injury34 
(1|4)
PCS/PCD49,84,85 (3|3)
Memory of traumatic 
event55,60,62 (3|3)
Poorer GOSE74 (1|1)
Lower QOLI74 (1|1)
Depression Older age52,87 (2|12)
Female gender34,75 (2|11)
Less education75 (1|11)
History of psychiatric disorders80,81 (2|6), 
depression75 (1|2)
History of substance abuse80 (1|4)
Lesion location52,69,83 (3|3)
Abnormal CT result87 (1|3)
Shorter34, longer75 time 
post-injury (2|5)
MD Older82, younger (16-59 year)11 age (2|6)
Pre-injury unemployment50 (1|4)
(No)33 History of psychiatric disorders41 (2|2), 
depression41,50,82 (3|3)
History of substance abuse11 (1|6)
MVA10 (1|3)
Lesion location41,50,69 (3|3)
PCS/PCD49,84 (2|2)
Axis I also includes disorders other than anxiety or depressive disorders (e.g. substance use, schizophrenia, psychotic disorders, 
dementia, etc.)
* Only risk factors which appear to be significant in 2 or more studies were presented.
In brackets: Number of studies in which the risk factor reached significance | Number of studies in which the risk factor was assessed.
Abbreviations: ASD = acute stress disorder; GOS = Glasgow Outcome Scale; MMSE = Mini-Mental State Examination; LOC = loss of 
consciousness; MD = major depression; MVA = motor vehicle accident; PCS/PCD = post-concussion symptoms/disorder (e.g. 
concentration deficits, dizziness, fatigue, headaches, sensitivity to sound, and visual disturbances); PTSD = post-traumatic stress disorder
Risk factors
In total, 30 articles assessed risk factors for psychiatric disorders, including 24 (71%) of the 34 
reference studies and six related articles.2,40,42,44,73,74 The most often assessed risk factors were 
age (n = 22), gender (n = 19), education (n = 18), marital or relationship status (n = 12), and TBI 
severity or GCS (n = 14). Other frequently studied factors were personal history of psychiatric 
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disorders prior to TBI (n = 11), employment, ethnicity, duration of PTA, and time post-injury (all 
n = 10), history of alcohol or substance abuse before TBI (n = 6), and involvement in litigation 
(n = 6). Females,33,34,63,75 those without employment,5,50,76,77 and those with a history of psychiatric 
disorders5,33,39,41,50,60,63,71,73,75,76,78-82 or substance abuse prior to TBI11,39,63,78,80 were at higher risk for 
psychiatric disorders following TBI (Table 3). Location of the brain lesion showed to be related 
to the risk of depressive disorders.41,50,52,69,83 Furthermore, psychiatric disorders were associated 
with worse outcomes on measures like the GOS,39,78 MMSE,39,78 or complications such as PCS/
PCD,49,84,85 and memory of the traumatic event.55,60,62 Contrasting findings were reported with 
respect to patients age, showing an increased risk of psychiatric disorders in older5,52,60,76,82,86,87 
and younger11,39,78 patients.
Discussion
Our systematic review aimed to provide insight into the prevalence of and risk factors for anxiety 
disorders and depressive disorders after TBI, collected with structured diagnostic interviews. Our 
findings showed that a substantial number of patients had a history of anxiety disorders (19%) or 
depressive disorders (13%) before TBI, or were diagnosed with those disorders in the first year 
after TBI (21% and 17%). The pooled prevalence estimates of psychiatric disorders increased 
over time, and indicated that years after TBI, half of the participants (54%) were diagnosed with 
Axis I disorders, including anxiety disorders (36%) or depressive disorders (43%). Females, those 
without employment, and those with a history of psychiatric disorders or substance abuse prior 
to TBI seem to be at higher risk for anxiety or depressive disorders following TBI.
Quality of the evidence
Several limitations of the included studies need to be considered. First, the studies faced 
difficulties in differential diagnosis of overlapping disorders (e.g. ASD and post-concussive effects) 
and overlapping symptoms between TBI and disorders, which may have led to higher79 or lower88 
prevalence rates of disorders. The included studies however all used structured diagnostic 
interviews to examine the presence of psychiatric disorders according to standard criteria like 
the DSM or ICD. The use of structured diagnostic interviews by clinical experts (e.g. one trained 
psychiatrist or psychologist) enables more stringent assessment of psychiatric outcomes after 
TBI than self-report measures.18 However, regardless of the method of assessment, patients may 
report more symptoms due to concerns about pending litigations.89
Second, the history of psychiatric disorders prior to TBI was often retrospectively assessed (e.g. 
with use of the structured interview), in some studies even years after TBI. Relying on recall of 
symptoms over such long periods may be less reliable.90 
Third, several studies reported on a small number of subjects,6,24,52,56,58,65,85,91 and their conclusions 
may not apply to all patients with TBI. Although most of the 34 included studies had difficulties 
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in contacting and interviewing all eligible patients, there is a need for a thorough and reliable 
assessment of the psychiatric outcome in all survivors of a TBI. Participation rates may be 
increased by using face-to-face recruitment and data collection, by using mail and Internet 
for contacting and informing patients, and by lowering the participant burden (for example by 
conducting interviews at home).92 
Prevalence rates
Consistent with findings in the literature,1-3 anxiety disorders (mainly PTSD) and depressive 
disorders (mainly major depression) were the most common and frequently studied disorders 
following TBI.
There was considerable variation in the post-injury prevalence rates of disorders among the 
patient samples of the included studies. The wide variation in prevalence rates of pre- and 
post-injury prevalence rates of anxiety and depressive disorders between studies has been 
reported previously1,3,15,93 and can be explained by differences in study design, characteristics of 
the patients, definitions, methods of assessment, and measures used to assess the psychiatric 
outcomes.
Our findings indicate that a history of psychiatric disorders before the TBI was common in TBI 
survivors, as approximately one in three adults (38%) had pre-injury Axis I disorders (often 
including substance abuse disorder), one in five (19%) a history of anxiety disorders, and one 
in eight (13%) a history of depressive disorders before TBI. According to our pooled prevalence 
estimates, prevalence rates of anxiety disorders were lower before TBI (19%) than in the first year 
after TBI (21%). In contrast, three studies that reported on pre- and post-injury prevalence rates 
of depressive disorders, indicated prevalence of depressive disorders to be higher before TBI 
than in the first year after TBI.5,47,48 In line with these findings, the included studies in our review 
that also reported on the community base rate of psychiatric disorders showed that patients 
with TBI had lower pre-injury rates of anxiety disorders than the general population (for example 
PTSD: 6% pre-TBI versus 8% in US adults33; 2% pre-TBI versus 6% in Australian population71). 
Although a history of psychiatric disorders before TBI was common, several studies reported 
a substantial share of novel disorders.2,35,44 These studies showed that numerous participants 
experienced Axis I disorders (78%), including anxiety disorders (74%) or depressive disorders 
(72%) for the first time following injury.35,44 However, a history of psychiatric disorders prior to 
TBI was significantly associated with a higher risk for psychiatric disorders in the aftermath of a 
TBI.5,33,39,41,50,60,63,71,75,76,78-82
A few of the included studies reported on the prevalence of co-morbid psychiatric disorders 
and indicated that 72-77% of those with a post-injury depressive disorder also had a co-morbid 
anxiety disorder, and 69% of those with an anxiety disorder also had a co-morbid depressive 
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disorder.44,50,71 According to findings of Gould et al, anxiety disorders tended to precede or 
emerge at the same time as depressive disorders.71
The pooled prevalence estimates of psychiatric disorders indicated that psychiatric disorders 
did increase over time, even after mild TBI. The increase of prevalence rates of disorders over 
time was a phenomenon that was also found within some of the included studies.2,5 This may 
be explained by the ongoing stressors and problems that may occur after the traumatic event, 
which may add to the maintenance of disorders after TBI.2,94 Additionally, the delayed onset 
of psychiatric disorders may occur due to psychosocial changes, as after the physical recovery 
insight into social, cognitive and emotional disability develops.71,95,96 Another explanation may 
be that a greater cognitive resource (e.g. higher education level before a TBI) may decrease the 
vulnerability to cognitive deficits after TBI, and may have a protective role in the development 
of psychiatric disorders.97 Although the included studies in our review assessed education 
level5,6,11,24,34,39,41,50-53,58,60,62,76,77,87,98 and pre-morbid IQ24,58,82 as risk factors for psychiatric disorders 
following TBI, only few of them reached significance showing less education to be associated 
with higher prevalence of anxiety and depressive disorders following TBI.39,75,78 In contrast, 
longitudinal results of Ashman et al showed that the risk of having an Axis I disorder decreased 3 
to 6 years post-injury.34 However, Koponen et al found high rates of current psychiatric disorders 
30 years after TBI,35 which suggests that the vulnerability of developing psychiatric disorders may 
remain throughout the life of a person with TBI.
Our pooled estimates of depressive disorders (MD: 15% first year, 27% > 1 year; dysthymia: 3% 
and 1%) were in line with those of a recent review of Osborn et al, in which 27% of the TBI 
survivors were clinically diagnosed with major depression and/or dysthymia after TBI.18 We, 
however, computed pooled prevalence estimates over time, showing lower estimates of major 
depression and dysthymia in the first year after TBI (15% and 3%), but higher estimates in the 
long-term (27% and 1%). Additionally, a review of van Reekum et al overall reported higher mean 
prevalence rates of major depression and PTSD compared to our pooled estimates: MD 44%22 
versus 15% in the first year and 27% after one year in our review; PTSD 14%22 versus 14% and 
7% in our review. Their review, however, did not specify prevalence of disorders over time, and 
included data from both structured diagnostic interviews and self-report measures.22 Osborn 
et al showed that, in comparison to structured diagnostic interviews, the use of self-report 
measures leads to far higher prevalence rates.18
Risk factors
The included studies in our review reported different directions of risk factors like the patients’ 
age,11,82 TBI severity level,33,56,58 time post-injury,34,71,75 and length of stay in the hospital.46,79 
However, these findings are not necessarily inconsistent. For example, in the studies that reported 
that younger people were more at risk of having a psychiatric disorder after TBI, the younger 
group comprised all those aged 18-64 years,39,78 or 16-59 years.11 However, the relationship 
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between age and psychiatric disorders after TBI is controversial, with studies showing contrasting 
findings on whether52,87 or not11 older patients are at increased risk of psychiatric disorders after 
TBI.
Additionally, inconsistent findings were reported on TBI severity, as more severe TBI was related 
to a higher risk for Axis I disorders33 and the number of anxiety symptoms,58 whereas less severe 
TBI was related to higher risk for anxiety disorders.56
The studies in our review tended towards higher prevalence rates of major depression among 
patients with more severe TBI, as 8-18% of the patients with mild TBI received this diagnosis 
versus 7-63% in patients with all TBI severity levels. However, the severity of TBI has not emerged 
as a significant risk factor of depressive disorders in previous studies.5,18,51,53,56,70,76,80,99
Female gender was identified as a risk factors for psychiatric disorders after TBI in several 
studies.33,34,75 This is underpinned by the fact that the included studies with a high share of 
women (≥ 70%, n = 5) tended to report somewhat higher prevalence rates of anxiety disorders 
than the samples with relatively more men (on average 6-12% higher rates), OCD (2-6%), PTSD 
(3-8%), depressive disorders (4-12%), and major depression (< 1-5%).
Finally, several studies included in this review reported depressive disorders being associated with 
lesion location, with higher rates of disorders in patients with left frontal abnormality,41,50,52,80,83 
left anterior lesions,41,69,80,83 left41 or right hemisphere lesions,41,83 cortical lesions,41 and parieto-
occipital lesions.41 Although investigations determining the relationship between lesion location 
and depressive symptoms have proven inconsistent,100 lesion site may influence the nature of 
depression but does not fully explain the occurrence and severity of depressive disorders.101
Strengths and limitations
Our review adds to the knowledge on psychiatric outcomes of TBI in civilian adults, by providing 
pooled prevalence estimates over time and insight into the risk factors associated with the full 
spectrum of anxiety disorders and depressive disorders. Our findings are based on evidence from 
structured diagnostic interviews, and emphasize that the prevalence of anxiety and depressive 
disorders after TBI is high and persists over time.
This review has limitations. First, because of our decision to only include studies on anxiety 
and depressive disorders following TBI, other psychiatric outcomes (e.g. including substance 
use disorders, schizoaffective disorders, or psychotic disorders) were not specifically taken into 
account. Second, the review solely focused on the prevalence of psychiatric disorders following 
TBI in civilian adults aged 16 years or older. Therefore, information on the prevalence of anxiety 
and depressive disorders among children or adolescents and military personnel is missing. 
Military personnel and veterans have a higher exposure to emotional trauma,25 and therefore 
show higher rates of psychiatric disorders (e.g. PTSD) than the civilian populations.26 Third, this 
Prevalence of and risk factors for anxiety and depressive disorders after traumatic brain injury
94
review did not elaborate on the cognitive impairments (e.g. deficits in attention, processing 
speed, and working memory) or post-concussion symptoms (e.g. dizziness, fatigue, and 
headaches) which may contribute or interact with psychiatric outcome after TBI.82,86 Fourth, only 
a few of the studies included in this review reported on the percentage of novel disorders after 
TBI.2,35,44,61 Research is needed to gain more insight into the prevalence of new versus recurrent 
anxiety disorders and depressive disorders after TBI. Finally, it was difficult to compare study 
results, due to the differences in study objectives, design, methodology and study population, 
including differences in definitions of TBI, inclusion and exclusion criteria, and interviews used 
to assess psychiatric disorders. Some of the studies in this review included participants with 
self-reported TBI (not medically documented) or from a variety of outpatient or rehabilitation 
settings. The studies assessed disorders in patients with varying TBI severity levels. As mild TBI is 
likely to be very different from severe TBI on many aspects, pooling of the data across these TBI 
severity levels may lead to an under- or overestimation of the prevalence rates amongst different 
cohorts. In addition, some studies (n = 3) reported prevalence over a period of time instead 
of point prevalence, and sometimes used different diagnostic criteria. Research showed that 
the latter variation in diagnostic criteria surprisingly provided different prevalence estimates, 
despite the overlap between these criteria.18 All the previous factors might have influenced the 
prevalence estimates of anxiety disorders and depressive disorders provided in this review. To 
enable comparisons between studies, consensus should be reached on standard definitions (e.g. 
for TBI, and TBI severity levels), study methods (e.g. which structured interview to use, which 
time points), and reporting styles (e.g. how to report on pre-injury and post-injury prevalence 
rates).
Implications for practice and research
Our review showed that, even years after TBI, a substantial number of patients experience 
psychiatric disorders. This underscores the need for recognition and treatment of anxiety and 
depressive disorders in all healthcare settings.10,11,58 Ideally, the routine treatment of patients 
with TBI should include a psychiatric evaluation and follow-up. Overall, early identification and 
treatment of psychiatric disorders may enhance the recovery of TBI survivors, their capacity 
to work, their HRQL and functional outcome, and may reduce the high costs associated with 
disability in TBI.102-104
As only a few of the studies included in this review reported on the percentage of novel disorders 
after TBI,2,35,44,61 research is needed to gain more insight into the prevalence of new versus 
recurrent anxiety and depressive disorders after TBI. Additionally, due to the increased risk of 
psychiatric disorders over time, it is recommended to assess the psychiatric outcome of patients 
soon after TBI (within one month), and after 3, 6, 12, and 24 months. Future studies on the 
psychiatric outcomes of TBI survivors should assess the prevalence of the full range of anxiety 
disorders and depressive disorders, with use of structured diagnostic interviews, and should 
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investigate the increased risk for these disorders among females, the unemployed, and those 
with a history of psychiatric disorders prior to TBI. 
Conclusions
Research conducted with the best available assessment instruments shows that a substantial 
number of patients encounter anxiety and depressive disorders before and after TBI, and that 
prevalence rates increase with time since injury. The pooled prevalence estimates provide insight 
into the magnitude of anxiety disorders and depressive disorders following TBI, and indicate that 
these disorders persist over time. All healthcare settings should pay attention to the occurrence of 
psychiatric symptoms in the aftermath of TBI, especially in females, those without employment, 
and those with a history of psychiatric disorders or substance abuse prior to TBI.
Supplemental material is available at www.marysecnossen.nl
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Abstract
Although major depressive disorder (MDD) and posttraumatic stress disorder (PTSD) are prevalent 
after traumatic brain injury, little is known about which patients are at risk for developing them. 
We systematically reviewed the literature on predictors and multivariable models for MDD and 
PTSD after TBI. We included 26 observational studies. MDD was associated with female gender, 
pre-injury depression, post-injury unemployment and lower brain volume, whereas PTSD was 
related to shorter posttraumatic amnesia, memory of the traumatic event and early post-
traumatic symptoms. Risk of bias ratings for most studies were acceptable, although studies that 
developed a multivariable model suffered from methodological shortcomings.
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Introduction
Traumatic brain injury (TBI), which is defined as “an alteration in brain function, or other evidence 
of brain pathology, caused by an external force”,1 comprises a serious public health concern 
with 262 per 100,000 patients admitted to the hospital each year.2 A substantial percentage 
of TBI patients develop psychiatric disorders in the first year post-injury,3,4 among which major 
depressive disorder (MDD) and posttraumatic stress disorder (PTSD) are the most frequently 
reported.4-7 MDD and PTSD after TBI are associated with functional impairments3,8,9 and a 
decrease in health-related quality of life (HRQL).9 They subsequently interfere with rehabilitative 
interventions and negatively affect recovery from TBI.3 Moreover, they are associated with high 
direct and indirect costs,10-12 resulting in a tremendous individual and societal burden. 
Although the significance of MDD and PTSD after TBI is well established, the literature yields 
limited information about which patients are at risk of developing these psychiatric conditions. 
This knowledge could be used to flag patients who might benefit from additional monitoring or 
(preventive) therapeutic interventions, which have shown to be effective in people at risk for 
MDD and PTSD.13-15 Multivariable models, which combine a number of characteristics to predict 
MDD or PTSD, might be particularly useful for this purpose. 
To our knowledge, there is currently one systematic review assessing psychological and 
psychosocial predictors of PTSD.16 The authors found that comorbid depression and anxiety, 
acute stress disorder (ASD), psychological processes (coping styles and attribution) and 
psychosocial variables (role impairment and reintegration) were associated with PTSD post-
TBI.16 The authors, however, included all factors associated with PTSD, rather than factors 
predicting PTSD. It is therefore unclear whether these specific factors predicted PTSD or were 
predicted by PTSD. Moreover, they included self-reported measurements to diagnose PTSD. Self-
reported measurements might not be reliable in a TBI population because of overlap between 
psychiatric symptoms and TBI symptoms (e.g. anxiety, irritability, fatigue), memory deficits, 
low self-awareness, attention problems and evidence that TBI patients tend to underestimate 
their problems.17-22 Structured diagnostic interviews, such as the structured clinical interview 
for diagnostic and statistical manual of mental disorders (SCID), constitute a better alternative 
as these interviews distinguish psychopathology symptoms from TBI symptoms and are less 
influenced by TBI related problems such as memory deficits.18
The objective of this systematic review and meta-analysis was to examine univariable predictors 
of and multivariable models for MDD and/or PTSD following TBI using structured diagnostic 
interviews. 
Predictors of major depression and posttraumatic stress disorder following traumatic brain injury
108
Material and methods
Information sources
We conducted a comprehensive literature search until October 2016. The search strategy was 
developed in consultation with a search expert using a combination of subheadings and text 
words (Online Supplement A). The following databases were searched: EMBASE, MEDLINE, 
Cochrane Central, PubMed, PsycINFO and Google Scholar. Reference lists and citation indices 
of included papers and relevant reviews were further inspected to identify any additional 
publications. The search strategy was restricted to studies published in peer-reviewed English 
language journals. We did not use any date restrictions. 
Study selection
We selected studies examining univariable predictors of and/or multivariable models for MDD 
and PTSD after TBI. We used the following inclusion and exclusion criteria to determine eligibility 
of a study: 
Participants – civilian adults (age ≥ 16) who sustained TBI. TBI was defined as “an alteration in 
brain function or other evidence of brain pathology, caused by an external force”.1 We included 
patients with mild, moderate and severe TBI (as defined by the study authors). We excluded 
military patients since there are major differences between military and civilian TBI. In the 
military, approximately 75% of the TBIs involve blast exposures,23 which may have unique injury 
mechanisms.24 In addition, mental health symptoms are more prevalent in the military than in 
civilians,25 which might also be due to other causes than the sustained TBI. 
Outcome measurement – MDD and/or PTSD according to the Diagnostic and Statistical Manual 
of Mental Disorders (DSM) or International Classification of Diseases (ICD) classification systems. 
We restricted our inclusion criteria to studies that used a structured diagnostic interview to 
diagnose MDD and PTSD, as structured diagnostic interviews are regarded as the gold standard in 
diagnosing psychopathology19 and better distinguish psychiatric symptoms from TBI symptoms. 
Moreover, structured diagnostic interviews are less influenced by potential memory deficits, low 
self-awareness and over- or underestimation by TBI patients. In addition, with respect to PTSD, 
clinical interviews can be used to specifically anchor the interview to the event in which the 
patient was injured.26
Predictors – we selected studies that examined at least one predictor of or multivariable model 
for MDD or PTSD after TBI. To be included, studies had to report at least one of the following: 
1) baseline differences in predictors between patients diagnosed with MDD or PTSD (MDD+ 
and PTSD+) and patients not diagnosed with MDD or PTSD (MDD- and PTSD-; i.e. means and 
standard deviations for continuous predictors and number of patients for categorical predictors), 
2) descriptive statistics (e.g., results from t-test, chi-square test, p-value) or 3) statistics from the 
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multivariable model (e.g., odds ratio, Area Under the Curve (AUC), Nagelkerke R2). To be included 
as a predictor, these factors must have preceded the diagnosis of MDD or PTSD. Preceding was 
defined as either 1) being measured earlier than the psychiatric diagnosis (in prospective studies) 
or 2) obviously preceding the diagnosis of MDD or PTSD such as gender, age and computed 
tomography (CT) abnormalities (in retrospective, cross-sectional and case-control studies). 
Multivariable models were defined as models that combined at least two factors to predict a 
clinical outcome,27,28 in our case MDD or PTSD.
Study design – we included retrospective- and prospective cohort studies, cross-sectional studies, 
and case-control studies. 
Data extraction and assessment of risk of bias
One author (MC or ASc) screened citations on title and abstract, and then again on full-text, 
excluding those that did not meet the inclusion criteria. Any doubts were resolved by consulting 
a senior member of the team (JH or SP). As an audit of performance, a random 20% of the full 
text screening was repeated by the other reviewer (MC or ASc) and concordance rates were 
calculated accordingly. The search process was documented according to the Preferred Reporting 
Items for Systematic Reviews and Meta-analyses (PRISMA) flowchart.29 
We developed a data extraction form based on the basis of the Critical Appraisal and Data Extraction 
for Systematic Reviews of Prediction Modeling Studies (CHARMS) checklist30 and subsequently 
extracted information on type of prediction modeling study, target population, participants, 
outcome measurements, candidate predictors, sample size, handling of missing values and 
model development methods. We additionally extracted baseline information on univariable 
associations between predictors and outcome by collecting means and standard deviation (SD) 
for MDD+/PTSD+ and MDD-/PTSD- group (continuous predictors) or number of patients with 
and without the predictor in MDD+/PTSD+ and MDD-/PTSD- groups (categorical predictors). We 
further extracted univariable and multivariable statistics and effect measurements, if available. 
Risk of bias, which refers to the risk of systematic errors which may result in the over-or 
underestimation of effects31 was assessed using the Quality in Prognostic Studies (QUIPS) risk of 
bias tool. The QUIPS has been recommended by the Cochrane Prognosis Methods Groups and 
has acceptable inter-rater reliability.32 We included information on the following domains: study 
participation, study attrition, prognostic factor measurement, outcome measurement, study 
confounding and statistical analysis and presentation. Each domain was subsequently rated as 
‘low’, ‘moderate’ or ‘high’ risk of bias. A domain obtained the score ‘low risk’ if all individual 
items of the domain were rated as ‘low risk’. A domain was rated as ‘moderate risk’ if at least 
one and maximum 50% of the items implied a high risk of bias or an unknown risk of bias, and a 
study received a score of high risk if > 50% of the items implied a high risk of bias or an unknown 
risk of bias. 
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We applied a quality threshold for study inclusion in the meta-analyses; that is, studies were 
omitted from the meta-analyses if they obtained a high score on at least two out of the following 
QUIPS domains: study participation, study attrition, prognostic factor measurement, outcome 
measurement and statistical analysis and presentation. Such a strategy is recommended by 
Cochrane.33 We did not include study confounding as criterion since we aimed to perform a 
meta-analysis with univariable predictors. Studies were additionally excluded from the meta-
analyses if they included less than 20 patients. The data extraction and risk of bias were done 
independently by one author (MC) with the data and decisions checked by a second author 
(ASc). Any discrepancies were resolved by discussion with a senior member of the team (SP). 
Data synthesis 
We performed meta-analyses of univariable predictors of MDD and PTSD. Predictors were 
included in the meta-analysis if univariable data (mean (SD) or numbers in MDD+/PTSD+ and 
MDD-/PTSD- groups) were reported in two or more studies measuring the same predictor. 
Studies were excluded from the meta-analyses if they measured the predictor differently from 
other studies (e.g. age dichotomized into two age groups instead of continuous), if they obtained 
a high risk of bias on at least two QUIPS domains (excluding confounding) of if they included less 
than 20 patients. If a study assessed predictors for multiple time points or multiple outcomes (e.g. 
chronic depression, late onset depression and recovered depression) scores were combined, or if 
this was not possible, the time point or outcome that was closest to that in the other studies in 
the same meta-analysis was chosen. We used Review manager (Revman) version 5.334 to perform 
the meta-analyses. All tests were two-sided and a p-value of 0.05 was considered statistically 
significant. We used Mantel-Haenszel statistic for categorical predictors as this method is 
recommended by Cochrane31 and inverse variance to analyze continuous predictors since this is 
not possible with the Mantal-Haenszel statistic. For all analyses, random effect models were used 
as we expected heterogeneity in time span and measurements. For dichotomous predictors, we 
reported the pooled odds ratio (pOR) and confidence interval (CI) and for continuous predictors, 
we reported the pooled mean difference (pMD) and CI. Heterogeneity was determined using I2 
and was defined as high when I2 was ≥ 50% (substantial heterogeneity according to Cochrane31). 
In that case, pooled results should not be calculated, or at the very least, be interpreted with 
caution. 
Since we included studies using the DSM-IV, DSM-III or ICD-10 criteria, we may have introduced 
heterogeneity in the association between predictor and the diagnosis of MDD or PTSD. We 
therefore performed sensitivity analyses in which we excluded studies using other criteria than 
the DSM-IV. 
Predictors that were reported in at least two studies, but not included in the meta-analyses 
were narratively described. Multivariable models of MDD and PTSD were narratively described 
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by comparing model performance (e.g. AUC / Nagelkerke R2 / calibration) and methods (e.g., 
number of candidate predictors). 
Multiple publications
Multiple publications were dealt with by selecting one main study based on the following criteria: 
1) the study that uses multivariable analyses; 2) the study with the largest number of patients 
included; and 3) the study with the largest number of predictors. If a second paper was written 
on the basis of the same data as the ‘main study’ but mentioned any new predictors, only the 
information on these new predictors was extracted from the study. 
Results
Study selection
A total of 9695 citations were identified through the electronic search strategy (Figure 1). After 
removing duplicates, 6291 were screened on title and abstract and 5966 citations were excluded. 
We obtained 325 citations in full text of which 295 were subsequently excluded. The most 
common reason for exclusion was using self-reported measurements instead of a structured 
diagnostic interview (n = 144). The 20% audit on full text screening obtained a concordance rate 
of 100% between two review authors. Five additional citations were found via reference lists and 
citation indices. We included 26 studies (reported in 36 publications) in the narrative synthesis. 
Of these, 14 studies were included in the meta-analyses. 
Study characteristics
Of the 26 studies included, the majority (n = 17) were prospective cohort studies.19,26,35-49 Four 
studies used a retrospective cohort design,50-53 three a cross-sectional design,54-56 and two were 
case-control studies.5,57 Studies were published between 1992 and 2016 and were conducted 
all over the globe, but mainly in high-income countries such as the United States (n = 7) and 
Australia (n = 5). Patients were recruited from general hospitals in the majority of studies 
(n = 9). Other studies included self-identified TBI patients (n = 3), patients admitted to a trauma 
center (n = 4) or ICU (n = 1) or patients in the post-acute phase in a rehabilitation unit (n = 3) or 
neuropsychological/neurocognitive TBI clinic (n = 6). The large majority of studies derived their 
patients from a single center (n = 20; Table 1).
Forty-two percent (n = 11) included patients with mild, moderate and severe TBI. The diagnosis 
of MDD/PTSD was determined according to the DSM-IV criteria in the large majority of studies 
(n = 20). Five studies used the DSM-III criteria36,38,39,46,51 and one study the ICD-10 criteria of MDD/
PTSD.40
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Figure 1. PRISMA flowchart of the selection process
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database searching
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Papers a"er duplicates removed
(n = 6291)
Papers screened !tle
and abstract (n = 6291)
Papers full-text
assessed for eligibility
(n = 325)
Addi!onal papers iden!fied
through reference lists and 
cita!on indices (n = 6)
Papers included in 
qualita!ve synthesis
(n = 36; 26 unique studies)
Papers included in 
meta-analyses (n = 14; 
14 unique studies)
Papers excluded
(n = 3404)
Papers excluded
(n = 5966)
Papers excluded a"er 
full-text assessed 
(n = 295), with reasons
No TBI (n = 51)
No PTSD/MDD (n = 21)
Study Design (n = 26)
No Civilians (n = 1)
No Adults (n = 7)
No structured interview 
(n = 144)
No predictors (n = 42)
Figure is adapted from Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6): e1000097. doi:10.1371/journal.pmed1000097
Abbreviations: MDD = Major Depressive Disorder; PTSD = Posttraumatic Stress Disorder; TBI = traumatic brain injury
Fourteen studies examined predictors of MDD,5,19,36,40-42,44-46,51,52,55-57 nine studies examined 
predictors of PTSD35,37-39,47-50,53 and three studies examined both.26 ,43,54 Nine studies included 
multiple predictors in a multivariable model to predict MDD (n = 5), PTSD (n =3) or both (n = 1). 
Studies included on average 125 patients (range 16 to 404). Studies that assessed predictors of 
MDD included on average 26 (range 9-65) patients with MDD (‘cases’) and 83 patients without 
MDD. Studies that assessed predictors of PTSD included on average 32 patients (range 7-127) with 
PTSD (‘cases’) and 142 patients without PTSD. The majority of studies included predominately 
male patients with a mean age between 30 and 40 years. Motor vehicle accidents (MVA) were the 
most reported cause of injury. Most predictors were measured during emergency department 
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(ED) visit or very soon after discharge. Outcome was measured between one month and six years 
post-injury with the majority of studies measuring MDD/PTSD between three months and one 
year post-injury (Table 1).
Risk of bias of the studies
The majority of studies (n = 18)5,19,26,36,38,40,41,43,46-49,51,53,55-58 were scored as high risk of bias for study 
confounding because they only assessed the effect of predictors in univariable analyses. It is 
therefore unknown whether the effect of the predictor is independent of other factors. Because 
we sought to perform a meta-analysis with univariable data, we did not exclude any studies 
based on a high risk of study confounding from the meta-analysis. 
Except for the high risk of study confounding, methodological quality of the included studies 
was acceptable (Table 2). Study participation19,43,55 and attrition40,46,53 were rated at high risk of 
bias in three studies. Additionally, one study was judged at high risk of bias for prognostic factor 
measurement5 and outcome measurement,53 and six studies were rated at high risk of bias on 
statistical analysis and reporting.5,42,47,49,50,53 Three studies5,49,53 were rated at high risk on two 
out of five (excluding study confounding) domains and were therefore omitted from the meta-
analyses. Two other studies55 included less than 20 patients and were therefore also excluded 
from the meta-analyses. 
Meta-analyses of univariable predictors
The included studies examined a total of 112 predictors of MDD and 59 predictors of PTSD (Figure 
2). Age and gender were most often assessed. The majority of predictors were assessed in only 
one study. Consequently, only 18 and 6 predictors were included in the meta-analyses for MDD 
and PTSD, respectively (Table 3, Online Supplement B). 
Figure 2. Frequency of predictors of MDD and PTSD following TBI
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Figure shows how frequent predictors were studied across the included studies. For example, for MDD one predictor (age) is studied 
in fourteen studies and one predictor (gender) is studied in thirteen studies. The majority of predictors (e.g. MRI abnormalities) were 
assessed in one study. 
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Table 2. Risk of bias assessment
Study Study 
participation
Study 
attrition
Prognostic factor 
measurement
Outcome 
measurement
Study 
confounding
Statistical analyses 
and presentation
Alway, Y. (2015) Moderate Moderate Low Low Low Low
Ashman, T.A. (2004) Moderate Moderate Moderate Low Low Moderate
Barker-Collo, S. (2013) Moderate Moderate Low Low High Low
Bryant, R.A. (1998) Low Low Low Low High Low
Bryant, R.A. (2000) Low Moderate Low Low High Low
Caspi, Y. (2006) Low Moderate Low Low Low High
Deb, S. (2007) Low High Low Moderate High Low
Diaz, A.P. (2012) Low Low Low Low High Low
Federoff, J.P. (1992) Low Low Low Low High Low
Gil, S. (2005) Low Moderate Low Low Low Low
Gould, K.R. (2011) Low Moderate Low Low Low High
Hibbard, M.R. (1998) High Moderate Moderate Low High Moderate
Jorge, R.E. (2004) Low Low Low Low High Low
Kennedy, R.E. (2005) High Moderate Low Low High Low
Koponen, S. (2002) Moderate Moderate Moderate Low High Low
Levin, H.S. (2005) Low Moderate Low Low Low Low
Li, L. (2016) Moderate Low Moderate Low High High
Mauri, M.C. (2014) Moderate Low High Low High High
O’Donnell, M.L. (2008) Low Low Low Low High Low
Rao, V. (2010) High Low Low Low High Moderate
Rapoport, M.J. (2003) Moderate Low Moderate Low Low Low
Rapoport, M.J. (2005) Moderate Low Moderate Low High Low
Reekum, R. (1996) Moderate High Low Low High Low
Roitman, P. (2013) Moderate Low Moderate Low High High
Turnbull, S.J. (2001) Moderate High Moderate High High High
Whelan-Goodinson, R. 
(2010)
Moderate Low Low Low Moderate Moderate
Table presents risk of bias assessment according to the Quality in Prognostic Studies (QUIPS) tool. 
We found a significant association between the development of MDD and female gender (pOR 
1.72, 95% CI 1.19 to 2.48, I2 = 10%, 8 studies). Additionally, patients with a pre-injury depression 
had a higher odds on developing MDD post-injury than did patients without a history of depression 
(pOR 3.86, 95% CI 2.26 to 6.59, I2 = 0%, 5 studies). Also, patients who were unemployed after 
sustaining TBI had a higher odds on developing MDD later on than did the employed patients 
(pOR 2.04, 95%CI 1.10 to 3.79, I2 = 9%, 3 studies). We further found that patients with a higher 
admission Glasgow Coma Scale (GCS), which refers roughly to moderate TBI versus severe TBI in 
these studies, had a higher risk on developing MDD (pMD 0.49, 95% CI 0.02 to 0.97, I2 = 0%). This 
was however only assessed in two studies and we did not find a significant association between 
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GCS after 24 hours and MDD (pMD 0.13, 95%CI -1.29 to 1.56, I2 = 42%, 2 studies). The association 
between the other predictors and MDD were all non-significant. 
PTSD was significantly associated with a shorter posttraumatic amnesia (PTA; pMD -8.07. 95% CI 
-15.46 to -0.69, I2 = 33%, 3 studies) and a memory of the traumatic event (pOR 5.15, 95% CI 2.37 
to 11.21, I2 = 0%, 2 studies). We did not find a significant association between the remainder of 
predictors and PTSD. Sensitivity analyses with only those studies using the DSM-IV criteria did 
not result in any differences (Online Supplement C).
Table 3. Meta-analyses of univariable predictors of MDD and PTSD following Traumatic Brain Injury 
Predictor No. of participants  
(No. of studies)
Pooled effect size meta-analysis 
OR (95% CI)*
Heterogeneity  
(I2)
MDD
Age (/y, MD (95% CI)) 611 (7) 1.20 (-1.96 to 4.36) 49%
Female Gender 768 (8) 1.72 (1.19 to 2.48) 10%
Education (/y, MD (95%CI)) 271 (4) -0.50 (-1.37 to 0.37) 43%
Caucasian race 341 (3) 1.04 (0.61 to 1.75) 0%
Marital status ⱡ 610 (6) 1.20 (0.82 to 1.75) 0%
Socioeconomic status ‡ 140 (2) 0.69 (0.33 to 1.43) 0%
Pre-injury depression 470 (5) 3.86 (2.26 to 6.59) 0%
Pre-injury psychiatric disorders 426 (4) 1.58 (0.42 to 5.99) 87%
Pre-injury alcohol abuse 244 (2) 1.49 (0.61 to 3.69) 0%
Pre-injury substance abuse 244 (2) 2.02 (0.75 to 5.42) 0%
Pre-injury unemployment 244 (2) 3.80 (0.34 to 42.09) 77%
Family history of psychiatric disorders 234 (2) 1.06 (0.52 to 2.14) 0%
Admission GCS (MD (95% CI)) 151 (2) 0.49 (0.02 to 0.97) 0%
24h GCS (MD (95% CI)) 138 (2) 0.13 (-1.29 to 1.56) 42%
CT abnormalities 259 (3) 0.70 (0.35 to 1.43) 0%
Brain contusion 101 (2) 1.78 (0.73 to 4.34) 0%
Post-injury unemployment 211 (3) 2.04 (1.10 to 3.79) 9%
Post-injury litigation situation 203 (2) 0.64 (0.16 to 2.53) 0%
PTSD
Age (/y, MD (95% CI)) 717 (5) 1.02 (-1.46 to 3.49) 75%
Female gender 621 (4) 1.27 (0.83 to 1.96) 0%
Education (/y, MD (95% CI)) 301 (3) 0.15 (-0.61 to 0.92) 11%
Pre-injury psychiatric disorder 425 (4) 1.32 (0.63 to 2.77) 49%
PTA (MD (95% CI)) 477 (3) -8.07 (-15.46 to -0.69) 33%
Memory of the traumatic event 240 (2) 5.15 (2.37 to 11.21) 0%
*pooled OR (95% CI) unless otherwise specified ⱡ married/relationship vs. unattached ‡ Hollinghead classes IV and V vs. lower
Abbreviations: MD = mean difference; MDD = major depressive disorder; OR = odds ratio; TBI = traumatic brain injury; GCS = Glasgow 
Coma Scale; PTA = posttraumatic amnesia; CT = computed tomography; PTSD = posttraumatic stress disorder; LOC = loss of consciousness
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Narrative synthesis of univariable predictors
For MDD, five out of six studies in the narrative synthesis did not find an association between 
the development of MDD and age5,40,43,46,52,55 and none of the studies reported a significant 
association with any other demographic factors and MDD (gender, education, marital status, 
income; Online Supplement D).5,19,43,52,55-57,59 For pre-injury variables, patients with a history of 
psychiatric disorders had a significantly higher risk of developing MDD.42,57,60 We did not find an 
association between pre-injury substance and alcohol abuse,36,42,56 pre-injury unemployment,52,56 
family history of psychiatric disorders,56,57 pre-injury TBI17,56 and mechanism of injury and 
MDD.19,45,56 For clinical variables, we did not find an association between GCS,19,36,43,46,57 PTA51,52,56 
and MDD. Bodily injuries were associated with MDD in one out of three studies.42,52,56
Three studies analyzed the association between imaging variables and MDD.55,57,61 Jorge et al.57 
found that the percentage of gray matter in the left lateral frontal cortex and the percentage 
of gray matter at the left inferior frontal gyrus on magnetic resonance imaging were higher in 
patients that developed MDD. The influence of brain volume was assessed in two studies that 
consistently found that a lower brain volume was associated with the development of MDD.55,61 
Early post-injury anxiety and depression were assessed in two studies.26,42 One study found that 
early post-injury depression, measured with the SCID, was associated with post-injury MDD 
and did not found an association between early post-injury anxiety and MDD.42 Another study 
reported that the Hospital Anxiety and Depression Survey (HADS) was significantly associated 
with MDD (AUC 0.72, p < .01).26 This study additionally developed a screening instrument based 
on pre-injury factors and post-injury irritability and concentration problems, which was also 
significantly related to MDD (AUC 0.77, p < .01).
For PTSD, demographic variables were not associated with PTSD in the studies in the narrative 
synthesis, except for one study54 which found that PTSD was more common among women. PTSD 
was not associated with injury mechanism in three studies48-50 (Online Supplement D). Also, GCS 
was not associated with the development of PTSD.39,48,62 One study reported that patients with 
loss of consciousness (LOC) had a higher odds on PTSD,47 whereas two other studies did not find 
statistical differences.48,49 One-month PTSD symptoms or symptoms of ASD were significantly 
associated with PTSD in four studies.26,35,38,49 Bryant et al.38 studied individual ASD symptoms 
and reported that the following symptoms were associated with six-month PTSD: helplessness, 
numbing, depersonalization, recurrent images and thoughts, avoidance of thoughts or talk, 
avoidance of places and people, insomnia, irritability and motor restlessness. Post-injury anxiety 
and depression were related to six-month PTSD in one study.35 Another study developed a 
screening instrument for PTSD based on pre-injury, peri-injury and post-injury factors and 
reported an AUC of 0.91, p < .001)26
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Narrative synthesis of multivariable models
Six studies used a multivariable model to predict MDD (Table 4). On average, models included 
6.3 cases (range 1.2-22) for every predictor in the model. None of the studies described whether 
there were missing values in predictors and if so, how they were handled. Nagelkerke R2 was 
calculated in three models,42,45,52 and ranged from 0.18 to 0.35. The AUC was calculated in 
one study44 and indicated good discriminative ability (AUC = 0.86). This model included age, 
depressive symptoms after one week post-injury and CT results. 
Four studies used a multivariable model to predict PTSD. Models included on average 7.7 
cases (range 1.1-19). Again, none of the studies described how they handled missing values in 
predictors. Nagelkerke R2 was reported for two models35,50 and ranged from 0.38 to 0.42. Both 
models included memory of the traumatic event and history of psychiatric disorders. None of 
the multivariable models for MDD and PTSD used internal or external validation to improve the 
generalizability.
Discussion
This systematic review provides an overview of univariable predictors of and multivariable models 
for MDD and PTSD following TBI. We included 26 studies and found that the development of 
MDD was associated with female gender and a pre-injury depression. Post-injury MDD might also 
be associated with post-injury unemployment status, early post-injury psychiatric symptoms, a 
higher GCS and a lower brain volume. The development of PTSD was associated with a shorter 
PTA and a memory of the traumatic event. It may also be associated with early symptoms (e.g., 
depression, anxiety, ASD). Only a few studies used a multivariable model to predict MDD or PTSD, 
of which the majority was of limited quality. 
This systematic review included studies over the last 23 years from all over the globe and therefore 
provides a complete overview of current knowledge about predictors and multivariable models 
for MDD and PTSD following TBI. Some notes should be made regarding the completeness and 
applicability of the evidence. First, the large majority of predictors were examined in only one study 
and therefore were not included in our meta-analyses. For many predictors, we consequently 
cannot draw firm conclusions. A possible solution might have been to include studies with self-
reported outcome measurements since these studies are more common and usually include 
more patients. However, self-reported measurements are less reliable in TBI patients.16-18 For 
example, a 2006 study found that the diagnosis of PTSD varied from 59% to 3% when using self-
reported measurements and structured diagnostic interviews, respectively.20 For MDD, a similar 
range is reported.22 In self-reported measurements, the overlap between TBI and the psychiatric 
disorder is usually not captured. For example, focus on the memory gap following coma without 
great distress could be inappropriately labeled as intrusive in a self-reported measurement.20 
Also the symptoms sleep problems, irritability and concentration problems, which might be 
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indicative of post-concussive syndrome, might be scored as hyperarousal symptoms in self-
reported instruments. Reliability of self-reported measurements might further be hampered 
by memory deficits, low self-awareness and attention problems.17-22 This is illustrated in a 2001 
case report.63 The inclusion of self-reported measurement might therefore have resulted in the 
reporting of invalid predictors, compromising the quality of this systematic review.
A second note that could be made regarding the completeness and applicability of evidence is 
that only a minority of studies used a multivariable model. The majority of results are based on 
univariable associations. As a consequence, we cannot exclude the possibility that some of the 
associations that we found were influenced by other factors. Also, factors that are non-significant 
in this review might comprise important predictors after correction for confounders. Third, the 
majority of studies included patients with mild, moderate and severe TBI and did not stratify or 
correct for TBI severity. Lastly, the large majority of studies were underpowered which might 
have resulted in non-significant findings in the narrative synthesis. This problem was partly 
captured by performing meta-analyses. This was however only possible for 18 and 6 predictors 
of MDD and PTSD, respectively. 
The risk of bias of most studies developing multivariable models was high. Models included on 
average six to eight cases for every predictor, while it is recommended to include at least ten.64,65 
Including too many predictors enhances the risk of finding too extreme estimates (‘statistical 
overfitting’), limiting generalizability of findings.66 Additionally, the majority of studies did not 
report how they handled missing data and how they selected candidate predictors. Also, none 
of the studies used internal or external validation. As a consequence, none of the multivariable 
models could be applied to clinical practice yet.
We found a significant association between female gender and the likelihood of developing 
MDD in our meta-analysis. This is in line with systematic reviews about gender and depression 
in the general population; females approximately have a twice as high risk of developing major 
depression as do males.67,68 However, this significant association was not found in three studies 
that were not included in the meta-analysis.43,55,56 These studies were however underpowered 
since they included only 48, 10 and 21 cases respectively. 
MDD was also associated with the presence of a pre-injury depression, which might be due 
to the high recurrence rates in MDD. A large prospective study reported that up to 85% of the 
patients with prior MDD developed a new MDD episode during a 15 years follow-up period.69 
Recurrence of MDD can be triggered by a stressful life event, such as a TBI, although causation is 
usually multifactorial.70,71 
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MDD was further more prevalent among those reporting post-injury unemployment and early 
post-injury psychiatric symptoms. This has also been shown in systematic reviews in the general 
population.72,73 Unemployment can result in reduced social interactions and status which may 
subsequently result in depression.74 
Higher admission GCS, referring predominately to moderate TBI patients compared to severe 
TBI patients, might also be associated with a higher odds of MDD. However, we did not find an 
association between 24-hours GCS and MDD and also failed to find an association between GCS 
as categorical variable and MDD in the narrative synthesis. As a consequence, the association 
between GCS and MDD remains uncertain. 
Lastly, MDD after TBI might also be associated with lower brain volume. This was in line with 
a 2012 meta-analysis about gray matter abnormalities in MDD.75 Since this was only assessed 
in two studies that used relatively low sample sizes, these finding should be interpreted with 
caution. 
PTSD was more likely among patients with a shorter PTA and those with a memory of the 
traumatic event. A shorter PTA (less amnesia) and a memory of the event basically mean the same 
thing, and it is suggested that amnesia for the traumatic events minimizes the establishment of 
cognitive representations and so reduces the likelihood of intrusive symptoms.50 However, one 
out of three studies found a significant association between the occurrence of LOC and PTSD, 
and the two studies assessing the association between PTSD and GCS did not find a significant 
effect, which might be contradictory to our findings on PTA and memory of the event; i.e., LOC 
and a low GCS are usually accompanied by at least some PTA. The difference in findings could be 
attributable to the lack of power in individual studies in the narrative synthesis. Future research 
is important in confirming the possible association between memory of the traumatic event and 
PTSD. PTSD was further significantly associated with ASD and early PTSD symptoms. Although 
studies could not be pooled because of different outcomes reported, four individual studies found 
a significant association between ASD or PTSD symptoms after one month and PTSD after six or 
twelve months. This was in line with a systematic review about predictors of sequelae in mild TBI 
patients76 and a review about predictors of PTSD using self-reported outcome measurement.16
Strengths of this systematic review include the comprehensive search strategy, the restriction 
to structured diagnostic interviews and the performance of meta-analyses, which improved the 
statistical power. Additionally, we combined results from the meta-analyses, narrative synthesis 
and multivariable models to obtain conclusions about the significance of predictors. We thereby 
integrated all available sources of evidence. A limitation of the use of meta-analyses is that there 
was between-study variation in time span, TBI severity and outcome measurement, resulting in 
estimates that are difficult to interpret. Also, the use of I2 statistic to interpret heterogeneity in 
the meta-analyses could be considered a limitation. Although I2 statistic is the best heterogeneity 
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measurement available, it might be biased and not very precise in small meta-analyses.77,78 
Therefore, overlap in CIs should also be considered when interpreting heterogeneity between 
studies. A third limitation concerns our screening process, which was conducted by one study 
author. We however performed an audit and found a 100% concordance between study authors, 
indicating that screening by two independent reviewers would probably not have resulted in the 
inclusion of any additional studies. 
The results of this systematic review imply that there is still limited knowledge regarding which 
patients develop MDD and PTSD after TBI. We therefore cannot recommend yet which patients 
should receive additional follow-up or preventive treatment and advise physicians to be aware 
in all patients who sustained TBI. Physicians could be extra aware in female patients with a 
pre-injury history of depression and post-injury unemployment or psychiatric symptoms. Also, 
a reduction in brain volume might indicate a risk of developing MDD post-injury. Furthermore, 
patients with a shorter PTA, a clear memory of the traumatic event and patients with early post-
traumatic symptoms might be at higher risk of developing PTSD post-TBI. 
More research is needed to confirm the relevance of these predictors of MDD and PTSD after 
TBI, and develop a multivariable model that could be implemented in hospitals and rehabilitation 
centers. 
Future prognostic studies should include a more homogenous group of TBI patients (e.g. only 
those with mild TBI). It is also recommended that future studies include a large sample size and 
a limited set of candidate predictors. Selection of candidate predictors could be based on current 
review, theory or clinical knowledge about etiology of psychiatric disorders. Additionally, the 
confirmation of specific predictions among different patient samples is critically important to 
increase our knowledge about predictors of psychiatric sequelae post-TBI. 
 
Conclusion
Our systematic review showed that MDD after TBI was associated with female gender, pre-
injury depressive disorder, post-injury unemployment, early post-injury psychiatric symptoms 
and a lower brain volume, while PTSD was related to PTA, a memory of the traumatic event 
and early post-traumatic symptoms. Currently available multivariable models of MDD and PTSD 
after TBI suffer from methodological shortcomings. The findings of the current review, together 
with clinical knowledge about etiology of psychiatric disorders, could form the basis for future 
development of a prognostic model from a large sample of TBI patients using solid methodology. 
Supplemental material is available at www.marysecnossen.nl
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Abstract
Post-concussive symptoms occur frequently after mild traumatic brain injury (mTBI) and may 
be categorized as cognitive, somatic, or emotional. We aimed to: 1) assess whether patient 
demographics and clinical variables predict development of each of these three symptom 
categories, and 2) develop a prediction model for six-month post-concussive symptoms.
MTBI patients (Glasgow Coma Scale score 13-15) from the prospective multicenter Transforming 
Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Pilot study (2010-2012) 
who completed the Rivermead Post-Concussion Symptoms Questionnaire (RPQ) at six months 
post-injury were included. Linear regression was utilized to determine the predictive value of 
candidate predictors for cognitive, somatic, and emotional subscales individually, as well as 
the overall RPQ. The final prediction model was developed using least absolute shrinkage and 
selection operator procedure and bootstrap validation. 
We included 277 mTBI patients (70% male, median age 42y). No major differences in the 
predictive value of our set of predictors existed for the cognitive, somatic, and emotional 
subscales, and therefore one prediction model for the RPQ total scale was developed. Years of 
education, pre-injury psychiatric disorders and prior TBI were the strongest predictors of six-
month post-concussive symptoms. The total set of predictors explained 21% of the variance, 
which decreased to 14% after bootstrap validation. 
Demographic and clinical variables at baseline are predictive of six-month post-concussive 
symptoms following mTBI; however these variables explain less than one-fifth of the total 
variance in outcome. Model refinement with larger datasets, more granular variables, and 
objective biomarkers are needed before implementation in clinical practice.
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Introduction
Traumatic brain injury (TBI) is a common and often debilitating injury. In the United States alone, 
at least 2.5 million people suffer TBIs annually, accounting for 52,000 deaths, 275,000 inpatient 
hospitalizations, and 1,365,000 emergency room visits.1 Approximately 70-90% of all TBI is 
characterized as mild TBI (mTBI) defined by a Glasgow Coma Scale (GCS) score of 13 to 15 upon 
admission to the emergency department (ED).2 Many patients recover completely from mTBI in 
the ensuing weeks to months.3,4 However, in 5-30% of subjects with mTBI, neurologic, cognitive 
and/or neuropsychiatric symptoms persist up to one year post-injury, or longer.5-8 Methodologies 
to predict those at greatest risk of incomplete recovery are limited, but are the subject of active 
research incorporating neuroimaging, patient demographics, and genetic polymorphisms. Data 
from any of these sources may portend poor recovery.9-13
Post-concussive syndrome (PCS) is a clinical term used to describe a constellation of post-
traumatic symptoms which may be divided into the domains of cognitive (forgetfulness, poor 
concentration, or slowed processing speed), somatic (headaches, double or blurred vision, photo 
or phonophobia, dizziness, nausea, disrupted sleep habits, or fatigue) or emotional (irritability, 
depression, frustration or restlessness).14-17 The International Classification of Diseases, tenth 
edition (ICD-10) states that a diagnosis of PCS should include a head injury “usually sufficiently 
severe to result in loss of consciousness (LOC),” as well as three or more subjective symptoms 
present for at least four weeks. Symptoms should cause significant clinical impairment.18 
In civilian populations, estimates suggest that roughly 10-20% of patients experience PCS within 
six months following mTBI.14 However, the complaints are non-specific and are also observed 
in patients with extracranial injuries; because systemic injuries often coexist with neurological 
injuries, accurate estimates of true prevalence of PCS are difficult to ascertain. The term is not 
without controversy – for instance, after being included in the DSM-IV as a research diagnosis, 
PCS has been removed as a standalone disorder from the DSM-5 in favor of “major or mild 
neurocognitive disorder due to TBI.”19 In addition, there is overlap between the diagnostic 
criteria for PCS and posttraumatic stress disorder (PTSD),20 further complicating the diagnosis 
of PCS. Therefore, it has been suggested that mTBI sequelae are more accurately understood as 
“post-concussive symptoms” rather than PCS.5,21 Nevertheless, prior efforts to identify and create 
prediction models of post-concussive symptoms have relied on surveying the entire constellation 
of PCS rather than analyzing individual symptoms and/or domains.22-24
The Rivermead Post-Concussion Symptoms Questionnaire (RPQ) is one validated metric to 
survey post-concussive symptoms, relying on self-report as to the presence and severity of 
16 symptoms.16,17,25 It has been widely utilized to characterize outcomes and formally endorse 
symptomatology across the acute and chronic phases following mTBI.26-29 The RPQ is composed 
of individual symptom domains: cognitive deficits, somatic complaints, and emotional complaints 
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– as described above.16 Thus, the RPQ permits separate analysis of potential predictors of post-
concussive symptoms in each domain. As different domains likely reflect different etiological 
pathways, one hypothesis is that each domain may be differentially susceptible to patient-
specific and clinical factors. Alternatively, these complaints may reflect more global processes 
and therefore may not demonstrate differential susceptibility. The predictors that overlap 
across domains (cognitive, somatic, and emotional), and the predictors specific to each domain, 
warrant further delineation. Utilizing the prospective multicenter Transforming Research and 
Clinical Knowledge in Traumatic Brain Injury Pilot (TRACK-TBI Pilot) dataset,30 we investigated 
whether cognitive, somatic, and emotional symptoms have different predictors, and whether 
multivariable prediction modeling using patient demographics and clinical variables can be 
successfully applied to identify those at greatest risk for suffering post-concussive symptoms 
following mTBI. 
Material and methods
This study was conducted and reported according to the criteria of the Transparent Reporting 
of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) statement.31
Study design
The TRACK-TBI Pilot study was a multicenter, prospective observational study conducted at three 
Level I Trauma Centers in the United States: San Francisco General Hospital (SFGH), University 
of Pittsburgh Medical Center (UPMC), and University Medical Center Brackenridge (UMCB) 
in Austin, Texas using the National Institute of Neurological Disorders and Stroke (NINDS) TBI 
Common Data Elements (CDEs) version 1 (https://commondataelements.ninds.nih.gov/TBI.
aspx). Eligible subjects were enrolled upon presentation to the ED through convenience sampling 
at all three sites between April 2010 and June 2012. Institutional Review Board approval was 
obtained at all sites. Informed consent was obtained for all participants prior to enrollment in 
the study. For participants unable to provide consent due to their injury, consent was obtained 
from their legally authorized representative. Participants were re-consented, if cognitively able, 
at later inpatient and/or outpatient study follow-up assessments. The current analysis focuses 
on post-concussive symptoms as measured by the RPQ; other outcome measures obtained at 
six months post-injury included the Glasgow Outcome Scale-Extended (GOS-E), Brief Symptom 
Inventory – 18 Item, Post-Traumatic Stress Disorder Checklist – Civilian Version, Trailmaking Test, 
and California Verbal Learning Test, Second Edition, as previously described.30
Patient selection
Inclusion criteria for the TRACK-TBI Pilot study were adult patients (age ≥ 16 years) presenting to 
one of the participating Level I trauma centers suffering external force trauma to the head with 
sufficient indications to triage to clinically indicated head computed tomography (CT) scan within 
24 hours of injury. There were no requirements for visible pathology on CT scan.30 Exclusion 
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criteria were pregnancy, comorbid life-threatening disease, incarceration, serious psychiatric and 
neurologic disorders that would interfere with outcome assessment, and non-English speakers 
due to limitations in participation with outcome assessments. For the present study, our analysis 
was restricted to the subset of patients with mTBI, defined by a GCS ≥ 13. 
Measurements
To assess the presence/absence and severity of post-concussive symptoms, subjects completed 
the RPQ at six months following injury, in-person with trained study personnel, preceded by the 
Galveston Orientation and Amnesia Test to assess capacity. All study personnel were trained 
on outcome measure administration by a single neuropsychological outcomes coordinator 
from UPMC. As previously described, the RPQ is a sensitive and validated assessment tool 
for the presence of post-concussive symptoms16,17,25-29 and is a “CORE” level NINDS TBI CDE.32 
It is comprised of questions directed toward the following 16 symptoms: headache, nausea 
or vomiting, dizziness, sensitivity to noise, disrupted sleep, irritability, frustration, fatigue, 
depression, impaired memory, poor concentration, slowed thinking, blurred vision, double 
vision, light sensitivity, and restlessness. Each symptom is rated on a 5-point scale to assess 
whether the symptom has been absent, no more of a problem, or a mild, moderate, or severe 
problem in the 24 hours prior to completing the questionnaire, compared to pre-injury. As 
recommended by previous research,33 the scores 0 and 1 were collapsed into a single category, 
scored at 0 points. This resulted in a 4-point scale with the following categories: symptom is 
absent or no more of a problem (0), symptom is mild (1), moderate (2), or severe (3). The total 
score was determined by adding up all scores 0 to 3, which results in a minimum score of 0 and 
a maximum score of 48. Subject responses may then be clustered into distinct neuropsychiatric 
domains: (i) cognitive deficits (impaired memory, poor concentration, slowed thinking), 
(ii) somatic complaints (headaches, blurred or double vision, noise sensitivity, dizziness, nausea, 
sleep disturbances, fatigue) and (iii) psychological complaints (irritability, depression, frustration, 
restlessness).16
Selection of candidate predictors
A systematic literature search was performed using subheadings and text words in EMBASE and 
Google Scholar to identify systematic reviews and prior published prediction model developing 
studies that assessed predictors of post-concussive symptoms (or related outcomes) following 
mTBI (see Online Supplement A for the EMBASE search strategy). To maximize the potential 
application of a prediction model to clinical practice, candidate predictors not readily available 
in the ED or during initial clinical evaluation were excluded. The following were chosen as 
candidate predictors: age, gender, years of education, pre-injury seizures, pre-injury migraine 
or headache, pre-injury psychiatric disorders, blood alcohol level (BAL > 80 mg/dl (U.S. legal 
limit); ≤ 80 mg/dl; not measured), GCS score, CT abnormalities (present; absent), posttraumatic 
amnesia (PTA; present; absent; not measured), LOC (present; absent; not measured), and 
extracranial injury. We further included whether subjects suffered a prior TBI per self-report as a 
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potential candidate predictor. Prior TBI was assessed using the NINDS TBI CDEs version 1,34 and 
classified as yes (with or without hospitalization) or no. Although not found in systematic reviews 
and previous prediction modeling studies, we hypothesized that deficits from repeated TBIs may 
be cumulative and thus may result in greater post-concussive symptoms burden. Information 
on candidate predictors was gathered through abstraction of medical records and from patient 
interviews during the index hospital visit. 
Statistical analyses
Baseline characteristics of the overall study population were reported as medians and 
interquartile ranges (IQR), and frequencies and percentages, for continuous and categorical 
variables respectively. To verify whether loss to follow-up resulted in possible bias, we compared 
baseline characteristics of included patients with those patients who had a missing six-month 
RPQ (n = 199), using the Pearson chi-square statistic for categorical variables and the Mann-
Whitney U test for continuous variables. Missing data on candidate predictors were subsequently 
imputed with a single imputation technique, meaning that values for the missing data points were 
estimated in a regression model using all other predictor variables and outcomes as independent 
variables. 
We described the RPQ total scale and subscales (mean, SD, range), and assessed the association 
between the RPQ total scale and subscales and functional outcome (as measured by the GOS-E) 
as well as intercorrelations between scales, using the non-parametric Spearman’s rho correlation 
coefficient. We subsequently calculated Cronbach’s alpha for the RPQ total scales and subscales 
as a measurement of internal consistency. 
To calculate the effect of candidate predictors on the RPQ cognitive, somatic and emotional 
subscales, we used univariable linear regression models with the candidate predictor of interest 
as independent variable and the RPQ subscale as dependent variable. To assess the adjusted 
effect of candidate predictors, we used multivariable linear regression models with all candidate 
predictors as independent variables. Unstandardized β’s and p-values were reported. The β 
coefficient indicates the change in outcome (points on the RPQ scale or subscale) for one unit 
change in the predictor variable. To enhance comparability of effect estimates for the different 
subscales, we additionally calculated standardized β coefficients. A standardized β indicates the 
change in outcome in SDs, for one SD change in the predictor variable. 
To assess whether the predictor effects differed across cognitive, somatic and emotional subscales, 
we tested for interaction between the predictors (summarized in the predicted values of the RPQ 
total scale) and the subscales. We created three rows per patient in the database: one with the 
cognitive outcome, one with the somatic outcome, and one with the emotional outcome. We 
subsequently fitted a random effects model with a random intercept for patient number, the 
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predicted value of the total RPQ scale based on the full multivariable model, ”outcome type” and 
an interaction between ”outcome type” and predicted value. 
We developed the final model by using the least absolute shrinkage and selection operator 
(Lasso) method. This method shrinks the β-coefficients in order to obtain less extreme βs to 
enhance the external validity of a prediction model.35 Variables with βs that are unstable are 
shrunk to zero and omitted from the model. It should be noted that Lasso shrinkage focuses 
on the overall fit rather than statistical significance of individual predictors. As a consequence, 
predictors with a p-value > 0.05 could still be included in the final model. External validity of the 
final model was further enhanced by performing bootstrap validation with 100 samples. 
The interaction test, Lasso shrinkage, and bootstrap validation were analyzed with R (version 
3.2.2.) using the lme4,36 penalized37 and foreign38 packages. All other analyses were performed 
using the Statistical Package for the Social Sciences (SPSS) version 21. A p-value < 0.05 was 
considered statistically significant in all analyses.
Sensitivity analyses
Although a prediction model with a linear outcome is statistically more appealing, models with a 
binary outcome variable are often preferred for clinical interpretation. We therefore performed 
multivariable logistic regression analysis with the variables obtained after Lasso shrinkage 
as independent variables and the dichotomized RPQ scale as dependent variable. For the 
dichotomization of the RPQ we utilized the eight symptoms mentioned in the ICD-10 criteria. 
Subjects were subsequently diagnosed with PCS if they meet three or more of the following 
symptoms: (1) headache, (2) dizziness, (3) fatigue, (4) irritability, (5) insomnia, (6) memory 
problems, (7) concentration issues, and (8) frustration or depression (in ICD-10 explained as 
reduced tolerance to stress, emotional excitement or alcohol). It should be recognized that the 
RPQ could not be used to truly diagnose ICD-10 PCS since the RPQ is based on self-report rather 
than clinical examination and does not include information on symptom duration and clinical 
significant impairment. In addition, there is no consensus as to whether symptoms should 
be included if they are rated as “mild symptom or worse” or if they are rated as “moderate 
symptom or worse.”39 We therefore applied both classifications.
We further examined the influence of attrition on estimates of the predictors by simulating three 
scenarios:
1. The patients lost to follow-up have relatively favorable outcomes in comparison to those 
included in current study
2. The patients lost to follow-up have similar outcomes to those included in current study
3. The patients lost to follow-up have relatively unfavorable outcomes in comparison to those 
included in current study
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For the first scenario, we simulated the outcome of those lost to follow-up by generating random 
numbers with the range 0-48 (possible scores on RPQ), a mean of 0.00 (25th percentile of those 
included), and a SD of 10.0 (actual SD of those included). For the second scenario, we simulated 
outcome of those lost to follow-up with the range 0-48, a mean of 5.0 (median of those included), 
and a SD of 10.0 (actual SD of those included). For the third scenario, we simulated outcome with 
the range 0-48, a mean of 15 (75th percentile of those included), and a SD of 10.0 (actual SD of 
those included). For simplicity, we did not predetermine the associations between predictors 
and attrition, while acknowledging that this may play a role in the influence of attrition on effect 
estimates.
Results
Patient characteristics
The TRACK-TBI Pilot study consisted of 580 TBI subjects, of whom 476 had mTBI (GCS 13-15); 277 
subjects (58%) completed six-month RPQ assessment and were included in the current analysis 
(Figure 1). Included subjects had more years of education (median: 14) than those lost to follow-
up (median: 13, p < 0.01). No other statistically significant differences existed between those 
included in the current analysis versus lost to follow-up (Table 1). 
Figure 1. Flow-chart of included patients in current study
Figure shows patients from the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK TBI) pilot study that 
were included in current study
Median age for subjects in the current analysis was 42 years (Interquartile range 26-57y) and 
most (70%) were male. Half of the subjects (n = 141) sustained a traffic accident. Fifty-four 
percent (n = 147) reported a prior TBI, for whom 88 were hospitalized. By ED triage, 38% were 
discharged home, 35% were admitted to the ICU or other monitored inpatient bed, 23% were 
admitted to the ward, and 4% went directly to the operating room.
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Table 1. Baseline characteristics of 277 subjects included in the study compared to 199 subjects lost to 
follow-up
Included subjects  
(n = 277)
Subjects lost to follow-up  
(n = 199)
Variable Missing N (%)‡ Missing N (%)‡ p-value
Age (median, IQR range) - 42 (26-57) - 43 (27-57) .66
Gender (Female) - 84 (30%) - 51 (26%) .26
Years of education (median, IQR range) 11 14 (12-16) 7 13 (12-15) < .01
Pre-injury seizures* - 30 (11%) - 18 (9%) .52
Pre-injury migraine & headache - 36 (13%) - 15 (8%) .06
Pre-injury psychiatric disorders** - 89 (32%) - 49 (25%) .08
Prior TBI 7 147 (54%) 14 84 (45%) .06
Mechanism of injury 1 - .11
 – Traffic accident 141 (51%) 83 (42%)
 – Fall 84 (30%) 70 (35%)
 – Assault 39 (14%) 40 (21%)
 – Other 12 (5%) 6 (2%)
BAL - - .41
 – ≤ 80 mg/dl (low BAL) 80 (29%) 53 (27%)
 – > 80mg/dl (high BAL) 39 (14%) 37 (19%)
 – Not measured 158 (57%) 109 (54%)
GCS < 15 - 63 (23%) - 56 (28%) .18
CT abnormalities*** - 95 (34%) - 74 (37%) .52
PTA
 – Yes or suspected
 – No
 – Unknown
1
173 (63%)
90 (32%)
13 (5%)
2
112 (56%)
72 (37%)
13 (7%)
.38
LOC
 – Yes
 – No
 – Unknown
2
190 (69%)
66 (24%)
19 (7%)
1
132 (67%)
55 (28%)
11 (5%)
.58
Extracranial AIS ≥ 3 in at least one body region - 36 (13%) - 32 (16%) .34
ED disposition - - .33
 – Home 105 (38%) 62 (31%)
 – Hospital ward 63 (23%) 42 (21%)
 – Step-down bed or ICU 97 (35%) 88 (44%)
 – Operating room 12 (4%) 7 (4%)
‡Values are presented as N (%) unless otherwise specified. 
p-value presents results of Chi-Square test (categorical variables) or Mann-Whitney U test (continuous variables) for the differences 
between the included subjects and subjects that were lost to follow-up. 
* Includes seizures and epilepsy. 
** Includes anxiety, depression, sleeping disorders and bipolar disorder. 
*** Includes EDH, SDH, SAH, contusion, ICH, IVH, DAI, brain swelling, midline shift, cistern compression, fourth ventricle shift and third 
ventricle shift. 
Abbreviations: BAL = blood alcohol level; ED = emergency department; TBI = traumatic brain injury; GCS = Glasgow Coma Scale; CT = 
computed tomography; PTA = posttraumatic amnesia; LOC = loss of consciousness; AIS = abbreviated injury scale. 
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At six-months post-injury, the mean RPQ score was 8.8 (SD = 10.0). Fifty-three percent (n = 147) 
reported at least three or more out of the eight symptoms defined for PCS by ICD-10 as ‘mild or 
worse,’ while 27% (n = 74) reported at least three out of eight symptoms rated as ‘moderate or 
worse.’ 
RPQ scales
The RPQ cognitive, somatic, and emotional subscales, and the RPQ total scale all demonstrated 
a skewed distribution with the majority of patients having relatively lower scores (Table 2). 
Cronbach’s alpha was > 0.80 for the subscales and the total scale, indicating adequate internal 
consistency.40 The RPQ total scale and subscales demonstrated moderate correlation with the 
GOS-E at six-months post-injury (r -0.61 to -0.71; p < 0.01), indicating that higher RPQ scores 
were associated with worse functional outcome. Inter-correlations between subscales were 
moderate (r 0.63 to 0.76; p < 0.01).
Table 2. RPQ outcome scales six months after mild traumatic brain injury
Psychometric characteristics Correlations
No. 
Items
Mean SD Range Possible 
range
Cronbach’s 
alpha
GOSE RPQ 
cognitive 
Scale
RPQ 
Somatic 
Scale
RPQ 
Emotional 
Scale
RPQ Cognitive scale 3 2.25 2.74 0-9 0-9 .92 -.61* -
RPQ Somatic scale 9 4.32 5.34 0-27 0-27 .85 -.65* .63* -
RPQ Emotional scale 4 2.19 3.07 0-12 0-12 .89 -.64* .69* .76* -
RPQ Total scale 16 8.76 10.03 0-44 0-48 .93 -.71* .82* .94* .90*
* p < .01
Results are presented after collapsing the RPQ scores 0 (no problem) and 1 (no more of a problem) together. 
Correlation coefficients represent non-parametric Spearman’s rho correlation coefficients.
Cognitive scale is based on the items forgetfulness, poor concentration and taking longer to think
Somatic scale is based on the items headache, dizziness, nausea, noise sensitivity, sleep disturbance, fatigue, blurred vision, light 
sensitivity and double vision
Emotional scale is based on the items irritability, depressed, frustrated and restlessness
Abbreviations: RPQ = Rivermead Post Concussion Questionnaire; SD = standard deviation; GOSE = Glasgow Outcome Scale Extended
Predictors of cognitive, somatic, and emotional post-concussive symptoms
The cognitive, somatic, and emotional subscales were significantly associated with years of 
education (p < 0.01), pre-injury psychiatric disorders (p < 0.01), and prior TBI (p < 0.01) in both 
univariable and multivariable linear regression analyses. Strengths of the effect sizes, illustrated 
with standardized βs, were similar across the three different scales (Online Supplement B). 
In addition, age, pre-injury seizures, pre-injury migraine and headache, and CT abnormalities 
were significant predictors for one or more subscales (Table 3). The interaction test between 
the cognitive, somatic, and emotional outcome subscales and the predicted value of the RPQ 
total scale was not statistically significant (t = 0.54; SE = 0.02). This indicates that although some 
differences exist on an individual predictor level, overall predictor effects are similar for the three 
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subscales. Hence, one prediction model using the RPQ total scale as the outcome measure of 
choice could be developed from the current dataset – which comprised the next phase of our 
analysis.
Prediction model of six-month post-concussive symptoms
The RPQ total scale was significantly associated with years of education (p < 0.01), pre-injury 
seizures (p = 0.03), pre-injury migraine and headache (p < 0.01), pre-injury psychiatric disorders 
(p < 0.01) and prior TBI (p < 0.01) in univariable analyses. In a multivariable model, the variables 
years of education (p < .01), pre-injury psychiatric disorders (p < 0.01), and prior TBI (p < 0.01) 
were statistically significant. We applied Lasso shrinkage to obtain the final set of independent 
predictors and their shrunken βs. After shrinkage, the occurrence and severity of persistent 
post-concussion symptoms (higher scores on the RPQ) were associated with older age, female 
gender, less years of education, a confirmed or unknown PTA, a confirmed or unknown LOC and 
the presence of pre-injury migraine and headache, pre-injury psychiatric disorders and prior TBI 
(Table 4). Comparison of the expected values of the scales with the actual scores resulted in an R2 
of 0.21, which decreased to 0.14 after bootstrap validation. The expected score on the subscales 
and total scale could be calculated for individual patients by using the regression formula (Table 
4, footnote). An example of the calculation for two individual patients is displayed in Box 1. 
Sensitivity analyses
Multiple logistic regression analyses with the variables obtained after Lasso shrinkage resulted 
in the same set of predictors being statistically significant (PCS classified as ≥ 3 ‘mild or worse’ 
symptoms: years of education OR = 0.84 (95% CI: 0.76-0.93), pre-injury psychiatric disorders 
OR = 2.05 (95% CI: 1.14-3.68), prior TBI OR = 2.94 (95% CI: 1.71-5.08); PCS classified as ≥ 3 
‘moderate or worse’ symptoms: years of education OR = 0.87 (95% CI: 0.77-0.97), pre-injury 
psychiatric disorders OR = 3.24 (95% CI: 1.77-5.91), prior TBI OR = 2.08 (95% CI: 1.10-3.93)). 
Female gender was a statistically significant predictor of PCS classified as ≥ 3 ‘mild or worse’ 
symptoms (OR 2.02; 95% CI: 1.11-3.68). The Areas under the Curve (AUCs) ranged from 0.74 
to 0.76, indicating reasonable discriminative ability (Online Supplement C). We did not apply 
further model development (e.g., shrinkage, bootstrap validation), since our sample size was too 
small to develop a valid model with a binary outcome. 
When analyzing different scenarios of attrition, the scenarios in which patients lost to follow-
up had similar or more favorable outcomes did not result in major changes in effect estimates. 
However, in the scenario where patients lost to follow-up had relatively unfavorable outcomes, 
prior TBI was no longer a statistically significant predictor of six-month post-concussive symptoms, 
while age, GCS, and PTA became significant predictors. 
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Box 1. Two cases and their predicted score on the RPQ scale according to our prediction 
model
Case 1 : Male patient, 65 years, 23 years of education with pre-injury headache or migraine, a pre-injury psychiatric 
disorder, a prior TBI, LOC, and PTA.
Predicted value total RPQ scale after six months = 14.45 (intercept) + (0.74*0) + (0.05*65) + (-0.79*23) + (2.07*1) + 
(3.73*1) + (3.71*1) + (-0.47*0) + (-0.38*0) = 9.04 (95% CI: 4.57 – 13.50)
Case 2: Female patient, 30 years, 10 years of education with pre-injury headache or migraine, a pre-injury psychiatric 
disorder and no prior TBI, LOC and PTA
Predicted value total RPQ scale after six months = 14.45 (intercept) + (0.74*1) + (0.05*30) + (-0.79*10) + (2.07*1) + 
(3.73*1) + (3.71*0) + (-0.47*1) + (-0.38*1) = 17.45 (95% CI: 13.00 – 21.90)
Expected scores can be calculated with the regression formula in the footnote of Table 4. The 95% Confidence interval can only be 
calculated with advanced statistical software. 
Table 4. Predictors of six-month post-concussive symptoms in 277 patients with mild traumatic brain 
injury
Predictors Univariable 
(β, p-value)
Multivariable 
(β, p-value)
LASSO shrinkage 
(β)
Age (/10y) 0.50 (p = .16) 0.58 (p = .08) 0.53
Gender (Female vs Male) 1.18 (p = .37) 1.68 (p = .19) 0.74
Years of education (/y) -0.94 (p < .01) -0.84 (p < .01) -0.79
Pre-injury seizures* (yes vs. no) 4.30 (p = .03) 0.91 (p = .63) -
Pre-injury migraine & headache (yes vs. no) 6.95 (p < .01) 3.30 (p = .06) 2.07
Pre-injury psychiatric disorders** (yes vs. no) 6.28 (p < .01) 4.15 (p < .01) 3.73
Prior TBI (yes vs. no) 5.11 (p <.01) 4.34 (p < .01) 3.71
BAL
 – high BAL vs. low/unmeasured
 – unmeasured BAL vs. high/low
-0.19 (p = .92)
-0.70 (p = .61)
-0.49 (p = .80)
-0.80 (p = .54)
-
-
GCS 13 or 14 vs GCS 15 1.07 (p = .46) 0.62 (p = .66) -
CT abnormalities*** (yes vs. no) -2.17 (p = .09) -0.31 (p = .82) -
PTA
 – yes vs. no/unknown
 – no vs. yes/unknown 
-0.47 (p = .87)
-0.53 (p = .86)
0.06 (p = .98)
-1.36 (p = .64)
-
-0.47
LOC
 – yes vs. no/unknown
 – no vs. yes/unknown
-0.94 (p = .70)
-2.65 (p = .31)
-1.02 (p = .66)
-2.01 (p = .43)
-
-0.38
Extracranial AIS ≥ 3 in at least one body region  
(yes vs. no)
-1.20 (p = .51) -1.09 (p = .52) -
R2 0.23 0.21Ⱡ
Unstandardized β’s and p-values are shown for all analyses. The multivariable model is based on all candidate predictors in the table. 
The expected 6-months RPQ score can be estimated with the following formula: 
6 month RPQ = 14.45 + (0.05*Age) + (-0.79*Years of education) + (0.74*female gender) + (2.07*pre-injury migraine or headache) + 
(3.73*pre-injury psychiatric disorder) + (3.71*prior TBI) + (-0.47* no PTA) + (-0.38*no LOC)
*Includes seizures and epilepsy 
**Includes anxiety, depression, sleeping disorders and bipolar disorder
***Includes EDH, SDH, SAH, contusion, ICH, IVH, DAI, brain swelling, midline shift, cistern compression, fourth ventricle shift and third 
ventricle shift
Abbreviations: BAL = blood alcohol level; ED = emergency department; TBI = traumatic brain injury; GCS = Glasgow Coma Scale; CT = 
computed tomography; PTA = posttraumatic amnesia; LOC = loss of consciousness; AIS = abbreviated injury scale. 
ⱠR2 decreased to 0.14 after bootstrap validation with 100 samples. 
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Discussion
We developed a prediction model to predict six-month post-concussive symptoms following 
mTBI in a multicenter study with 277 subjects. Post-concussive symptoms were associated with 
older age, female gender, less education, pre-injury migraine or headache, pre-injury psychiatric 
problems, prior TBI, PTA, and LOC, of which years of education, presence of pre-injury psychiatric 
disorders and prior TBI were the most robust predictors. This set of predictors accounted for less 
than one-fifth of the variance in post-concussive symptoms. 
Previous investigations have often reported that PCS is a multidimensional concept.5,16,17,33,41,42 
Therefore, it has been hypothesized that the cognitive, somatic, and emotional RPQ subscales 
are differentially susceptible to predictor variables. We did not find a difference in the predicted 
probabilities of the total set of candidate predictors for the three subscales, and therefore, we 
developed one overall prediction model for six-month post-concussive symptoms using the 
RPQ total scale. This might indicate that post-concussive symptoms from different domains 
share etiological factors. However, we did find differences in the predictive ability for some 
predictors (age, pre-injury seizures, pre-injury migraine and headache, CT abnormalities) and 
the inter-correlations between the three subscales were modest. Therefore, confirmation of our 
findings in larger patient samples is necessary to confirm the adequacy of the total RPQ scale 
as an outcome variable in prognostic research. Our final prediction model has an R2 of 0.21, 
which decreased to 0.14 after bootstrap validation. This indicates that less than one-fifth of the 
variation in post-concussive symptoms could be explained by the predictors in the model. Despite 
being low for a prediction model, this is consistent with previous studies examining predictors of 
post-concussive symptoms using the linear RPQ as an outcome measurement. For example, in a 
systematic review conducted by Silverberg et al.43 R2s ranged from 0.06 to 0.89 in six studies that 
used the RPQ as a continuous outcome measurement, and was only above 0.40 in two studies 
deemed at high risk of statistical overfitting.43 
In prior systematic reviews, the most robust predictors of mTBI sequelae were gender, pre-
injury mental health, early post-injury neurological functioning, and post-injury anxiety.43,44 
Consistent with this, pre-injury mental health was also a significant predictor in our study. 
Patients with pre-injury psychiatric disorders are known to be vulnerable to recurrence of the 
psychiatric disorder45 or the development of other psychopathology,46 which might be triggered 
by a stressful or traumatic event such as mTBI. Other significant predictors in our study were 
years of education and prior TBI. Both of these were also candidate predictors in the prediction 
model developed by Stulemeijer et al.24 but were not found to be statistically significant in their 
final model, which was confirmed by the systematic review of Silverberg et al.43 Nevertheless, 
higher education is associated with return to work in several studies,24,47,48 and highly educated 
people generally have improved coping skills, cognitive and financial reserves, and a wider social 
network to deal with possible consequences of mTBI. The influence of prior TBI on persistent 
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post-concussion symptoms is less often studied. However, emerging basic science and clinical 
research on repetitive brain injury suggests that the deleterious effects of brain injury are 
cumulative.49 Therefore, inclusion of a history of prior TBI is an important consideration for future 
work on post-concussive symptoms and other neuropsychiatric sequelae of TBI. The predictors 
age, gender, pre-injury migraine and headache, PTA and LOC also appeared in our final prediction 
model because they contributed to the overall model fit. It however should be noted that they 
were not statistically significantly associated with persistent post-concussion symptoms and their 
potential as predictors should therefore be examined in future studies. 
In creating our prediction model, we attempted to methodologically overcome several of the 
shortcomings of prior work. Our set of candidate predictors was based on existing literature 
and was appropriately limited to not exceed the rule of thumb of a maximum of one candidate 
predictor for every ten cases,50,51 which limits the risk of statistical overfitting.50,52 Additionally, 
we used Lasso shrinkage and bootstrap validation to correct for model optimism, improving 
generalizability of the model.50,52 Third, we examined the influence of predictors on the three 
RPQ subscales and tested whether the total RPQ scale as an outcome variable was adequate. 
The use of the RPQ as a linear scale might also be regarded as a strength of our study. Since 
there is no clear cut-off point determining whether a patient should be diagnosed with PCS, 
dichotomization might result in an arbitrary difference between favorable and unfavorable 
outcome, limiting its potential for clinical practice. For example, in our study we found that two 
different classifications of PCS (i.e. PCS ≥ 3 ‘mild or worse’ symptoms vs. PCS ≥ ‘moderate or 
worse’ symptoms) resulted in a prevalence difference of 26%. Further, dichotomization results 
in a loss of information and potentially overoptimistic results.50 Large sample sizes are needed 
to prevent statistical overfitting in prognostic studies with a dichotomous outcome, especially 
when the prevalence of patients with the outcome of interest is relatively low. In our study, we 
would have needed a total of 599 patients to develop a prediction model with a binary outcome 
variable (PCS defined as ≥ 3 moderate symptoms or worse). On the other hand, models with a 
dichotomized outcome are clinically appealing since these models can directly estimate the risk 
of post-concussive symptoms. In addition, it might be more relevant for clinicians to predict a 
clinical significant problem (e.g., PCS) rather than predicting an increase on the RPQ scale. The 
latter may also necessitate clinically relevant cut-off points that are currently unavailable. To 
improve clinical interpretation, we created a model with a dichotomous outcome for clinical 
interpretation.
We note several limitations. First, there was a significant proportion of subjects lost to follow-up 
(42%). Although this percentage is similar to other prospective studies in mTBI research24,53,54 and 
patients lost to follow-up did not differ from those who remained, we cannot exclude selection 
bias. Patients included in our sample may, for instance, differ from those not included on factors 
that were not measured, or on the severity of their post-concussive symptoms. To estimate the 
possible effect of attrition on our estimation of predictors, we performed sensitivity analyses in 
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which we simulated scenarios where patients lost to follow-up had a more favorable, similar, 
or more unfavorable outcome compared with those included in our study. We did not find 
major differences in the predictive probability of our set of predictors in the scenarios where 
patients lost to follow-up had similar or more favorable outcomes than the included patients. 
This corroborated similar studies analyzing the influence of attrition on predictor estimates.55,56 
However, in the scenario were patients lost to follow-up had less favorable outcomes, additional 
predictors were associated with post-concussive symptoms, while prior TBI, which is a strong 
predictor in this study, was no longer statistically significant. The effect of attrition on outcome 
should therefore be taken into account when interpreting the results of the current study. A second 
limitation is that our sample size is relatively small for the development of a prediction model.57 
Consequently, our study might not have been sufficiently powered to detect the significance 
of some of the candidate predictors and current regression coefficients might be relatively 
unstable.52 Third, in the present study, the included mild TBI patients were relatively severely 
injured. For example, 34% of the patients had CT abnormalities, and the majority of patients had 
PTA and LOC. In addition, 35% of the patients were admitted to step-down beds or the ICU. The 
relative severity of our study population may have implications for the generalizability to other 
populations of mTBI patients. Given these limitations, the results of the current study should be 
considered preliminary; validation in an independent population is needed. 
We chose to develop a model with baseline and clinical predictors that can be gathered during 
the ED visit to maximize the potential application of the model in clinical practice. The inclusion 
of post-injury characteristics may be less useful as mTBI patients may not receive routine follow-
up after leaving the ED.58 However, since our model explained less than one-fifth of the variation 
in six-month post-concussive symptoms, additional variables are likely necessary to obtain more 
reliable predictions. Since early post-injury symptoms have been shown to associate highly with 
chronic symptoms,43 the addition of these symptoms could substantially improve our prediction 
model. Ideally, two models could be developed, validated, and implemented in future ED 
practices. First, a model based on baseline and clinical characteristics collected at ED presentation 
with a high sensitivity should be developed. This model could select high-risk patients that 
should be seen at a follow-up appointment soon after their ED visit. Such a model could be based 
on current findings and could further be refined with larger datasets, more granular variables 
and objective biomarkers. At the follow-up appointment, early post-injury symptoms could be 
further investigated and added to the model. This second model could subsequently identify 
patients at risk for long-term sequelae, who should be prioritized for preventive or rehabilitative 
interventions.
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Conclusion
Demographic and clinical variables at baseline predict post-concussive symptoms after mild 
traumatic brain injury, however these variables explain less than one-fifth of the total variance 
in outcome. Model refinement with larger datasets, more granular variables, and objective 
biomarkers are needed before implementation in clinical practice.
Supplemental material is available at www.marysecnossen.nl
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Abstract
Objectives: To externally validate existing models for persistent post-concussion symptoms, and 
to develop a new model based on the synthesis of existing models and the addition of complaints 
at the emergency department.
Methods: Patients with mild traumatic brain injury (Glasgow Coma Scale score 13-15) were 
prospectively recruited from three Dutch level I trauma centers between 2013-2015 in the 
UPFRONT study. Persistent post-concussion symptoms were assessed using the Head Injury 
Severity Checklist at six-month post-injury. Two prognostic models (Stulemeijer et al.; Cnossen 
et al.) were examined for calibration and discrimination. The final model, based on variables of 
existing models was developed with the addition of headache, nausea/vomiting and neck pain at 
emergency department, using logistic regression and bootstrap validation to correct for model 
optimism.
Results: Overall 591 patients (mean age 51years, 41% female) were included; 241 (41%) 
developed post-concussion symptoms at six months. Existing models performed poorly at 
external validation (AUC: 0.57-0.64). The newly developed model included female sex (OR 1.48, 
95% CI 1.01-2.18), neck pain at emergency department (OR 2.58, 95% CI 1.39-4.78), two-week 
post-concussion symptoms (OR 4.89, 95% CI 3.19-7.49) and two-week posttraumatic stress (OR 
2.98, 95% CI 1.88-4.73) as statistically significant predictors, with adequate discrimination (AUC 
after bootstrap validation: 0.75)
Interpretation: Existing prognostic models for persistent post-concussion symptoms perform 
poorly. A new model including female sex, complaints at emergency department and symptoms 
after two weeks performed reasonably and warrants further external validation. Prediction 
research in mild traumatic brain injury should be improved by standardizing definitions and data 
collection. 
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Introduction
Mild Traumatic Brain Injury (mTBI) is a common condition in the general population1 and 
is associated with substantial burden to patients and relatives and high societal costs.2 A 
considerable proportion of patients with mTBI report post-concussion symptoms (PCS), including 
cognitive (e.g. memory problems, cognitive deficits), somatic (e.g. headache, nausea) and 
emotional symptoms (e.g. depression, irritability) days to weeks following injury.2,3 Although it is 
generally assumed that these symptoms resolve within weeks to months,2-4 recent prospective 
studies indicate persistence of post-concussion symptoms (PPCS) in a large subset of patients six 
months to one year post-injury.5,6 PPCS is associated with work absenteeism7,8 and a reduction 
in health-related quality of life.7,9 Hence, a current priority in mTBI research is the understanding 
of the etiology of PPCS.
Despite an abundant number of studies aiming to identify risk factors for PPCS, no study to date 
has successfully developed a prediction model to identify risk-prone patients.10-12 Such a model 
could be used to flag patients at risk for prolonged sequelae who might benefit from additional 
monitoring or early treatment interventions such as cognitive behavioral therapy.13 One of the 
challenges for prognostic modeling in mTBI is the lack of standardized outcome measurement. 
The Rivermead Post Concussion Questionnaire (RPQ) is often used to assess PPCS but there is a 
lack of consensus on how this scale should be analyzed and interpreted. Previous studies used 
the RPQ total scale,14,15 RPQ subscales16,17 or mapped the International Classification of Diseases 
(ICD)-10 diagnosis of Post-Concussion Syndrome18 to the RPQ. This variation may substantially 
influence prevalence rates and the relevance of predictors across studies18-20 and therefore 
hampers generalizability of prediction research.
Generalizability is further confined by methodological shortcomings of existing prognostic 
studies, including the use of cross-sectional study designs, small sample sizes in combination with 
the examination of a large number of candidate predictors, inappropriate handling of missing 
values, data-driven selection methods and lack of validation.11 None of the models for PPCS have 
been externally validated in an independent patient sample,11 which is necessary to determine 
model validity and to be able to recommend use in clinical practice.21,22 Models for functional 
outcome after mTBI, using the Glasgow Outcome Scale-Extended, have been externally validated 
but performed poorly.23
The aims of this study were: (1) to externally validate existing prognostic models for six-month 
PPCS in an independent sample of patients with mTBI; and (2) to develop a new model (‘The 
UPFRONT-PPCS model’) based on relevant predictors from existing models and complaints at the 
emergency department (ED). Although prognostic research has focused extensively on pre-injury 
characteristics (e.g. pre-injury mental health)10,12 and post-injury characteristics (e.g. two-week 
PCS and posttraumatic stress),10,12 the role of acute complaints at the ED (e.g. headache, nausea, 
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vomiting or neck pain) is less often studied. These complaints have the potential to be relevant 
predictors,24,25 and could be easily applied to a prognostic model as they are gathered during 
standard clinical assessment on ED examination.
Methods
This study was conducted and reported according to the criteria of the ‘Transparent Reporting 
of a Multivariable Prediction Model for Individual Prognosis or Diagnosis’ (TRIPOD) statement.26 
Patient population
Data were obtained from a prospective cohort study conducted in three level I trauma centers in 
the Netherlands (the UPFRONT study).27 Patients admitted to the EDs of these centers between 
2013 and 2015 were included if they were sixteen years or older, had an admission Glasgow Coma 
Scale (GCS) score of 13-15 and had sufficient comprehension of the Dutch language. Exclusion 
criteria included drug or alcohol addiction, homelessness, dementia and whiplash injury without 
loss of consciousness (LOC). The UPFRONT study was approved by the local medical ethics 
committee of the University Medical Center Groningen, which acted as a central committee for 
the three participating centers. All patients provided written informed consent. 
Measurements
Demographics, pre-injury characteristics and complaints at the ED
Demographics and clinical variables and the presence of a prior TBI were extracted from hospital 
records. Education was divided into low (less than 11 years of formal education), middle (11-14 
years of formal education) and high (more than 14 years of formal education) and LOC and PTA 
were noted as present or absent. The following symptoms were examined during ED admission: 
headache, nausea/vomiting and neck pain. Information on pre-injury characteristics was 
examined with a short questionnaire completed by patients.
Post-concussion symptoms
Post-concussion symptoms (PCS) at two weeks and six months post-injury were assessed 
with the Head Injury Symptom Checklist (HISC).28 The HISC consists of 21 frequently reported 
symptoms and patients were asked to complete each item, for both the pre-injury and current 
level, on a 3-point scale (never, sometimes, often). The HISC can be directly mapped to the 
ICD-10 criteria for post-concussion syndrome, since all eight symptoms are examined. Patients 
were subsequently classified as having PCS (persisting for two weeks) and PPCS (persisting for six 
months) if they indicated that at least three of the following symptoms were worse than before 
the injury (difference score of 1 or 2): (1) headache; (2) dizziness; (3); fatigue; (4) irritability; (5) 
difficulties falling asleep or staying asleep; (6) concentration problems; (7) memory difficulties; 
or (8) intolerance of alcohol or being anxious. 
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Posttraumatic stress symptoms
Posttraumatic stress symptoms at two weeks were examined with the Impact of Event Scale 
(IES);29 a 15-item questionnaire in which patients have to rate whether they experience intrusive 
and avoidant posttraumatic stress symptoms on a 5-point Likert scale, resulting in a minimum 
score of 0 and a maximum score of 75. Scores above 26 were classified as severe, in line with 
recommendations.30
Selection of prognostic models
Existing prognostic models were identified by screening reference lists of systematic reviews 
on prognosis following mTBI10,12 and by updating the search strategy of Silverberg et al.10 until 
March 2017. Models were considered for our external validation study if they were developed 
in prospectively collected data on adult (age ≥ 16 years) patients with mTBI (Table 1). To be 
included, studies had to fulfill at least one out of three quality criteria:21 1) A large sample size 
(N > 500 patients); 2) > 10 cases (patients with PCS) for each candidate predictor consider; or 
3) the use of shrinkage or internal validation. 
Two models met our eligibility and quality criteria (Online Supplement A).19,31 Stulemeijer et al.31 
had developed a prediction model based on data from a level I trauma center in the Netherlands 
(2004-2006) to predict six-month PPCS using the RPQ. They investigated 201 patients among 
whom 49 developed PPCS. Among the 19 candidate predictors, three (pre-injury physical 
comorbidities, early PCS, early posttraumatic stress) were included in their final model. The final 
model had an Area Under the Curve (AUC) of 0.82, which decreased to 0.73 after bootstrap 
validation. 
Cnossen et al.19 had developed a prediction model based on 277 patients from three level 
I trauma centers in the United States (2010-2012) applying the RPQ. The RPQ was used as a 
linear scale and 14 candidate predictors available at the ED were considered. After least absolute 
shrinkage and selection operator (lasso) procedure and bootstrap validation, the final model 
with 8 predictors (age, sex, years of education, pre-injury migraine or headache, pre-injury 
psychiatric disorders, prior TBI, PTA and LOC) explained 14% of the variation in outcome. The 
final set of predictors was examined in a logistic model with the RPQ dichotomized according 
to the ICD-10 criteria, resulting in an AUC of 0.74. A list of included and excluded studies as 
well as detailed characteristics of the included prediction models are presented in the Online 
Supplements B and C.
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Table 1. Eligibility criteria for the external validation of existing prediction models in the curent study
o Data:
o Prospectively collected 
o Patients:
o Patients with mild TBI (GCS 13-15)
o Adult patients (age ≥ 16 years)
o Outcome:
o Examined at ≥ 6 months post-injury
o Outcome measurement: HISC or another self-reported measurement in which the prevalence of post-concussion  
  symptoms was broadly dichotomized into ‘PCS according to the ICD-10 criteria’ and ‘no PCS according to the  
  ICD-10 criteria’
o Predictors:
o ≥ 80% of the predictors in the model should be measured in the current study
o Quality Requirements model: 
o Multivariable model of at least two predictors
o At least one out of three quality criteria reported by Mushkuadini et al.21
1. Large sample size (N > 500)
2. > 10 cases (patients with PCS) for each candidate predictor considered 
3. The use of shrinkage and/or internal validation
Abbreviations: GCS = Glasgow Coma Scale; HISC = head injury severity scale; ICD = international classification of diseases; PCS = post-
concussion symptoms; TBI = traumatic brain injury 
Statistical analyses
Patient characteristics were reported by medians and interquartile ranges (IQR) for continuous 
variables and frequencies and percentages for categorical variables. To assess the possible 
influence of loss to follow-up, we compared characteristics of patients who completed the 
six-month outcome assessment and patients who were lost to follow-up using Chi-Square and 
Mann-Whitney U tests, since all continuous variables had a skewed distribution. Missing data on 
candidate predictors were subsequently imputed using multiple imputation.
The external validity of two existing models was assessed in terms of calibration and discrimination. 
Calibration refers to the agreement between observed and predicted outcomes. Calibration was 
graphically assessed and expressed as calibration-in-the-large, indicating whether predictions 
are systematically too low (calibration-in-the-large > 0) or too high (calibration-in-the-large < 0) 
and calibration slope (indicating the average strength of predictor effects and ideally equal to 1). 
Discrimination refers to the ability of a model to distinguish between patients who will develop 
PPCS and patients who will not develop PPCS and was expressed as the AUC. An AUC of 1 implies 
perfect discrimination and an AUC of 0.5 indicates that the model is no better than random 
chance. All variables from the Stulemeijer et al.31 and Cnossen et al.19 models were available 
in the UPFRONT data. However, education was measured as a continuous variable in study by 
Cnossen et al.19 but as a categorical variable in the UPFRONT dataset. Therefore, for the external 
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validation we used the mean years of education for each category (low education: 8 years, middle 
education: 12 years, higher education: 15 years).
To examine the role of complaints at the ED (headache, nausea or vomiting, neck pain) we 
developed a new model with all predictors from the Stulemeijer et al.31 and Cnossen et al.19 
models in a backwards selection procedure (p < .157).32 We subsequently assessed whether the 
addition of complaints at the ED significantly improved this model by comparing goodness-of-fit 
of a model with and without complaints at the ED. To correct for optimism of the new model, we 
used bootstrap validation with 100 samples, where all modeling steps were repeated. Analyses 
were performed using SPSS statistics version 21.0 and R (version 3.2.2) using the rms, foreign, 
pROC and mice packages. 
Results
Patient population
A total of 1,151 patients were included in the UPFRONT study, of whom 591 (51%) completed the 
six-month outcome assessment. Included patients had a median age of 51 years (Interquartile 
range 32 to 64) and 41% (n = 241) were female. Sixteen per cent (n = 94) had intracranial 
traumatic abnormalities on the initial head computed tomography (CT) scan. Patients included in 
the study were significantly older (p < 0.01), more often female (p = 0.03) and showed more CT 
abnormalities (p = 0.01) than patients lost to follow-up. In addition, patients included in the study 
less often reported pre-injury psychiatric disorders (p = 0.04) and more often reported pre-injury 
physical disorders (p = 0 .04, Table 2).
Persisting post-concussion symptoms
At six months post-injury, 370 patients (63%) reported at least one out of eight symptoms. A 
total of 241 patients (41%) reported three or more symptoms, indicating PPCS according to our 
criteria. Fatigue (38%), concentration problems (36%) and memory problems (35%) were most 
frequently reported (Figure 1).
External validation of existing models 
Both existing models performed poorly; with an AUC of 0.64 (95% CI 0.60-0.68) for the Stulemeijer 
et al. model31 and an AUC of 0.57 (95% CI 0.52-0.62) for the Cnossen et al. model19 (Figure 2). 
Both models systematically underestimated the proportion of patients with PPCS (calibration-in-
the-large > 0) and average effects of the set of predictors were too low (calibration slopes < 1).
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Table 2. Characteristics of 591 subjects included in the study and 560 subjects lost to follow-up
Included subjects  
(n = 591)
Subjects lost to follow-up  
(n = 560)
Variable Missing N (%) Missing N (%) p-value
Demographic and preinjury characteristics 
Age (median, IQR range) - 51 (32-64) - 34 (22-53) < .01
Sex (Female) - 241 (41%) 194 (35%) .03
Education† 31 249 .07
 – Low 105 (19%) 66 (21%)
 – Middle 210 (37%) 134 (43%)
 – High 245 (44%) 111 (36%)
Preinjury psychiatric disordersⱢ 30 58 (10%) 238 58 (18%) < .01
Preinjury physical disorders‡ - 185 (31%) - 145 (26%) .04
Preinjury headache or migraine 57 156 (29%) 279 87 (31%) .60
Prior TBI 131 15 (3%) 113 27 (6%) .05
ED characteristics 
CT abnormalitiesⱡ 13 94 (16%) 8 61 (11%) .01
LOC 3 494 (84%) 3 483 (87%) .20
PTA 37 490 (88%) 41 440 (85%) .08
Headache 87 263 (52%) 63 259 (52%) .98
Nausea or vomiting 92 173 (35%) 78 174 (36%) .64
Neck pain 120 71 (15%) 97 91 (20%) .07
Early postinjury symptoms
2-week PCS¥ 160 240 (56%) 348 108 (51%) .26
2-week posttraumatic stressⱠ 117 114 (22%) 287 69 (25%) .20
†Low education = less than 11 year of formal education; middle education = 11-14 years of formal education; high education = 15 or 
more years of formal education
ⱢIncludes any psychiatric disorder necessitating treatment by a psychologist or psychiatrists or use of psychotropic medication, or both
‡Includes cerebrovascular accident, heart diseases, hypertension, diabetes, asthma or other respiratory diseases, epilepsy or any 
malignant disorder 
ⱡAny lesions, compressed cisterns or midline shifts
¥Meeting the ICD-10 criteria for post-concussion symptoms, 2 weeks postinjury. 
ⱠScore on the Impact of Events Scale above 26, 2 weeks postinjury
Abbreviations: ED = emergency department; CT = computed tomography; IQR = interquartile range; LOC = loss of consciousness; 
PCS = post-concussion symptoms; PTA = posttraumatic amnesia; TBI = traumatic brain injury
Development of the UPFRONT-PPCS model
Backward selection (p < 0.157) with all variables from the Stulemeijer et al. and Cnossen et 
al. models19,31 resulted in the inclusion of three variables: female sex (OR 1.48, 95% CI 1.01-
2.18), two-week PCS (OR 4.89, 95%CI 3.19-7.49) and two-week posttraumatic stress (OR 2.98, 
95% CI 1.88-4.73; Table 3). PCS after two weeks was the strongest predictor: among the 241 
patients with six-month PPCS, 192 (80%) already reported three or more symptoms after two 
weeks and almost all patients (n = 233, 97%) reported at least one symptom after two weeks. 
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However, among the patients reporting three or more symptoms after two weeks (n = 333), only 
half (n = 192) still reported three or more symptoms after six months. In the other half, early PCS 
resolved over time. 
Figure 1. Frequency of post-concussion symptoms six months post-injury
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Fa!gue
Percentage of pa!ents 
repor!ng that the symptom was 
worse than before the injury
The addition of complaints at the ED (headache, nausea or vomiting and neck pain) significantly 
improved the model (p < 0.01). Of these complaints, only neck pain was statistically significantly 
associated with six-month PPCS (OR 2.58, 95% CI 1.39-4.78). The AUC of the final prediction 
model was 0.77 and decreased to 0.75 after bootstrap validation (Table 3). An overview of all 
uni- and multivariable associations of predictors is shown in Table 4.
Table 3. Prediction model for six-month PPCS based on existing models and the role of ED symptoms
Variable OR (95% CI)
Female sex 1.48 (1.01-2.18)
Nausea or vomiting 0.88 (0.54-1.43)
Headache 0.94 (0.61-1.47)
Neck Pain 2.58 (1.39-4.78)
2-week PCS 4.89 (3.19-7.49)
2-week posttraumatic stress 2.98 (1.88-4.73)
AUC 0.77
AUC after bootstrap validation 0.75
Intercept: B = -2.241
Abbreviations: AUC = area under the curve; PCS = post-concussion symptoms
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Figure 2. Calibration plots for external validation Stulemeijer et al. and Cnossen et al. models 
X-axis shows predicted probabilities by the model in quantiles of patients and Y-axis shows observed proportion. The dotted diagonal 
lines represent perfect predictions. The triangles indicate the observed outcome frequency in quantiles of predicted probabilities, with 
95% confidence interval. Calibration -i.t.l= Calibration-in-the-large.
Table 4. Univariable and Multivariable Associations of all predictors in this study and 6-month PPCS
Variable Univariable association 
OR (95% CI)
Multivariable association 
OR (95% CI)
Age† 0.99 (0.99-1.00) 0.99 (0.98-1.01)
Female gender† 2.40 (1.60-3.14) 1.56 (1.05-2.32)
Education†
 – Low vs medium / high 1.10 (0.69-1.73) 0.87 (0.54-1.72)
 – Medium vs low/high 1.26 (0.87-1.83) 1.39 (0.91-2.13)
Preinjury physical comorbidities†‡ 1.05 (0.74-1.50) 1.20 (0.73-1.95)
Preinjury migraine or headache† 1.06 (0.74-1.51) 0.96 (0.63-1.47)
Preinjury psychiatric disorders† 1.63 (0.92-2.86) 1.18 (0.64-2.18)
Prior TBI† 1.22 (0.46-3.27) 1.25 (0.34-4.62)
PTA† 1.41 (0.82-2.40) 1.06 (0.55-2.03)
LOC† 0.92 (0.59-1.44) 0.89 (0.53-1.50)
2-week PCS‡ 5.82 (3.94-8.60) 5.18 (3.39-7.91)
2-week posttraumatic stress‡ 3.22 (2.12-4.50) 3.15 (1.93-5.16)
ED symptoms
Headache 1.46 (1.03-2.07) 1.15 (0.73-1.75)
Nausea or vomiting 1.31 (0.85-2.01) 1.13 (0.73-1.76)
Neck pain 3.66 (2.23-6.01) 3.44 (2.05-5.78)
In the multivariable model, all variables are included. Therefore, the effect estimates might diverge slightly from the effect estimates 
in Table 3 
‡Variable derived from Stulemeijer et al. model
†Variable derived from Cnossen et al. model
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Discussion
Two existing prognostic models for persistent post-concussion symptoms (PPCS) performed 
poorly in the UPFRONT data. A new model including female sex, complaints at the ED and two-
week PCS and posttraumatic stress as predictors for six-month PPCS, performed reasonably. 
This is the first study that externally validated prognostic models specifically for PPCS following 
mTBI. Strengths of our study include the comprehensive search strategy for existing models 
and the large sample size, which is a requirement for external validation of logistic regression 
models.33,34 In addition, our final prediction model was developed according to methodological 
recommendations for prediction modeling.11,21,22,35 Limitations include the high percentage of 
patients lost to follow-up. Although follow-up rates were similar to other prospective studies 
in patients with mTBI,6,36 selection bias cannot be excluded, which could have influenced the 
significance of predictors.19 For example, our sample has a relatively large proportion of females 
and patients with intracranial CT abnormalities. In addition, our outcome measurement (HISC) 
differed from the outcome measurement used in both development studies (RPQ). The HISC 
includes eight symptoms from the ICD-10 criteria for post-concussion syndrome, whereas the 
RPQ includes only seven out of eight symptoms. In addition, using the HISC, patients rated 
symptoms for both their current and pre-injury situation and symptoms were only included if 
there was evidence of deterioration. In comparison, using the RPQ, patients had to provide one 
rating in which they were asked to compare current symptoms with symptoms before the injury. 
The difference in outcome measurement may have contributed to the poor model performance. 
For example, poor calibration-in-the-large of both models may have resulted from differences in 
outcome measurement and subsequent differences in prevalence rates of PPCS among studies. 
Another potential source for unsatisfactory model performance in external validation is poor 
modeling methodology in the development studies.22,37 In the model by Stulemeijer et al.31 
the relatively small sample size, the consideration of a large number of candidate predictors 
and data-driven selection methods, may have resulted in statistical overfitting.22,37 Statistical 
overfitting means that a model appears to predict outcome well in the development population, 
but performs poorly in new patients.37 An example is the extreme, and potentially imprecise 
effect estimate for early posttraumatic stress (OR = 10.0) in the development data, which 
was based on only 16 patients scoring above the cut-off point.31 This may have contributed to 
the low calibration slope found in external validation. In the Cnossen et al.19 study, modeling 
methodology was in line with recommendations.21,22,35 Differences in the operationalization 
and coding of predictors might however have contributed towards poor external validity.37 For 
example, pre-injury mental health and prior TBI were no relevant predictors in the current study. 
In the study by Cnossen et al.19 these variables were based on self-report without a threshold for 
severity. In the current study, however, the presence of a prior TBI required documentation from 
medical records and pre-injury mental problems necessitated that a patient received treatment. 
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This difference in assessment may have caused the large differences in baseline prevalence (pre-
injury mental health problems: 32% vs. 10%; prior TBI: 54% vs. 3%) between the Cnossen et al. 
study19 and the current study, influencing performance in external validation. Next to model-
related and measurement-related factors, differences in patient characteristics might further 
have contributed towards the poor model performance of both models. The sample from the 
UPFRONT study diverges substantially from both development samples in terms of demographics, 
TBI severity and pre-injury characteristics, which might have affected the discriminative ability 
of the models. 
Predictors from both models, as well as complaints at the ED, were used to develop a new 
model. This model had a reasonable discrimination and can therefore be potentially valuable for 
clinical practice. Yet, external validation in a new and independent set of patients with mTBI is 
necessary to demonstrate its validity and applicability. In our newly developed model, we found 
that female sex, early PCS and early posttraumatic stress were associated with six-month PPCS, 
which is congruent with a systematic review on prognosis following mTBI.10 In addition, we found 
that neck pain was a predictor. Although the influence of neck pain on PPCS has not been studied 
in large-scale prospective studies before, our findings are in line with the emerging view that 
concomitant cervical soft tissue injury may contribute to prolonged sequelae following mTBI.38 
Among the predictors in our final model, early PCS was the strongest predictor and showed high 
sensitivity; i.e. 80% of the patients with PPCS already reported three or more symptoms after 2 
weeks. This was in line with a 2015 study stating that 82% of the patients experiencing PPCS one 
year after mTBI already reported symptoms one month post-injury.18 Specificity was however 
much lower with approximately half of the patients reporting three or more symptoms after 
two weeks developing PPCS. The feasibility of early PCS as predictor for PPCS is nevertheless 
hampered by the practical constraint that patients with mTBI are rarely followed-up routinely.39 
 
In line with previous work,10,18 our study demonstrates the complexity in developing a prognostic 
model for PPCS that is both valid and applicable for clinical practice. Given the heterogeneity 
of mTBI,2 the multifactorial and complex nature of PPCS18,40 and the lack of unity for definitions 
and assessment of PPCS,20 improvement in consensus on definitions and standardization of data 
collection might be necessary before advances in prediction modeling can be accomplished. A 
recent initiative to standardize data collection in TBI are the Common Data Elements (CDEs), 
which have specific recommendations for the measurement of socio-demographic, pre-injury 
and clinical variables,41 and thereby have the potential to enhance the comparability of future 
prognostic studies. For outcome assessment, the CDEs recommend the RPQ to assess PPCS. 
However, no guidance is provided on how the RPQ should be analyzed, while this varies widely in 
clinical practice.14-18 More detailed recommendations are therefore warranted.
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Conclusion
Existing prognostic models for persistent post-concussion symptoms perform poorly in an 
independent set of patients with mTBI. A new model, including female sex, complaints at the 
emergency department and two-week post-concussion and posttraumatic symptoms, performs 
reasonably. External validation is however necessary before this model can be considered 
for clinical practice. In addition, improvement in definition of post-concussion symptoms and 
standardization of data collection may further aid to future advances in this area. 
Supplemental material is available at www.marysecnossen.nl
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Abstract 
Background: There is growing interest in health related quality of life (HRQoL) as an outcome 
measure in international trials. However, there might be differences in the conceptualization of 
HRQoL across different socio-cultural groups. The objectives of current study were: (I) to compare 
HRQoL, measured with the short form (SF)-36 of Dutch and Chinese traumatic brain injury (TBI) 
patients one year after injury and; (II) to assess whether differences in SF-36 profiles could be 
explained by cultural differences in HRQoL conceptualization. TBI patients are of particular 
interest because this is an important cause of diverse impairments and disabilities in functional, 
physical, emotional, cognitive, and social domains that may drastically reduce HRQoL
Methods: A prospective cohort study on adult TBI patients in the Netherlands (RUBICS) and a 
retrospective cohort study in China were used to compare HRQoL one year post-injury. Differences 
on subscales were assessed with the Mann-Whitney U-test. The internal consistency, interscale 
correlations, item-internal consistency and item-discriminate validity of Dutch and Chinese SF-36 
profiles were examined. Confirmatory factor analysis was performed to assess whether Dutch 
and Chinese data fitted the SF-36 two factor-model (physical and mental construct).
Results: 447 Dutch and 173 Chinese TBI patients were included. Dutch patients obtained 
significantly higher scores on role limitations due to emotional problems (p < .001) and general 
health (p < .001), while Chinese patients obtained significantly higher scores on physical 
functioning (p < .001) and bodily pain (p = .001). Scores on these subscales were not explained 
by cultural differences in conceptualization, since item- and scale statistics were all sufficient. 
However, differences among Dutch and Chinese patients were found in the conceptualization of 
the domains vitality, mental health and social functioning.
Conclusions: One year after TBI, Dutch and Chinese patients reported a different pattern of 
HRQoL. Further, there might be cultural differences in the conceptualization of some of the SF-36 
subscales, which has implications for outcome evaluation in multi-national trials. 
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Background
Health-related quality of life (HRQoL) reflects an individual’s perception of how an illness and 
its treatment affect physical, mental and social aspects of his/her life.1 Because it provides well-
standardized information on recovery patterns, frequency, nature, and predictors of disabilities, 
HRQoL has been recognized as an important outcome in many medical fields, including injury.2 
Similarly, there is growing interest in international HRQoL assessment as a result of the increasing 
number of international trials.3 
Traumatic brain injury (TBI) is a major public health concern with a rising incidence all over the 
globe. In Europe, the annual number of hospital admissions is estimated at 262 per 100,000 
population.4 In other parts of the world, data on TBI incidence is less often collected systematically. 
Nevertheless, a 2004 epidemiological study in Eastern China found that the incidence of TBI 
among 77 hospitals was substantial.5 TBI is an important cause of impairments and disability 
in functional, physical, emotional, cognitive, and social domains that may drastically reduce 
HRQoL.6,7 As a consequence, HRQoL has been emerged as an important outcome measurement 
following TBI.8 
Previous literature has indicated that there might be differences in the experience and 
conceptualization of HRQoL across different socio-cultural groups.9-14 For example, in Western 
countries body and mind are usually regarded as two different entities, whereas Asian cultures 
have a more holistic sense among body and mind.15 Therefore, the strict dichotomization 
of physical versus mental health, which is often included in HRQoL assessment, might not be 
applicable to Asian cultures.9,12 Also, previous evaluations of the short form (SF)-36 among 
Asians have shown that they conceptualize social role functioning differently from Western 
populations.9,10,12,16,17 For example, Asians are more directed towards others and the use of 
“sickness” as an excuse for avoiding social and labour responsibilities is considered unacceptable 
in the Asian culture.10,15 Furthermore, while Western populations associate energy level strongly 
with physical health, Asians associate energy more strongly with mental health.10-13,18 
To our knowledge, there is no previous study that directly compared HRQoL between Western 
and Asian patients after injury. The purpose of this study was to compare HRQoL, measured with 
the SF-36, of Dutch and Chinese TBI patients one year after the injury. Secondly, we aimed to 
assess whether potential differences in SF-36 profiles between these patients could be explained 
by cultural differences in HRQoL conceptualization. 
Methods
This study was conducted and reported according to the ‘Strengthening the Reporting of 
Observational Based Studies’ (STROBE) statement version 4.19
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Participants
Data for the current study were obtained from two cohort studies performed in the Netherlands 
and China. The Radboud University Brain Injury Cohort Study (RUBICS) includes patients 
aged 16 years and older with mild, moderate and severe TBI presenting at the emergency 
department (ED) of a level I trauma center in Nijmegen, the Netherlands. Patient demographics, 
clinical characteristics as well as outcome measurements after twelve months follow-up were 
prospectively collected between June 2003 and June 2010. More information on data collection 
and included patients can be found in previous publications.20-24 Data on Chinese patients were 
obtained from a retrospective study on injury patients admitted to one of three national injury 
surveillance hospitals in Zhuhai, Guangdong Province, China between January and December 
2006. Patients were 15 years or older and were examined at twelve months post-injury. Data 
on age, gender and injury severity were collected from the hospital database. No other baseline 
and injury characteristics that might be relevant in the current study (e.g. education, Glasgow 
Coma Scale) were measured. More information about this study can be found in a previous 
publication.25
To warrant comparability of patient groups, the following inclusion criteria to determine eligibility 
for current study were used: age ≥ 16 years, admitted to the hospital with a clinical diagnosis of 
TBI, provision of informed consent and completion of at least all items of one SF-36 subscale 
after twelve months follow-up. Patients referred home after the ED visit and patients who died 
within the first year post-injury were excluded. 
TBI definition and classification
In the Dutch dataset, all patients sustained a TBI. Consequently, all patients meeting the inclusion 
criteria for the current study were included in the analyses. The Chinese dataset was not 
restricted to patients with TBI, but contained patients with various injuries. The TBI patients were 
selected by including all patients with an International Classification of Diseases and Related 
Health Problems (ICD-10) code of S06, referring to traumatic intracranial injury. 
Severity of TBI was determined by the Abbreviated Injury Scale – Head (AISH). The AISH is, 
together with the Glasgow Coma Scale (GCS), the most commonly used index of severity in TBI.26 
Severity of TBI is ranked on a scale from 1 to 6 in which 1 being mild, 2 being moderate and 6 
being unsurvivable.27 Patients were classified into mild/moderate and severe TBI according to 
their AISH score (1-2 versus > 2). 
The Chinese dataset did not report data on AISH. However, ICD-10 codes can be translated into 
AISH scores by using the ICD/AIS MAP.28,29 Consequently, those patients with ICD-10 codes of 
S06.0, S06.1, S06.2 and S06.9 were classified as having mild or moderate TBI and those with 
ICD-10 codes of S06.3, S06.4, S06.5, S06.6, S06.7 and S06.8 were classified as having severe TBI. 
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Measurement of HRQoL
The SF-36 was used to measure 12-month HRQoL. The SF-36 is the most frequently used generic 
instrument for HRQoL30 and has adequate internal consistency and validity in TBI patients.31,32 The 
questionnaire has been translated and tested in more than 50 languages,30 including Dutch33 and 
Cantonese.30 The SF-36 has two versions (version 1 and version 2) that differ slightly in wording, 
lay-out and the fact that the role questions have a dichotomous answer category in version 1 and 
a 5-point scale in version 2.
The SF-36 yields a profile of the following eight concepts: physical functioning (PF), role limitations 
related to physical health problems (RP), bodily pain (BP), general health perceptions (GH), 
vitality (VT), social role functioning (SF), role limitations related to emotional health problems 
(RE) and mental health (MH). The raw scores for each concept were transformed into a 0-100 
scale in which higher scores indicated better HRQoL. 
In the Dutch dataset, the 12-month SF-36 version 1 was administered by a postal questionnaire 
that was sent to all patients. In the Chinese dataset, the 12-month SF-36 version 1 was 
administered by a telephone interview. Patients were interviewed by a hospital nurse who 
received specific interview training.25
 
Statistical analyses
Differences between patients included in the study and those lost to follow-up were calculated 
using the non-parametric Mann-Whitney U test for continuous data and Chi square test for 
categorical data. Similarly, Dutch and Chinese patients included in this study were compared 
using these statistical tests on age, gender and TBI severity. 
Means, standard deviations, medians, interquartile ranges and the percentage of patients with 
the highest (“ceiling”) and lowest (“floor”) scores on the SF-36 subscales were calculated for 
Dutch and Chinese patients classified by TBI severity. Since the number of severe TBI patients 
in the Chinese dataset was small (n = 20), the analyses were continued with mild and moderate 
TBI only. 
Differences in SF-36 subscales between the Dutch and Chinese patients were calculated with the 
Mann-Whitney U test, since all subscales had a skewed distribution. To allow for multiple testing, 
a stringent p-value of 0.0065 (0.05 divided by 8 subscales) was considered statistically significant. 
To assess whether differences between Dutch and Chinese patients could be explained by age 
differences between both populations, the sample was stratified into three equal age groups 
based on percentiles (33th and 66th) in the total population and the analyses were repeated 
accordingly. Since sample sizes of the age cohorts were small, statistically significance was 
assessed on both the stringent p-value (p < .0065) and the standard p-value (p < .05).
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To examine whether there were differences in cultural conceptualization of HRQoL among 
Dutch and Chinese patients, the psychometric assumptions underlying the construction of the 
SF-36 were assessed for both Dutch and Chinese patients. Therefore, the reliability coefficient 
(“Cronbach’s alpha”) for each subscale was estimated. Adequate internal consistency was defined 
as a reliability coefficient ≥ 0.70.34 Additionally, the reliability coefficient of each subscale should 
be larger than the subscale’s interscale correlations with all other subscales.35
Item-internal consistency and item-discriminate validity of the 35 items in both datasets were 
subsequently assessed. One item (“health change”) was excluded since this provides an indication 
of perceived change in health rather than the health status one year post-injury. The correlation 
between each item and its hypothesized subscale (“corrected item-to-scale correlation”) should 
be at least 0.40 for adequate item-internal consistency.35,36 Item-discriminate validity was 
considered adequate if the correlation between an item and its hypothesized scale was larger 
than the correlations between that item and all other subscales.35
To examine whether Dutch and Chinese SF-36 subscales reflected the same underlying 
dimensions, i.e. a physical and mental dimension,30,37 confirmatory factor analysis (CFA) with 
two latent constructs was performed. Based on theory and research in Western populations, it 
was hypothesized that the PF, RP and BP subscales were associated with the physical construct, 
whereas the MH, RE and SF subscales were associated with the mental construct.30,37 For VT 
and GH it was expected that they load equally on both components.30,37 To achieve model 
identification, for every latent variable, one factor loading was fixed to one (PH for physical 
construct; MH for mental construct; Online Supplement A). Maximum likelihood methods were 
used to estimate the associations between subscales and latent factors. The Tucker-Lewis Index 
(TLI; recommended > 0.95), Comparative Fit Index (CFI; recommended > 0.95) and the Root 
mean Square Error of Approximation (RMSE; recommended < 0.08) were used to examine model 
fit, as recommended by previous research.38 The CFA analyses were performed using the Analysis 
of Moment Structures (AMOS) version 4 statistical software package. All other analyses were 
performed using Statistical Package for the Social Sciences (SPSS) version 21. 
Results
Study population
The Dutch dataset consists of 2286 TBI patients. Of these patients, 223 were excluded because 
they were younger than 16 years and 804 patients were subsequently excluded because they did 
not receive the follow-up questionnaires because of various reasons (e.g. dementia, unknown 
address). 360 patients were further excluded because they were not admitted to the hospital 
after the ED visit. This results in 899 eligible patients of whom 447 completed all items of at least 
one of the SF-36 subscales after 12-month follow-up. Patients with a missing 12-month SF-36 
did not differ from those included in this study on age and gender. Those lost to follow-up were 
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however less often diagnosed with severe TBI (p < .01). Of the included patients, 64% was male 
and the median age was 46 years (interquartile range 27-58). Half of the patients had an AISH of 
1-2, indicating mild and moderate TBI. 
The Chinese dataset comprises information on 3664 injury patients of whom 695 patients were 
diagnosed with TBI according to their ICD-10 codes. Forty-five patients were removed since 
they were younger than 16 years of age. Of the 650 eligible patients, 173 (27%) completed the 
12-month follow-up assessment. The main reason for non-inclusion in the study was that the 
telephone number was not available in the hospital database.25 Respondents were significantly 
older (median age respondents = 36; median age non-respondents = 32, p = .01) and less often 
diagnosed with severe TBI (respondents: 12% severe TBI, non-respondents: 18% severe TBI, 
p = 0.04). Median age of the included patients (n = 173) was 35 years (interquartile range 24-50) 
and 67% of the study population was male. The large majority (88%) had an AISH of 1 or 2 (mild 
or moderate TBI). 
Dutch and Chinese patients did not differ in terms of gender. Dutch patients were however 
significantly older than Chinese patients (p < .001) and were significantly more often diagnosed 
with severe TBI (p < .001). Comparison of other demographic and clinical characteristics between 
patient groups was not possible since these were not measured in the Chinese data. 
SF-36 scores of Dutch and Chinese patients 
Scores on SF-36 subscales for Dutch and Chinese patients, stratified by TBI severity, are presented 
in Table 1. Generally, severe TBI patients seemed to report more problems with HRQoL than mild 
and moderate TBI patients. Ceiling effects were prominent for both Dutch and Chinese patients; 
more than half of the patients obtained a maximum score for role limitations due to physical 
problems. In the Dutch dataset, the strong ceiling effect was also shown for role limitations due 
to emotional problems, while in the Chinese dataset more than half of the patients obtained a 
maximum score for physical functioning. Since the Chinese dataset included 20 patients with 
severe TBI, all subsequent analyses were performed for only those patients with mild and 
moderate TBI. 
When using the stringent p-value (p < .0065), Chinese patients obtained significantly higher 
scores on the subscales PF (p < .001) and BP (p = .001), while Dutch patients obtained higher 
scores on RE (p < .001) and GH (p < .001; see Figure 1 and Online Supplement B). Chinese patients 
also obtained higher scores on SF (p = .026), but this was not statistically significant using the 
stringent p-value. 
Age differences between Dutch and Chinese patients did not explain the differences in the PF and 
RE scale scores, since differences remained statistically significant in the different age cohorts 
(p < .0065 in two age cohorts; p < .05 in one age cohort, see Online Supplement B).
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Table 2. Reliability coefficients (in diagonals) and Pearson’s correlation coefficients between Short 
Form (SF)-36 subscales in patients with mild and moderate traumatic brain injury
Nijmegen, the Netherlands 
PF RP BP GH VT SF RE MH
PF (.94)
RP .73** (.90)
BP .64** .71** (.88)
GH .54** .68** .56** (.83)
VT .41** .60** .50** .66** (.75)
SF .54** .67** .54** .63** .73** (.83)
RE .38** .59** .37** .47** .55** .66** (.86)
MH .31** .50** .35** .61** .78** .72** .61** (.89)
Zhuhai, China
PF RP BP GH VT SF RE MH
PF (.93)
RP .53** (.90)
BP .47** .68** (.90)
GH .44** .69** .61** (.76)
VT .30** .50** .43** .51** (.66)
SF .53** .64** .61** .59** .50** (.49)
RE .26** .56** .41** .49** .47** .45** (.78)
MH .28** .47** .40** .47** .63** .51** .47** (.70)
Table shows reliability coefficients and Pearson’s correlation coefficients between SF-36 subscales in patients with mild and moderate 
traumatic brain injury 12 months post-injury
Abbreviations: PF = physical functioning; RP = role physical; BP = bodily pain; GH = general health; VT = vitality; SF = social functioning; 
RE = role-emotional; MH = mental health
For BP, however, the statistically significant differences between Dutch and Chinese patients did 
not withstand after stratification for age (no significant differences between Dutch and Chinese 
patients in 2 out of 3 age strata, see Online Supplement B). With regard to GH, Dutch patients 
obtained significantly higher scores in two out of three age cohorts (p < .0065). In the youngest 
age cohort, however, no statistically significant differences were found between Dutch and 
Chinese patients. 
Cultural conceptualization of HRQoL
In the Dutch dataset, all SF-36 subscales had an adequate internal consistency and none of the 
intercorrelations between subscales were larger than the values of Cronbach’s alpha (see Table 
2). Item-internal consistency and item-discriminate validity were also adequate for all items. 
One of the items of the vitality scale (VT1), nevertheless, correlated higher with the MH scale 
(r = 0.55) than with the VT scale itself (r = 0.49; see Online Supplement C). 
Comparing health-related quality of life of Dutch and Chinese patients with traumatic brain injury
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In the Chinese dataset, internal consistency was insufficient for two subscales (VT and SF). Also, 
the intercorrelations between SF and six other subscales were larger than the value of Cronbach’s 
alpha for the SF scale. Item-internal consistency and item-discriminate validity were adequate for 
the large majority of items. However, four items (VT2, SF1, SF2 and MH3) obtained a corrected 
item-to-scale correlation below 0.40. Furthermore, some items from the GH, VT, SF and MH 
subscales correlated higher with other subscales than with their own hypothesized subscales 
(see Online Supplement C). 
Figure 1. Short Form (SF)-36 score profiles of Dutch and Chinese patients 
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Figure shows SF-36 score profiles of Dutch and Chinese patients with mild and moderate traumatic brain injury 12 months post-injury. 
Scale scores range from 0-100, with 100 representing optimal functioning. 
Abbreviations: PF = physical functioning; RP = role physical; BP = bodily pain; GH = general health; VT = vitality; SF = social functioning; 
RE = role-emotional; MH = mental health; AISH = Abbreviated Injury Scale Head
CFA with a two-factor model in the Dutch population resulted in a TLI of 0.88, a CFI of 0.95 
and an RMSEA of 0.13, indicating a mixed pattern of model fit. The associations between the 
SF-36 subscales and the two latent constructs was as hypothesized for seven subscales. The VT 
subscale, however, was strongly associated with the mental component (β = 1.08, p < .01) but 
not with the physical component (β = 0.01, p = 0.94). The association between the physical and 
mental health construct was strong in the Dutch data (r = 0.70).
CFA with a two-factor model in the Chinese population had an adequate model fit (TLI: 0.95, 
CFI: 0.97 and RMSE: 0.08). However, the VT scale was negatively associated with the physical 
construct (β = -2.31, p = .18) and the association between the mental construct and VT (β = 2.87) 
was larger than its correlation with MH (β = 1.00). In addition, the association between GH and 
the physical construct (β = 1.25, p = .01) was larger than the association between GH and the 
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mental construct (β = 0.49, p = .14). The correlation between the physical and mental health 
construct was very strong (r = 0.92) in the Chinese data. 
Table 3. Confirmatory Factor Analysis of the Short Form (SF)-36 subscales 
Nijmegen, the Netherlands Zhuhai, China
Observed variable Latent construct β B p-value β B p-value
PF Physical 1.00† 0.78 NA 1.00† 0.60 NA
RP Physical 2.02 0.94 < .01 3.58 0.88 < .01
BP Physical 1.04 0.76 < .01 2.04 0.77 < .01
GH Physical 0.48 0.45 < .01 1.25 0.52 .01
VT Physical 0.01 0.01 .94 -2.31 -0.97 .18
GH Mental 0.59 0.45 < .01 0.49 0.28 .14
VT Mental 1.06 0.86 < .01 2.87 1.65 .03
SF Mental 1.13 0.88 < .01 1.19 0.75 < .01
RE Mental 1.39 0.70 < .01 1.89 0.63 < .01
MH Mental 1.00† 0.86 NA 1.00† 0.67 NA
Table represents unstandardized (β) and standardized (B) regression weights between subscales and the physical and mental component 
for both the Dutch and the Chinese mild and moderate traumatic brain injury patients 12 months post-injury. *Statistically significant 
(p < .05) association
†Regression weight was set to 1.00
Abbreviations: PF = physical functioning; RP = role physical; BP = bodily pain; GH = general health; VT = vitality; SF = social functioning; 
RE = role-emotional; MH = mental health
Discussion
Dutch and Chinese patients with mild and moderate TBI showed a different HRQoL pattern 
one year post-injury. Dutch patients reported less role limitations due to emotional problems 
and a better general health, whereas Chinese patients reported better physical functioning 
and less bodily pain. Differences in these subscales cannot be explained by variation in cultural 
conceptualization. However, there were differences in the conceptualization of some of the 
other subscales (vitality, mental health and social functioning).
Differences in SF-36 profiles among Dutch and Chinese patients were also recently found in 
cardiac patients.39,40 There are various hypotheses that may explain these differences. Firstly, 
Dutch and Chinese patients might value similar symptoms and limitations differently. In China, 
health is usually described as a balance between “yin and yang” and the appreciation of one’s 
health is largely influenced by spirituality.15 In the Dutch culture, on the opposite, HRQoL might 
be more related to the number and severity of symptoms. In addition, because cultural values 
emphasize harmony in Asian cultures, Asians might be more optimistic when experiencing similar 
symptoms and less likely to report negative and extreme feelings.41 Related, coping strategies of 
Dutch and Chinese patients might vary, since these are largely influenced by cultural systems.9 
Comparing health-related quality of life of Dutch and Chinese patients with traumatic brain injury
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Another hypothesis might be that the differences between Dutch and Chinese patients, especially 
in the physical health dimension, reflect the variation in acute and rehabilitation treatment 
between countries. In China, a part of the TBI related care is not reimbursed42 and therefore, 
it is possible that some of the Chinese patients included in this study did not receive adequate 
acute or rehabilitative care, influencing their HRQoL one year post-injury. Lastly, the differences 
between Dutch and Chinese patients might also be explained by a lack of comparability of the 
included patients (e.g. there might have been baseline differences between patients) and study 
designs (prospective study with postal questionnaire versus retrospective study with telephone 
interview). 
Our finding that social functioning is conceptualized differently among Dutch and Chinese mild 
and moderate TBI patients is consistent with previous research about psychometrics of the 
SF-36 in Asian cultures.9,10,14,16-18 It has been suggested that the concept of social functioning is 
more Westernized and less clear for Asian people.14 The strong association between vitality and 
mental health in our Chinese sample was also consistent with previous literature of the general 
population.11,13,14,18 In traditional Chinese medicine a mental disorder is referred to as “the loss 
of a vital substance of spirit”,17 which could explain this strong association. Notwithstanding, 
we also found that vitality was strongly associated with mental health but not with physical 
health in the Dutch population, suggesting that this association could also be related to the TBI 
rather than to cultural conceptualization. The sequelae of mild and moderate TBI often includes 
mental health problems as well as fatigue or lack of energy,43,44 whereas physical problems, such 
as headache, usually resolve within a few months.45 Since this is the first study that performed 
CFA with the SF-36 in a TBI population, current findings should be confirmed by future studies 
with larger numbers of patients. The high correlation between mental and physical health in 
Chinese patients may indicate that these patients have a more holistic sense among body and 
mind.15 As a consequence, one latent factor rather than two (physical and mental health) might 
have been more appropriate for the Chinese patients. This should also be confirmed in studies 
with larger sample sizes.
This is the first study that directly compared HRQoL between Asian and Western patients 
after injury. A strength of current study is that we did not only assess differences on the SF-36 
subscales between Dutch and Chinese patients, but also examined whether these differences 
could be explained by cultural differences in the conceptualization of quality of life. In addition, 
we stratified our analyses for age and severity and included an adequate sample size. 
Results should however be interpreted in the light of the following limitations. First, response 
rates were relatively low (50% for the Netherlands and 27% for China) for both datasets. Although 
low response rates do not necessarily result in bias,46 we cannot exclude that the patients in our 
study comprise an a-select sample. A second limitation concerns the comparability of Dutch and 
Chinese patients. Although patients were similar in terms of gender, and were stratified based 
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on TBI severity and age, we cannot exclude that the patient groups differed on demographic 
and clinical variables (e.g. education, Glasgow Coma Scale) that were not measured in the 
Chinese dataset. Related, comorbidity was not assessed in both cohorts, while it is common in 
TBI patients47,48 and could also influence HRQoL.49 Moreover, the Dutch study administered the 
SF-36 by a postal questionnaire while the Chinese study used telephone interviews, which might 
not be comparable. For example, in a telephone interview, social desirability bias is relatively 
likely to occur,50,51 which might have resulted in more optimistic results among Chinese patients. 
Also, a postal questionnaire, especially in patients with severe TBI, might not be reliable because 
of memory and concentration problems experienced by these patients.52 Comparability of Dutch 
and Chinese patients is further hampered by differences in study design; the Dutch database was 
a prospective cohort study whereas the Chinese dataset was retrospectively collected. 
The time between injury and follow-up can also be considered a limitation in this study. 
Although it is known that a subset of mild and moderate TBI patients experience long-lasting 
symptoms,44,49,53 the majority is expected to be recovered one year post-injury.54 This might have 
caused the strong ceiling effects in our study. Ceiling effects are considered to be present if the 
highest score on a subscale is obtained in more than 15% of the respondents,55,56 which was 
the case in the majority of subscales for Dutch and Chinese mild and moderate patients. Ceiling 
effects may reduce reliability and validity of subscales56 and might indicate that the SF-36 lacks 
sensitivity to examine differences in TBI patient groups one year after the injury. In addition, the 
skewed distribution might have influenced the validity of the CFA analyses because normality 
is one of the assumptions of the maximum likelihood method. However, in small sample sizes 
(N < 200) the maximum likelihood method outperformed other analytical methods such as 
diagonally weighted least squares.57
Given these limitations, the findings of current study should be interpreted as preliminary 
and hypothesis generating. We therefore recommend future studies to use highly comparable 
patient groups in terms of demographics and clinical variables and a detailed registration of the 
acute and rehabilitative care provided. Additionally, the inclusion of more objective outcome 
measurements (e.g. Glasgow Outcome Scale Extended) might provide insight on whether 
Western and Asian patients experience other symptoms or interpret/cope differently with 
similar symptoms following injury. Related, next to the SF-36, which is a measurement of general 
HRQoL, a disease-specific measurement such as the QOLIBRI58 is recommended to measure the 
full impact of TBI on HRQoL.59 In addition, qualitative studies, such as interviews or focus groups 
might also be suitable to study cultural differences in HRQoL after injury. 
Our finding that Chinese mild and moderate TBI patients conceptualize some of the subscales 
differently, poses a challenge for multi-national trials with HRQoL as outcome measurement. 
A prerequisite in multi-national trials measuring health status is that the same underlying 
dimensions are measured and that these dimensions are culturally meaningful in all participating 
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countries.13 Our research shows that this can be doubted in a TBI population, which was in 
line with findings in the general population.9,11 We therefore recommend multi-national trials 
including both Asian and Western countries to be cautious in their interpretation of health 
outcome. 
Conclusions
One year after TBI, Dutch and Chinese patients reported a different pattern of HRQoL. Further, 
we found cultural differences in the conceptualization of some of the SF-36 subscales, which has 
implication for outcome evaluation in multi-national trials. 
Supplemental material is available at www.marysecnossen.nl
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Abstract
Guidelines aim to improve the quality of medical care and reduce treatment variation. The extent 
to which guidelines are adhered to in the field of traumatic brain injury (TBI) is unknown. The 
objectives of this systematic review were to (1) quantify adherence to guidelines in adult patients 
with TBI, (2) examine factors influencing adherence, and (3) study associations of adherence to 
clinical guidelines and outcome. 
We searched EMBASE, MEDLINE, Cochrane Central, Pubmed, Web of Science, PsycINFO, SCOPUS, 
CINAHL, and grey literature in October 2014. We included studies of evidence-based (inter)
national guidelines that examined the acute treatment of adult TBI patients. Methodological 
quality was assessed using the Research Triangle Institute item bank and Quality in Prognostic 
Studies Risk of Bias Assessment Instrument. 
Twenty-two retrospective and prospective observational cohort studies, reported in 25 
publications, were included, describing adherence to 13 guideline recommendations. Guideline 
adherence varied considerably between studies (range 18%-100%) and was higher in guideline 
recommendations based on strong evidence compared to those based on lower evidence, and 
lower in recommendations of relatively more invasive procedures such as craniotomy. A number 
of patient-related factors, including age, Glasgow Coma Scale and intracranial pathology, were 
associated with greater guideline adherence. Guideline adherence to Brain Trauma Foundation 
guidelines seemed to be associated with lower mortality. 
Guideline adherence in TBI is suboptimal and wide variation exists between studies. Guideline 
adherence may be improved through the development of strong evidence for guidelines. Further 
research specifying hospital and management characteristics that explain variation in guideline 
adherence is warranted. 
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Introduction
Traumatic brain injury (TBI) is a major public health concern affecting approximately 150-300 per 
100,000 people annually in Europe.1 The World Health Organization has predicted that TBI will be 
one of the leading causes of death and disability worldwide by the year 2020.2
The care for TBI patients is often complex and multidisciplinary. Guidelines, protocols and care 
pathways have been developed to improve quality of care, to reduce variation in practice and to 
ensure that evidence-based care is optimally implemented.3 
A 2013 systematic review4 found that the use of protocols in the management of severe TBI in the 
intensive care unit (ICU) led to improved patient outcomes. However, the findings were based 
on observational studies that did not report on adherence rates. Without an understanding of 
adherence rates, the improved outcomes stated in the review cannot be directly attributed to 
the use of protocols. 
Guideline adherence can be defined as the proportion of patients treated according to a guideline 
recommendation, which often represents evidence-based or best practice care. Previous studies 
have found that guideline adherence in medicine is generally low5-7 and varies widely across 
centers,7,8 medical condition,9 types of guideline,10,11 and time period.8,10 As a result, many 
patients do not receive evidence-based care, while others receive unnecessary care that may 
even be harmful.5 To date, no systematic review of the literature about guideline adherence in 
TBI has been conducted. 
The aim of this systematic review was to provide a comprehensive overview of professionals’ 
adherence to guidelines in adult TBI patients. The objectives were threefold: 
1. To quantify adherence to guidelines in adult patients with TBI; 
2. To explore factors influencing adherence to TBI guidelines in those studies reporting on 
adherence; 
3. To examine the association between adherence to guidelines and outcome in patients with 
TBI in those studies reporting on adherence. 
Material and methods
This review was conducted and reported in line with the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) Statement.12 Details of the protocol for this systematic 
review were registered on PROSPERO (registration number CRD42014012863) and can be 
accessed at http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014012863.
Adherence to guidelines in adult patients with traumatic brain injury: A living systematic review
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This review is being prepared as a “living systematic review” as part of the CENTER-TBI project13 
(www.center-tbi.eu). A living systematic review is a high quality, up-to-date, online summary 
of health research that is updated as new research becomes available.14 This means that the 
searches will be re-run frequently and new studies will be incorporated into the review, with 
revisions to recommendations as appropriate. We will seek to publish regular updates.
Information sources
A comprehensive literature search was conducted on October 22th, 2014. Search strategies 
were developed in consultation with search experts using a combination of subheadings and 
text words (Online Supplement A). The databases EMBASE, MEDLINE (via Ovid SP), Cochrane 
Central, Pubmed as supplied by publisher, Web of Science, PsycINFO, SCOPUS and CINAHL 
were searched. In addition, grey literature was examined via Google Scholar, opengrey.eu and 
dissertation databases (openthesis.org, dissertation.com). Reference lists and citation indices of 
the included papers and relevant reviews were inspected to identify additional relevant citations. 
All selected studies were downloaded to the reference management database Endnote X515 and 
duplicates were removed. We restricted the search to original articles published in English. There 
was no date restriction. 
Inclusion and exclusion criteria and study selection
We used the following inclusion and exclusion criteria to select studies:
Study designs: We included retrospective and prospective cohort studies, cross-sectional studies, 
time series and controlled clinical trials. Reviews, qualitative studies, case reports and editorials 
were excluded. 
Participants: Studies were included if they were conducted in adult patients with suspected or 
confirmed TBI. Studies including a mixed population (e.g. all trauma patients) were only included 
if they presented their results for TBI patients separately. Studies solely about children were 
excluded as other factors, such as radiation, might play a role in guideline adherence in this 
group. If studies presented results for children and adults separately, only the information on 
adults was extracted. 
Guidelines: Evidence-based international and national clinical TBI guidelines were included. 
Evidence-based guidelines were defined as guidelines for which evidence was found in quantitative 
research. We included studies analyzing adherence to a complete guideline or protocol as well 
as studies analysing adherence to one or more single guideline recommendations. Local and 
regional guidelines, and guidelines based on expert opinion were excluded. Studies were further 
excluded if they assessed adherence to guidelines not published or implemented during the 
study period. 
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Adherence: Adherence or compliance was conceptualized as the percentage of patients who 
were treated according to a guideline, a subset of guidelines or an individual recommendation of 
a guideline. This definition was chosen to enable comparison of adherence to different guidelines 
or guideline recommendations. Studies using self-reported adherence were excluded due to the 
risk of overestimation.16
Setting: Studies were included if they examined the acute curative care of TBI patients, in the pre-
hospital setting, emergency department (ED), hospital ward care and intensive care unit (ICU). 
The first review author (MC) screened all titles and abstracts and deleted obviously irrelevant 
citations. After the initial selection, two independent reviewers (MC and ACS) screened the 
remaining citations on title and abstract and obtained those selected in full text. Results were 
compared and any disagreement was resolved by discussion or consulting a third author (SP). 
The search process was documented according to the PRISMA flowchart.12
Data collection and assessment of methodological quality
Two reviewers (MC and ACS) independently extracted data and assessed the risk of bias of 
included studies. Any discrepancies were resolved by discussion or consulting a third author 
(SP). A data extraction form was developed based on the Effective Practice and Organization 
of Care Cochrane Review Group (EPOC) data collection checklist,17 and the Strengthening the 
Reporting of Observational Studies in Epidemiology (STROBE) statement.18 In addition, topic-
relevant criteria about guidelines, adherence, and influencing factors were extracted. Guideline 
recommendations were classified as strong or weak/moderate recommendations. Strong 
recommendations were defined as being based on good quality randomized controlled trials 
(RCTs). Weak or moderate recommendations were defined as being based on moderate- or poor 
quality RCTs, cohort studies, case control studies or case series. 
We developed three risk of bias forms to rate the risk of bias in quantifying adherence (objective 
1), exploring factors influencing adherence (objective 2) and examining the association between 
adherence and outcome (objective 3). Risk of bias forms were based on items from the Research 
Triangle Institute (RTI) Item Bank for observational studies19,20 (Objective 1 and 3) and the Quality 
in Prognostic Studies (QUIPS) risk of bias tool21 (Objective 2). The risk of bias was assessed for 
each of the three objectives separately as different risks are relevant in the three objectives. 
Moreover, it was possible that studies assessing more than one review objective had a low risk of 
bias for one objective but a high risk for another. 
Risk of bias items were subdivided into six categories for every objective: selection bias/
confounding, performance bias, attrition bias, detection bias, reporting bias and information 
bias19,22 (see Online Supplement B). For every category, individual items were scored as high, low 
or unclear risk of bias. 
Adherence to guidelines in adult patients with traumatic brain injury: A living systematic review
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If at least one item in a bias category was scored as high, the risk of bias within this category was 
scored as moderate risk. If at least 50% of the items in a bias category were scored as high, the 
risk of bias category was scored as high risk. Every study received a total risk of bias score for 
every objective that was equal to the highest score obtained in all risk of bias criteria. 
Risk of bias was presented with a table stratified by objective. Attrition and detection bias 
were not reported for objective 1 because these were considered irrelevant for the percentage 
adherence obtained. We accounted for risk of bias by narratively describing studies with a low 
(none of the criteria was rated as high risk of bias) and moderate (< 50% of the criteria was rated 
as high risk of bias) risk of bias separately for the three objectives. 
In order to enhance inter-rater reliability, data extraction and risk of bias forms were pilot-tested 
on three studies that were likely to be included in the review. Inter-rater reliability was assessed 
by calculating concordance rates between the two independent reviewers in data screening, 
data extraction and risk of bias assessment. 
 
Data synthesis
Due to heterogeneity in settings, guidelines, populations, statistical methods and outcomes, 
meta-analytic techniques were not used. Instead, we conducted a narrative synthesis of results 
stratified by objective. 
For every guideline recommendation that was examined in at least two studies, mean guideline 
adherence was calculated by adding up the total number of patients treated according to the 
guideline recommendation and subsequently dividing them by the total number of patients 
eligible for the guideline. In addition, the percentage adherence was presented separately for 
strong and moderate/weak recommendations. We also compared the differences in percentage 
adherence for relatively more invasive (e.g. intracranial pressure monitoring and intracranial 
operation) and less invasive (e.g. computer tomography scanning and anti-seizure prophylaxis) 
procedures separately. A total percentage adherence was not calculated, as there was 
considerable variation in guidelines and patient severity. 
An overview of factors influencing adherence was conducted. We examined whether associations 
between predictive factors and adherence were positively or negatively directed and whether 
they were statistically significant (p < 0.05). Additionally, we conducted an overview of the 
association between adherence and outcome and reported whether associations were positively 
or negatively directed and statistically significant. 
All eligible studies were used for objective 1. Those that also reported factors influencing 
adherence and/or outcome were further analyzed for objective 2 and/or objective 3. There were 
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no further specific inclusion criteria for these objectives. All results are presented before and 
after the exclusion of studies that were judged as high risk of bias. 
Treatment of studies with multiple publications
Multiple publications refer to the situation where more than one article has been written based 
on the same dataset.23 Multiple publications assessing the same guideline in an overlapping time 
period and setting were dealt with by extracting information from the study that could be used 
for the most study objectives. If the number of objectives was similar across studies with multiple 
publications, the article that included the largest number of patients was chosen. Articles from 
the same dataset that assessed different guidelines or that were conducted during a different 
study period or in a different setting, were analyzed separately. 
Results
Study selection
A total of 1,903 citations were identified through the extensive search strategy (Figure 1). 
After removing duplicates, 912 were screened on citation and 518 obviously irrelevant records 
(determined on title) were removed. We screened 394 citations on title and abstract and excluded 
310. We obtained 84 citations in full text of which 62 were excluded. Three additional citations 
were found via reference lists and citation indices. For an overview of related studies excluded at 
the full text stage, see Online Supplement C.
The concordance rates between the two independent reviewers were generally high in screening 
of title and abstract (91%), screening of full text (81%), and data extraction (93%). 
Study characteristics
We included 22 studies, reported in 25 publications (Table 1). Three articles were removed 
from the analyses because of multiple publications.10,24,25 Two more studies were based on the 
same dataset,26,27 but the study describing the least number of objectives26 was still included for 
extracting the amount of adherence to another guideline recommendation. 
All included studies used an observational cohort design with fourteen being retrospective 28-41 
and eight being prospective.26,27,42-47 Twelve studies described multicenter studies26-31,34,36,40,41,44,46 
with a median of eight (range 2-155) hospitals included. All studies were conducted in North 
America (n = 9) or Europe (n = 13) and were published between 2002 and 2014. Six of the 
included studies33,40,41,43,44,46 examined adherence to more than one guideline recommendation 
(mean number of guideline recommendations in studies describing more than one guideline 
recommendation: 3.6; range 2-6). The sample size in the included studies ranged from n = 2738 
to n = 10,62828 patients.
Adherence to guidelines in adult patients with traumatic brain injury: A living systematic review
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Figure 1. PRISMA flowchart of the selection process
Sc
re
en
in
g
In
clu
de
d
El
ig
ib
ili
ty
Id
en
!fi
ca
!o
n
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Records iden!fied through 
database searching
(n = 1903)
Records a"er duplicates removed
(n = 912)
Records screened !tle
and abstract (n = 394)
Full-text ar!cles assessed 
for eligibility
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through reference lists and 
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Studies included 
in qualita!ve synthesis
(n = 25)
Studies included in 
quan!ta!ve synthesis 
(meta-analysis) (n = 0)
Papers excluded
(n = 518)
Records excluded
(n = 310)
Full-text ar!cles
excluded (n = 62), 
with reasons
Study design (n = 16)
Guidelines (n = 17)
Adherence (n = 17)
TBI (n = 5)
Se#ng (n = 3)
Language (n = 3)
Solely about children 
(n = 1)
Reasons for exclusion full text: Study design: the study was no prospective or retrospective cohort study, RCT, clinical trial, cross-sectional 
study or time series; Guideline: the study did not describe a guideline, the guideline was local or not evidence-based, the guideline was 
not implemented or disseminated before the study period; Adherence: the study did not measure adherence per patient, adherence 
was self-reported; TBI: the study was not about TBI patients; Setting: the study was not conducted during the hospital and prehospital 
setting; Language: the study was not published in English; Solely about children: the study did not include adults. 
Abbreviation: TBI = traumatic brain injury
Adapted From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6): e1000097. doi:10.1371/journal.pmed1000097
Adherence to a total of thirteen guideline recommendations was assessed, including those 
from the Brain Trauma Foundation (BTF),48 National Institute of Health and Clinical Excellence 
(NICE)49 and Scandinavian guidelines for the initial management of minimal, mild and moderate 
head injury.50 The most frequently studied guideline recommendation was the BTF guideline for 
Intracranial Pressure (ICP) monitoring (n = 9). Other guidelines that were studied in more than 
one study were the NICE guidelines for CT scanning (n = 5), the BTF guidelines for pre-hospital 
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intubation (n = 7), transport (n = 2), steroids (n=2) and resuscitation (n = 2), and the Scandinavian 
guidelines for computer tomography (CT) scanning and hospital admission (n = 2).
Six studies were performed during ICU admission, seven during an emergency department 
(ED) visit and three during the pre-hospital phase. The remainder (six studies) reported on a 
combination of these settings. The majority of studies reported on guideline recommendations 
that were judged as weak/moderate. Only seven studies included strong recommendations. The 
majority of studies were funded by government organizations. One study29 was funded by the 
BTF.
Methodological quality
Overall, the methodological quality of studies was good, with the majority of studies judged at 
low risk of bias in most domains (Table 2). For studies measuring the amount of adherence to 
guidelines (objective 1, n = 22), 19 had an overall low risk of bias. The remainder (n = 3)34,36,38 
received a high risk of bias score, due to high scores on selection bias / confounding. 
For studies exploring factors influencing adherence to guidelines (objective 2, n = 10), respectively 
three and four studies received a low and moderate overall risk of bias score. Three studies34,43,44 
were judged as being at high risk of bias due to selection bias / confounding. 
None of the studies examining the association between adherence to guidelines and outcome 
(objective 3, n = 11) had an overall low risk of bias. Nine studies received a moderate risk of bias 
score and two studies42,46 a high risk of bias score. This was due to selection bias / confounding, 
performance bias and information bias. None of the studies sufficiently isolated the impact of the 
guideline studied from concurrent interventions. In addition, some studies used inappropriate 
control groups or did not adjust for confounders while others calculated adherence- or quality 
scores that were based on non-validated scoring mechanisms or partly based on guideline 
recommendations that were not evidence-based or (inter)national. Concordance rates between 
independent reviewers in assessing risk of bias was high (92%), and any discrepancies were 
resolved by discussion or consulting a third author. 
Amount of adherence to guidelines
The amount of guideline adherence was reported in all included studies (Table 1) and varied 
considerably between (range 18%-100%) and within (range 0%-100%) studies. Excluding studies 
with a high risk of bias34,36,38 did not influence this variation.
Adherence to guidelines in adult patients with traumatic brain injury: A living systematic review
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Among the guidelines that were examined by more than one study, adherence was the highest 
in NICE CT-scan guidelines35-39 (mean 87%, range 70-100%) and the lowest in BTF Intracranial 
Pressure (ICP) monitoring guidelines10,26,28-30,32,40,41,46,47 (mean 31%, range 18-83%). Studies about 
the NICE CT scan guidelines were all performed at the ED in the United Kingdom and included 
patients with head injury. The majority had a single-center design. Studies about ICP monitoring 
were performed in Europe and North America and performed during ICU admission. Most studies 
used a multi-center design. The studies with the lowest and highest percentage adherence to ICP 
monitoring guidelines were comparable multi-center studies performed in North America. The 
study with the highest percentage adherence was based on the TBI-Trac database, which is a 
database from the BTF aiming to track and improve adherence, while the study with the lowest 
percentage was based on general trauma databases. A visual display of adherence per guideline 
is provided in Figure 2. After removing studies with a high risk of bias (n = 3), adherence to the 
NICE guidelines was 75%. Adherence to other guidelines did not differ substantially. 
Figure 2. Percentage Guideline Adherence for various guideline recommendations
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Figure displays lowest, highest and mean percentages adherence for various guideline recommendations. Numbers correspond with 
number of guideline recommendation and not to individual studies since some studies reported on multiple guideline recommendations.
“Other” is a summary measure of following: BTF ICU protocol for patients with severe TBI42, BTF hyperventilation46, BTF barbiturates46 
BTF anti-seizure prophylaxis46, BTF ICP directed therapy40 and BTF craniotomy41.
Abbreviations: BTF = Brain Trauma Foundation; ICP = Intracranial Pressure; NICE = National Institute for Health and Care Excellence; 
CT = Computer Tomography 
To assess whether strength of recommendation was related to guideline adherence, we divided 
guidelines into strong, and moderate/weak recommendations. Strong recommendations 
consisted of NICE CT scan guidelines, reported in five studies, and BTF steroids guidelines, reported 
in two studies. All other guideline recommendations were based on low levels of evidence. Mean 
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adherence to strong recommendations was 93% (range 70-100%) while adherence to moderate/
weak recommendations was considerable lower (mean 49%, range 18-94%). Percentages did not 
differ substantially after removing studies that were found to be at high risk of bias. One study42 
was excluded from this analysis as it reported adherence to an ICU protocol that was based on 
both strong and moderate/weak recommendations. 
In addition, we considered whether the invasiveness of the intervention was related to adherence. 
Across studies, relatively invasive interventions such as ICP monitoring and intracranial operations 
obtained a mean adherence rate of 30% (range: 8-83%), while less invasive interventions such 
as CT scanning and anti-seizure prophylaxis obtained a much higher adherence rate (mean: 79%, 
range 51-100%). 
Factors influencing guideline adherence
Ten studies identified factors influencing adherence (Table 3). Most studies assessed patient 
demographics and clinical characteristics. Three studies assessed treatment, hospital or country 
characteristics. Taking the results together, the BTF guidelines, in particular the ICP monitoring 
recommendations, were consistently more often adhered to in younger patients with extra-
cranial injury and more severe TBI (indicated by Glasgow Coma Scale (GCS), Head Abbreviated 
Injury Scale (HAIS), abnormal pupillary reactions and intracranial pathology). The Scandinavian 
guidelines were more often adhered to in older patients with moderate head injury in comparison 
with mild and minimal head injuries. 
Among studies with a relatively low risk of bias that assessed factors influencing adherence using 
multivariable analyses, age was significantly associated with adherence in all studies (younger 
age is associated with greater adherence in severe TBI patients; older age is associated with 
greater adherence in minimal, mild and moderate TBI patients). Studies about ICP monitoring 
further reported that adherence was more often accomplished in patients with a lower GCS and 
the occurrence of intracranial pathology. 
Factors that were studied but not significantly associated with adherence included race, 28,40 certain 
severity indices (GCS motor score28; Acute Physiology and Chronic Health Evaluation (APACHE) II 
score32), certain laboratory values (international normalized ratio and prothrombin time47; blood 
alcohol level33) certain complications (tachycardia47; hypoxia47), referral status27 and structural 
hospital characteristics (hospital type28; number of beds28; trauma center designation28). For an 
overview of factors significantly associated with adherence in at least one study see Table 3. For 
a complete overview of all factors studied, see Online Supplement D.
Adherence to guidelines in adult patients with traumatic brain injury: A living systematic review
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The association between guideline adherence and outcome
Eleven studies examined the association between guideline adherence and outcome (Table 4). 
All studies examined the BTF guidelines with six studies investigating ICP monitoring guidelines, 
one study examining direct transfer, and the remainder combining various BTF recommendations 
into a compliance or quality score. 
Outcome measurements included in-hospital mortality,28,29,42 29,32,40,47 two-week mortality,30,34 28-
day mortality,32 six-month mortality,27 Glasgow Outcome Scale (GOS) and Rancho Los Amigos 
Table 4. The association between adherence to guidelines and patient outcome
Study ID Outcome variables Direction of association
Alali (2013) In-hospital mortality --
Biersteker (2012) 6 month mortality -
6 month unfavorable outcome +
ICU LOS ++C
Hospital LOS ++C
Bulger (2002) In-hospital mortality --
Hospital LOS -
Fakhry (2004) Mortality --C
ICU LOS --C
Hospital LOS --C
Unfavorable outcome (GOSE) at discharge --C
Lower RLAS at discharge --C
Farahvar (2012)
Gerber (2013)
2-weeks mortality --
Griesdale (2010) In-hospital mortality ++
28-days mortality +
ICU LOS ++C
Härtl (2006) 2-weeks mortality --
Mauritz (2008) ICU mortality -/--
Rusnak (2007) ICU mortality -
90 days unfavorable outcome (GOS) -
ICU LOS +C
Hospital LOS -C
Shafi (2014) In-hospital mortality --
Talving (2013) In-hospital mortality --
ICU LOS ++
Hospital LOS ++
**+ = Positive, non-significant effect; - = negative, non-significant effect; ++ = positive, significant effect; -- = negative, significant effect. 
The direction of the multivariable analyses were noted. If there was no multivariable analysis performed, the univariate analysis was 
reported and a C was noted. 
C= Univariate association adherence – outcome
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Scale (RLAS) at discharge,42 90-day Extended Glasgow Outcome Scale (GOSE),46 six-month GOSE,27 
ICU survival,44,46 and ICU and hospital length of stay (LOS).27,29,42,47
The majority of studies (n = 8) analyzed the adherence-outcome association with multiple 
regression adjusted for relevant confounders30,34,40,44,46 or for propensity scores.27,32,47 Two multi-
center studies analyzed the association on hospital level by dividing hospitals into quartiles 
based on their percentage adherence28 or by dividing hospitals into having an aggressive or 
nonaggressive approach.29 One study assessed the association in univariable analyses.42
Eight out of eleven studies reported a statistically significant association between adherence 
and a reduction in mortality with odds ratios ranging from 0.15 to 0.9628-30,34,40,42,44,47 One study 
additionally described an association between adherence and higher scores on GOSE and RLAS.42 
One study reported increased in-hospital mortality in those treated according to the guideline but 
no significant differences between groups in 28-day mortality.32 For ICU and hospital LOS, three 
studies27,32,47 reported an association with longer LOS and one study reported an association with 
shorter LOS.42 All other associations were non-significant. 
After adjusting for the risk of bias by removing studies with a high risk of bias on at least one of 
the criteria and outcomes that have been assessed in univariable analyses, all but one of the nine 
remaining studies32 reported an association between adherence and a reduction in mortality. 
Functional outcome was assessed in one study,27 showing non-significant results. The association 
with LOS was assessed with multivariable analyses in two studies29,47 showing contradictory 
results. Statistical methods and results can be found in Online Supplement E. 
Discussion
This systematic review provides an overview of adherence to guidelines, its determinants 
and association with outcomes in patients with TBI. We included 22 studies, reported in 25 
publications. Guideline adherence in TBI was found to be suboptimal overall, and varied widely 
between studies (from 18%-100%) and within multi-center studies. Guideline recommendations 
based on strong evidence were more often adhered to in comparison with recommendations 
based on lower level evidence. Guideline adherence was also influenced by age and severity 
(indicated by intracranial pathology and lower GCS). Importantly, guideline adherence appears 
related to patient outcomes, as adherence to BTF (especially ICP monitoring) guidelines was 
associated with a reduction in mortality in all but one study after correction for risk of bias.
This systematic review included three objectives, and thereby provided an overview of the 
entire scope of adherence to guidelines in TBI. However, five important notes should be made 
regarding the completeness and applicability of the evidence. First, despite the existence of over 
100 evidence-based guideline recommendations,51 adherence was assessed for only thirteen 
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recommendations. Results can therefore not be generalized to all guideline recommendations. 
Second, the variability in adherence might have been confounded by the invasiveness of the 
recommended intervention. We found a lower adherence rate in studies about invasive 
interventions such as ICP monitoring and craniotomy in comparison to studies with less invasive 
interventions. Invasive interventions require more experience and skills within the institution 
and therefore may face greater barriers to be implemented than less invasive interventions. 
Third, no definitive conclusion about the efficacy of guidelines can be drawn from this review as 
we did not include any cluster RCTs. These results should encourage the conduct of cluster RCTs 
to more rigorously examine the efficacy of guidelines for TBI. 
Fourth, all included studies were conducted in Europe and North America. Hence, our findings are 
not generalizable to non-Western countries because lack of resources restricts the routine use of 
aggressive treatment strategies in these countries.52 Related, our findings cannot be generalized 
to children as it is known that guideline adherence in children varies from guideline adherence in 
adults36 and might also be influenced by other factors such as concern about radiation.
Last, the majority of current TBI guidelines are not based on high quality evidence. TBI is however 
emerging as an important topic in research with large-scaled, high-quality multicenter studies 
conducted all over the globe13. These are likely to result in revised guidelines based on more 
rigorous evidence.13 The findings of this review might not be generalizable to a situation in which 
TBI guidelines are based on robust evidence, which underlines the importance of keeping this 
systematic review, as well as other systematic reviews in the field of TBI, ‘living’. 
Overall, the methodological quality of the studies was good. The association between adherence 
to guidelines and outcome was however highly suspect for performance bias, as none of the 
studies sufficiently isolated the impact of the guideline studied from concurrent interventions. It 
is, nevertheless, plausible that patients who had, for example, an ICP monitor inserted, also had 
a higher chance of receiving other relatively aggressive treatment, and that these treatments 
confounded the association with outcome. 
Although selection bias/confounding did not seem a major threat to validity in the association 
between adherence and outcome, the risk of bias form we used did not account for confounding 
by indication. Observational studies in critical care may easily suffer from confounding by 
indication, i.e. a different a priori risk of unfavorable outcome between those treated and those 
not treated according to the guideline.53,54 Although the majority of studies made attempts to 
reduce the risk of confounding by multivariable analysis or propensity score adjustment, these 
methods may still insufficiently resolve the problem of confounding by indication as they do 
not account for unmeasured confounders.54-56 This is in contrast to an RCT, where comparability 
between groups is achieved on measured and unmeasured characteristics. In this review, two 
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studies defined guideline adherence at the level of the hospital, which is more likely to provide a 
valid estimate of the effect of adherence on outcome. 
Suboptimal adherence and between center variation have been reported in other systematic 
reviews about guideline adherence in critical care.6,57 Ebben and associates6 reported a variation 
as large as 0 to 98% in a systematic review about guideline adherence in the pre-hospital and 
emergency care. 
The large between-center variation suggests that guideline adherence is a management or 
structural characteristic, which is consistent with a qualitative study about guideline adherence 
in the ICU.58 These authors reported that unit culture and communication were among the most 
important factors in guideline adherence. Furthermore, the availability of electronic protocols, 
education, reminders and an audit-feedback system were identified by participants as important 
determinants of guideline adherence. Surprisingly, only one of the included studies in this review 
assessed the association between hospital characteristics and adherence.28
In this review we found that strong recommendations were more often adhered to than 
recommendations based on lower level evidence. This is consistent with the findings of 
a study about oncology guidelines.59 This may imply that clinicians are not convinced by the 
benefit of moderate and weak guideline recommendations, which is supported by our finding 
that intracranial pathology is associated with adherence to ICP monitoring guidelines. The 
recommendation to place an ICP monitor in patients without CT abnormalities but with additional 
risk factors stems from one prospective study published in 1982,60 while the recommendation to 
place an ICP monitor in patients with an abnormal head CT is, albeit still controversial, based on 
more robust evidence. 
Other clinical characteristics that were associated with guideline adherence were age and GCS. 
The negative association between age and adherence in severe TBI patients is conceivable as 
older age is associated with medical comorbidity and premorbid anticoagulant- or antiplatelet 
use.61 It has been suggested that these patients should not be treated aggressively,62 although 
the BTF guidelines do not specify any subgroups in their recommendations.
The positive association between lower GCS and adherence to BTF guidelines is in line with 
findings from methodological studies about confounding by indication in critical care, which 
describe that the most intensive treatments, such as ICP monitoring, are often reserved for the 
most ill.53,63
The association between adherence and a reduction in mortality is consistent with a systematic 
review of protocolized management of patients with TBI in the ICU4 and a cost-benefit analysis 
about the effectiveness of the BTF guidelines.64 Although these findings are consistent, they 
Adherence to guidelines in adult patients with traumatic brain injury: A living systematic review
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should be interpreted with caution because of the high risk of confounding by indication and 
performance bias in these studies. 
Strengths of this systematic review include the use of a comprehensive search strategy and 
independent screening, data extraction and quality assessment by two review authors. As 
there is no gold standard for risk of bias assessment in observational studies,65 we developed 
and pilot-tested our own form. This could be considered a review limitation, however, we 
attempted to describe the six threats to validity as described by the Cochrane Collaboration and 
used two validated forms. In addition, concordance rates in assessing bias were high suggesting 
unambiguous items. Finally, despite an extensive search strategy, we found no unpublished 
studies. Although the performance of audits to test and improve guideline adherence is well 
practiced,66 these reports are seldom published in international journals. Combined with the 
fact that we excluded non-English language studies, it is likely that some publication bias exists 
within this review. 
The results of this review imply that guideline adherence in TBI is suboptimal. Certain subgroups, 
such as older patients or severe TBI patients with a relatively high GCS are even less likely to be 
treated according to the guidelines. One solution may be for guideline developers to take into 
account specific subgroups of patients and tailor their recommendations accordingly.
The fact that strong guideline recommendations were more often followed than those based 
on less robust evidence, speaks to the need for adequate investment in high-quality research to 
evaluate treatment efficacy and effectiveness, and for this research to be incorporated rapidly into 
guidelines. We would recommend high quality RCTs and large-scale comparative effectiveness 
studies using robust methods to adjust for confounding by indication for this purpose. 
The large variation found in this systematic review highlights the importance of hospital 
characteristics and/or management strategies in guideline adherence. Although this has been 
reported in qualitative studies, further quantitative research may shed greater light on its 
importance and elucidate which characteristics inhibit clinicians from adhering to guidelines. 
In this systematic review, we found an association between adherence to current guidelines and 
reduced mortality. These results should be interpreted as preliminary because only two studies 
accounted for confounding by indication and none could eliminate the effect of concurrent 
interventions. It is important that future studies investigating guideline adherence or treatment 
effectiveness use robust methods to adjust for confounding by indication and concurrent 
treatment interventions to estimate effectiveness. 
Supplemental material is available at www.marysecnossen.nl
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Adherence to guidelines in adult patients with traumatic brain 
injury, Living Systematic Review Update 3
About this LSR
This Living Systematic Review will be updated at approximately a three to six month intervals 
(Table 1), at which time this online supplementary material will be updated accordingly. 
Table 1. Living Systematic Review History
Version Search date* Number of new included  
studies
Implications for conclusions
Update 3 June 2017 This update: 5
Cumulative for updates: 13
As update 1. 
Adherence to the anti-seizure prophylaxis guidelines is 
90% in one study.
Adherence to BTF mannitol recommendation was 72% 
in one study.
Guideline adherence ranges from 0-100%.
Update 2 January 2017 This update: 1
Cumulative for updates: 8
As update 1
Update 1 September 2016 This update: 7
Cumulative for updates: 7
Adherence to ICP monitoring guidelines was higher in 
studies published in 2015 and 2016 than reported in 
the original review.
The association between guideline adherence and 
clinical outcome became more uncertain due to the 
inclusion of a high-quality study that did not find an 
association between adherence and outcome.
Original October 2014 22 Guideline adherence is suboptimal and varies widely 
(18-100%).
Guideline adherence is associated with age and 
TBI severity and the quality and invasiveness of the 
guideline recommendation.
Adherence to BTF guidelines might be associated with 
a reduction in mortality.
*Date at which the search was run
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Key information from new included studies
The update search in June 2017 identified seven new studies,1-7 of which three were based on 
the same data.4-6 Therefore, data from five studies were extracted.1-4,7 The cumulative number of 
studies since the publication of the original review is 13 (see Table 2). In this update we describe 
the 13 studies that have been included since the original review.
CT guidelines
One study examined adherence to the NICE head CT guidelines in a hospital in Czech Republic 
and found that adherence decreased from 72% in 2000 to 20% in 2015.8 The adherence rate 
of 20% is significantly lower than adherence to NICE head CT guidelines in the original review 
(Median 97%). Authors elaborate that the decrease in adherence might be related to a decrease 
in number of hospital beds. One study examined adherence to the most recent version of the 
Scandinavian head CT guidelines for patients with mild TBI that also incorporated S100B as a 
biomarker in a level II trauma center in Sweden.9 Adherence was 85%. Among the patients with 
normal S100B (n = 229), 73 (32%) received a CT scan while there was no indication. Furthermore, 
a total of 39 (7%) patients did not receive a CT scan while they had an elevated S100B value 
(n = 497) and thus an indication according to the guidelines. One study examined adherence to 
the Canadian head CT rule in a tertiary care hospital in Singapore.2 Adherence was 71%. A total 
of 20% of the patients did not receive a CT scan while they had an indication according to the 
Canadian head CT rule, whereas 9% of the patients received a CT scan without an indication. In 
this study, guideline adherence was higher among patients with retrograde amnesia, patients 
injured in motor vehicle accidents and patients presenting with headache (Table 3). 
Anti-seizure prophylaxis guidelines
One study examined adherence to the anti-seizure prophylaxis guidelines from the AANS in a 
level I trauma center in the US.1 They found that in 90% of the patients, anti-seizure prophylaxis 
was stopped > 7 days from injury, in line with the guideline recommendations.
Brain Trauma Foundation guidelines
The other studies examined adherence to the BTF guidelines.3,4,10-15 Two studies examined 
adherence to a set of BTF criteria, resulting in adherence rates of 70 and 74%.12,13 One study 
examined mannitol administration in a center in Canada and found that 72% of the patients that 
received mannitol had an appropriate indication.11 One study examined guideline adherence 
in a tertiary care hospital in Tanzania and reported adherence rates in the range 0-36%.7 The 
remainder of studies, including the two studies that examined a total set of BTF guidelines and 
the study from Tanzania, examined guideline adherence to ICP monitoring guidelines.3,4,7,10,12-15 
Mean adherence was 53% (range 0-100%), which is higher than the percentage reported in the 
original review (31%).
Adherence to guidelines in adult patients with traumatic brain injury: A living systematic review
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One study examined predictors of adherence to ICP monitoring guidelines.14 None of their 
predictors (including age, gender, GCS, hypotension and CT abnormalities) was statistically 
significant associated with guideline adherence (Table 3). 
The association between guideline adherence and patient outcome was studied in five studies 
using the BTF guidelines (Table 4).4,10,12-14 Higher adherence was associated with lower in-hospital 
mortality in two studies analysing the guideline-adherence association on the patient level.13,14 
One study assessed the adherence-outcome association in both India and in the US. They found 
that higher adherence resulted in lower mortality in India but not in the US.12 Two studies did 
not find a statistically significant association between guideline adherence to ICP monitoring 
guidelines and patient outcome.4,10 One of these however did report an association between ICP 
monitoring, complications and worse functional independence.4
We note that the BTF guidelines have been revised in 2016.16 Therefore, a new cycle of audits of 
compliance will need to be undertaken with regard to the BTF guidelines.
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Table 3. Factors significantly associated with adherence to guidelines
Study ID Significant predictors
Tan (2017) Motor vehicle crashes, headache, retrograde amnesia
Tang (2015) No significant predictors
Table 4. The association between adherence to guidelines and patient outcome
Study ID Outcome variables Direction of association
Aiolfi (2017) 30-day mortality +
Complications ++
Functional independence --
Dawes (2015) In-hospital mortality +/- ‡
Gupta (2015) In-hospital mortality India --
In-hospital mortality Seattle -
Lee (2015) In-hospital mortality -/-- †
Tang (2015) In-hospital mortally --
**+ = Positive, non-significant association between adherence and outcome; - = negative, non-significant association between adherence 
and outcome; ++ = positive, significant association between adherence and outcome (e.g. guideline adherence is associated with an 
increase in in-hospital mortality); -- = negative, significant association between adherence and outcome (e.g. guideline adherence is 
associated with a decrease in in-hospital mortality). The direction of the multivariable analyses were noted. If there was no multivariable 
analysis performed, the univariate analysis was reported and a C was noted. 
‡ Risk adjusted mortality for ICP monitoring was 41.8% in the lowest tercile, 33.8% in the middle tercile and 42.0% in the highest tercile. 
Risk adjusted mortality for craniotomy was 55.8% in the lowest tercile, 47.1% in the middle tercile and 56.0% in the highest tercile. 
†Patients in the lowest compliance group (< 55%) had a higher odds on mortaility, while patients in the moderate and high compliance 
groups (55-75% and > 75%) were indisguishable. 
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Abstract
Introduction: The strength of evidence underpinning care and treatment recommendations in 
traumatic brain injury (TBI) is low. Comparative effectiveness research (CER) has been proposed 
as a framework to provide evidence for optimal care for TBI patients. The first step in CER is to map 
the existing variation. The aim of current study is to quantify variation in general structural and 
process characteristics among centers participating in the Collaborative European NeuroTrauma 
Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study.
Methods: We designed a set of 11 provider profiling questionnaires with 321 questions about 
various aspects of TBI care, chosen based on literature and expert opinion. After pilot testing, 
questionnaires were disseminated to 71 centers from 20 countries participating in the CENTER-
TBI study. Reliability of questionnaires was estimated by calculating a concordance rate among 
5% duplicate questions. 
Results: All 71 centers completed the questionnaires. Median concordance rate among 
duplicate questions was 0.85. The majority of centers were academic hospitals (n = 65, 92%), 
designated as a level I trauma center (n = 48, 68%) and situated in an urban location (n = 70, 
99%). The availability of facilities for neurotrauma care varied across centers; e.g. 40 (57%) had 
a dedicated neuro-intensive care unit (ICU), 36 (51%) had an in-hospital rehabilitation unit and 
the organization of the ICU was closed in 64% (n = 45) of the centers. In addition, we found 
wide variation in processes of care, such as the ICU admission policy and intracranial pressure 
monitoring policy among centers. 
Conclusion: Even among high-volume, specialized neurotrauma centers there is substantial 
variation in structures and processes of TBI care. This variation provides an opportunity to study 
effectiveness of specific aspects of TBI care and to identify best practices with CER approaches.
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Introduction
Traumatic Brain Injury (TBI) is an important threat to public health with a crude incidence rate 
of up to 849 per 100,000 people in European countries.1,2 TBI is emerging as one of the leading 
causes of death and disability worldwide resulting in huge personal suffering and far-reaching 
socioeconomic consequences.3,4 
Different perspectives on various aspects of care exist, and the evidence underpinning guideline 
recommendations for treatment of patients with TBI is weak.3,5 There is growing realization that 
randomized clinical trials alone will not be able to provide the evidence base that is needed to 
address these knowledge gaps.6 Comparative effectiveness research (CER) has been proposed 
as a good complementary approach to strengthen the evidence base. CER has been defined as 
“the generation and synthesis of evidence that compares the benefits and harms of alternative 
methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery 
of care”.7 CER exploits between-center differences in patient management by comparing centers 
that perform a certain intervention routinely to others that do not. This approach is expected to be 
particularly suitable for TBI since large between-center differences in both patient management 
and outcomes have been previously reported.8,9 
The Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury 
(CENTER-TBI) study is a large-scale observational multicenter study focusing on characterization 
and CER in TBI. The first step for CER is to provide an overview of variation in structures and 
processes of care in the participating centers (‘provider profiling’). Such an overview can be used 
to identify areas where large between-center variation exists, to guide future CER analyses. But it 
can also directly be used for CER. For example, treatment effectiveness of a certain intervention 
can be studied by comparing outcome in patients from centers that routinely perform the 
intervention to outcome in patients from centers that do not routinely perform the intervention. 
Therefore, the objective of the current study is to quantify variation in general structure and 
process characteristics among centers participating in the CENTER-TBI study and to identify 
topics for CER. 
Material and methods
CENTER-TBI study
CENTER-TBI is a prospective longitudinal observational study conducted in 72 centers from 20 
countries across Europe and Israel.3 One of the global aims is to “identify the most effective 
clinical care and provide high-quality evidence in support of treatment recommendations and 
guidelines”.3 This will be pursued by CER approaches. For more information, see also www.
center-tbi.eu. Before the patient inclusion started, a detailed inventory of center characteristics 
was performed by distributing a set of questionnaires on structures and process of TBI care: The 
Variation in structure and process of care in traumatic brain injury
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Provider Profiling (PP) questionnaires (see Online Supplement A). This set of questionnaires was 
distributed among 71 centers, since two CENTER-TBI centers represented different departments 
from the same hospital with similar structures and processes. 
Development process of the Provider Profiling Questionnaires
The PP questionnaires went through a comprehensive developing process to warrant completeness 
and relevance of topics and face validity of questions. The neurotrauma evidencemap (http://
neurotrauma.evidencemap.org/) was searched for gaps and inconsistencies in knowledge of 
optimal treatment and organization of TBI care, and used to define topics of interest. We included 
topics relevant for CER as well as topics relevant for descriptive analyses. Initial questions were 
formulated based on literature and suggestions from experts in the field. Available surveys and 
questionnaires in the field of TBI or critical care10,11 were searched for and used for the (re)
formulation of (additional) questions. 
Questions related either to structures or processes of general or TBI-specific care. Structure 
refers to the conditions under which patient care is provided (e.g. the number of beds, trauma 
center designation, hospital facilities), and process refers to activities that constitute patient care 
(e.g. general hospital or department policies).12 Structural information could be extracted from 
hospital databases, annual reports and local registries. Process information refers to general 
policies rather than individual treatment preferences of responsible physicians. General policy 
was defined as ‘the way the large majority of patients (> 75%) with a certain indication would be 
treated’, recognizing that there might be exceptions. We included open questions and multiple-
choice questions. All questions were presented with text boxes that contained definitions and a 
short explanation about the interpretation and completion of the question. The definitions used 
in this paper are summarized in Online Supplement B. 
Experts in the field provided feedback on the initial formulated questions and proposed new 
questions and topics in three subsequent phases. Consulted experts included neurosurgeons, 
(neuro)intensivists, neurologists, emergency department (ED) physicians, rehabilitation 
physicians, medical ethicists, health care economists and epidemiologists. Some of the consulted 
experts had previous experience with the design and conduct of surveys in the field of TBI or 
critical care. In a first phase, a small group of experts discussed the questionnaires during an email 
conversation and a group discussion. In a second phase, an international expert panel, consisting 
of 25 experts from 9 countries, was consulted per email. These experts provided feedback on one 
or more of the questionnaires. Decisions on proposed content and formulation were then made 
during a group discussion with a small group of experts. These draft PP questionnaires were then 
pilot-tested in 16 of the participating CENTER-TBI centers. Each center completed two or three 
questionnaires, such that each questionnaire was pilot-tested at least three times. All answers 
were checked for unexpected or missing values and ambiguous questions were subsequently 
reformulated or deleted. Pilot-testers additionally completed a form in which they were asked to 
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provide feedback, which was incorporated accordingly. All these processes resulted in a final set 
of eleven questionnaires related to different phases of TBI care (see Table 1). In total, there were 
321 questions included in the PP.
Table 1. Characteristics of the Provider Profiling questionnaires 
Questionnaire No. of 
questions
Topics
1. General 41 Structural characteristics of the hospital, catchment area, volume, 
facilities, staffing characteristics, payment, equipment, costs
2. Medical ethics 17 Department of medical ethics, IRB approval, informed consent 
procedures
3. Prehospital trauma care 28 First aid initiatives, dispatch systems, emergency services, hospital 
reception and initial treatment
4. Emergency department 50 Structural characteristics of the ED, imaging, guidelines, ED 
overcrowding, treatment, admission policy, discharge policy, withdrawal 
of life support
5. Admission 22 Structural characteristics of the ward, admission policy, guidelines, 
observations, treatment policy, step down beds, discharge policy
6. Structural and organizational 
aspects of the ICU
27 Structural characteristics of the ICU(s), staffing characteristics, admission 
policy, ICU decision making
7. Treatment at the ICU 70 Protocol use, ICP- and CPP monitoring, sedation, non-surgical treatment 
of severe TBI patients, seizure prophylaxis, treatment of fever, DVT 
prophylaxis, mechanical ventilation
8. Ethical aspects of the ICU 20 Withdrawal of life support, age and ICU admission
9. Neurosurgery 21 Volume, staffing characteristics, decision making, protocols, surgical 
management of mass lesions
10. Rehabilitation 14 In-hospital rehabilitation facilities, referral to post-acute care
11. Country 11 Health care policy, dispatch systems, insurance
The provider profiling questionnaires consist of 11 separate questionnaires. Table shows number of questions and topics for each of 
the questionnaires. 
Abbreviations: IRB = institutional review board, ED = emergency department, ICU = intensive care unit, ICP = intracranial pressure, 
CPP = cerebral perfusion pressure, TBI = traumatic brain injury, DVT = deep venous thrombosis prophylaxis
Distribution of the questionnaires
During presentations and workshops at two consecutive CENTER-TBI investigators meetings, 
information on the PP questionnaires was provided. Local investigators, as the senior persons 
supervising the CENTER-TBI study in the centers, were extensively informed in person and per 
email about the aim of the study and we emphasized the confidentiality of their responses. 
Additionally, to achieve unequivocal responses, we instructed them on how to respond to 
the process questions. We emphasized that we were asking for general policies, rather than 
individual treatment preferences and stimulated discussions with colleagues to identify the 
general policy of their department/center. Questionnaires were completed using a web-based 
system (Quesgen Systems Inc.) An instruction video was made available and any questions from 
local investigators were answered per email. 
Variation in structure and process of care in traumatic brain injury
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The local investigators in each center were responsible for the completion process in their center. 
Staff members with the appropriate expertise and knowledge needed to complete one or more 
questions or questionnaires. The local investigators were responsible for monitoring progress 
and checking face validity of all answers. The first author (MC) reminded local investigators 
regularly and answered any questions by email. 
We aimed to receive completed questionnaires before centers started recruiting patients. As 
CENTER-TBI had a phased start of the inclusion period, PP questionnaires were completed 
between December 2014 and April 2016. 
Questionnaire completion and data cleaning 
A questionnaire was considered completed by a center if > 90% of the questions had been 
answered. Data from participating centers were included in the current paper if the center 
had completed the first PP questionnaire (‘general’), since the first questionnaire provides the 
general structure information necessary for provider profiles. The first author (MC) screened the 
completed questionnaires for missing values and contacted local investigators if any missing data 
were present. They were asked to complete the missing data if possible or provide a reason for 
missingness. Data were further screened for outliers and local investigators were contacted to 
confirm values that were considered out of range. 
Statistical analyses
To estimate reliability of the questionnaires, we included 17 (5%) duplicate questions, including 
all question formats. We equally included structure and process questions in the duplicate 
questions. Concordance rates were estimated by calculating the percentage of overlap between 
duplicate questions, and presented as mean, median and range. For open questions (e.g. what 
is the number of intensivist in your center), a maximum difference of 10% was considered 
concordant. For all hospital characteristics in this paper, frequencies and percentages were 
presented for categorical variables and medians and interquartile ranges (IQR) were presented 
for continuous variables. For a more in-depth understanding of the variation among centers, we 
checked whether there were differences between relatively high- and middle-income countries 
versus relatively lower-income countries, and also if there were differences between countries 
from different geographic locations (North and West Europe versus South and East Europe and 
Israel). We used the Chi-square test, and if appropriate, Fisher’s exact test to examine whether 
differences between groups were statistically significant (p < .05). The designation into relatively 
lower-income countries was based on a 2007 report by the European Commission.13 Bosnia 
Herzegovina, Bulgaria, Hungary, Latvia, Lithuania, Romania and Serbia were subsequently 
classified as relatively lower-income countries. The subdivision into geographic location was 
based on the classification by the United Nations. Austria, Belgium, Denmark, Finland, France, 
Germany, Lithuania, the Netherlands, Norway, Sweden and the United Kingdom (UK) were 
subsequently classified as countries from West and North Europe, while all other countries were 
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classified as countries from South and East Europe and Israel. Analyses were performed using the 
Statistical Package for Social Sciences (SPSS) version 21. 
Results
Completion process 
All 71 eligible centers completed the provider profiling questionnaire about general structural and 
process information. Questionnaires were completed by multiple persons per center, including 
neurologists, neurosurgeons, trauma surgeons, intensivists, research nurses and administrative 
staff members. The 71 centers were from 20 European countries (see Figure 1). Each country 
had 1 to 9 participating centers (median = 2.5). The United Kingdom (UK) had most centers 
participating (n = 9), while Serbia and Switzerland both had one participating center. Thirteen 
of the included centers were from relatively lower-income countries and 25 centers were from 
countries in South and East Europe (including Israel). 
Reliability of the questionnaires 
The median concordance rate between duplicate questions was 0.85 (mean: 0.81; range 
0.44-0.97), meaning that 85% of the responses were similar. Concordance rates were lowest for 
questions about treatment policy (e.g. on what indications would you admit a patient with mild 
TBI to the ward) and for open questions (e.g. what is the number of intensivists working at your 
center). Most multiple-choice questions about structure had concordance rates above 0.90. 
General structural characteristics 
The participating centers were predominately academic centers (n = 65, 92%), designated as a 
level I or II trauma center (n = 54, n = 74%) and situated in an urban location (n = 70, 99%, see 
Table 2). The majority of participants indicated that they had access to a helicopter platform 
(n = 57, 80%) and an acute trauma team (n = 63, 89%). Around half of the centers (n = 40, 57%) 
had a dedicated neuro ICU. Centers from relatively high- and middle-income countries more 
often indicated that they have a dedicated neuro ICU (n = 35, 61%) than centers from relatively 
lower-income countries (n = 5, 39%, p = .13, see Online Supplement C). The large majority of 
centers had participated previously in research about acute cerebral disorders. Fifty-one (72%) 
centers were involved in more than five neurotrauma research applications over the past five 
years (see Table 2). 
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Figure 1. Centers and countries included in the Collaborative European NeuroTrauma Effectiveness 
Research in Traumatic Brain Injury (CENTER-TBI) study
Reprinted and updated from Maas et al. (2015). Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury: a 
prospective longitudinal observational study. Neurosurgery, 76:67-80, under a CC BY license, with permission from professor A.I.R Maas.
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Table 2. General structural characteristics of the participating centers (n = 71)
Characteristic N completed N (%)*
Academic hospital (vs. non-Academic) 71 65 (92%)
Trauma center designation 71
 – Level I 48 (68%)
 – Level II 4 (6%)
 – Level III 1 (1%)
No designation / NA 18 (25%)
Urban location (vs. suburban and rural location) 71 70 (99%)
Helicopter platform 71 57 (80%)
Acute trauma team 71 63 (89%)
The availability of a dedicated neuro ICU 70 40 (57%)
Number of ICUs (median, IQR) 69 3 (2-5)
The availability of an in-hospital rehabilitation unit 70 36 (51%)
Neurotrauma research applications in the past 5 y 71
 – > 5 51 (72%)
 – 3-5 13 (18%)
 – 1-2 4 (6%)
 – 0 or unknown 3 (4%)
Distance nearest trauma center that receives patients  
with severe TBI (km, median, IQR)
52 56 (17-100)
* Table presents number and percentage of centers unless otherwise specified
Abbreviations: ICU = Intensive care unit; IQR = Interquartile Range
The median number of beds in the participating centers was 1000 (IQR 682-1395) of which 31 
(IQR 22-44) were ICU beds (see Table 3 and Online Supplement D). Centers had a median of 3 
(IQR 2-6) resuscitation rooms at the ED and 24 (IQR 16-39) operating rooms. Three (IQR 2-4) of 
these were potentially available for TBI patients. The median number of annual ED visits was 
53,428 (IQR 30,002-90,268). The median number of annual ICU admission was 1240 (IRQ 560-
2019), of which 91 (IQR 52-160) were TBI patients. 
Seventy-five per cent (n = 53) of the centers had separate 24/7 emergency operation rooms. The 
majority of centers indicated that they had an electronic patient system at the ward (n = 57, 80%) 
and the ICU (n = 56, 79%). There was variation in the organization of the ICU in the participating 
centers; i.e. 45 (64%) centers had a closed ICU organization, 3 (4%) an open ICU organization 
and the remainder (n = 22, 32%) a mixed ICU organization. Centers from relatively high- and 
middle-income countries more often reported that they had a closed ICU structure (n = 40, 
70%) compared to centers from relatively lower-income countries (n = 5, 39%). Step down beds 
were available in 71% (n = 50) of the centers. Centers from North and West Europe more often 
reported that they had a step down bed facility than centers from South and East Europe and 
Israel (n = 36, 80% vs. n = 14, 56%, p = .03, see Online Supplement C). Maximum laboratory 
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turnaround times, the possibility for in-hospital coma stimulation and the location of TBI relevant 
facilities also varied widely among the included centers (see Table 4). 
Table 3. Volume characteristics of the participating centers (n = 71)
Characteristic N completed Median (IQR)
Number of beds
Number of ED observational beds 69 16 (7-32)
Number of hospital beds 69 1000 (682-1395)
Number of ICU beds 71 31 (22-44)
Number of resuscitation and operating rooms
Number of resuscitating rooms 69 3 (2-6)
Number of operating rooms 70 24 (16-39)
Number of operating rooms potentially available for TBI patientsA 69 3 (2-4)
Number of patients 
Annual ED visits 63 53,428 (30,002-90,268)
Annual ICU admissions 65 1240 (560-2019)
Number of TBI patients 
Annual number of TBI patients at the ICU 63 91 (52-160)
Annual neurosurgical procedures to evacuate contusion 59 9 (4-21)
Annual decompressive craniectomies 56 13 (8-22)
A Operating rooms potentially available for TBI patients are the operating rooms that can be used for emergency and non-emergency 
TBI patients (e.g. trauma operating rooms, neurosurgical operating rooms). Rooms that are used for non-TBI surgery in TBI patients (e.g. 
orthopedic surgery in patients with multiple trauma) should be excluded here. 
Abbreviations: IQR = interquartile range; ED = emergency department; ICU = intensive care unit; TBI = traumatic brain injury; SAH = 
subarachnoid hemorrhage
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Table 4. Hospital facilities of the participating centers (n = 71)
Characteristic N completed N (%)
General
Separate 24/7 emergency operation rooms 71 53 (75%)
Electronic patient system
 – Ward 71 57 (80%)
 – ICU 71 56 (79%)
Facility for overnight observation 69 54 (78%)
Lab turnaround timeA 68
 – 0-30minutes 25 (36%)
 – > 30 minutes 26 (38%)
NA. No lab SOP at the ED 17 (25%)
Organization of the ICU 70
 – Closed 45 (64%)
 – Open 3 (4%)
 – Mixed 22 (32%)
Step down beds 70 50 (71%)
In-hospital coma stimulation 70 34 (49%)
TBI related
Location TBI facilities 71
 – Different buildings 20 (28%)
 – Same building, different floors 45 (63%)
 – Same building, same floors 6 (9%)
A The laboratory turnaround times that are record in the lab Standard Operating Procedures (SOP) at the emergency department for 
severely injured patients
Abbreviations: ICU = intensive care unit; NA = not applicable; SOP = Standard Operating Procedures; TBI = traumatic brain injury
On average 14 neurologists, 10 neurosurgeons, 17 intensivists, 4 trauma surgeons and 10 ED 
physicians were working in the centers (see Table 5). Nearly all centers (n = 69, 97%) had at least 
one residency program for trainees towards becoming a specialist. The specialist most often in 
charge of TBI patients at respectively the ED, ward and ICU were predominately ED physicians, 
neurosurgeons and intensivists. Most centers had 24/7 in-house availability of OR personnel 
(n = 62, 87%) and CT technicians (n = 66, 93%). Median intensivist-to-patient ratio, and ICU nurse-
to-patient ratio were 1: 5 (IQR 1:3 to 1:8) and 1:2 (IQR 1:1 to 1:3). Night coverage at the ICU was 
performed by a certified intensivist in two-third of the centers (n = 44, 65%) and by a trainee or 
fellow in the remainder of centers. Almost all centers from the relatively lower-income countries 
(n = 12, 92%) reported that night coverage was performed by a certified intensivist, in comparison 
to 58% of the centers from the relatively high- and middle-income countries. Also, more centers 
from South and East Europe (n = 22, 88%) had night coverage by a certified intensivist, compared 
to centers from North and West Europe (n = 22, 51%, see Online Supplement C). 
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Table 5. Staffing characteristics of the participating centers (n = 71)
Characteristic N completed N (%)*
Number of specialists (median, IQR)
 – Neurologist 71 14 (8-21)
 – Neurosurgeon 68 10 (7-13)
 – Intensivist 68 17 (10-28)
 – Trauma surgeon 68 4 (0-10)
 – ED physician 69 10 (3-19)
Residency programs
 – Neurologist 70 65 (93%)
 – Neurosurgeon 71 67 (94%)
 – Intensivist 71 64 (90%)
 – Trauma surgeon 71 36 (51%)
Availability OR personnel 71
 – 24/7 in-house availability 62 (87%)
 – On call within 30 minutes 9 (13%)
Availability CT technicians 71
 – 24/7 in-house availability 66 (93%)
 – On call within 30 minutes 5 (7%)
Intensivist-to-patient ratio (median, IQR) 69 1: 5 (1: 3- 1: 8)
ICU nurse-to-patient ratio (median, IQR) 69 1: 2 (1: 1- 1: 3)
Night coverage ICU 68
 – Certified intensivist/ ICU physician 44 (65%)
 – Trainee (in residency training) 20 (29%)
 – Fellow in training for ICU 4 (6%)
* Table presents number and percentage of centers unless otherwise specified 
A Number of specialists is displayed per 40-hour workweek. 
Abbreviations: IQR = interquartile range; ED = emergency department; OR = operating rooms; CT = computed tomography
General process characteristics
With regard to computed tomography (CT) scanning in patients with mild TBI at the ED, 79% of 
the centers (n = 54) indicated to use CT guidelines (see Table 6). In addition, seven centers (10%) 
from Austria, Denmark, France, Spain and Sweden routinely determine S100B as a prognostic 
biomarker for neurological deterioration at the ED. There was variation among centers in their 
ICU admission policy; i.e. 44 (64%) centers generally admit patients with moderate TBI (Glasgow 
Coma Scale (GCS) 9-12) and CT abnormalities to the ICU, while 25 (36%) centers only admit 
these patients to the ICU in the presence of other risk factors. This variation was also shown for 
moderate TBI patients without CT abnormalities and patients with mild TBI on anti-coagulant 
therapy. There was a trend towards a higher ICU admission rate in centers from relatively high- 
and middle-income countries than in centers from relatively lower-income countries (see Online 
Supplement C). 
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The large majority of participants (n = 61, 91%) indicated that their general policy is to insert 
intracranial pressure (ICP) monitors in patients with GCS < 9 and CT abnormalities. However, 
centers vary in whether they would place an ICP monitor in patients with GCS < 9 without CT 
abnormalities and patients with intraventricular haemorrhages. Variation in ICP monitoring is also 
reported within the centers, since half of the centers indicated that there is structural variation 
between (neuro)surgeons in their center with regard to the decision to place an ICP monitor. The 
threshold for medical management of elevated ICP was 20 mmHg in the large majority of centers 
(n = 57, 87%). However, centers varied widely in their threshold for decompressive craniotomy; 
i.e. in 12% (n = 7) the threshold was 20 mmHg, in 57% (n = 35) the threshold was 25 mmHg and 
in 31% (n = 19) the threshold was 30 mmHg. 
Table 6. General process information of the participating centers (n = 71)
Characteristic N Completed N (%)
Emergency department
Use of CT scan guidelines at the ED 68 54 (79%)
Routine use of S100B as prognostic biomarker at the ED 71 7 (10%)
ICU admission policy
Patients with moderate TBI (GCS 9-12) without CT abnormalities are admitted to the ICU 69
 – No or only in the presence of other risk factors 50 (72%)
 – General policy 19 (28%)
Patients with moderate TBI (GCS 9-12) with CT abnormalities are admitted to the ICU 69
 – No or only in the presence of other risk factors 25 (36%)
 – General policy 44 (64%)
Patients with mild TBI (GCS 13-15) using anti-coagulant therapy are admitted to the ICU 69
 – No or only in the presence of other risk factors 53 (77%)
 – General policy 16 (23%)
ICP monitoring
ICP monitoring is performed in patients with GCS<9 and CT abnormalities 67
 – No or only in the presence of other risk factors 6 (9%)
 – General policy 61 (91%)
ICP monitoring is performed in patients with GCS<9 without CT abnormalities 67
 – No or only in the presence of other risk factors 52 (78%)
 – General policy 15 (22%)
ICP monitoring is performed in patients with intraventricular hemorrhages 67
 – No or only in the presence of other risk factors 46 (69%)
 – General policy 21 (31%)
ICP sensors that are used at the ICU: 67
 – Parenchymal 21 (31%)
 – Ventricular 6 (9%)
 – Both 40 (60%)
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Table 6. Continued
Characteristic N Completed N (%)
ICP monitoring is performed in patients with intraventricular hemorrhages 67
 – No or only in the presence of other risk factors 46 (69%)
 – General policy 21 (31%)
ICP sensors that are used at the ICU: 67
 – Parenchymal 21 (31%)
 – Ventricular 6 (9%)
 – Both 40 (60%)
Management of elevated ICP
Threshold for medical management of elevated ICP 66
 – > 15mmHg 3 (5%)
 – > 20mmHg 57 (86%)
 – > 25mmHg 6 (9%)
Threshold for decompressive craniotomy in elevated ICP 61
 – > 20mmHg 7 (12%)
 – > 25mmHg 35 (57%)
 – > 30mmHg 19 (31%)
ICU policies
Structural variation between (neuro)surgeons with regard to their decision to place an 
ICP sensor
69 33 (48%)
General policy with regard to the management of extremity fractures in patients with 
sTBI
68
 – Damage control 58 (85%)
 – Definitive care 10 (15%)
Abbreviations: CT = computed tomography; ED = emergency department; ICU = intensive care unit; ICP = intracranial 
pressure; BTF = Brain Trauma Foundation; GCS = Glasgow Coma Scale; sTBI = severe traumatic brain injury
Insurance and payment systems
In the majority of countries (n = 16, 80%), a health care insurance was compulsory for all 
inhabitants. In 45% of the countries (n = 9), patients nevertheless had to pay a part of the 
delivered care themselves via either a co-payment (5 countries) or a deductible (4 countries). 
Most centers were funded by the government (n = 60; 85%). Centers typically got reimbursed 
by all-in amounts per patient rather than by payment for individual interventions. Most doctors 
received a fixed monthly salary (n = 58, 82%). In 11% (n = 8) of the centers, doctors received 
an additional fee for services. Twenty-three (32%) centers received additional payment for the 
treatment of privately insured patients. 
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Discussion
We found considerable variation in general structure and process characteristics among 71 
specialized neurotrauma centers participating in the CENTER-TBI study. Most of these centers 
were high-volume academic level I trauma centers situated in an urban location. Centers varied 
widely in their ICU organization, hospital facilities and admission- and treatment policies. The 
effectiveness of these structures and interventions can therefore adequately be studied with 
CER. 
Our provider profiling questionnaires have strengths and limitations. One of the strengths is 
the comprehensive development process, which consisted of several stages and involved many 
experts. As a consequence, the questionnaires address all aspects relevant to TBI care. Secondly, 
local investigators were extensively informed about the aim, procedures and practical issues 
during presentations, workshops and emails. This might explain the 100% response rate. The 
length of our questionnaires can be regarded as a limitation. Long questionnaires have been 
associated with lower data quality,14,15 an effect that is often due to fatigue and boredom.15 Since 
the questionnaires could be spread over time and over different persons, the negative effect of 
length was however confined.
Another limitation of our study concerns the generalizability of our findings. The included 
centers comprise a group of neurotrauma centers participating in a European multicenter study. 
Our findings therefore cannot be generalized to all centers caring for neurotrauma patients in 
Europe. Furthermore, our study provides information on what centers reported rather than 
characteristics that were directly observed. Therefore, we cannot exclude that some of our 
findings provide a too optimistic picture. For example, almost all centers indicated that they would 
insert an ICP monitor in patients with severe TBI and CT abnormalities, which is recommended by 
Brain Trauma Foundation guidelines. However, a systematic review about guideline adherence 
reported that ICP monitoring guidelines were only followed in one-third of the patients.5 Later, 
results from the ongoing CENTER-TBI study will provide insight into discrepancies between 
reported and actual policies in the participating centers. 
The concordance rate between duplicate questions (median: 0.85), indicates a certain degree 
of subjectivity in the responses. The concordance rate was especially low for process questions, 
which indicates that there might be differences in policy among wards and doctors, no clear 
policy at all or difficulties in understanding and interpreting the questions. It might also indicate 
that some of the doctors that completed the questionnaire might not be representative of 
their department or center. Although our concordance rate was very similar to a 2001 survey 
study among European countries,11 results on process characteristics should be interpreted 
with caution. The reported concordance rate does not account for chance concordance since no 
statistical measures are available that do account for chance and can also provide one figure for 
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different outcomes (dichotomous, categorical and continuous) that we had in our questionnaire. 
When interpreting the concordance rate, it should however be acknowledged that some answers 
might be similar by chance. 
Finally, there were only 13 centers from a relatively lower-income country and 25 centers from 
South and East Europe (including Israel). We therefore had limited power to detect differences 
between centers from relatively high-and middle-income countries versus centers from relatively 
lower-income countries and centers from different geographic locations.
Although we studied a sample of highly specialized centers, we found substantial differences 
in important structural and process characteristics. Largest differences were seen in the 
specialization and organization of the ICU, i.e. half of the centers indicated to have a dedicated 
neuro ICU and 64% indicated to have a closed ICU organization. Additionally, rehabilitation 
facilities varied widely, with half of the centers having an in-hospital rehabilitation unit and 
the possibility for coma stimulation. We also found large differences in the reported policies 
regarding ICU admission and ICP monitoring across centers. The variation in structure and process 
among specialized neurotrauma centers was in line with previous survey studies.11,12 Enblad 
and associates11 included European centers with a particular interest in neuro ICU and brain 
monitoring in their survey study. They also found large between-center differences in structures 
of care (e.g. 76% had a separate NICU, 50% had a neurosurgeon as ICU director). Checkley and 
associates12 reported similar findings. They conducted a survey in 69 centers participating in 
the United States critical illness and injury outcome study. The majority of their centers were 
teaching hospitals with critical care training. However, 58% of their centers had a closed ICU 
organization and their annual hospital admission rate ranged from 1,170 to 56,330, indicating 
large between-center differences in volume. Also there were large differences in the protocols 
available at their surveyed ICUs. 
Although in this study we only reported on general structure and process characteristics, it is clear 
that the between-center variation is substantial and provides an opportunity for CER. Variation 
among centers and countries comprises an important prerequisite for CER and enables between-
center and between-country comparisons of effective structures and processes of care. We can 
for example study the influence of a dedicated neuro ICU on outcome in severe TBI patients by 
studying patients’ outcome in the 40 centers with a dedicated neuro ICU and in the 30 centers 
without a dedicated neuro ICU. This requires outcome data on patient level, which are currently 
collected in the CENTER-TBI study. In such a comparison it is important to correct for differences 
in other structural and process characteristics between these centers, which can potentially 
be accomplished with advanced statistical modeling. Other potential interesting topics for CER 
based on the current study include the effectiveness of an in-hospital rehabilitation unit, the 
effectiveness of high-volume vs. low-volume hospitals, the effectiveness of closed vs. mixed ICU 
organization, and the effectiveness of admission- and ICP monitoring policies. 
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Conclusion
Even among high-volume, specialized neurotrauma centers there is substantial variation in 
structures and processes of TBI care. This variation provides an opportunity to study effectiveness 
of specific aspects of TBI care and to identify best practices with CER approaches.
Supplemental material is available at www.marysecnossen.nl
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Abstract
Previous studies have indicated that there is no consensus about management of mild traumatic 
brain injury (mTBI) at the emergency department (ED) and during hospital admission. We aim 
to study variability between management policies for TBI patients at the ED and hospital ward 
across Europe. 
Centers participating in the Collaborative European NeuroTrauma Effectiveness Research in 
Traumatic Brain Injury (CENTER-TBI) study received questionnaires about different phases of TBI 
care. These questionnaires included 71 questions about TBI management at the ED and at the 
hospital ward. 
We found differences in how centers defined mTBI. For example, 40 centers (59%) defined mTBI 
as a Glasgow Coma Scale (GCS) score between 13-15 and 26 (38%) as a GCS score between 14-
15. At the ED various guidelines for the use of head CT in mTBI patients were used; 32 centers 
(49%) used national guidelines, 10 centers (15%) local guidelines and 14 centers (21%) used no 
guidelines at all. Also differences in indication for admission between centers were found. After 
ED discharge, 7 centers (10%) scheduled a routine follow-up appointment, while 38 (54%) did so 
only after ward admission. 
In conclusion, large between-center variation exists in policies for diagnostics, admission and 
discharge decisions in patients with mTBI at the ED and during hospital admission. Guidelines 
are not always operational in centers, and reported policies systematically diverge from what is 
recommended in those guidelines. The results of this study may be useful in the understanding 
of mTBI care in Europe and show the need for further studies on the effectiveness of different 
policies on outcome. 
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Introduction
Traumatic brain injury (TBI) is a common reason for presentation at the emergency department 
(ED) and hospital admission in Europe.1 A recent systematic review estimated the number of 
annual hospital admissions at 262 per 100,000 persons.2 However, many more patients are 
seen at the Emergency Department (ED) each year. TBI is associated with significant long-term 
disability and has become a major socioeconomic and health burden throughout the world.
Among the TBI patients presenting at the ED, the large majority (75-90%) are classified as ‘mild’ 
TBI. The most frequently used definition of mild TBI is a GCS score between 13-15 and loss of 
consciousness of less than 30 minutes or amnesia not extending beyond 24 hours after blunt 
head injury.3,4 Because of the low risk of intracranial damage, a computed tomography (CT) 
scan of the head or hospital admission is not always necessary in these patients. To estimate 
the risk of intracranial abnormalities in mild TBI, various prediction rules and guidelines have 
been developed, for example the Canadian CT head rule, National Institute for Health and Care 
Excellence (NICE) guidelines for head injury and CT in Head Injury Patients (CHIP) rule.5-8 Based 
on a set of minor and major risk factors, these prediction rules recommend whether a CT scan 
of the head should be performed. The results of the CT scan subsequently influence the decision 
on whether a patient should be admitted to the hospital or could be safely discharged home. 
After mild TBI, patients may experience post-traumatic symptoms such as headaches, dizziness 
and memory or concentration problems, resulting in significant disability. In many cases these 
symptoms dissolve over time, however a group of patients (estimated between 5% and 30%) 
may suffer from prolonged symptoms.9 Studies showed that handing out discharge information 
and scheduling routinely follow-up sessions could reduce these post-traumatic symptoms.10,11
However, still little is known about the optimal treatment of mTBI and there is no consensus 
about management of these patients.12 Therefore, variation in structure and process of mTBI 
care is expected, which may result in variation in outcome. In this study, we aim to describe the 
current management of mild TBI at the emergency departments and hospital wards in Europe. 
Specifically, we aim to provide insight in the use of diagnostics, admission policy and discharge 
policy at the ED and hospital ward. 
Methods
Questionnaires
Between 2014 and 2016, we approached the principal investigators of 71 centers from 19 European 
countries and Israel, participating in the CENTER-TBI (Collaborative European NeuroTrauma 
Effectiveness Research in Traumatic Brain Injury) study, a multicenter prospective observational 
study on TBI,13 with the request to complete a set of 11 questionnaires about structure and 
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process of care for TBI patients: The Provider Profiling (PP) questionnaires. The questionnaires 
were developed based on literature and expert validation and were subsequently pilot-tested. 
Questionnaires were discussed during presentations, workshops and email conversations. 
Reliability, which was assessed by calculating concordance rates between duplicate questions 
(5% of the questions) in all 11 questionnaires, was adequate (median concordance rate of 0.85). 
More detailed information about the development, administration and content of the total set 
of provider profiling questionnaires is available in a previous publication.14
For this study, we analyzed the results of a questionnaire about ED and a questionnaire about 
hospital admission policy, for a total of 71 questions (Online Supplement A). Topics included 
structural characteristics of hospital and ED, imaging, guidelines, treatment, admission policy, 
observation and discharge policy at the ED and in hospital ward. 
Question formats and definitions
Most questions had a multiple choice format where one or more answers could be selected. Two 
questions had an open format. Questions addressed structures (e.g. “is overnight observation at 
the ED available for patients with TBI”) and processes (e.g. “are guidelines or protocols used to 
decide when mild TBI patients are discharged from the ED”). The questions about processes refer 
to general policies rather than individual treatment preferences. General policy was defined as 
the way the majority of patients with a certain indication would be treated (> 75%). 
Statistical analysis
We used standard descriptive statistics. Categorical variables were presented as frequencies and 
percentages and continuous variables were presented as medians and interquartile ranges (IQR). 
Analysis was performed using IBM Statistical Package for Social Sciences (SPSS) version 21.
Results
All 71 centers completed the ‘Hospital admission’ questionnaire and 68 centers completed the 
‘ED’ questionnaire (response rates 100% and 96% respectively). Among the centers that did not 
complete the ED questionnaire, three centers (4%) indicated that their center had no ED since 
they were specialized in severe neurotrauma or collaborated with the ED of another hospital. 
The questionnaires were answered by ED physicians, neurosurgeons, neurologists, intensivists 
and administrative staff members. The majority of participating centers were academic (n = 65; 
92%), level 1 trauma centers (n = 48; 68%) situated at an urban location (n = 70; 99%). 
Classification of TBI
It appeared that different definitions of severity levels for TBI were used (Table 1). Forty centers 
(59%) defined mild TBI as a patient with a GCS score between 13-15 and 26 centers (38%) as a 
GCS score between 14-15. Moderate TBI was considered a GCS score between 9-12 in 38 centers 
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(56%) and 9-13 in 22 (32%). The majority of the centers considered severe TBI as a GCS score 
between 3-8 (n = 62; 91%). 
Table 1. GCS scores that are considered as mild, moderate and severe TBI
GCS score N (%)
Mild TBI
11-14
12-15
13-15
14-15
1 (1.5%)
1 (1.5%)
40 (59%)
26 (38%)
Moderate TBI
8-11
8-12
9-12
9-13
9-14
10-13
11-13
11-14
12-13
1 (1.5%)
2 (3%)
38 (56%)
22 (32%)
1 (1.5%)
1 (1.5%)
1 (1.5%)
1 (1.5%)
1 (1.5%)
Severe TBI
3-7
3-8
3-9
3-10
3-11
1 (1.5%)
62 (91%)
2 (3%)
2 (3%)
1 (1.5%)
The responders were asked to enter the lowest and highest GCS score per TBI group, the bold 
GCS range represents the range most common in the literature.
Diagnostics at the ED
ED physicians (n = 35; 49%) and neurosurgeons (n = 15; 21%) were most often in charge for the 
treatment of TBI patients at the ED. At the ED various rules or guidelines for the use of head CT in 
patients with mild TBI were used: more than half of the centers used (multi)national guidelines, 
such as NICE-guidelines (n = 16; 24%), Scandinavian guidelines (n = 7; 10%), other (inter)national 
guidelines (n = 12; 17%). Only few of the centers use prediction rules such as the Canadian CT 
Head rule (n = 4; 6%), New Orleans criteria (n = 1; 1.5%) and CHIP rule (n = 4; 6%). In addition 10 
centers (15%) used other local guidelines and 14 centers (20.5%) used no guidelines at all. More 
than 90% (n = 62) of the centers considered their CT scanning policy liberal. Most centers (n = 45; 
66%) stated to be more restrictive in the use of a CT scan in children compared to adults. CT scans 
at the ED were mostly ordered by ED physicians (n = 37; 54%) and neurosurgeons (n = 16; 24%). 
Only in 7% of the centers (n = 5, including 4 centers from the Netherlands) neurologists order 
the CT scans. Most centers standardly perform a CT scan in patients with clinical signs of skull 
base fracture, any neurologic deficit or a seizure (Figure 1). In some situations the indication for 
CT differs among centers. For example, 50 centers (74%) standardly use a CT scan in patients on 
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anticoagulant therapy, while 15 (22%) indicated that they would do this often. The CT scanning 
guidelines were mainly implemented by written protocols and algorithms (n = 38; 56%) or via 
verbal direction from senior doctors in 22 centers (32%, Online Supplement B). In half of the 
centers guideline development and maintenance is overseen by multidisciplinary groups (Online 
Supplement B). The majority of centers have not performed audits to check for adherence to 
guideline at ED (n = 27; 40%, Online Supplement B)
Figure 1. Frequency of ordering head CT scan in patients with mild TBI, by clinical indication
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Use of SSRI drugs
Increased serum levels of S100B
Age ≥ 60  
Contusion of the face
Headache
Fall from any eleva"on
Intoxica"on (alcohol / drugs)
In children: suspicion of non- accidental injury
Physical evidence of trauma to head / skull
Vulnerable road user (pedestrian or cyclist)
Vomi"ng
Any an"platelet therapy
Prior loss of consciousness
Signs of facial fracture
PTA ≥ 4 hours 
Any an"coagulant therapy
Alterna"on of consciousness
Seizure
Any neurologic deficit
Clinical signs of fracture skull base or vault
always o#en only if other risk factors never
Per situation the responders had to choose the correct policy for their center: Always/general policy: if the situation is, in general, 
a reason for ward admission in your hospital. This must represent a general consensus among colleagues, rather than individual 
preference; Often/partial: the situation is often seen as a reason for ward admission in your hospital. However, it is not general practice, 
because not everyone in your hospital agrees or admission is only general policy in a subset of the patients; Only in the presence of other 
risk factors: if the situation is never solely a reason for ward admission, but it might be a reason in combination with one or more other 
risk factors; Never: if the situation is never the only reason for ward admission. 
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Magnetic Resonance Imaging (MRI) was used in addition to the CT scan if there was discrepancy 
between clinical symptomatology and presence of CT abnormalities in mild TBI patients (75% 
of the centers). In six centers (9%) from Austria, Denmark, Spain, Sweden and United Kingdom, 
s100B is routinely determined as a prognostic biomarker for neurologic deterioration. Many 
centers had the availability of overnight observation at the ED for TBI patients before they were 
discharged (n = 54; 79%).
Admission at the ward
At the hospital ward, neurosurgeons (n = 56; 79%) were most often in charge for the treatment 
of TBI patients. Forty-four (65%) centers indicated to use guidelines in the decision on whether 
mild TBI patients should be admitted to the hospital ward. Most centers admitted TBI patients 
to the neurosurgical ward (n = 53; 75%). In addition, TBI patients were routinely admitted to the 
neurology (n = 16; 23%) or surgery ward (n = 15; 21%). Patients with cerebrospinal fluid (CSF) 
leak, CT progression, new CT abnormalities and shock were standardly admitted to the ward. 
For other admission indications, the policy was more diverse. For example 25 centers (37%) 
indicated that patients with pre-injury anticoagulation were routinely admitted to the ward, 
while 27 centers (39%) indicated that they would only admit these patients to the ward if other 
risk factors are present (Figure 2). 
When patients are admitted at the ward, GCS is assessed systematically to detect neurological 
deterioration. About half of the centers (n = 37; 52%) used the scheme ‘half-hour for 2 hours, 
then 1-hourly for 4 hours, then 2-hourly’, thus in accordance with the NICE guidelines. The other 
half of the centers had another frequency of GCS assessment, ranging from hourly to every 24 
hours. In 11 centers (16%) the Galveston Orientation and Amnesia Test (GOAT), a test for PTA, is 
systematically used at the ward and 12 centers (17%) use another form of PTA assessment. 
Fifty-three centers (75%) have step down beds for patients who no longer need ICU care but 
are also not well enough for a routine hospital ward. At these high care wards, neurosurgeons 
(n = 32; 60%) and intensivists (n = 13; 25%) were most often in charge of the patients. Reasons for 
admission to the high care wards in isolated TBI patients included decreased consciousness level 
(n = 48; 68%), to monitor vital functions (n = 45; 63%), frequent GCS assessments (n = 38; 54%), 
confusion (n = 35; 49%) and intracranial complications (n = 32; 45%). 
Treatment 
Fifty-four centers (79%) state that they reverse pre-injury oral anticoagulation use if CT 
abnormalities are present, 46 (68%) do so if surgery was considered and 2 (3%) centers reverse 
anticoagulation in all patients admitted to the ward. Anticoagulation was commonly reversed 
with vitamin K (n = 62; 91%) or prothrombin complex concentrate (n = 55; 81%). Other treatments 
mentioned in this context were: FFP (n = 47; 69%), platelets (n = 40; 59%), fibrinogen (n = 20; 
29%) or recombinant factor VII (n = 11; 16%).
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Figure 2. Frequency of ward admission of patients with mild TBI, by clinical indication
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Pa!ent or family demands it
Homeless pa!ents
Other injuries
Pre-injury an!platelets
Drugs or alcohol intoxica!on
Clinician is concerned (without specific reason)
Severe headaches
There is no responsible adult available to check pa!ent
Pre-injury an!coagula!on
Suspected non-accidental injury
Persistent vomi!ng
Planned surgery
CT unavailable or pa!ent uncoopera!ve for scanning
Pa!ents GCS < 15 a"er imaging, regardless of results
TBI as result of a suicide a#empt
Meningism
Shock (hypotension/tachycardia)
Computed Tomography progression
Cerebrospinal fluid leak
Pa!ents with new, clinically significant CT
abnormali!es
always o"en only if other risk factors never
Per situation the responders had to choose the correct policy for their center: Always/general policy: if the situation is, in general, 
a reason for ward admission in your hospital. This must represent a general consensus among colleagues, rather than individual 
preference; Often/partial: the situation is often seen as a reason for ward admission in your hospital. However, it is not general practice, 
because not everyone in your hospital agrees or admission is only general policy in a subset of the patients; Only in the presence of other 
risk factors: if the situation is never solely a reason for ward admission, but it might be a reason in combination with one or more other 
risk factors; Never: if the situation is never the only reason for ward admission. 
If TBI patients have a cerebrospinal fluid leak (with possibly an increased risk of infections), 34 
of the centers (48%) would employ a strategy of watchful waiting before they start treatment 
with antibiotics. In contrast, 26 centers (37%) start antibiotics immediately and 9 (13%) start 
antibiotics only if patients have a fever. 
TBI patients with an early seizure (a posttraumatic seizure occurring within 7 days of the trauma) 
receive anti-epileptic drugs (AED) immediately in 39 centers (55%). About one third (n = 22) start 
AED only in patients with CT abnormalities and an early seizure and 7 centers (10%) never start 
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AED in TBI patients with early seizure. Additionally, there are differences in the use of anti-seizure 
prophylaxis in patients with specific characteristics (Online Supplement C). 
Discharge information
In 38 centers (56%) guidelines are used to decide whether patients with mild TBI could be 
discharged from the ED. In 54 centers (79%) printed discharge information is available in the 
ED and hospital ward to hand out to patients who are discharged home. After discharge from 
the ED, 42 centers (62%) provide information about post-traumatic symptoms verbally, while 55 
centers (78%) do so after discharge from the hospital ward. Overall, more information is provided 
verbally than in written form (Table 2).
Table 2. General discharge information provided at discharge from the ED and hospital ward
ED Hospital ward
Information Verbally  
n (%)
Written  
n (%)
Verbally  
n (%)
Written  
n (%)
Details of nature and severity of injury 49 (72%) 40 (59%) 51 (72%) 47 (66%)
Symptoms that prompt patients to return for 
consultation
42 (62%) 58 (85%) 52 (73%) 44 (62%)
Details about the recovery process, including the fact 
some patients may appear to make quick recovery but 
later experience difficulties or complication
51 (75%) 38 (56%) 58 (82%) 30 (42%)
Contact details of community and hospital services in 
case of delayed complication
37 (54%) 50 (74%) 40 (56%) 45 (63%)
Information about return to everyday activities, 
including school/work/sports/driving
44 (65%) 37 (54%) 52 (73%) 39 (55%)
Information about post-concussion syndrome/ 
persisting symptoms and what to do in this situation
42 (62%) 38 (56%) 55 (78%) 22 (31%)
Information about use of pain killers and other 
medication
45 (66%) 45 (66%) 46 (65%) 45 (63%)
Details of support organization 39 (57%) 8 (12%) 39 (55%) 22 (31%)
Follow-up policy
A routine follow-up appointment at the outpatient clinic is scheduled in 7 centers (10%) after 
discharge from the ED, at a median period of 4 weeks after discharge (IQR 2.5-6). After discharge 
from the hospital ward, 38 centers (54%) routinely schedule a follow-up appointment at a 
median period of 6 weeks (IQR4-7.8). In 16 centers (24%) patients are referred to the general 
practitioner, regardless of persisting symptoms. In case of persisting symptoms, the patients are 
advised to go back to the general practitioner (ED n = 30; 44% and ward n = 17; 24%) or hospital 
(ED n = 34; 50% and ward n = 24; 34%). 
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Discussion 
This study provides a broad overview of the current care for mild TBI patients in Europe and 
shows that there are wide between-center variations in diagnostic, admission and discharge 
policies. The most striking findings are the large variation in; GCS scores that are considered a 
specific TBI severity, the use of CT guidelines, and policies for patients on anticoagulants. We also 
found large variation in follow-up policy after discharge, where the majority of patients is not 
receiving routinely follow-up, despite the existing evidence and guidelines for TBI.
Our findings are in line with previous research. For example, in 2001 de Kruijk et al.15 performed 
a survey study in 67 European centers. They also reported a lack of consensus of mild TBI 
management (e.g. definitions, guidelines) in Europe at ED and hospital admission. Pulhorn et al.16 
investigated management of mild TBI at 19 hospital wards in Britain and also found variation in 
the assessment of GCS at the ward and discharge recommendations. Our study confirms results 
of Stern at al.17, they performed a survey study at the ED in 72 centers in New England and found 
significant variability in the use of guidelines and management of mild TBI care as well. 
What this study adds to previous research is that it shows that not only guidelines are not 
always operational in centers, but also that actual policies systematically diverge from what is 
recommended in those guidelines. Audits to check for adherence to the guidelines could give 
more insight in this, but the majority of the centers have not perform audits in the last five years. 
Moreover, our survey pinpoints areas of clinical controversy that could do well with more clinical 
research. 
In recent years the use of prognostic biomarkers such as s100B has been studied extensively.18,19 The 
Scandinavian guideline for mild TBI even incorporated s100B in their CT scan recommendations.20 
However, in our study we observed that S100B is used as a prognostic biomarker in only 6 centers, 
of which 3 centers are Scandinavian. 
Future research is needed to investigate whether the variation in guideline use and policies is 
associated with outcome. Currently, all the participating centers are collecting patient outcome 
data for the CENTER-TBI study.13 By combining current data with data on patient outcomes, we 
will be able to investigate whether between-center differences in policy are associated with 
patient outcomes, and subsequently explore the effectiveness of different policy strategies 
in comparative effectiveness research (CER). CER requires variation to study effectiveness of 
treatments or policies by comparing centers who routinely perform an intervention to centers 
who do not, or at least less frequently.12 In our study we found large between-center differences 
that enable further study with CER approaches. For example, we can compare centers that 
routinely perform follow-up at the outpatient clinic, with centers that do not routinely perform 
follow-up and analyze the relation with outcome. And we can compare the effects of routinely 
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giving platelets to patients on antiplatelet drugs, a procedure which has been associated with 
poor outcome in spontaneous ICH, but has not been studied in TBI. Thus, in the CER context, we 
are actually satisfied with the observed variation in care because this provides the opportunity 
to compare outcomes between centers with different treatment policies. 
This study has some limitations that should be taken into account when interpreting the data. The 
reliability of the results depends on the interpretation and willingness of the investigators to be 
truthful and transparent in their answers. We tried to enhance this by explicitly asking for general 
policy rather than individual preferences and explained all answer options carefully. Furthermore, 
because the majority of participating centers were academic level 1 trauma centers, the findings 
might not be generalizable to centers with a lower trauma center designation. However, we 
believe the variation in policies will only increase when also lower trauma center designations 
would be included. 
In conclusion, large between-center variations exist in policies for diagnostics, admission and 
discharge decisions in patients with TBI at the emergency department and hospital ward. The 
results of this study may be useful in the understanding of TBI care in Europe and show the need 
for further studies on the effect of different policies on patient outcome.
Supplemental material is available at www.marysecnossen.nl
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Abstract
Background: No definitive evidence exists on how intracranial hypertension should be treated 
in patients with traumatic brain injury (TBI). It is therefore likely that centers and practitioners 
individually balance potential benefits and risks of different intracranial pressure (ICP) 
management strategies, resulting in practice variation. The aim of this study was to examine 
variation in monitoring and treatment policies for intracranial hypertension in patients with 
TBI. 
Methods: A 29-item survey on ICP monitoring and treatment was developed based on 
literature and expert opinion, and pilot-tested in 16 centers. The questionnaire was sent to 68 
neurotrauma centers participating in the Collaborative European Neurotrauma Effectiveness 
Research (CENTER-TBI) study. 
Results: The survey was completed by 66 centers (97% response rate). Centers were mainly 
academic hospitals (n = 60, 91%) and designated level I trauma centers (n = 44, 67%). The 
Brain Trauma Foundation guidelines were used in 49 (74%) centers. Approximately ninety 
percent of the participants (n = 58) indicated placing an ICP monitor in patients with severe 
TBI and computed tomography abnormalities. There was no consensus on other indications 
or on peri-insertion precautions. We found wide variation in the use of first- and second-tier 
treatments for elevated ICP. Approximately half of the centers were classified as having a 
relatively aggressive approach to ICP monitoring and treatment (n = 32, 48%), whereas the 
others were considered more conservative (n = 34, 52%).
Conclusions: Substantial variation was found regarding monitoring and treatment policies 
in patients with traumatic brain injury and intracranial hypertension. The results of this 
survey indicate a lack of consensus between European neurotrauma centers and provide an 
opportunity and necessity for comparative effectiveness research.
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Background
Secondary brain injury associated with elevated intracranial pressure (ICP) is an important 
cause of mortality and morbidity in patients with severe traumatic brain injury (TBI).1 
Therefore, identifying high ICP and optimizing its management is believed to be critically 
important. Yet, no definitive evidence exists on how ICP should be monitored and treated.2 
Patient and treatment heterogeneity make conducting randomized controlled trials (RCTs) 
challenging; the majority of RCTs to-date have non-significant findings.3 On the other hand, 
observational studies, which are easier to conduct, are at risk for confounding by indication, 
hampering causal inference.4,5 
In the absence of conclusive evidence, treatment policy is usually based on local practices, 
individual preferences and resource availability.6-9 It is likely that centers and practitioners 
individually balance potential benefits and risks of different ICP management strategies, which 
may result in some centers being relatively aggressive while others being more conservative 
in their treatment policies. 
A novel and promising approach in estimating treatment effectiveness is to exploit the 
existing variation by comparing standard practices between different centers or countries 
which is referred to as comparative effectiveness research (CER).10,11 The Collaborative 
European Neurotrauma Effectiveness Research in TBI (CENTER-TBI) study (grant: 602150) is 
currently recruiting and will use CER methodology to study treatment effectiveness of ICP 
management.10 As a first step, we examined self-perceived practices of ICP monitoring and 
associated treatment policies, by sending a survey to the centers participating in the CENTER-
TBI study. Since previous European survey studies that addressed ICP management have been 
published more than ten years ago,12,13 this study will provide an up-to-date overview of ICP 
management in Europe. Topics identified as showing substantial between-center variation that 
are plausibly associated with patient outcome will be selected for CER, and their treatment 
effectiveness can be studied once the CENTER-TBI patient-level data becomes available. 
Methods
Study sample
All centers participating in the prospective longitudinal observational CENTER-TBI study 
(https://www.center-tbi.eu) were asked to complete a set of questionnaires on structures 
and processes of care for patients with TBI. Questionnaires were sent to 71 centers from 20 
countries between 2014 and 2015.14 Three centers dropped-out from the CENTER-TBI study, 
resulting in 68 eligible centers from Austria (n = 2), Belgium (n = 4), Bosnia Herzegovina (n = 2), 
Denmark (n = 2), Finland (n = 2), France (n = 7), Germany (n = 4), Hungary (n = 2), Israel (n = 2), 
Italy (n = 9), Lithuania (n = 2), Latvia (n = 3), the Netherlands (n = 7), Norway (n = 2), Romania 
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(n = 1), Serbia (n = 1), Spain (n = 4), Sweden (n = 2), the United Kingdom (n = 9) and Switzerland 
(n = 1).
Questionnaire development and administration
A set of questionnaires to measure structure and process of TBI care was developed based on 
available literature and expert opinion, and has been comprehensively described in a previous 
publication.14 Pilot-testing was undertaken in 16 of the participating centers and feedback was 
incorporated into the final questionnaire design. 
One of the questionnaires contained 29 questions on ICP monitoring and treatment at the 
ICU (Online Supplement A). In most questions, we explicitly asked for the ‘general policy’, 
which was defined as the treatment or monitoring modality estimated to be used in more 
than 75% of patients, recognizing that there might be exceptions. In some questions, we asked 
for quantitative estimations. The representatives of the centers could indicate how often they 
used a particular monitoring or treatment strategy (never 0-10%, rarely 10-30%, sometimes 
30-70%, frequently 70-90%, always 90-100%). The options ‘frequently’ and ‘always’ were 
interpreted as representing the general policy, in line with a previous report.15 All definitions 
used in the questionnaire are described in Online Supplement B. 
Analyses
We calculated frequencies and percentages for all variables related to the number of responders 
for that variable. We examined factors associated with a relatively aggressive ICP monitoring 
and treatment strategy with the Chi-squared or Fisher’s exact test as appropriate. Centers 
were classified as being relatively aggressive if they: (a) place an ICP monitor in patients with 
a Glasgow Coma Scale (GCS) score ≤ 8 and an abnormal head computed tomography (CT) 
scan, and (b) if they generally perform at least one out of three second-tier treatments that 
represented a maximum therapy intensity (barbiturates, decompressive craniectomy and 
hypothermia < 35° Celsius).16 
We examined whether there were differences between and within geographic regions in 
the use of first and second-tier treatments. Countries were divided into seven geographic 
regions (Northern Europe, Western Europe, UK, Southern Europe, Eastern Europe, Baltic 
States and Israel). Within each region, we examined the percentage of centers that indicated 
that the particular treatment was their general policy. In addition, we assessed the influence 
of geographic region on treatment decision by performing logistic regression analysis with 
treatment as dependent variable (general policy yes / no) and geographic region (categorical 
variable) as independent variable. The Nagelkerke R2 was reported, representing the 
proportion of variation in treatment that can be explained by geographic region. Analyses 
were performed using the Statistical Package for Social Sciences (SPSS) version 21.17 
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Results
Participating centers 
Sixty-six centers (97% response rate) completed the questionnaire on ICP monitoring and 
treatment in severe TBI patients. Questionnaires were mainly completed by intensive care 
physicians (n = 33, 50%) and neurosurgeons (n = 23, 35%). Most centers (n = 60, 91%) had 
an academic affiliation and 44 (67%) were designated level I trauma centers (see Online 
Supplement B for definitions). Centers had a median of 33 (interquartile range 22-44) ICU beds 
in total and treated a median of 92 (interquartile range 52-160) severe TBI patients annually. 
Forty-three (65%) centers operated a ‘closed’ ICU model; an ‘open’ model was adopted in 
three (5%) centers and a ‘mixed’ model in 20 (30%) centers. Approximately half (n = 39) of the 
centers had a dedicated neurosciences ICU. Approximately three-quarters of sites (n = 49, 74%) 
indicated that they used the 2007 Brain Trauma Foundation (BTF) guidelines or institutional 
guidelines that were based on the BTF guidelines. 
Indications for ICP monitoring
The majority of participants (n = 58, 91%) indicated that they would generally place an ICP 
monitor in patients with GCS ≤ 8 and CT abnormalities (Figure 1). ICP monitors were less 
often considered for other indications, e.g. GCS ≤ 8 without CT abnormalities (n = 15, 23%), 
inability to assess a patient with CT abnormalities clinically (e.g. due to sedatives; n = 11, 
17%), and intraventricular hemorrhage (n = 21, 33%). Around one-third of the participants 
would place an ICP monitor in polytrauma patients (GCS > 8) who require extracranial surgery 
or mechanical ventilation but would not otherwise have an indication for ICP monitoring. 
Patient-specific reasons for not monitoring ICP included: the risk of raised ICP was considered 
low (n = 40, 62%), patients were considered unsalvageable (n = 37, 57%) or GCS was above 8 
(n = 37, 57%; Online Supplement B). 
Variability in monitoring and treatment of intracranial hypertension
There is large variation in monitoring and treatment characteristics among European centers 
treating patients with TBI (Figure 2A and 2B).
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Figure 1. Indications for ICP monitoring placement
0% 20% 40% 60% 80% 100%
2.Have polytrauma that requires mechanical
ven!la!on
1.Have polytrauma that requires extracranial
surgery
Pa!ents  that would not otherwise have an ICP
monitoring indica!on but:
Intraventricular haemorrhage
Inability to assess a pa!ent with CT
abnormali!es clinically
GCS 9-12 with contusion
GCS ≤ 8 without CT abnormali!es
GCS ≤ 8 and CT abnormali!es
% of centers that indicated that they would
generally place an ICP monitor in pa!ents 
with this indica!on
Figure presents percentage of centers that indicated that they would generally place an ICP monitor in patients with the described 
characteristics. 
Question is completed by 64/66 centers.
Abbreviations: CT = Computed Tomography; GCS = Glasgow Coma Scale; ICP = Intracranial Pressure
Parenchymal and ventricular ICP devices
Both parenchymal and ventricular ICP devices were available in more than half of centers (n 
= 38, 59%). One-third (n = 21) of the participants indicated that they only used parenchymal 
monitors, whereas five (8%) participants indicated that they only used ventricular catheters. 
In centers that used both types of monitors, parenchymal monitors were typically used 
routinely with ventricular catheters placed either when the ventricles were enlarged or when 
cerebrospinal fluid (CSF) drainage was indicated. When a ventricular drain was used, half of 
the participants indicated that their local practice was generally to leave the drain open (n = 
19, 50%) while the other half indicated a policy of intermittent drainage (n = 19, 50%; Figure 
2A).
Precautions with ICP monitor placement
Half of the participants (55% ventricular catheter and 43% parenchymal sensor) indicated that 
they generally administered prophylactic antibiotics prior to the insertion of an ICP monitor, 
which was continued in around 10% of the centers. The majority of participants (n = 50, 77%) 
generally assessed the coagulation status prior to ICP monitor insertion. There was wide 
variability regarding the minimum international normalized ratio and minimum platelet count 
considered safe for device insertion (Figure 2A). 
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Figure 2a. Algorithm for ICP management: ICP monitoring 
The blue box represents ICP monitoring with the policy for parenchymal monitor on the left and ventricular catheter on the right. Orange 
boxes are checkpoints during the ICP monitoring process. The N represents the number of centers that indicated this answer as general 
policy with a corresponding percentage (%). The number in parenthesis after the titles represents the number of centers that completed 
this question. 
Abbreviations. CSF: cerebrospinal fluid, ICP: intracranial pressure, INR: International Normalized Ratio
1) Centers that indicated these situations as top 1 of the top 3 reasons for choosing a ventricular or parenchymal catheter 2) Frequently 
and always summed 3) Arterial blood pressure, midauricular level, ventrix motor, NA (we only use parenchymal monitors), room air, 
calibrated by device and meatus externa 4) Prior to insertion ventricular catheter for ICP monitoring 5) Depending on other factors such 
as the use of platelet aggregation inhibitors 6) Multiplate and rotem analysis prior to surgery if concerns 
Additional neuromonitoring
Half of the participants (n = 33) indicated that they generally used at least one additional 
neuromonitoring device (Online Supplement B). Transcranial Doppler was generally applied in 
24 (38%) centers and brain tissue oxygenation in 12 (19%) centers. 
First-tier treatment of elevated ICP
The majority of participants indicated an ICP threshold for medical treatment above 20 mmHg 
(n = 54, 83%, Figure 2B). There was less consensus on cerebral perfusion pressure (CPP) 
treatment thresholds; 39 participants (59%) indicated a threshold of 60 mmHg in their center, 
whereas 25 (38%) indicated individualized CPP targets. 
Propofol (n = 54, 83%), midazolam (n = 48, 75%), fentanyl (n = 37, 58%) and morphine (n = 32, 
51%) were generally used as part of first-tier treatment in patients with elevated ICP, whereas 
the use of alpha 2 agonists (n = 10, 16%) and barbiturates (n = 12, 19%) was less frequent 
(Figure 2B; Online Supplement B). Neuromuscular blocking agents were generally used in 
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16 (25%) centers. Participants typically preferred a specific combination of sedatives and 
analgesics as part of first-tier treatments; i.e. 50 participants (76%) indicated they used 2-4 out 
of 8 sedatives and analgesics as general policy and the other interventions only infrequently 
(Online Supplement B).
Figure 2b. Algorithm for ICP management: treatment indications, first- and second- tier treatment
The red box represents ICP treatment with first-tier treatment on top and second-tier treatment at the bottom. Orange boxes are 
checkpoints during the ICP treatment process. The N represents the number of centers that indicated this answer as general policy 
with a corresponding percentage (%). The number in parenthesis after the titles represents the number of centers that completed this 
question. 
Abbreviations: CSF: cerebrospinal fluid, CPP: cerebral perfusion pressure, EEG: electro-encephalogram, HS: hypertonic saline, ICP: 
intracranial pressure, IV: intravenous 
1) Decompressive craniectomy is (almost) never performed in our hospital 2) Multiple answers were possible 3) Only if ventricles 
are enlarged 4) Frequently and always summed 5) Clonidine or dexmedetomidine 6) Sufentanil (4), reminfentanyl (2), beta blockers 
(1), alfentanil (2), esketamine (1) 7) Standard continuous infusion 8) PaCO2 < 30 mmHg 9) Variable, depends on patient 10) Variable, 
depends on physician 
Regarding the use of osmotic therapy, two-thirds of the participants indicated generally using 
mannitol (n = 43, 65%) and/or hypertonic saline (n = 44, 67%). Seventeen participants indicated 
the use of mannitol, but not hypertonic saline, as their general policy, whereas 18 participants 
indicated the opposite. Fourteen (22%) participants indicated to generally using hypertonic 
saline in conjunction with mannitol (Figure 2B). Crystalloids were the most commonly used 
intravenous (IV) fluids to augment CPP (n = 60, 91%), while other fluids (starches, albumin 
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and other combinations) were less often used (12-23%). Vasopressors were generally used 
in almost all centers to support CPP (n = 63, 96%). Among the parameters that are used to 
titrate vasoactive drugs, mean arterial pressure targets (n = 51, 77%) and transpulmonary 
thermodilution monitoring by means of pulse contour cardiac output (n = 35, 53%) were most 
often used (Online Supplement B). 
Second-tier treatments for refractory intracranial hypertension
Among the second-tier treatments, decompressive craniectomy (n = 26, 39%), barbiturates 
(n = 21, 32%) and CSF drainage (n = 22, 33%) were the most often employed (Figure 2B). 
Hypothermia and hyperventilation (PaCO2 < 30 mmHg) were the general policy in 24.6% and 
15.4% of the centers respectively, while approximately one-third of the participants indicated 
to never use hypothermia and hyperventilation (Online Supplement B). Participants typically 
preferred one (n = 27, 42%) or two (n = 20, 31%) second-tier treatments and indicated to use 
the other options infrequently (Online Supplement B). Details on indication, administration 
and targets of second-tier treatments are presented in Online Supplement B and show a high 
degree of variability.
Factors associated with aggressive monitoring and treatment policies
Around half of the centers were classified as using an aggressive ICP monitoring and treatment 
policy (n = 32, 48%). Centers with an open or mixed ICU model more often applied an aggressive 
ICP management style in comparison to centers with a closed ICU model (p = .05). We did 
not find significant associations between aggressiveness and any of the other factors studied 
(Table 1). 
The influence of geographic region on treatment decisions
The use of first and second-tier treatments varied substantially within and between geographic 
regions (Table 2). Morphine and CSF drainage showed the largest within-region variation 
with approximately half of the participants within each region stating to generally use these 
treatments. Between-region differences were especially pronounced for barbiturates as first-
tier treatment. Barbiturates were mainly used in the Baltic States and Eastern Europe and 
geographic region explained 63% of the variance in barbiturate use. In addition, the use of 
mannitol varied substantially across regions with all participants in the Baltic States, Eastern 
Europe and Israel indicating to generally use mannitol, while only 11% of the participants in 
Northern Europe stated to generally use mannitol. In Northern Europe, Western Europe and 
the UK, propofol, midazolam, morphine and hypertonic saline are generally applied as first-tier 
treatment, while participants in Southern Europe, the Baltic States, and Eastern Europe also 
indicated to generally use fentanyl, barbiturates, CSF drainage and mannitol.
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Table 1. Factors associated with an aggressive ICP management style
Factor Relatively aggressive centers  
(n = 32)
Relatively conservative centers  
(n = 34)
p-value
ICU organization .05
 – Closed 17 (40%) 26 (60%)
 – Open/Mixed 15 (65%) 8 (35%)
Dedicated neuro ICU .96
 – Available 19 (49%) 20 (51%)
 – Not available 13 (48%) 14 (52%)
BTF guidelines usedⱢ .48
 – Yes 25 (51%) 24 (49%)
 – No 7 (41%) 10 (59%)
Volume† .82
 – High-volume 17 (47%) 19 (53%)
 – Low-volume 15 (50%) 15 (50%)
Income country‡ .83
 – High income 27 (49%) 28 (51%)
 – Relatively low income 5 (46%) 6 (54%)
Geographic locationⱠ .84
 – Northern Europe 4 (44%) 5 (56%)
 – Western Europe 13 (52%) 15 (48%)
 – UK 3 (43%) 4 (57%)
 – Southern Europe 5 (42%) 7 (58%)
 – Baltic States 2 (40%) 3 (60%)
 – Eastern Europe 3 (50%) 3 (50%)
 – Israel 2 (100%) 0 (0%)
Ɫ BTF guidelines or institutional guidelines that were broadly based on the Brain Trauma Foundation (BTF) guidelines
†Relatively high volume (number of severe TBI patients admitted to the ICU higher than the median number of severe TBI patients 
admitted to the ICU (n = 92)) vs. relatively low volume (number of severe TBI patients admitted to the ICU lower than or equal to the 
median number of severe TBI patients admitted to the ICU.
‡ The division into relatively high and low income was based on a 2007 report by the European Union.18 High-income = Austria, Belgium, 
Denmark, Finland, France, Germany, Israel, Italy, the Netherlands, Norway, Spain, Sweden, United Kingdom and Switzerland; Relatively 
low-income = Bosnia Herzegovina, Bulgaria, Hungary, Latvia, Lithuania, Romania and Serbia.
ⱠNorthern Europe = Norway, Sweden, Finland and Denmark; Western Europe = Austria, Belgium, France, Germany, Switzerland and the 
Netherlands; Southern Europe = Italy and Spain; Eastern Europe = Hungary, Romania, Serbia and Bosnia Herzegovina; Baltic States = 
Latvia and Lithuania
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Discussion
We found substantial variation in the general approaches to ICP monitoring and treatment 
among 66 European neurotrauma centers. The majority of centers indicated that they would 
insert an ICP monitor in patients with severe TBI and an abnormal head CT. There was however 
no consensus on other indications, nor was there consensus on peri-insertion precautions. 
The use of both first- and second-tier treatments for elevated ICP varied widely between 
centers and regions. We found that half of the centers employed a relatively aggressive ICP 
management approach while the other half showed a more conservative approach.
Strengths of this study include the high response rate (97%), the extensive development 
process of the questionnaire, and the comprehensive examination of both monitoring and 
treatment. In addition, since our survey was completed by centers that are currently collecting 
patient-level data for the CENTER-TBI study, the results of this study can directly be used as 
input for the CER analyses, once the patient-level data becomes available. A limitation of 
our study is that the included centers represent a selected group of European neurotrauma 
centers that are prominent in the field of neurotrauma care and research. Consequently, the 
picture obtained might be skewed. In addition, this study is dependent on perceived practices 
rather than on clinical data. Although we repeatedly emphasized confidentiality of results, we 
cannot exclude that some physicians presented (even subconsciously) a more favorable image 
or presented individual treatment preferences rather than the general policy in a center. 
This can be explored when individual patient-level data are available. A further limitation is 
that we asked for isolated general treatments but did not assess specific combinations. In 
clinical practice, however, different treatments are used simultaneously and outcome might 
be determined by the combination of treatments provided rather than by one particular 
intervention.
The substantial variation in strategies for ICP management in our study was in line with previous 
survey studies in Europe12,13 and the United States.15 For example, Hesdorffer et al.15 found that 
mannitol, hypertonic saline and hyperventilation were generally used in half of their centers. 
Guidelines have been proposed to reduce treatment variation in medicine.19 Although there 
has been an increase in protocolisation of medicine and awareness of guidelines during the last 
decade, variation in ICP management may not have reduced.12,13 Moreover, some participants 
claimed using treatments that are discouraged in the BTF guidelines. For example, one-fifth 
of the participants specified to use barbiturates as first-tier treatment, while this is a second-
tier treatment in the BTF guidelines.20 The discrepancy between BTF guidelines and reported 
policies indicates that there is little consensus among neurotrauma centers with respect to 
ICP management. This might be due to the relatively small evidence-base underpinning the 
guidelines.3 
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Our study has several implications for the planned CER analyses. We found wide variation 
for most of the topics studied, which enables analyzing effectiveness of ICP management on 
the hospital-level. Analyzing effectiveness on the hospital-level might be especially useful for 
treatments that were indicated to be used ‘rarely’, ‘sometimes’ or ‘frequently’ by the large 
majority of participants. For these treatments, patient characteristics play an important role 
and these can dramatically confound conventional patient level analyses.4,5 Caution should 
however be applied in the interpretation of the effects of treatments that are solely performed 
in some regions but not in others. For example, barbiturates as first-tier treatment are often 
performed in the Baltic States and Eastern Europe but not in other regions. A harmful or 
beneficial effect could therefore also be attributed to other aspects of care in the particular 
regions rather than barbiturate use itself. In principle, it is possible to adjust statistically for 
between-center differences other than the treatment variable of interest with a random-
effects model with a random intercept for center. However, when correlations between the 
treatment variable of interest and other factors that differ between centers are strong, as 
for the first line use of barbiturates and region, this might not be sufficiently captured by 
the random-effects model. In such a case differences in outcome cannot be attributed with 
certainty to the treatment under study. 
Based on current findings, we would recommend prioritizing the following topics for CER 
because of feasibility of the center-level approach: 
1. ICP monitoring in patients with other indications than GCS ≤ 8 and CT abnormalities; 
2. Parenchymal vs. ventricular monitoring (with and without CSF drainage); 
3. Use of first-tier treatments for elevated ICP (including use of neuromuscular blocking agents, 
mannitol vs hypertonic saline vs mannitol + hypertonic saline, fentanyl vs no fentanyl, fluid 
management), 
4. Use of second-tier treatments (including decompressive craniectomy vs barbiturates vs 
hypothermia) and 
5. The effect of an aggressive ICP management policy versus a more conservative approach. 
Conclusion
Substantial variation was found in the monitoring and treatment of patients with severe 
traumatic brain injury and intracranial hypertension. These results indicate a lack of consensus 
among European neurotrauma centers and provide an important opportunity and necessity 
for comparative effectiveness research to support the development of optimal treatment 
protocols for these severely affected patients.
Supplemental material is available at www.marysecnossen.nl
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Abstract
Objective: To describe variation in structural and process characteristics of acute in-hospital 
rehabilitation and referral to post-acute care for patients with traumatic brain injury (TBI) across 
Europe.
Methods: A 14-item survey about in-hospital rehabilitation and referral to post-acute care was 
sent to 71 neurotrauma centers participating in a European multicenter study (CENTER-TBI). The 
questionnaire was developed based on literature and expert opinion and was pilot-tested before 
sending out to the centers.
Results: 70 (99%) centers in 20 countries completed the survey. The included centers were 
predominately were academic level I trauma centers. Among the 70 centers, a multidisciplinary 
rehabilitation team can be consulted at 41% (n = 29) of the ICUs and 49% (n = 34) of the wards. 
Only 13 (19%) centers used rehabilitation guideline in patients with TBI. Age was reported as 
a major determinant of referral decisions in 32 (46%) centers, with younger patients usually 
referred to specialized rehabilitation centers, and patients ≥ 65 years also referred to nursing 
homes or local hospitals. 
Conclusion: Substantial variation exists in structural and process characteristics of in-hospital 
acute rehabilitation and referral to post-acute rehabilitation facilities among neurotrauma 
centers across Europe. 
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Introduction
Moderate and severe traumatic brain injuries (TBI) are a growing public health problem and 
often lead to substantial physical and psychological burden for patients and relatives. Since TBI 
is not a single event, but a life-long disorder with differential needs over time, it is recognized as 
one of the most challenging areas in modern rehabilitation medicine.1 
Patients with moderate or severe TBI are usually referred to level I trauma centers where the 
process of rehabilitation starts with an emphasis on issues such as swallowing, contractures, 
pressure sores and neurobehavioral disorders. From the acute care setting patients may be 
referred to specialized in- or outpatient rehabilitation settings, nursing facilities or for example 
neuropsychiatric wards in psychiatric hospitals. A patient out of post-traumatic amnesia with an 
attention span and physical condition that allows for two or three therapy sessions of about 10-
15 minutes a day, is usually referred to an inpatient rehabilitation setting. Patients with disorders 
in consciousness, who recover slowly or suffer from severe neurobehavioral problems, may 
be referred to nursing facilities or psychiatric hospitals. However, well accepted algorithms to 
support the choice of follow-up treatment do not exist.2 
Although there is growing evidence that both acute and post-acute rehabilitation interventions 
are beneficial for patients with acquired brain injury, including TBI,3-5 their specific ingredients, 
mechanism of action and efficacy is still referred to as a ‘black box’.6 As a consequence, large 
variations in structure and process characteristics of TBI rehabilitation may exist. Structures 
refer to conditions under which rehabilitation care is provided (e.g. availability of an in-hospital 
rehabilitation unit, personnel, facilities),7 and processes refer to treatment- and referral policies.7 
As they may be related to differences in patient outcomes, exploring the variations in structure 
and process characteristics of TBI rehabilitation might provide directions for the identification of 
effective interventions. 
The objective of this study is to provide a broad overview of structural and process characteristics 
of TBI rehabilitation among European neurotrauma centers, with a focus on acute in-hospital 
rehabilitation and referral to post-acute inpatient or outpatient care. 
Methods
Study sample
This study is part of the Collaborative European NeuroTrauma Effectiveness Research in TBI 
(CENTER-TBI) study, which is a prospective longitudinal observational study conducted in 72 
centers from Austria, Belgium, Bosnia Herzegovina, Denmark, Finland, France, Germany, Hungary, 
Israel, Italy, Lithuania, Latvia, the Netherlands, Norway, Romania, Serbia, Spain, Sweden, the 
United Kingdom and Switzerland.8 The included centers predominately were academic hospitals 
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(n = 65, 92%), situated in an urban location (n = 70, 99%), with a level I or II trauma center 
designation (n = 52, 74%). Centers had a median of 1000 (Interquartile range 682-1395) hospital 
beds and treat approximately 91 (interquartile range 52-160) patients with moderate and severe 
TBI annually. For more information about the participating centers, see our previous publication.9
Questionnaire development and administration
Between 2014 and 2016, the local investigators, who are the senior persons supervising the 
CENTER-TBI study in each center, were approached to complete a set of 11 questionnaires, 
containing 321 questions: The Provider Profiling (PP) questionnaires. Questions concerned 
structures and processes of TBI care. For questions about process, we specifically asked for the 
‘general policy’ in a particular center, which was defined as the way the large majority of patients 
(> 75%) with a certain indication would be treated, recognizing that there might be exceptions. 
We also explicitly mentioned that we were interested in the general policy at the department or 
hospital rather than individual treatment preferences. 
The set of questionnaires was distributed among 71 out of 72 centers, since two CENTER-TBI 
centers represented different departments from the same hospital with similar structures 
and processes. The questionnaires were developed based on literature (e.g. the neurotrauma 
evidencemap: http://neurotrauma.evidencemap.org) and expert opinion and were subsequently 
pilot-tested in 16 of the participating centers. All answers were checked for unexpected or 
missing values, and ambiguous questions were subsequently reformulated or deleted. Pilot-
testers additionally completed a form in which they were asked to provide feedback, which 
was incorporated accordingly in the final questionnaires. Local investigators were informed 
about the PP questionnaires by presentations, workshops and emails. To be able to assess the 
reliability of the questionnaires, 17 (5%) questions were duplicated and asked twice in different 
parts of the questionnaires. We assessed the percentage of overlap between duplicate questions 
and calculated the median concordance rate over these 17 questions. The concordance rate 
was adequate, with a median of 0.85, meaning that 85% of the responses were similar. For 
more information about the development, administration and content of the total set of PP 
questionnaires, see our previous publication.9
The questionnaire about rehabilitation addressed both in-hospital rehabilitation and referral to 
post-acute rehabilitation facilities (Online Supplement A). This questionnaire included fourteen 
multiple-choice questions about structures (e.g. “what rehabilitation facilities are available 
at your institution”) and processes (e.g. “where are TBI patients with the following clinical 
characteristics generally referred to”) of rehabilitation care. 
Statistical analyses 
Frequencies and percentages of all categorical variables were reported. We subsequently 
calculated differences between relatively high- and middle-income countries versus relatively 
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lower-income countries using Chi-Square, and if appropriate, Fisher’s exact test. The designation 
into relatively lower-income countries was based on a 2007 report by the European Commission10 
and the countries Bosnia-Herzegovina, Bulgaria, Hungary, Latvia, Lithuania, Romania and Serbia 
were subsequently classified as relatively lower-income countries. Analyses were performed 
using the Statistical Package for Social Sciences (SPSS) version 21. 
Results
Participating centers
The questionnaire about rehabilitation was completed by 99% (n = 70) of the participating 
centers. In the majority of centers, the questionnaire was completed by a rehabilitation physician 
(n = 28, 40%) or a neurosurgeon (n = 22, 31%). Other specialists that completed the questionnaire 
included neurologists, intensivists, heads of in-hospital rehabilitation units and study nurses.
Rehabilitation specialists
The majority of participants indicated that rehabilitation physicians could be consulted for 
patients with TBI at the Intensive Care Unit (ICU; n = 48, 70%) and the ward (n = 54, 78%; 
Table 1). Of the centers that indicated that they could consult rehabilitation physicians at the 
ICU (n = 48) and ward (n = 54), around one third reported that rehabilitation physicians were 
consulted in all patients with TBI. The remainder indicated that rehabilitation physicians were 
asked for a consult on indication.
The large majority of centers could consult physical therapists, occupational therapists, speech 
therapists, dieticians, social workers and/or rehabilitation nurses in both the ICU and ward. 
Neuropsychologists were available in half of the centers (ICU: n = 36, 52%; ward: n = 45, 65%). 
In around half of the centers, a multidisciplinary rehabilitation team could be consulted for 
patients with TBI at the ICU (n = 29, 41%) and ward (n = 34, 49%). A multidisciplinary team was 
here defined as a full multidisciplinary rehabilitation service and not as isolated physiotherapy 
provision. There were no differences between high/middle-income and relatively lower-income 
countries on any of the described characteristics (Table 1).
Guidelines
In only 13 (19%) centers, rehabilitation guidelines or protocols were used when treating patients 
with TBI. Most of these guidelines were developed based on expert opinion within the center 
and not based on evidence-based guidelines. 
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Table 1. In-hospital rehabilitation in 70 European neurotrauma centers participating in the CENTER-TBI 
study
Characteristic All centers  
(n = 70)
Centers in high- and 
middle-income 
countriesⱠ (n = 57)
Centers in relatively 
lower-income 
countriesⱡ (n = 13)
P-value
Rehabilitation specialists that can be 
consulted for TBI patients at the ICU
Rehabilitation physician 48 (70%) 38 (67%) 10 (83%) .32*
Neuropsychologist 36 (52%) 31 (54%) 5 (42%) .42
Physical therapist, occupational therapist  
or speech therapist 
67 (96%) 55 (97%) 12 (92%) .47*
Dietician, social worker or rehab nurse 63 (90%) 51 (99%) 12 (93%) .61*
Multidisciplinary rehabilitation team 29 (41%) 21 (37%) 8 (62%) .10
Rehabilitation specialists that can be 
consulted for TBI patients at the ward
Rehabilitation physician 54 (78%) 43 (75%) 11 (92%) .44*
Neuropsychologist 45 (65%) 37 (65%) 8 (67%) .59*
Physical therapist, occupational therapist  
or speech therapist 
68 (97%) 56 (98%) 12 (92%) .34*
Dietician, social worker or rehab nurse 65 (93%) 53 (93%) 12 (92%) .65*
Multidisciplinary rehabilitation team 34 (49%) 56 (44%) 9 (69%) .10
Structural characteristics
TBI specific rehabilitation guidelines 13 (19%) 12 (22%) 1 (8%) .44*
In-hospital coma stimulation 34 (49%) 27 (47%) 7 (54%) .67
In-hospital rehabilitation unit 36 (51%) 28 (49%) 8 (62%) .45
Outpatient rehabilitation facility 25 (36%) 21 (37%) 4 (31%) .76*
Structural connection with rehabilitation 
facilities
57 (81%) 47 (83%) 10 (77%) .64*
Table presents characteristics of in-hospital rehabilitation in 70 neurotrauma centers across Europe. P-values represent differences 
between high- and middle-income versus lower-income countries calculated by Chi Square test or Fisher’s exact test (*). 
ⱠHigh / middle income: Austria, Belgium, Denmark, Finland, France, Germany, Israel, Italy, the Netherlands, Norway, Spain, Sweden and 
the United Kingdom; Relatively low income: Bosnia Herzegovina, Bulgaria, Hungary, Latvia, Lithuania, Romania and Serbia
ⱡ North and West Europe: Austria, Belgium, Denmark, Finland, France, Germany, Lithuania, the Netherlands, Norway, Sweden and 
the United Kingdom; South and East Europe and Israel: Bosnia Herzegovina, Hungary, Israel, Italy, Latvia, Romania, Serbia, Spain and 
Switzerland
Coma stimulation
Half of the participants (n = 34) reported that they use coma stimulation in their center. In these 
centers, mobility stimulation (n= 29, 85%) was used most often, followed by sensory stimulation 
(n = 25, 74%) and pharmacological stimulation (n= 19, 56%, Online Supplement B).
Rehabilitation facilities
Half of the participants (n = 37) reported to have an in-hospital rehabilitation unit, while one 
third had an outpatient rehabilitation facility (n = 25). In addition, 57 (81%) participants indicated 
to have structural connections with rehabilitation facilities in the area. There were no differences 
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between relatively high- and middle-income and lower-income countries on any of these 
characteristics (Table 1).
  
Referral to post-acute rehabilitation facilities
To assess referral patterns to post-acute rehabilitation facilities, participants were presented four 
cases and they were requested to indicate which referral institutions they would consider. They 
were allowed to provide more than one answer, as long as it reflected their ‘general policy’. The 
cases included (1) patients < 65 years and (2) elderly patients > 65 years; both age groups with 
the following characteristics: (A) not obeying commands and (B) obeying commands but still in 
posttraumatic amnesia (PTA) and with severe behavioral problems. 
The large majority indicated that the young patients would be referred to rehabilitation centers 
(Figure 1). Young patients not obeying commands could also be referred to nursing homes 
(n = 17), local hospitals (n = 19) or coma care facilities (n = 16). For young patients obeying 
commands but still in PTA and with severe behavioral problems, psychiatric hospitals (n = 17), 
local hospitals (n = 20) or outpatient facilities (n = 15) were also reported as referral possibilities. 
Figure 1. Referral to rehabilitation facilities in 70 neurotrauma centers participating in the CENTER-TBI 
study
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Figure shows which rehabilitation facilities a center would consider in patients with certain characteristics. Centers were allowed to 
select more than one facility as long as it reflected their general policy. Elderly patient: age ≥ 65year
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For elderly patients, a more mixed image appeared. Elderly patients not obeying commands 
could be referred to either rehabilitation centers (n = 33), nursing homes (n = 32) or local hospitals 
(n = 29). For elderly patients obeying commands but still in PTA and with severe behavioral 
problems, rehabilitation centers (n = 46) were most often considered, followed by nursing homes 
(n = 26) and local hospitals (n = 27). 
Influence of age on referral decisions
Participants were asked explicitly whether patient’s age has a major influence on referral 
decisions. Forty-six per cent (n = 32) indicated that this was the case. Participants declared 
that rehabilitation programs have age limits or selection favoring younger patients. Also, the 
rehabilitation potential of older patients is regarded lower, and as a consequence, older patients 
are more often referred to non-specialized rehabilitation programs or nursing homes (Online 
Supplement C). 
We elaborated whether the influence of age on referral decisions was dependent on income, 
geographic location (North and West Europe vs. South and East Europe and Israel), the completer 
of the questionnaire (rehabilitation physician vs. other completer), personnel characteristics 
(availability of a rehabilitation physician and neuropsychologist) and the availability of an in-
hospital multidisciplinary team and an in-hospital rehabilitation unit (Online Supplement D). 
We found that high- and middle-income countries more often indicated that age has a major 
influence on referral in comparison to relatively lower-income countries (p < .01). There were 
however no differences between high- and middle and relatively lower-income countries in 
whether they would generally refer elderly patients to nursing homes. We additionally found 
a trend toward higher referral to nursing homes in elderly patients with PTA and behavioral 
problems in North and West Europe in comparison in South and East Europe and Israel (p = .09). 
In addition, we found that centers in which a rehabilitation physician was available more often 
indicated that age has a major influence on referral decisions in comparison to centers in which 
a rehabilitation physician was not available (p = .05). 
Waiting time for rehabilitation facilities
We asked for the average waiting time for rehabilitation facilities, which was defined as the time 
between the moment that the patient is ready to be discharged from the center and the time of 
admission or first visit at the referral institute. The average waiting time was usually no longer 
than one month (Table 2). For specialized rehabilitation centers, patients could be admitted 
within a few days in seven (10%) centers, within one week in 26 (38%) centers and within one 
month in 27 (40%) centers. The waiting time for nursing homes and coma care facilities was 
slightly longer. 
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Table 2. Waiting time for rehabilitation facilities among 70 European neurotrauma centers participating 
in the CENTER-TBI study
Waiting time Rehabilitation 
center (n = 68)
Nursing home  
(n = 58)
Psychiatric hospital 
(n = 55)
Local hospital  
(n = 63)
Coma care facility  
(n = 53)
Within a few days 7 (10%) 8 (14%) 20 (36%) 31 (49%) 6 (11%)
Within one week 26 (38%) 15 (26%) 14 (25%) 20 (32%) 10 (19%)
Within one month 27 (40%) 21 (36%) 13 (24%) 10 (16%) 21 (40%)
> 1 month 8 (12%) 14 (24%) 8 (15%) 2 (3%) 16 (30%)
Table presents the waiting time for rehabilitation facilities among 70 neurotrauma centers across Europe. 
Factors relevant for referral decision 
Participants had to indicate how important certain factors were in their referral decision 
to rehabilitation facilities. They were asked to give a score of 1 (most important) to 5 (least 
important) to the following aspects: quality of care, distance to a patient’s home, availability 
at short notice, specialized neuro-rehabilitation, and funding (Figure 2). Distance to a patient’s 
home was rated as the most important factor for rehabilitation referral and funding/financial 
reason was rated as the least important factor. 
Figure 2. Factors considered important in the referral decision of 70 neurotrauma centers participating 
in the CENTER-TBI study 
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Figure shows the number of centers that responded with an 1 (most important) or 2 (second most important) to the five 
factors that could be considered relevant in decisions about referral to rehabilitation facilities.  
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Satisfaction with rehabilitation possibilities
We subsequently asked participants how satisfied they were with rehabilitation possibilities in 
their area, using the same criteria (except for funding/financial reason). Regarding quality of care 
and specialized neuro-rehabilitation possibilities, the majority of centers were satisfied (score 4 
or 5 out of 5). However, for distance to a patient’s home and availability at short notice, less than 
half of the centers gave a score of 4 or 5 (Figure 3). Three centers, from three different countries 
indicated that they were dissatisfied with all four items (score 1 or 2 on all items). 
Figure 3. Satisfaction with rehabilitation facilities in 70 neurotrauma centers participating in the 
CENTER-TBI study
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Centers were asked whether they were satisfied with the rehabilitation facilities in their region: 1 = not satisfied; 5 = completely satisfied
Discussion
We found marked variation in structure and process characteristics of early in-hospital TBI 
rehabilitation and referral to post-acute rehabilitation care among 70 centers participating in a 
European TBI research project. 
The following limitations should be taken into account when interpreting the data. First and 
foremost, the included centers comprise a selected group of neurotrauma centers participating 
in a European multicenter study. The centers are all active in the field of neurotrauma care 
and research, and therefore, it may be that the picture obtained is better than the real overall 
situation in Europe. The differences in structures and processes may be even larger when 
considering non-specialized centers. Our findings therefore cannot be generalized and should 
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be interpreted with caution. Secondly, our study provides information on what centers reported 
rather than characteristics that were directly observed. Lack of concordance between reported 
and observed characteristics is common in survey studies. For example, a 2007 survey study 
about intracranial pressure (ICP) monitoring reported that 77% of the patients were treated 
according to the guidelines,11 while a recent systematic review found that the mean percentage 
adherence to ICP monitoring guidelines was only 31%.12 We cannot exclude that the centers in 
our study also provided a more favorable image of their structural and process characteristics. 
This would again result in a more favorable picture. Related, questionnaires were completed by 
only a few physicians in every center rather than by all physicians that treat patients with TBI in a 
particular center. Although we asked for their general policy, we cannot exclude that some of the 
answers display personal opinions rather than the department or hospital policy. Results from 
the ongoing CENTER-TBI study will provide insight into possible discrepancies between these 
policy opinion statements and actual practice. Another limitation is that the question on referral 
preferences did not take into account patients’ and proxies’ preferences and needs. It should be 
acknowledged that referral decisions in clinical practice often incorporate patients’ and proxies’ 
preferences and might be based on shared decision-making. Therefore, the results on referral 
preferences should be interpreted as the participant’s rating of relative importance of five factors 
rather than displaying actual referral patterns. The PP questionnaires themselves also have some 
limitations. For example, the length (321 questions) may have resulted in lower data quality.9 
The observed variation in structure and process is consistent with other surveys about 
rehabilitation after TBI.13-16 Large variation in rehabilitation practices might be partly explained 
by the limited use of guidelines. Only one-fifth of the centers in our survey indicated that they 
use TBI-specific rehabilitation guidelines during the acute treatment phase. These guidelines 
were based on expert opinion and developed within the center, rather than based on national/
international evidence-based guidelines. This reflects an absence of evidence-based guidelines 
on this topic. For instance, the Brain Trauma Foundation guidelines, which are probably the 
most often used guidelines for the treatment of patients with severe TBI, have not included 
recommendations regarding in-hospital rehabilitation.17 We would therefore recommend 
guideline developers to include recommendations about early rehabilitation in their guidelines. 
Another interesting finding is the influence of age on referral decisions. In our survey, patients 
above age 65 are less often referred to specialized rehabilitation centers than younger patients 
and around half of the centers indicated that age has a major influence on referral decisions. 
This shows a clear disparity in access to care, and is against the Article 21 of the Fundamental 
Rights of EU. Inequality in access to rehabilitation care after brain injury has been widely shown 
for racial and ethnic minorities18-21 and uninsured patients19,21 and our study implies that patients 
with an older age are also at risk. Notwithstanding, it has been shown that elderly patients can 
make substantial improvements during inpatient rehabilitation and could often be discharged 
home.22,23 Since the prevalence of elderly TBI patients is increasing,24 physicians and policy 
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makers should be aware of the age disparity, and the influence of age on rehabilitation potential 
should be studied further in future studies. The concept of inferior rehabilitation potential in 
the elderly may be a consequence of a self-fulfilling prophecy in earlier practices and studies. In 
addition, further qualitative research might unravel why age is an important factor in referral to 
rehabilitation facilities for some doctors and centers and not for others. 
Another implication of our work is that the effectiveness of rehabilitation interventions could 
be studied with comparative effectiveness research (CER). Knowledge about effectiveness and 
best practices of TBI rehabilitation is critically important since recent research has suggested 
that differences in outcome between developed and developing countries are mainly due to 
differences in rehabilitation care, rather than differences in acute care.25 CER refers to the use of 
existing differences in policy between centers to analyze treatment effectiveness. A prerequisite 
for CER is that there is considerable variation in policy among centers, which is shown in our 
study. We therefore think that CER is an adequate framework to enhance knowledge about 
effectiveness of rehabilitation interventions in TBI and inform patients, clinicians and guideline 
developers directly about this information. CER within the CENTER-TBI project can be studied 
by comparing patients in centers that perform a certain intervention as the general policy to 
patients in centers that do not generally use this intervention. For example, we can compare 
the outcome of comatose patients from the 34 centers that use in-hospital coma stimulation 
to comatose patients from the 36 centers that do not use in-hospital coma stimulation, after 
correcting for case mix and other differences among centers. Other potential interesting topics 
for CER based on the current results include the availability of an in-hospital multidisciplinary 
team, the treatment of elderly patients in specialized rehabilitation centers vs. in nursing homes 
and the impact of waiting time on outcome. 
Conclusion
Marked variation in structure and process of in-hospital rehabilitation and referral to rehabilitation 
facilities exists between European neurotrauma centers. This variation provides the possibility to 
study effectiveness of specific rehabilitation interventions in comparative effectiveness research, 
but also indicates that there is likely room for improvement in quality of care, long-term outcome 
and cost-effectiveness of TBI rehabilitation. In addition, this study found a disparity in access to 
specialized rehabilitation care for elderly patients. Future research is warranted to study referral 
decision-making processes and further investigate the rehabilitation potential of elderly patients. 
Supplemental material is available at www.marysecnossen.nl
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Abstract
Objectives: Although guidelines have been developed to standardize care in traumatic brain 
injury (TBI), between-center variation in treatment approach has been frequently reported. 
We examined variation in treatment for TBI by assessing factors influencing treatment and the 
association between treatment and patient outcome.
Design: Secondary analysis of prospectively collected data. 
Setting: Five level-I trauma centers in the Netherlands (2008-2009).
Patients: 503 patients with moderate or severe TBI (Glasgow Coma Scale: 3-13).
Interventions: We examined variation in seven treatment parameters: direct transfer, 
involvement of mobile medical team, mechanical ventilation, intracranial pressure (ICP) 
monitoring, vasopressors, acute neurosurgical intervention and extracranial operation.
Measurements and Main Results: Data were collected on patient characteristics, treatment and 
six-month Glasgow Outcome Scale Extended (GOSE). Multivariable logistic regression models 
were used to assess the extent to which treatment was determined by patient characteristics. To 
examine whether there were between-center differences in treatment, we used unadjusted and 
adjusted random effect models with the seven treatment parameters as dependent variables. 
The influence of treatment approach in a center (defined as aggressive and nonaggressive based 
on the frequency ICP monitoring) on outcome was assessed using multivariable random effect 
proportional odds regression models in those patients with an indication for ICP monitoring. 
Sensitivity analyses were performed to test alternative definitions of aggressiveness. 
Treatment was modestly related to patient characteristics (Nagelkerke R2 range 0.12-0.52) and 
varied widely among centers, even after case-mix correction. Outcome was more favorable in 
patients treated in aggressive centers than those treated in nonaggressive centers (OR: 1.73; 
95% CI 1.05-3.15). Sensitivity analyses, however, illustrated that the aggressiveness-outcome 
association was dependent on the definition used.
Conclusions: The considerable between-center variation in treatment for patients with brain 
injury can only partly be explained by differences in patient characteristics. An aggressive 
treatment approach may imply better outcome, although further confirmation is required.
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Introduction
Although clinical guidelines have been developed to reduce variability in care of patients with 
traumatic brain injury (TBI), between-center variation in treatment approach has been frequently 
reported.1-3 It is not fully understood to what extent differences in treatment approach among 
centers reflect differences in patient population (‘case-mix’) or differences in hospital policy. 
Clinical patients characteristics, such as age and Glasgow Coma Scale (GCS), are associated with 
treatment approach and guideline adherence in TBI.4,5 However, it is also known that treatment 
approach is at least partly a hospital characteristic and is influenced by local routines2 and health 
care policies.6 Moreover, insufficient numbers of prospective, randomized controlled trials are 
available to underpin clinical TBI guidelines,7 which vary widely in content,8 thereby failing to 
sufficiently reduce treatment variation 
Whether treatment variability among centers reflects variation in quality of care and subsequently 
influences patient outcome is unknown. For the majority of interventions for moderate- and 
severe TBI, effectiveness is not established yet.7 Additionally, deviation from best practices could 
theoretically also reflect adequate, patient-tailored care.9 Large between-center variation in 
outcome after TBI has however been described10 and it has been suggested that differences in 
quality of care might at least partly explain this variation.
In this study, we therefore examined variation in treatment for moderate and severe TBI by 
assessing factors influencing treatment and the association between treatment and patient 
outcome.
Materials and methods
Design, setting and patients 
We performed a secondary analysis of the Prospective Observational COhort Neurotrauma 
(POCON) study dataset, which contains prospectively collected data about 508 patients with 
moderate and severe TBI (GCS 3-13) presenting at five level I trauma centers in the Netherlands 
between June 1, 2008 and May 31, 2009. Patients were consecutively enrolled and extensive 
data checks were performed to warrant that all eligible patients were asked to participate in this 
study. All centers were Academic centers. Three centers were from urban areas and two from 
rural regions. In each center, protocols based on the Brain Trauma Foundation (BTF) guidelines 
(2007)11 were available. Patients younger than 16 years old and those who were admitted to 
the hospital more than 72 hours post-injury were excluded.12 We further excluded patients with 
gunshot injuries (n = 4) or a missing value on one of the seven treatment variables of interest 
(n = 1).
Causes and consequences of treatment variation in moderate and severe traumatic brain injury
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The institutional review board (IRB) of the coordinating hospital (Radboud University Nijmegen 
Medical Center) approved the study protocol and the other participating hospitals provided 
a feasibility statement.12 Informed consent was obtained orally or written during outcome 
assessment after six months.12 Further details on the development of the POCON database have 
been reported in a previous publication.12 
Patient variables
Data from medical records were entered into a research database by trained research staff 
supervised by a physician.12 Collected variables included age, gender, GCS, Abbreviated Injury 
Scale (AIS) scores for head, face, neck, skin, thorax, abdomen, spine and extremities, pupillary 
reactivity, hypoxic episode (at injury scene or emergency department (ED), yes = confirmed 
(SaO2 < 90%) or suspected based on clinical grounds), hypotensive episode (at injury scene or ED, 
yes = confirmed (SBP < 90 mmHg) or suspected based on clinical ground), glucose (mmol/L) and 
hemoglobin (g/dL) levels. For all these variables (except for hypoxia and hypotension), the first 
score after arriving at the ED was used for analysis. 
Severe and moderate TBI were defined as a GCS score at ED 3-8 and 9-13, respectively. 
Extracranial injury severity score (ISS) was calculated by adding the squared AIS scores of the 
three most severely injured body regions with exclusion of the AIS head. The initial computed 
tomography (CT) scan performed was assessed using the Traumatic Coma Data Bank (TCDB) 
score.13 Additionally, the presence of subarachnoid hemorrhages (SAH, present/absent) and 
epidural hemorrhages (EDH, present/absent) were scored. In case of missing values, the second 
CT scan was taken on condition that the scan was made within six hours after the first scan and 
prior to any neurosurgical intervention. 
Outcome was measured with the Glasgow Outcome Scale Extended (GOSE) six months post-
injury by either a postal questionnaire or a telephone interview. The categories ‘vegetative state’ 
(GOSE = 2) and ‘lower severe disability’ (GOSE = 3) were combined, as there were only two 
patients with a vegetative state. The seven-point GOSE was subsequently used as an ordinal 
outcome variable.
Differences in case-mix according to observed patient characteristics were summarized as 
the probability on survival and favorable outcome (GOSE ≥ 5) for each patient, based on the 
International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT) lab model, 
including age, GCS motor score (first score after arriving at the ED), pupillary reaction (first score 
after arriving at the ED), hypoxia, hypotension, CT classification, SAH, EDH, glucose (first score 
after arriving at the ED) and hemoglobin (first score after arriving at the ED) as predictors.14 These 
prognostic scores reflect the chances, respectively, of survival and favorable outcome given a 
patient’s baseline- and clinical characteristics. 
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Treatment variables
The following acute treatment processes were considered based on the BTF and Dutch 
prehospital guidelines: transfer (direct/indirect); involvement of the mobile medical team 
(yes / no), endotracheal intubation (at the scene / during transport / during hospital stay / before 
operation), mechanical ventilation (yes / no), sedation (yes / no), ICP monitoring (yes / no), 
barbiturates (yes / no), cerebrospinal fluid (CSF) drainage (yes / no), vasopressors for cerebral 
perfusion pressure (CPP) support (yes / no), hyperventilation (yes / no), osmotherapy (mannitol, 
hypertonic saline and/or HyperHAES®: yes / no), induced hypothermia (< 35°C: yes / no), 
acute neurosurgical intervention (yes / no), delayed neurosurgical intervention (yes / no) and 
extracranial operation (yes / no).
We excluded endotracheal intubation for further analysis, as the BTF recommendation at the 
scene is not fully applicable to the Netherlands due to short travelling distances from scene to level 
I trauma center.15 We also excluded sedation, CSF drainage, hyperventilation and osmotherapy 
as no reliable information was collected on treatment doses while different doses of these 
therapies are considered as representing different treatment intensity in the BTF guideline.16 
Barbiturates, hypothermia and delayed neurosurgical intervention were further excluded as they 
were conducted in less than 10% of the patients.
To examine the association between treatment approach and outcome, we divided centers into 
“aggressive” and “nonaggressive” based on the frequency of ICP monitor placement in patients 
with a BTF indication for ICP monitoring; i.e. patients with severe TBI and an abnormal head CT 
(TCDB score ≥ 2) or patients with severe TBI (GCS ≤ 8), a normal head CT (TCDB score = 1) and two 
out of the following three risk factors: (1) age > 40 years, (2) hypotensive episode (SBP < 90 mmHg), 
and (3) motor score ≤ 3 (unilateral or bilateral motor posturing).16 Centers inserting an ICP 
monitor in ≥ 50% of patients meeting the criteria were defined as aggressive; the remainder 
was defined as nonaggressive. This subdivision has been reported in previous studies about 
treatment effectiveness.1,17,18 
Statistical analyses
To calculate whether patient characteristics and treatment differed significantly among five 
centers, we used the chi-square test for dichotomous and ordinal variables and the non-para-
metric Kruskal-Wallis test for continuous variables, since these all had a skewed distribution. 
To assess to what extent treatment was determined by patient characteristics, we used 
multivariable logistic regression models with treatment as dependent variable and the IMPACT 
prognostic variables and extracranial ISS as predictors. Backward elimination of predictors (at 
p > .15719) was used to select patient characteristics that were the strongest determinants 
of treatment. We calculated Nagelkerke R2 to determine the variance in treatment that was 
determined by patient characteristics. 
Causes and consequences of treatment variation in moderate and severe traumatic brain injury
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To explore the effect of center on treatment we subsequently used random effect logistic 
regression models with treatment as dependent variable and a random intercept for center 
as independent variable. Random effect models correct for between-center differences in 
treatment that are attributable to factors not in the model or differences that exist by chance. In 
a univariable model (with only a random intercept for center), crude differences between centers 
in treatment were estimated. Subsequently, the relevant patient characteristics were added as 
covariates to adjust for between-center differences in case-mix. 
Differences between aggressive and nonaggressive centers in patient- and treatment 
characteristics were calculated using chi-square and Kruskall Wallis tests. Only those patients 
with an indication for ICP monitoring were selected. The effect of aggressiveness on outcome 
was subsequently analyzed with a random effects proportional odds regression model with 
aggressiveness (yes / no), a random intercept for center and the IMPACT probability score of 
favorable outcome as independent variables and the ordinal GOSE as dependent variable. This 
model estimates the effect of aggressiveness on outcome adjusted for patient characteristics 
and for other differences between centers than the treatment under study. The effect of 
aggressiveness was expressed as an odds ratio (OR). The corresponding 95% confidence interval 
(CI) was calculated using bootstrapping with 500 samples. 
From the random effect models we derived the model parameter tau2 20 to quantify the between-
center variation in respectively treatment and outcome that cannot be explained by factors in 
the model or chance. We expressed the between-center variation as an OR for the difference 
of a hospital at the 97.5th percentile versus the 2.5th percentile (Exp(3.92√T2)), for better clinical 
interpretation. A value of 1 represents no unexplained differences in respectively treatment or 
outcome between centers with the most and least treatment or unfavorable outcomes. 
Missing values in baseline- and clinical characteristics were imputed with multiple imputations 
with all patient baseline- and clinical characteristics and GOSE as covariates. The random effect 
analyses were performed in R (version 3.1.2) using the ordinal21, lme422 and graphics23 packages. 
All other analyses were performed using Statistical Package for the Social Sciences (SPSS) version 
21. A p-value < 0.05 was considered statistically significant in all analyses. 
Sensitivity analyses
As the definition of aggressiveness was arbitrary, we performed sensitivity analyses with 
alternative definitions. The following alternative definitions of aggressiveness were considered: 
1. ICP monitor inserted in ≥ 45% of those with a BTF indication, as this would move one center 
from the less aggressive to the aggressive group. 
2. Treatment with a Therapy Intensity Level (TIL)24 ≥ 2 in ≥ 50% of the patients with a BTF 
indication for ICP monitoring. TIL ≥ 2 refers to mild to extreme ICP lowering therapy and 
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includes vasopressors for CPP support, osmotic therapy, hyperventilation, CSF drainage, 
hypothermia, barbiturates and neurosurgical interventions
3. Acute neurosurgical intervention performed in ≥ 50% of the patients with a mass lesion. 
4. ICP monitoring, TIL ≥ 2 and intracranial operation performed in ≥ 50% of those indicated. 
Results
Patient characteristics
The study population consisted of 503 patients with a median age of 46 years (Interquartile 
range 28-65). Patients were predominately male (n = 349; 69%) and 335 (67%) patients had 
a presenting GCS ≤ 8. There were 191 missing data points, which we imputed with multiple 
imputation techniques. 
Patient characteristics varied considerably among the centers (Table 1). In the center with the 
most favorable case-mix, the probability of survival based on patient characteristics was 87% (95% 
CI: 49%-97%). In the center with the most severe patients this probability was 57% (24%-92%). 
Actual outcome (n=410) differed significantly among centers with the poorest outcome in the 
center with the most severe and oldest patients (center 3). 
Effect of patient characteristics on treatment 
Patient characteristics modestly predicted treatment (Table 2). The regression models based 
on patient characteristics explained 12% to 52% of the variance in treatment. The wide 
range indicates variation in how much a decision to treat is determined by observed patient 
characteristics.
The models included on average 6 (range 4-8) predictors with age, GCS motor score, pupillary 
reactivity, CT classification and extracranial ISS score being significant variables in the majority of 
models predicting treatment. More intensive treatments were generally more often performed 
in younger patients with more severe TBI. 
Treatment variation among centers
Treatment varied substantially among centers (Figure 1). There was significant variation in six out 
of seven treatment interventions (mobile medical team, mechanical ventilation, ICP monitoring, 
vasopressors, acute neurosurgical intervention and extracranial operation). The greatest 
variability was seen in involvement of the mobile medical team (range 26%-54%) and the use of 
ICP monitoring (range 12%-40%). 
Causes and consequences of treatment variation in moderate and severe traumatic brain injury
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Figure 1. Treatment characteristics by center (n = 503)
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Figure shows the percentage of patients that receive treatment per center. 
*P < 0.05; ** p < 0.01
Abbreviations: ICP = Intracranial Pressure; CPP = Cerebral Perfusion Pressure
Unadjusted random effect models confirmed the wide between-center variation in treatment 
(Figure 2). For example, an average patient had a 9.06 higher odds of having an ICP monitor 
placed in the hospital that performed most ICP monitoring (97.5th percentile) compared to the 
hospital that performed least ICP monitoring (2.5th percentile). Substantial differences were also 
reported for mobile medical team (OR = 4.30), mechanical ventilation (OR = 4.26), vasopressors 
(OR = 7.02), acute neurosurgical intervention (OR = 5.92) and extracranial operation (OR = 4.08). 
Between-center variation generally became smaller after case-mix correction (correction for 
relevant predictors from Table 2), indicating that patient characteristics explained some of the 
variation. However, for the majority of treatments the between-center differences remained 
remarkable with differences in odds of receiving treatment up to 5.21 between centers that 
performed most and least treatment (ORadjusted Mechanical ventilation: 3.51; ICP monitoring: 
5.21; Vasopressors: 3.20). 
Exceptions were transfer, for which between-center differences were completely explained 
by differences in case-mix among centers (ORadjusted = 1.00), and mobile medical team, acute 
neurosurgical intervention and extracranial operation, for which the difference in odds of 
receiving treatment increased after case-mix correction (ORadjusted Mobile medical team: 6.61, 
Acute neurosurgical intervention: 7.32; Extracranial operation: 5.13). This indicates that there 
is even more variation among centers after correction for demographic and clinical patient 
characteristics. 
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Figure 2. Between-center differences in treatment characteristics in unadjusted and adjusted random 
effect models 
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Figure presents the random intercepts for center based on random effect models with treatment as dependent variable. Model 1 
(unadjusted) includes only a random intercept for hospital, and model 2 (adjusted) includes a random intercept for hospital and all 
relevant patient characteristics as covariates. The random hospital coefficients and 95% Confidence Intervals are shown.
Model parameter tau2 was derived to quantify the between-center variation in treatment, not explained by factors in the model or by 
chance. Tau2 was expressed as the OR for the difference of a hospital at the 97.5th percentile vs the 2.5th percentile (Exp(3.92√T2)) for 
better clinical interpretation. 
Tau2: Direct transfer unadjusted = 2.21; Direct transfer adjusted = 1.00; Mobile medical team unadjusted = 4.30; Mobile medical team 
adjusted = 6.61; Mechanical ventilation unadjusted = 4.26; Mechanical ventilation adjusted = 3.51; Intracranial pressure monitoring 
unadjusted = 9.06; Intracranial pressure monitoring adjusted = 5.21; Vasopressors unadjusted = 7.02; Vasopressors adjusted = 3.20; Acute 
neurosurgical intervention unadjusted = 5.92; Acute neurosurgical intervention adjusted = 7.32; Extracranial operation unadjusted = 4.08; 
Extracranial operation adjusted = 5.13.
Abbreviations: Unadj = unadjusted model; Adj = adjusted model; MMT = Mobile Medical Team; ICP = Intracranial Pressure; Neurosurg 
Intervention = Acute neurosurgical intervention
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Effect of treatment variation on patient outcome
Since ICP monitoring is indicated in patients with severe TBI and CT abnormalities or two out 
of three risk factors (age > 40, SBP < 90mmHg, unilateral/bilateral motor posturing) we omitted 
patients who did not fulfill these criteria from the aggressiveness-outcome analyses. This resulted 
in 300 eligible patients, of whom 266 completed the 6-month follow-up assessment. Patients 
with a follow-up assessment were generally older (median age 49 vs. 43), were more often 
female (33% vs. 15%) and had more often a SAH at the CT-scan (55 vs. 32%). There were no other 
statistically significant differences between patients with and without an outcome assessment.
Two centers were classified as having an aggressive approach towards ICP monitoring (center 1: 
55% and center 5: 54%) and three as having a nonaggressive approach (center 2: 19%; center 
3: 47%; center 4: 26%). Baseline- and clinical characteristics, summarized as the predicted 
probability of survival and favorable outcome, did not differ among aggressive and nonaggressive 
centers (Online Supplement A). Aggressive and nonaggressive centers did not differ on general 
procedures except for direct transfer (88% vs. 79%, p = .04) and mechanical ventilation 
(86% vs. 96%, p < .01). As expected, aggressive centers used more vasopressors for the treatment 
of patients with elevated ICP (43% vs. 29%, p = .02). Adjusted for case-mix, patients treated 
in aggressive centers had a more favorable outcome than patients treated in nonaggressive 
centers (OR: 1.73; 95% CI 1.05-3.15, Table 3). Additionally, treatment approach explained the 
between-center differences in outcome among centers. In the reference model adjusted for 
case-mix, the center with the best outcome (97.5th percentile) had a two-times higher odds on 
favorable outcome compared to the center with the worst outcome (2.5th percentile) that was 
not explained by factors in the model or chance. After the addition of aggressiveness, this value 
decreased to one, indicating that differences in outcome among centers can be attributed to 
the extent to which centers maintain an aggressive treatment approach. Alternative definitions 
of aggressiveness resulted in non-significant effects (Table 3). However, combining all definition 
into one ‘aggressiveness’ score resulted in a statistically significant positive association between 
aggressiveness and patient outcome (OR: 2.11, 95%CI 1.12-3.99)
Causes and consequences of treatment variation in moderate and severe traumatic brain injury
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Table 3. Estimates of treatment effect (odds ratio (OR) and 95% confidence interval (CI) and between-
center differences in six-month outcome (Glasgow outcome scale extended) in 266 patients with an 
indication for Intracranial Pressure (ICP) monitoring 
Model OR (95% CI) Exp(3.92√T2)
Reference
Adjusted for probability of favorable outcome - 1.93
Analysis aggressiveness
ICP monitor in ≥ 50%, adjusted for probability favorable outcomeA 1.73 (1.05-3.15) 1.00
Sensitivity analyses
I: ICP monitor in ≥ 45%, adjusted for probability favorable outcomeB 1.24 (0.73-2.11) 1.71
II: TIL2+ in ≥ 50% adjusted for probability favorable outcomeB 1.24 (0.73-2.11) 1.71
III: Acute neurosurgical intervention in ≥ 50% of patients with CT score ≥ 5  
(mass lesion) adjusted for probability favorable outcome (160 patients)C
0.72 (0.34-1.41) 1.00
IV: ICP monitor, acute neurosurgical intervention and TIL2 in ≥ 50%, adjusted for 
probability favorable outcomeD
2.11 (1.12-3.99) 1.00
Table presents Odds Ratio (OR) and 95% Confidence Interval (CI) of random effect proportional odds analyses with aggressiveness 
and the probability of favorable outcome as dependent variables and six-month Glasgow Outcome Scale Extended (ordinal scale) as 
outcome. 
Parameter Tau2 (T2) represents between-center variation not explained by factors in the model or by chance. The value of T2 was 
expressed as the OR for the difference between the hospital with the most favorable outcome (97.5th) percentile versus the hospital with 
the most unfavorable outcome (2.5th percentile (Exp(3.92√T2))) 
CT score is based on the Traumatic Coma Databank 13.
Abbreviations: ICP = Intracranial Pressure; GCS = Glasgow Coma Scale; CT = computer tomography; TIL2+ = therapy intensity level 
2 (any of the following: vasopressors for CPP support, osmotic therapy, hyperventilation, cerebrospinal fluid drainage, hypothermia, 
barbiturates and neurosurgical intervention). 
A Center 1 and 5 are classified as aggressive 
B Center 1,3 and 5 are classified as aggressive
C Center 1, 3 and 4 are classified as aggressive 
D Center 1 is classified as aggressive
Discussion
We found considerable variation in patient population, treatment and outcome among five level 
I trauma centers treating moderate and severe TBI patients. Treatment was modestly related 
to patient characteristics, and varied substantially between centers, even after correcting for 
case-mix. Treatment approach was significantly related to six-month outcome after case-
mix correction, with a more favorable outcome in patients treated in centers maintaining an 
aggressive approach with respect to ICP management. Yet, these results depended on the 
definition of aggressiveness and should therefore be interpreted with caution.
Variation in treatment approach is commonly reported in the field of TBI.1,4 ,25 A multicenter study 
in the United States reported that the use of ICP monitors in severe TBI patients even ranged 
from zero to 100% among centers.1 Differences in treatment approach might be explained by 
differences in policies and guidelines among centers.2,6,8 It remains, nevertheless, surprising that 
five level I trauma centers from the same country with similar structures, policies and guidelines, 
show substantial treatment variation. 
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One of our hypotheses was that treatment variation at least partly reflected variation in case-mix, 
as we found major differences in patient characteristics between centers. The a priori chances 
on survival and favorable outcome based on patient characteristics were almost twice as high in 
the center with the least severe patients compared to the center with the most severe patients. 
This could reflect differences in admission policy, dispatch decisions and population served. 
Further, recruiters were neurologists in some centers (center 2 and 5) and neurosurgeons and 
intensivists in others. Although the inclusion was consecutive and extensive data checks have 
been performed in all centers, we cannot exclude the possibility that less severe patients were 
missed in centers where a neurosurgeon or intensivist included patients. 
Despite extensive variation, patient characteristics only modestly predicted treatment in our 
study. This was consistent with a previous study about factors influencing ICP monitoring.5 Similar 
findings were also reported in a study about adherence to various BTF recommendations.26 A 
possible explanation is that the associations between patient characteristics and treatment 
interventions are not linear but instead follow an inverse U curve, i.e. intensive treatment is 
considered in those with a poor prognosis, and not in those with an extremely poor prognosis 
(no treatment benefit expected) or those with a good prognosis (treatment is not necessary). 
The findings from our study suggest a new alternative explanation; treatment is merely a center 
characteristic. We found large differences in the odds of receiving certain treatments among 
centers, even after case-mix correction; i.e. similar patients had an over five times higher odds 
of having an ICP monitor placed in the center that used most ICP monitors (97.5th percentile) 
compared to the center that used least ICP monitors (2.5th percentile). 
We found a more favorable outcome in patients treated in centers maintaining an aggressive 
treatment approach. This was previously shown in a multicenter study in the United States.1 
Authors divided centers as being aggressive and nonaggressive based on a cut-off of 50% 
adherence to ICP monitoring guidelines and found lower mortality in patients treated in aggressive 
centers. One other multi-center study divided centers into quartiles based on their percentage 
ICP monitoring.4 They also found that patients in centers in the higher ICP quartiles had a more 
favorable outcome. These studies did not assess to what extent treatment approach explained 
differences between centers in outcome. We did and we found that treatment approach in terms 
of ICP monitoring did explain between-center differences in outcome. This finding is important, 
as unexplained differences in outcome between centers have been frequently reported in the 
field of TBI.10
Analyzing treatment effectiveness by comparing outcome in aggressive and nonaggressive 
centers has strengths and limitations. A major strength is that this method may better avoid 
biases related to confounding by indication, which is a threat in observational studies examining 
treatment effectiveness on patient level.27,28 A limitation is however that the subdivision results 
in an artificial difference between centers with no relevance for clinical practice. Related, the 
Causes and consequences of treatment variation in moderate and severe traumatic brain injury
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cut-off point of aggressiveness is arbitrary; our sensitivity analyses showed that shifting the 
cut-off point with 5% already resulted in non-significant findings. Also, we defined centers as 
aggressive if they placed an ICP monitor in ≥ 50% of the patients with a BTF indication, consistent 
with previous investigations.1,17,18 It might however be argued that 50% adherence to standards 
is still rather low and that a cut-off of 80-90% would comprise a more appropriate definition 
for aggressiveness. This was however not possible in our dataset, since the highest percentage 
patients treated with ICP monitoring in our sample was 55%, congruent with a systematic review 
on guideline adherence in TBI.29
Another limitation of our study is that the number of patients available was modest for the 
number of treatment variables examined, which may result in false positive findings. However, our 
sensitivity analyses all showed consistent results. A last limitation concerns the generalizability 
of our study. Our data was collected between 2008 and 2009 in five level I trauma centers within 
the same country. However, all participating centers implemented the 2007 BTF guidelines,11 
which makes them comparable to other level I trauma centers in Western countries that have 
implemented these guidelines. The BTF guidelines have recently been updated16 but the ICP 
monitoring indications have not been changed, further improving the generalizability of our 
study. 
Our study has implications for clinical practice and future research in the field. Observational 
studies analyzing the effectiveness of ICP monitoring on patient level have resulted in 
contradictory findings,30 which might be due to confounding by indication. Our study adds 
to the increasing evidence that ICP monitoring might be an effective treatment strategy for 
patients with TBI, as suggested by previous studies with a relatively low risk of confounding by 
indication.1,4 More research is however needed to further strengthen the evidence, especially 
since the significance of the effect depended on the definition of aggressiveness. In future studies, 
ideally, treatment approach should be defined in advance, independently from the data with for 
example a questionnaire about treatment policy or former registry data. We further recommend 
(observational) treatment effectiveness studies in the field of TBI to analyze effectiveness on the 
hospital level. Although this method is statistically inefficient, especially in case of large within-
center variation, it may better adjust for unobserved confounding by indication. Rather than 
dividing centers into aggressive and nonaggressive, there should be enough centers included to 
divide them into for example deciles based on the percentage treated. 
We would further recommend examining what structure, process and physician-related factors 
underlie center differences in treatment approach. This will give insight in decision-making 
processes around TBI treatment and additionally can provide policy makers targets for quality 
improvement interventions. 
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We also recommend to further assess patient characteristics that determine TBI treatment. 
The variables used in this study were all commonly reported confounders for which treatment 
effectiveness studies usually correct in their analyses. The finding that they only modestly relate 
to treatment might imply two things. There might either be additional unobserved patient 
characteristics influencing treatment decision-making or treatment is relatively independent 
from patient characteristics. The first situation would be problematic as these unobserved patient 
characteristics could confound the association between treatment and outcome. The second 
situation would be favorable as treatment allocation is relatively random and consequently, the 
influence of patient-level confounders would be minimal. 
  
Conclusion
In conclusion, the considerable between-center variation in treatment for patients with brain 
injury is only partly explained by differences in patient characteristics. Although many patient- 
and center factors may be relevant for treatment decision-making, patients treated in more 
aggressive centers may have a more favorable outcome. Future studies with treatment approach 
defined at center level are needed to validate our findings.
Supplemental material is available at www.marysecnossen.nl
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With great interest we read the study by Yuan et al.1 in a recent issue of Critical Care Medicine. In 
this retrospective observational multicenter study the authors aimed to assess the effectiveness 
of intracranial pressure (ICP) monitoring in patients with moderate and severe traumatic brain 
injury (TBI). They found a favorable effect of ICP monitoring on mortality in three subgroups. 
There are two drawbacks that we would like to address concerning this study. First, although 
knowledge about differential treatment effects in subgroups is valuable for individualized patient 
care, subgroups in this study were not predefined. Testing multiple subgroups within the same 
patient population is not recommended, since there is a high risk of spurious findings.2 For 
example, when testing 20 subgroups, one of these will be statistically significant just by chance 
when using p < 0.05. The subgroup results should therefore be interpreted as explorative. 
Further confirmation in large-scale observational studies is required before starting randomized 
controlled trials in the suggested subgroups. 
Second, the adjustment for confounding by indication has likely been incomplete. As expected, 
patients with ICP monitoring differed from those not monitored in several aspects. Authors aimed 
to adjust for confounding by indication by estimating propensity scores of receiving treatment 
and corrected their analyses accordingly. Propensity scores can however only correct for observed 
confounders3 while treatment decisions may also be based on factors that are not captured in 
the data. As an alternative approach, we would suggest instrumental variable (IV) analyses to 
estimate treatment effects in observational studies in TBI. IV analysis is a relatively new method 
that can adjust for unobserved confounders. The instrument should be highly correlated with the 
treatment under study but not with the observed and unobserved confounders. Since between-
center variation in treatment is large in TBI, center might be a suitable instrument. To our 
knowledge, two studies estimated effectiveness of ICP monitoring using this IV-like approach.4,5 
In both studies, patients treated in centers that more often performed ICP monitoring, had a 
lower mortality and a more favorable outcome. This approach is expected to provide a less bias 
estimate of treatment effects. 
In sum, the results of Yuan et al.1 should be interpreted with caution. We recommend future 
studies with IV-like methods to validate their subgroups findings. 
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Abstract
Background: Observational studies are at risk for confounding by indication, referring to a 
situation where the indication for a particular intervention is a confounder in the association 
between the intervention and outcome. The objective of the current study was to define the 
circumstances for the validity of methods to adjust for confounding by indication in observational 
studies.
Methods and findings: As a case-study, we performed post-hoc analyses of data prospectively 
collected from three European and North-American TBI studies including a total of 1,725 
patients with moderate and severe TBI. The effects of three interventions (intracranial pressure 
(ICP) monitoring, intracranial operation and primary referral) were estimated in a proportional 
odds regression model with the Glasgow Outcome Scale as ordinal outcome variable. Three 
analytical methods were compared: classical covariate adjustment; propensity score adjustment; 
and instrumental variable (IV) analysis in which the percentage exposed to an intervention in 
each hospital was added as an independent variable, together with a random intercept for 
each hospital. In addition, a simulation study was performed in which a hypothetical beneficial 
intervention (OR = 1.65) was simulated for scenarios with and without unmeasured confounders. 
For all three interventions, covariate adjustment and propensity score adjustment resulted in 
non-significant estimates of the effect (OR range 0.80-0.92), whereas the IV approach indicated 
that ICP monitoring was beneficial (OR per 10% change: 1.17; 95% CI 1.01-1.42). 
In our simulation study, we found that covariate adjustment and propensity score adjustment 
provided estimates in line with the simulated effect if all confounders were adjusted for (OR 
range: 1.37-1.67). However, the estimates became invalid in case of unmeasured confounders 
(OR range: 0.98-1.03). The IV approach provided an estimate with a similar direction as the 
simulated effect (OR per 10% change 1.04-1.05), but was statistically inefficient.
Conclusions: The effect estimation of interventions in observational TBI studies strongly 
depends on the analytical method used. When unobserved confounding and practice variation 
are expected, instrumental variable analysis should be considered to estimate effectiveness of 
interventions in large-scale observational multicenter studies.
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Introduction 
Randomized controlled trials (RCTs) are considered the cornerstone of evidence-based 
medicine. They are however not always feasible due financial, ethical and practical constraints.1 
Observational studies constitute the main alternative. A key challenge in observational studies 
is confounding by indication, referring to a situation where the indication is a confounder in the 
association between the intervention and outcome.2 As a consequence, patients exposed and 
not exposed to a particular intervention might not be exchangeable, hampering causal inference. 
The epidemiological and statistical literature describes several analytical methods to account for 
confounding, among which covariate- and propensity score adjustment are probably the most 
commonly applied. In covariate adjustment, measured confounders are added as independent 
variables to the analytical model. This results in a risk-adjusted effect estimate.3,4 In propensity 
score adjustment, the chance (‘propensity’) of being exposed to the intervention, based on 
measured patient characteristics, is added as a covariate to the model or used to match patients 
exposed and not exposed.4 Propensity score adjustment aims to balance factors influencing 
management decisions3,5,6 and is especially to be considered when there are few outcome 
events.4 These commonly applied methods however cannot adequately correct for unmeasured 
confounders. For example, a surgeon may decide to perform an operation because of his clinical 
intuition. Clinical intuition might be related to the patient’s prognosis but may not be adequately 
captured in the clinical data and thereby may leave residual confounding.2,7,8 A relatively new 
method to adjust for confounding is instrumental variable (IV) analysis. In IV, a substitute 
variable, ‘the instrument’ (e.g. hospital), is used as level of analysis. IV is becoming more 
popular in comparative effectiveness research (CER) and can theoretically adjust for unmeasured 
confounders.3,4,9 However, its validity depends on the degree to which the following three 
assumptions are met: The instrument should be strongly associated with the intervention under 
study (assumption 1), not related to the confounders (assumption 2) and not independently 
associated with the outcome under study (assumption 3).3,4,9
Clinical practice in patients with traumatic brain injury (TBI) is generally hypothesized to be prone 
to confounding by indication because treatment choice and outcome are highly dependent 
on injury severity. In addition, the combination of a low evidence-base and strong (cultural or 
eminence based) beliefs of best practice leads to large practice variation between hospitals.10 
This combination makes IV analysis of observational studies in TBI a promising approach. For the 
purpose of the current study, we selected three interventions that have shown to be effective 
according to best available evidence and expert consensus meetings, 11-15 with guidelines 
advocating these strategies,16-21 but also have shown extensive practice variation: ICP placement 
for ICP directed therapies versus serial clinical and radiological assessment,22 to operate or not in 
mass lesions,23 and primary versus secondary referral to specialized care.21
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The objective of the current study was to define the circumstances for the validity of methods 
to adjust for confounding by indication using three selected interventions in TBI patients and a 
simulation study.
Methods
Study populations and interventions
Three TBI datasets were used. The Prospective Observational Cohort Neurotrauma (POCON) 
dataset consists of 557 consecutive patients with moderate and severe TBI (Glasgow Coma Scale 
(GCS) score 3-13) from five level I trauma centers in the Netherlands between 2008-2009. Detailed 
information on data collection, procedures and patients has been described previously.24 From 
the POCON dataset, we extracted 266 patients with an indication for intracranial pressure (ICP) 
monitoring according to the 2007 Brain Trauma Foundation (BTF) guidelines;25 that is, patients 
with a GCS ≤ 8 and a Computed Tomography (CT) Marshall score ≥ 2, or patients with a GCS 
score ≤ 8, CT Marshall score < 2 and at least one of the following risk factors: 1) age > 40 years; 
2) hypotensive episode (SBP < 90 mmHg); and 3) motor score ≤ 3 (unilateral of bilateral motor 
posturing).
We further used the International Mission for Prognosis and Analysis of Clinical Trials (IMPACT) 
dataset, which consists of data from prospective studies and phase III trials in patients with 
moderate and severe TBI.26 The International and North American Tirilazad trial (86 hospitals 
between 1992 and 1994) was selected from the IMPACT dataset to estimate the effectiveness of 
intracranial operations (craniotomy or craniectomy). From the 2159 patients included in these 
trials, data of 677 patients with severe TBI, a mass lesion and a six-month outcome assessment 
were extracted. 
We additionally selected the European Brain Injury Consortium (EBIC) study (67 hospitals, 
in 1995) from the IMPACT dataset, which contains information on 822 patients. Referral and 
outcome were assessed in 782 patients, who were subsequently extracted. Detailed information 
on the IMPACT dataset has been comprehensively described in previous publications.26-28 
Data collection
Collected patient variables in all datasets included age, gender, GCS (motor) score, pupillary 
reactivity (both pupils reactive, one pupil reactive, no pupil reactivity), hypoxic episode (at 
injury scene or emergency department), hypotensive episode (at injury scene or emergency 
department), admission glucose level (mmol/L) and admission hemoglobin level (hb, g/L). In 
all datasets, the initial CT scan was assessed using the Marshall score,29 and the presence of 
traumatic subarachnoid hemorrhages (tSAH) and epidural hemorrhages (EDH) were scored. 
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To summarize patient characteristics, we calculated the probability of survival and favorable 
outcome (Glasgow Outcome Scale (GOS) score ≥ 4) for each patient based on the IMPACT 
laboratory model30 with all above-mentioned demographic and clinical factors as predictors. 
These prognostic scores reflect chances on respectively survival and favorable outcome based 
on baseline characteristics. 
Six-month outcome was assessed using the Glasgow Outcome Scale Extended (GOS-E) in the 
POCON dataset and the GOS in the EBIC and Tirilazad trial datasets. Both scales were collapsed 
into a four-point ordinal scale: 1= death or persistent vegetative state; 2 = severe disability; 
3 = moderate disability; 4 = good recovery. 
Statistical analyses 
Missing values in patient characteristics were imputed using single imputation. To assess 
differences in patient characteristics between patients exposed and not exposed to the 
interventions in the imputed datasets, we used Chi-Square tests for dichotomous and ordinal 
variables and non-parametric Mann-Whitney U tests for continuous variables since they all had 
a skewed distribution.
To examine the effectiveness of interventions, we used proportional odds logistic regression 
models with the 4-point ordinal GOS as outcome variable. A proportional odds model increases 
statistical power in comparison to a conventional logistic regression model with a binary 
outcome.31 The odds ratios (OR) derived from a proportional odds regression model could be 
interpreted as the average shift over the GOS caused by the intervention under study.31 
As a reference, we estimated unadjusted effects of the interventions with patient (exposed to the 
intervention yes / no) as the unit of analysis. To adjust for confounders, we performed covariate 
adjustment, propensity score adjustment and IV analysis. In the covariate-adjusted model, the 
variables from the IMPACT prognostic model30 (age, GCS motor score, pupillary reaction, hypoxia, 
hypotension, CT classification, tSAH, EDH, glucose and Hb) were added as independent variables. 
In a propensity score adjusted model, the propensity of being exposed to the intervention was 
computed using multivariable logistic regression with the intervention under study as dependent 
variable and all IMPACT variables as predictors. The linear predictor of the propensity score 
model was added as a covariate to the proportional odds regression models. We used fixed 
effect models for all the patient-level analyses. The ORs and 95% confidence intervals (CIs) were 
obtained from the models and the ORs indicated the odds of a more favorable outcome for 
patients who were exposed to the intervention compared to patients not exposed. 
For the IV analyses, we entered the percentage exposed to the intervention in each hospital 
(the instrument) as an independent variable to the analyses, together with a random intercept 
for hospital to correct for other between-hospital differences than the intervention under study 
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or between-hospital differences that existed by chance. All IMPACT prognostic variables were 
added as covariates to increase statistical power.32 To minimize the influence of chance, we only 
included hospitals with data on at least 20 patients in the IV analyses. The ORs were obtained 
from the models and the corresponding 95% CIs were calculated using bootstrapping with 500 
samples. The ORs indicated an odds of a more favorable outcome for a 10% increase in exposure 
to the intervention. Assumptions of the IV approach were checked by calculating the partial F 
statistic, in line with recommendations.33 In addition, we checked associations with measured 
confounders by calculating Spearman’s correlation coefficients between the instrumental 
variables and the prognostic scores of survival and favorable outcome. The third assumption 
(the instrumental variable is not independently associated with outcome) cannot be empirically 
verified, but is captured in the random effect model that we used. 
The proportional odds analyses were performed in R (version 3.1.2) using the ordinal package.34 
Other analyses were performed using the Statistical Package for the Social Sciences (SPSS) version 
21. A p-value < 0.05 was considered statistically significant.
Sensitivity analyses
As sensitivity analyses we explored alternative methods related to propensity score adjustment 
and IV. Propensity score matching was used to match patients who were exposed to the 
intervention to patients who were not exposed to the intervention with a maximum difference of 
0.10 between propensity scores. An advantage of propensity score matching is that patients with 
non-overlapping propensity scores are omitted from the analyses, increasing the comparability 
of those exposed and not exposed.3,5 This however may also result in a non-representative 
sample3 and a loss of statistical power.35 We further used inverse probability weighting (IPW) 
as an alternative propensity score method. In IPW, the outcome of patients exposed to the 
intervention is extrapolated to the non-exposed patients with similar propensity scores; i.e. for 
every patient exposed with a probability of 0.20, there are four patients with the same probability 
who were not exposed. The outcome of the exposed patient is subsequently extrapolated to all 
other four patients with the same propensity score.36 We used standardized weights in which we 
divided the unadjusted chance of receiving the intervention in the total study population by the 
propensity score.37 Since this still resulted in large standard errors, we winsorized our cohort by 
95%; i.e. patients below the 2.5th and above the 97.5th percentile received the scores belonging 
to the 2.5th and 97.5th quartile, respectively. 
As an alternative to the IV approach used in this study, we divided hospitals into two groups based 
on their preference for the intervention. The mean percentage exposed to each intervention was 
calculated and hospitals scoring above these means were classified as having a high preference, 
whereas hospitals scoring below the means were classified as having a low preference. 
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Since the percentage patients exposed to the intervention in each hospital can still be based on 
case-mix (e.g. in a hospital with more severely injured patients, the percentage patients receiving 
aggressive interventions might be higher) and could also exist by chance, we estimated a random 
intercept for hospital from a model predicting exposure to the intervention yes / no adjusted for 
the IMPACT variables. This random intercept for exposure represents the chance of receiving the 
intervention in a specific hospital corrected for case-mix and was subsequently used instead of 
the percentage exposed in the IV analyses. A disadvantage of this method is that the estimate 
obtained is hard to interpret and very uncertain due to the shrinkage of the between-hospital 
variation by the random effects model. 
Simulation study 
In empirical data, ‘true’ effects are never known and as a consequence, estimating the validity of 
analytical methods remains difficult. Therefore, we performed a simulation study in which a true 
treatment effect was simulated in the data. The simulation study was built around the POCON 
dataset, which was inflated to 133,000 patients from 20 hospitals. We simulated a hypothetical 
intervention with a beneficial effect of OR = 1.65. For the association between the hypothetical 
intervention and confounders, we used the observed associations between ICP monitoring and 
confounders in the POCON dataset. We used six-month survival (yes / no) as outcome variable, 
which was generated based on a combination of the prognostic effect of the confounders and 
the effect of the hypothetical intervention. 
We simulated four different scenarios and estimated the treatment effect using covariate 
adjustment, propensity score adjustment and IV analysis. In the first scenario, there were 
only measured confounders. We used motor score and pupillary reactivity as representing the 
measured confounders. In the second scenario, both measured and unmeasured characteristics 
comprised confounders. Marshall CT scores and the presence of a tSAH were used as unmeasured 
confounders. For both the first and second scenario, no between-hospital variation existed, which 
is comparable to a single-center study. The third and fourth scenarios were similar to the first and 
the second, but included between-hospital variation in how often the hypothetical intervention 
was performed. Since the observed variation of ICP monitoring among hospitals ranged from 17 
to 58%, every hospital received a random percentage within this range. The simulations were 
performed in R statistical software using the rms38 and lme439 packages.
Results
Patient characteristics 
In the POCON dataset, used for exploring the effects of ICP monitoring, patients who received 
an ICP monitor (n = 110) had a worse a priori prognosis than patients who did not receive an ICP 
monitor (n = 156; chance on survival 39% and 58% respectively, p = .03). Also, observed outcome 
was less favorable in patients who received an ICP monitor (p < .01). 
Adjusting for confounding by indication in observational studies in traumatic brain injury
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In the Tirilazad dataset, used for exploring the effects of intracranial surgery, patients who did (n = 
579) and did not (n = 98) receive an intracranial operation did not differ on baseline characteristics 
except for hypotension (14% vs. 21%, p = .05) and the presence of an EDH (31% vs 10%, p < .01), 
nor did the observed outcome differ (p = .22). 
In the EBIC dataset, used for exploring the effects of referral policy, patients who were primary 
referred (n = 334) had higher blood glucose levels (8.1 vs. 7.9 mmol/L, p = .01) and more often a 
tSAH (47% vs. 38%, p = .01) compared to patients who were secondary referred (n = 448). There 
were no other differences between groups (Table 1).
Covariate and propensity score adjustment
Univariable analyses showed that patients receiving an ICP monitor in the POCON dataset had 
a worse outcome than patients not receiving an ICP monitor (OR 0.51; 95%CI 0.32-0.81; Table 
2). For intracranial operation and primary referral, as analyzed in the Tirilazad and EBIC datasets 
respectively, no statistically significant differences between treated and non-treated patients 
were found. Adjusting the effect for demographic and clinical covariates or for the propensity 
score resulted in non-significant estimates below one for all three interventions (OR range 
0.80-0.92), indicating that exposure to the interventions might be associated with unfavorable 
outcome. 
Instrumental variable analysis
In the POCON dataset, the percentage of patients that received an ICP monitor ranged from 
17-58% between participating hospitals. All five hospitals included at least 20 patients (range 
37-51 patients). For intracranial operation, only seven hospitals from the Tirilazad dataset 
included more than 20 patients, encompassing 172 patients. The percentage of patients receiving 
an intracranial operation ranged from 67 to 100% between hospitals. For primary referral, 12 
hospitals from the EBIC dataset included more than 20 patients, reducing the sample size to 350 
patients. The percentage primary referrals ranged from 17 to 83% between hospitals. 
The instruments (percentage of patients exposed to the intervention in each hospital) were 
associated with the interventions under study (Partial F statistic 6.96 to 65,9, all p < .01). In 
addition, correlations between the instruments and confounders were small and generally 
non-significant (Online Supplement A). However, the percentage treated with an intracranial 
operation in each center in the Tirilazad dataset was significantly associated with the prognostic 
score on survival (r = .17, p = .03). 
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Using IV analysis, we found that patients treated in hospitals that performed 10% more ICP 
monitors had an 1.17 (95% CI 1.01-1.42; Table 2) higher odds on favorable outcome, compared 
to patients treated in hospitals where ICP monitoring was less often employed. For intracranial 
operation a 10% increase resulted in a higher odds of favorable outcome, but this was not 
statistically significant (OR 1.42, 95% CI 0.95-1.96). For primary referral, centers admitting more 
primary referred patients and less secondary referred patients had a worse outcome (OR: 0.91, 
95% CI 0.81-1.03), but this estimate was not statistically significant. More primary referrals and 
consequently less secondary referrals are indicative for less specialized neurocritical care, and 
therefore, an odds ratio below one was in line with expectations.
Table 2. Comparing analytical methods to adjust for confounding by indication in proportional odds 
logistic regression models with the Glasgow Outcome Scale as outcome
Approach POCON dataset ICP 
monitoring
OR (95% CI)
Tirilazad dataset 
Intracranial operation
OR (95% CI)
EBIC dataset Primary 
referral
OR (95% CI) 
Univariable model 0.51 (0.32-0.81) 1.04 (0.70-1.54) 0.85 (0.66 – 1.10)
Covariate adjustment* 0.91 (0.48-1.74) 0.92 (0.59-1.42) 0.85 (0.64 – 1.15)
Propensity score adjustment** 0.80 (0.66-0.96) 0.86 (0.57-1.28) 0.92 (1.28 – 0.65)
Hospital-level approach† 1.17 (1.01-1.42) 1.42 (0.95-1.97)ⱡ 0.91 (0.81 – 1.03)Ⱡ
*Model was adjusted for the following confounders: Age, GCS motor score, pupillary reaction, hypoxia, hypotension, CT classification, 
tSAH, EDH, glucose and hemoglobin
**A propensity score was calculated based on the following variables: Age, GCS motor score, pupillary reaction, hypoxia, hypotension, 
CT classification, tSAH, EDH, glucose and hemoglobin. The natural logarithm of the propensity score was added the analytic model.
†Per 10% change; Model was adjusted for the following confounders: Age, GCS motor score, pupillary reaction, hypoxia, hypotension, 
CT classification, tSAH, EDH, glucose and hemoglobin
ⱡAnalyses in 7 centers with a total of 172 patients
ⱠAnalyses in 12 centers with a total of 350 patients
Abbreviations: POCON = Prospective Observational Cohort Neurotrauma; EBIC = European Brain Injury Consortium
Sensitivity analyses
Propensity score matching and IPW resulted in similar effect estimates compared to covariate 
adjustment and propensity score adjustment (Online Supplement B). The alternative hospital-
level approaches resulted in effect estimates in the same direction as the instrumental variable 
analyses. Confidence intervals were however large, indicating an increase of statistically 
inefficiency. 
Simulation study
The univariable analyses resulted in ORs ranging from 0.69 to 1.02 for the four different scenarios 
(Table 3). In the scenarios where the associations between intervention and outcome were 
influenced by measured confounders only (scenario 1 and 3), covariate- and propensity score 
adjustment resulted in ORs in the range of 1.37-1.67, broadly in line with the simulated effect 
(OR = 1.65). However, in the scenarios where unmeasured confounders also influenced the 
association between intervention and outcome (scenario 2 and 4), the adjusted ORs were all 
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non-significant and close to the point of no effect (OR range 0.98-1.03), implying no difference in 
outcome among patients exposed and not exposed to the hypothetical intervention. IV analysis 
resulted in a positive and statistically significant effect (OR 1.04-1.05 per 10% change), indicating 
that patients admitted to hospitals that more often performed the hypothetical intervention had 
better odds on survival than patients admitted to hospitals where the intervention was less often 
performed. The standard errors of the hospital-level analyses (SE = 0.07) were however far larger 
than the standard errors in the patient-level analyses (SE 0.01), indicating a substantial reduction 
in statistical efficiency. A summary of findings about validity and efficiency of analytical methods 
is presented in Table 4.
Table 3. Comparing analytical methods to adjust for confounding by indication in a simulation study 
with 6-month survival as binary outcome 
Approach Scenario 1*  
OR (95% CI)
Scenario 2*  
OR (95% CI)
Scenario 3*  
OR (95% CI)
Scenario 4*  
OR (95% CI)
Univariable model 1.02 (1.00-1.04) 0.69 (0.68-0.71) 0.96 (0.93-0.98) 0.72 (0.70-0.74)
Covariate adjustment 1.67 (1.63-1.71) 0.99 (0.97-1.02) 1.52 (1.47-1.56) 1.03 (1.00-1.06)
Propensity score adjustment 1.52 (1.48-1.55) 0.98 (0.98-1.01) 1.37 (1.34-1.41) 1.00 (0.97-1.03)
Hospital-level approach† NA NA 1.05 (1.04-1.07) 1.04 (1.02-1.05)
*Scenario 1 = observed confounders, no hospital variation; Scenario 2 = observed and unobserved confounders, no hospital variation; 
scenario 3 = observed confounders, hospital variation (17-58%), scenario 4 = observed and unobserved confounders, hospital variation 
(17-58%)
†Per 10% change
Table 4. Characteristics of analytical methods to adjust for confounding by indication based on our 
simulation- and validation study
Approach Adjustment 
for measured 
confounders 
Adjustment for 
unmeasured 
confounders
Statistical 
efficiency
Relying on strong 
assumptions
Interpretation
Univariable model - - + - +
Covariate adjustment + - +/- ⱡ - +
Propensity score 
adjustment
+ - + - +
Instrumental variable 
analysis
+ +* - + -
ⱡ Statistical efficiency depends on the number of covariates and the number of patients with the outcome of interest (‘events’). 
*In theory, instrumental variable analysis can correct for unmeasured confounders.
Discussion
We compared analytical methods to adjust for confounding by indication in observational studies 
using three empirical case studies and a simulation study. The estimated effects strongly depended 
on the analytical method applied. As expected, the presence of unmeasured confounders, makes 
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covariate and propensity score adjustment invalid. Instrumental variable (IV) analysis, although 
statistically inefficient and relying on strong assumptions, may then provide more valid estimates 
of the effectiveness of interventions.
Covariate and propensity score adjustment
Covariate and propensity score adjustment are commonly used in observational studies. We 
found that these methods could provide an unbiased estimate of the effect of the intervention, 
on the condition that all relevant confounders are measured and adjusted for. Covariate and 
propensity score adjustment cannot adjust for unmeasured confounders.2,3,7,8,35 In our simulation 
study, for example, the beneficial interventions appeared non-effective when analyzed with 
covariate or propensity score adjustment, due to residual confounding by indication. 
Instrumental variable analysis
IV analysis resulted in better estimates of the effect of interventions in our simulation study; the 
direction of the effect was congruent with the simulated effect. In our empirical case studies, the 
directions of effects were in line with how patients should be treated according to guidelines for 
TBI16-20 and best available evidence.11,20,21,40
IV analysis is becoming more popular in TBI research. Several recently published TBI studies 
analysed effectiveness at the hospital level41-44 and a large European CER study is planning to 
use hospital-level analysis to assess effectiveness of many TBI interventions.45 Previous studies 
typically divided hospitals into groups (e.g. tertiles41 or quartiles42) based on the percentage 
of patients treated. The percentage treated in each hospital can also be used as a continuous 
variable, which increases statistical power. 
Nevertheless, IV analysis also has limitations that warrant comment. First, IV analysis is 
statistically inefficient compared to conventional analytical methods. Since the analyses are 
performed at the level of the hospital, the effective sample size decreases. As a consequence, 
a large number of centers and patients and substantial variability in exposure to interventions 
across centers are needed to obtain statistically significant results in case of a true beneficial 
effect. The conduct of IV analysis might therefore be relatively expensive and resource-intensive. 
Second, the interpretation of the OR differs from the conventional analyses. Rather than providing 
information on the effect size of interventions in individual patients, IV provides information on 
whether patients’ outcome will improve when hospitals change their policy with respect to a 
specific intervention.3,5 The issue of interpretation is prominent for primary referral. Although 
primary referral on the patient-level might be associated with more specialized neurocritical 
care, at the hospital-level a larger number of secondary referrals are indicative for relatively more 
specialized neurocritical care. Therefore, for primary referral, a negative association between 
the instrument ‘percentage primary referrals’ and outcome was expected, which was indeed 
found in the EBIC data. Third, the success of IV analysis depends on whether the underlying 
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assumptions are met.5,46,47 Thus, IV analysis might not always be defendable. For example, we 
found that for intracranial operation, the instrument was statistically significantly associated 
with patient-level confounders and therefore, the second assumption was violated. Between-
hospital variation, caused by other variables than those in the model, could theoretically be 
captured by the random effect model. Nevertheless, when correlations are strong (e.g. centers 
that often perform a particular intervention are all from the same geographic region that differs 
from other regions in many aspects), the statistical model will be unable to separate the effect 
of the intervention from the effect of the confounder. In these situations, one should consider 
other analytical methods or conclude that it is not possible to analyze the effectiveness of the 
particular intervention in the dataset.
Strengths and limitations
A major strength of our study is that we included both empirical case studies and a simulation. 
The TBI examples show how the various analytical methods worked with actual patient data 
and demonstrated the influence of analytical method on effect estimate. The simulation study 
subsequently provided insight into the underlying mechanisms and thereby indicated which 
methods provided valid estimates of the treatment effect in different situations. A limitation of 
our simulation study is that we only examined four scenarios while there are many more possible 
interactions between treatment and confounders that might be of interest. A second limitation 
is that we used the observed range from one dataset (POCON), whereas the actual range 
might differ. Future simulation studies could address alternative scenarios and should further 
investigate how statistical power can be optimized when using IV analysis. Another limitation of 
the simulation study is that we included two variables as presenting the measured confounders 
and two variables as presenting the unmeasured confounders. As a consequence, the predictive 
value of our predictors is relatively modest which may have resulted in unstable estimates. 
Our case studies also have several limitations. The data is relatively outdated (data was collected 
between 1992 and 2009) and analyzed post-hoc. Therefore, the current study cannot be used 
to draw conclusions about the effectiveness of interventions. In addition, each intervention was 
measured in only one dataset while it would be more interesting to demonstrate the different 
analytical methods for each intervention over different datasets. This was not possible in our 
study since not all interventions were measured in all three datasets. Furthermore, specific 
concerns exist in the data with regard to the three interventions. An ICP monitor is a diagnostic 
procedure and cannot influence outcome on itself, while it can cause complications. The actual 
comparison is between ICP driven therapies versus clinical/radiological driven therapies. With 
regard to the variable intracranial operation, the clinical applicability is unclear since the exposure 
and intervention in these data are not defined specifically (What kind of mass lesions? What 
intracranial operation?). More granular information on these interventions was unavailable 
inherent to the post-hoc setup. A final limitation is that all three datasets were relatively modest 
in terms of number of hospitals and number of patients. The POCON dataset had only five 
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hospitals, while the Tirilazad and EBIC datasets had only seven and 12 hospitals that included 
at least 20 patients, respectively. Therefore, differences among hospitals might also exist by 
chance, e.g. if a hospital included only 20 patients, these patients might not be representative 
for the general policy in the particular hospital. Therefore, we recommend future studies using 
IV analyses in TBI to include a larger number of hospitals and a large number of patients in 
each hospital. In addition, since the ‘percentage treated’ in each hospital is based on data of 
the included patients, it might still be subject to confounding by indication. We indeed found 
that the instrument ‘percentage patients treated with intracranial operation’ was associated 
with the patient-level confounders. Alternatively, policies with regard to an intervention might 
be identified by (former) registry data or by an independent survey study completed by all the 
participating hospitals. Such an approach will be used in an ongoing TBI study.45 
Conclusion
Effect estimates of interventions in observational studies strongly depend on the analytical method 
used. Covariate- and propensity score adjustment could easily result in an invalid estimate due 
to confounding by indication. Instrumental variable analysis may provide a more valid estimate, 
but is statistically inefficient and its validity depends on whether underlying assumptions are 
met. When unobserved confounding and practice variation are expected, IV analysis should be 
considered to estimate effectiveness of interventions in large-scale observational multicenter 
studies.
Supplemental material is available at www.marysecnossen.nl
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The aim of this thesis was to study outcome and opportunities for comparative effectiveness 
research (CER) in patients with traumatic brain injury (TBI) from a methodological perspective. 
This chapter describes the main findings of this thesis and highlights some important 
methodological considerations. The chapter ends with recommendations for research, policy, 
and clinical practice.
Part I – MAIN FINDINGS
Outcome following traumatic brain injury
Prevalence
We found substantial variation in prevalence rates for both post-concussion symptoms and 
psychiatric disorders. Prevalence rates may depend on timing and patient population, but were 
also largely influenced by diagnostic criteria and analysis strategy. Using the definition of three 
or more self-endorsed symptoms (any severity) from the ICD-10, approximately half of the mild 
TBI (mTBI) patients could be ‘diagnosed’ with post-concussion symptoms six months post-injury 
(Chapter 2, 3, 6, 7). Anxiety and major depressive disorder following TBI (all severities) were 
diagnosed during the first year post-injury in 21% and 17% of the patients, respectively (Chapter 
4). Although these percentages were significantly higher than population base rates, they 
do not vary substantially from pre-injury prevalence rates (13-19%). Pooled prevalence rates 
for psychiatric disorders appeared to increase over time, with prevalence rates of more than 
40% in studies using relatively long follow-up periods (3-10 years; Chapter 4). With regard to 
health-related quality of life (HRQoL), one year following mild and moderate TBI, the majority of 
patients scored in the upper levels (Chapter 8). Scores on the domain vitality, however, remained 
suboptimal, in line with the finding that fatigue was one of the most prevalent post-concussion 
symptoms (Chapter 2, 3, 7). 
Predictors
The etiology of post-concussion symptoms following mTBI is complex and multidimensional and 
may include biological factors (e.g. diffuse axonal injury, repetitive TBI), psychological factors (e.g. 
pre-injury psychiatric disorders), social factors (e.g. social support) and personality factors (e.g. 
coping). In addition, post-concussion symptoms might be more often endorsed among females, 
those with a lower education, those reporting neck pain at the emergency department and 
those involved in litigation and compensation procedures. A large proportion of those reporting 
persistent post-concussion symptoms (e.g. after six months) already experienced symptoms in 
the first weeks post-injury (Chapter 2, 7). Psychiatric disorders following TBI were associated with 
pre-injury psychiatric disorders, TBI severity (moderate TBI vs. severe TBI), brain volume, post-
injury unemployment, early post-injury psychiatric symptoms and a memory of the traumatic 
event (Chapter 5). These results should however be interpreted with caution since predictors 
were predominately assessed in underpowered studies using univariable analyses. 
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Prediction models for post-concussion symptoms
A prediction model based on age, sex, years of education, pre-injury migraine and headache, 
pre-injury psychiatric disorders, prior TBI, posttraumatic amnesia (PTA) and loss of consciousness 
(LOC) explained 21% of the variance in six-month post-concussion symptoms, which decreased 
to 14% after bootstrap validation (Chapter 6). This model performed poorly at external validation 
(Chapter 7). A new model based on sex, subjective complaints at the emergency department 
and early post-injury post-concussion symptoms and posttraumatic stress performed reasonably 
(Area Under the Curve (AUC) 0.77; AUC after bootstrap validation: 0.75; Chapter 7). 
Comparative effectiveness research in traumatic brain injury
Variation in structures and processes of care 
To assess variation in structures and processes of care, we developed a set of questionnaires ‘The 
provider profiling questionnaires’ in the context of the Collaborative European NeuroTrauma 
Effectiveness Research in TBI (CENTER-TBI) study, a large observational cohort study in 68 
European neurotrauma centers (see Chapter 1 and Chapter 10 for more information). We found 
considerable variation in structures and processes of TBI care across Europe. Although the large 
majority of centers were academic hospitals, designated level I trauma centers from urban areas 
with a research interest in TBI, there were major differences in organization of care, facilities 
and treatment policies (Chapter 10). In addition, computed tomography (CT) scan policy, ward 
admission, discharge policy, intracranial pressure (ICP) management, in-hospital rehabilitation 
and referral to rehabilitation institutes varied considerably (Chapter 11-13). The wide variation 
found in the provider profiling questionnaires was in line with an observational cohort study 
where we found large between-center variation in treatment decisions, even after correction 
for case-mix (Chapter 14). The existing treatment variation provides an opportunity to study 
treatment effectiveness with CER. 
Guideline adherence
Although, the majority of European neurotrauma centers indicated to use TBI guidelines (Chapter 
11, 12), guideline adherence for most interventions was low and ranged from 18% to 100% in 
a systematic review (Chapter 9). In addition, some European neurotrauma centers claimed to 
have a treatment policy that systematically diverges from guideline recommendations (Chapter 
11, 12). For example, one-fifth of European neurotrauma centers claimed to use barbiturates 
as first tier therapy in the treatment of intracranial hypertension, while barbiturates are only 
recommended as second tier treatment.1
Analytical methods for observational CER studies
Estimates of treatment effects in observational CER studies are strongly dependent on the 
analytical method used. Covariate- and propensity score adjustment are by definition unable 
to correct for unobserved confounders and may therefore result in an invalid estimate of the 
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treatment effect (Chapter 15, 16). Instrumental variable analysis, using the percentage of 
patients exposed to an intervention in each hospital as substitute variable, may provide a more 
valid estimate. However, this method is statistically quite inefficient, relies on strong assumptions 
and is difficult to interpret. In addition, substantial between-center variation in the treatment of 
interest is required to make this approach feasible. 
Part II – INTERPRETATION
Outcome following traumatic brain injury
Definitions and measurement 
Although mild TBI (mTBI) is usually defined by a Glasgow Coma Scale (GCS) score 13-15 (Chapter 
2), almost 40% of the European neurotrauma centers participating in the CENTER-TBI study 
indicated to use more restrictive criteria (GCS 14-15; Chapter 11). This may result in differences 
in prevalence rates and may also influence the importance of predictors. For example, clinical 
variables and CT abnormalities might be predictive of mTBI outcome in patients with GCS scores 
13 and 14, but not in those scoring in the upper level (GCS score 15).2 
In addition, there seems to be variation in the measurement of patient characteristics across 
different studies. For example, in Chapter 6, the presence of a prior TBI and pre-injury psychiatric 
disorders were based on self-report without a threshold for severity, resulting in rates of 54% and 
32%, respectively. In Chapter 7, however, more stringent criteria were applied for prior TBI and 
pre-injury psychiatric disorders, resulting in rates of 3% and 10%, respectively. Therefore, it is not 
surprising that the model developed in Chapter 6 performed poorly in the external validation 
study in Chapter 7.
Improvements in consensus on definitions of mTBI and standardization of data collection are 
necessary to compare different studies examining prevalence and predictors of mTBI sequelae. 
This could be accomplished by studies adhering to data collection standards provided by the 
common data elements (CDE)3,4 that were recently tested in the Transforming Research and 
Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Pilot study.5
Role of misattribution
In Chapter 3, 6 and 7, we found that at six months post-injury a substantial proportion (39-53%) 
of mTBI patients reported three or more post-concussion symptoms of any severity. This high 
prevalence was in line with previous studies using similar criteria.6,7 However, it can be debated 
whether patients ‘diagnosed’ with post-concussion symptoms in these studies truly reflect a 
subgroup with clinically significant symptomatology necessitating follow-up and treatment. It is 
known that post-concussion symptoms are also reported in non-brain injured trauma patients8,9 
and in healthy adults.10 Consequently, a part of the patients ‘diagnosed’ with post-concussion 
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symptoms in this thesis likely consists of patients experiencing benign, everyday symptoms that 
were misattributed as being related to the sustained TBI.
 
To prevent potential misattribution, in Chapter 7 patients had to rate symptoms for both their 
current and pre-injury situation. Symptoms were only included if they deteriorated in comparison 
to the pre-injury level. It is nevertheless unlikely that such a strategy circumvents the problem of 
misattribution since patients might be tempted to report fewer pre-injury symptoms; referred 
to as the ‘good-old-day’ bias.11-13 Misattribution could be prevented by using comprehensive 
multidisciplinary assessment and clinical evaluation of symptoms (Chapter 2). There are however 
no standards available on how and when this should be accomplished. 
Next to misattribution of benign, everyday symptoms, it is also possible that psychiatric disorders 
following TBI are misattributed as being related to TBI. For example, in Chapter 4 we observed 
a trend towards a higher prevalence of psychiatric disorders over time. Late onset of psychiatric 
disorders is relatively common14,15 and can be explained by ongoing stressors and problems 
experienced by TBI patients or because insight into social, cognitive and emotional disability 
might develop after physical recovery. However, it cannot be excluded that the onset of mental 
health problems years after TBI is related to independent stressors rather than to the sustained 
TBI and its consequences. 
We further found a high pre-injury prevalence of psychiatric disorders and a strong association 
between pre- and post-injury disorders. Since recurrence of psychiatric disorders is common (up 
to 85%),16 the causal role of TBI for the development of psychiatric disorders becomes uncertain. 
Since many studies only record if there is a psychiatric history and not when the patient suffered 
from psychiatric disorders, it cannot be excluded that some patients already had a psychiatric 
disorder during the injury, which continued over the follow-up period. Since psychiatric disorders 
are associated with an enhanced risk of sustaining a TBI,17-19 the proportion of TBI patients 
with an existing psychiatric disorder might be relatively pronounced, increasing the post-injury 
prevalence rates. 
It should nevertheless be noted that there is a subgroup of patients who develops novel 
psychiatric disorders following TBI. It might be particularly interesting to study which pre-injury, 
peri-injury, clinical, social and personality factors contribute to the onset of a psychiatric disorder 
following TBI in previously healthy adults. 
Research setting
The research setting should be taken into account when analyzing prevalence rates and 
determining the relevance of predictors for outcome following TBI. Many studies about mTBI 
recruit patients seeking care at the emergency department. These patients are usually relatively 
severely injured, and have a higher incidence of LOC and intracranial hemorrhages. The outcome 
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of these patients might therefore not be comparable to outcome of patients sustaining sport-
concussion or patients seeking medical care at the general practitioner. 
Some studies included in the systematic reviews in Chapter 4 and 5 recruited patients from 
rehabilitation institutes and patients who self-enrolled. These patients might also diverge 
substantially from those recruited at the emergency department since they likely comprise a 
subgroup of patients experiencing sequelae, causing their rehabilitation needs or their interest 
in a TBI outcome study. 
Notwithstanding, patients included in studies using similar inclusion criteria and settings are not 
necessarily comparable, since there are large between-country and between-center differences 
in admission and referral policies (Chapter 11). In addition, case-mix variation among hospitals can 
be substantial (Chapter 14), which may drastically influence outcome. Therefore, study-specific 
inclusion criteria and case-mix of included patients should always be described comprehensively 
and taken into account when comparing prevalence rates and predictors of sequelae following 
TBI.
Attrition
Studies in mTBI generally have high attrition rates. In Chapter 6-8, outcome after six and twelve 
months was assessed in only 50-58% of the patients. This may imply selection bias, which could 
have important implications for the interpretation of both prevalence rates and predictors. 
Therefore, minimizing attrition should be a key objective in future prognostic studies and can 
potentially be accomplished by ongoing contacts with participants,20 incentives for participation,21 
sending postcard and telephone reminders,21 and using telephone interviews21 or home visits.22 
Overlap between post-concussion symptoms and psychiatric disorders
In this thesis, we either focused on post-concussion symptoms or on psychiatric disorders, 
whereas there is substantial overlap in symptoms; i.e. the post-concussion symptoms depressed 
mood, sleep disturbances, concentration problems, irritability, memory problems and fatigue 
are also symptoms of depression and posttraumatic stress disorder (PTSD; Figure. 1). Therefore, 
PTSD and depression should always be considered as differential diagnoses. In addition, it should 
be examined whether post-concussion syndrome (PCS) is a unique clinical syndrome or that 
post-concussion symptoms might be better interpreted as (prodromal) symptoms of psychiatric 
disorders.9 The validity of PCS as a clinical diagnosis has been debated for decades,23 and to 
prevent ongoing controversies, the following two research projects are recommended:
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Figure 1. Overlap in symptoms of PTSD (DSM-5), MDD (DSM-5) and PCS (Rivermead post-concussion 
questionnaire)
PTSD  
PCS  
MDD  
* Depressed mood  
* Sleep disturbances  
* Concentra!on  
 problems  
* Decreased  
interest in  
ac!vi!es 
* Feelings of  
worthlessness  
and guilt 
* Irritability 
* Memory problems 
* Fa!gue 
• Weight loss / gain 
• Increase / decrease in appe!te 
• Psychomotor agita!on / retarda!on 
• Indecisiveness 
• Recurrent thoughts of death  
• Avoidance of trauma related  
       s!muli  
• Feeling isolated  
• Risky behavior 
• Hypervigilance  
• Heightened startle response  
• Headache 
• Dizziness 
• Nausea or vomi!ng  
• Noise sensi!vity 
• Feeling frustrated or impa!ent 
• Taking longer to think 
• Blurred vision 
• Light sensi!vity 
• Double vision 
• Restlessness 
Abbreviations: MDD = major depressive disorder; PCS = post-concussion symptoms; PTSD = posttraumatic stress disorder
• A qualitative study in which patients reporting post-concussion symptoms on the Rivermead 
Post-concussion questionnaire (RPQ) from a larger cohort study are invited for an interview. 
During this interview, the endorsed post-concussion symptoms can be assessed in-depth, for 
example by investigating how distressing the symptoms are, whether the symptoms influence 
daily life, how often the patient experiences the symptoms and whether the patient has 
treatment needs. In addition, a structured diagnostic interview can be used to assess the 
presence of a psychiatric disorder and to determine whether the reported post-concussion 
symptoms can be better explained by the psychiatric disorder. Such a study provides insight 
into the clinical relevance of post-concussion symptoms, treatment needs and overlap 
between psychiatric disorders and post-concussion symptoms.
• A prospective cohort study with a comprehensive outcome battery including post-concussion 
symptoms, psychiatric disorders and other relevant outcome measurements such as HRQoL, 
return to work and clinical outcome (e.g. Glasgow Outcome Scale Extended (GOSE). The 
association between post-concussion symptoms (using different cut-off points) and the other 
relevant outcome measurements (HRQoL, return to work, GOSE) can be assessed, controlled 
for psychiatric disorders. This study could provide insight into the overlap between post-
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concussion symptoms and psychiatric disorders and the clinical relevance of post-concussion 
symptoms
Measuring outcome following TBI
In this thesis, we used clinical outcome, post-concussion symptoms, psychiatric disorders and 
HRQoL to assess outcome following TBI. All these outcome measurements have their strengths 
and limitations. Clinical outcome (e.g. measured with the GOSE) might be relatively objective 
but may not be sensitive in an mTBI population. Post-concussion symptoms might be common 
and distressing and are relatively easy to assess, but the diagnosis of PCS is controversial and 
there is lack of consensus on definitions and analysis strategy. Psychiatric disorders can be validly 
assessed but the causal role of TBI is difficult to ascertain due to high pre-injury rates. HRQoL 
might provide valuable information on recovery from a patient’s perspective, but caution should 
be taken when using the physical and mental summary scores from the SF-36, since the two-
factor structure has not been convincingly confirmed in patients with TBI (Chapter 8). 
Given these strengths and limitations, multidimensional outcome assessment, including clinical 
outcome (GOSE), post-concussion symptoms (RPQ), psychiatric disorders (structured clinical 
interview for DSM-5 (SCID-5) and HRQoL (SF-36, Quality of life after brain injury (QOLIBRI) is 
highly recommended in studies on outcome following TBI. In addition, tests of neuropsychological 
functioning (e.g. Rey auditory verbal learning test, trail making test, Wechsler adult intelligence 
scale) should be used to measure impaired cognitive functions. Rather than using a large outcome 
battery, novel psychometric applications such as item response theory, in which the outcome 
assessment can be tailored to the severity of symptoms experienced by the patient, might be 
useful in capturing the full range of mTBI outcome while minimizing the response burden.24
For psychiatric disorders, there is generally consensus that the presence or absence of psychiatric 
disorders should be assessed by clinical examination, a structured diagnostic interview (e.g. the 
SCID-5), or both. Structured diagnostic interviews have shown to be reliable in a TBI population 
with interrater reliability ranging from 80 to 100% (Chapter 4). The use of structured diagnostic 
interviews in TBI outcome studies is however relatively expensive and labor-intense. As a 
consequence, many studies using structured diagnostic interviews have small sample sizes 
(Chapter 4, 5). However, since the prevalence of psychiatric disorders during the first year 
post-injury is approximately 20% (Chapter 4), a large sample size is necessary to reliably assess 
the effect of predictors for psychiatric disorders. For example, if 10 candidate predictors are 
considered, at least 100 patients with psychiatric disorders are needed to prevent statistical 
overfitting. A prognostic study with 100 patients with a psychiatric disorder, and thus 500 patients 
in total (prevalence 20%) using structured diagnostic interviews might not be feasible. Hence, 
many researchers may face the dilemma of either using a valid outcome measurement in a small 
sample or using self-reported questionnaires in a larger sample. This dilemma might be partially 
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solved by data sharing (e.g. combining smaller studies using structured diagnostic interviews) or 
meta-analyses of published studies (Chapter 5), when measurements are comparable. 
Predicting post-concussion symptoms and psychiatric disorders
Despite a considerable number of publications on prognostic factors, currently no model can validly 
predict TBI sequelae in terms of post-concussion symptoms and psychiatric disorders.8,25,26 It has 
been repeatedly reported that the predictive value of clinical factors, including CT abnormalities, 
GCS and pupillary reactivity is limited in mTBI patients.11,25 Outcome following mTBI seems to 
be more determined by “what the patient brings to the injury” than by “what the injury brings 
to the patient”. Among the factors that a patient can bring to the injury, socio-demographics, 
pre-injury psychiatric disorders, prior TBI and early symptoms have been repeatedly tested and 
comprise consistent predictors of mTBI sequelae. In addition, it has recently been shown that 
coping may predict poor outcome following mTBI.27 Other patient-related factors including the 
appraisal of the trauma, emotional and behavioral response during the trauma, attributions of 
the traumatic event, social support and personality factors have been widely described,11,28,29 
but have not been examined in prospective studies with sufficient statistical power yet. The 
relevance of these factors are however in line with psychological theories, such as the cognitive 
model for PTSD by Ehlers and Clark,30 Seligman’s learned helplessness theory of depression,31 
and Iverson’s conceptual model of the post-concussion syndrome,11 and should be the target of 
future prognostic studies. 
To increase our knowledge on relevant predictors for TBI sequelae it is also important that 
prediction-modeling studies use solid methodology26,32-36 and are replicated. In Chapter 5, 
however, we found that a total of 171 predictors for psychiatric disorders were studied in the 
literature, among which only 24 (14%) were examined by at least two studies using comparable 
measurements. Similarly, there is no external validation study for prediction models of psychiatric 
disorders following TBI yet and we were the first to externally validate existing models for post-
concussion symptoms (Chapter 7). 
MTBI sequelae are complex and the strongest predictors (symptoms after two weeks) are 
impractical to include in a prediction model. Hence, it can be debated whether prediction modeling 
is the most valid, economic and practical way to identify risk-prone patients. Alternatively, post-
concussion symptoms could be tracked with a mobile phone or web application during the first 
months post-injury. If a patient scores above a certain cut-off point (e.g. three or more symptoms), 
the symptom-track application could recommend the patient to visit the general practitioner. 
General practitioners can subsequently be trained to assess post-concussion symptoms, exclude 
or confirm concomitant diseases, reassure and inform the patient and refer to specialized 
treatment if necessary. The feasibility of such an approach and the comparative effectiveness 
of tracking patients versus predicting risk-prone patients should be the target of future studies.
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Comparative effectiveness research in traumatic brain injury
Provider profiling
Provider profiling aims to profile structural and process characteristics of centers participating in 
a multicenter study. It provides information on treatment variation and potential relevant topics 
for CER analyses. We showed that a sound development process and regular contacts between 
local investigators and a researcher, resulted in a reliable questionnaire (concordance rate: 0.85) 
with a completion rate of 96 to 100%. Although provider profiling is highly recommended for 
future multicenter studies, it might be preferable to develop a shorter questionnaire focused 
on a subset of pre-specified research questions. In addition, to obtain additional insight into 
reliability of responses and within-center variation, it can be recommended to ask multiple 
clinicians in each center to complete the questionnaire.
Another recommendation for future provider profiling studies is to add vignettes of hypothetical 
patients to the questionnaire. In vignettes, multiple treatment interventions that are used 
simultaneously can be assessed. In addition, responses to vignettes are not influenced by 
differences in case-mix among centers. For the provider profiling questionnaires, however, the 
influence of case-mix cannot be excluded. For example, if some centers receive more severely 
injured patients than other centers (e.g. level I vs. level II/III trauma center), they might routinely 
use more aggressive treatment interventions. Therefore, case-mix should be taken into account 
when interpreting the results of the provider profiling questionnaires.
Treatment variation and guideline adherence 
We found considerable variation in treatment and adherence to TBI guidelines. Guideline 
adherence was dependent on the invasiveness of the intervention (more adherence to less 
invasive interventions) and patient-related factors (age and TBI severity). Moreover, guideline 
adherence was associated with quality of the evidence underpinning the recommendations, 
with higher adherence to higher-quality guideline recommendations (Chapter 9). Consequently, 
to improve guideline adherence and reduce practice variation, there is an urgent need for 
high-quality evidence regarding treatment effectiveness in TBI. Observational CER studies 
might provide a promising framework to enhance our knowledge and to support guideline 
recommendations. 
Comparative effectiveness research
Although observational CER studies are promising in enhancing our knowledge on treatment 
effectiveness, we found that the effect estimate obtained in such studies was largely dependent 
on the analytical method used (Chapter 16). Analytical methods can broadly be divided into 
patient-level approaches (e.g. covariate adjustment) and hospital-level approaches (e.g. 
instrumental variable analysis). Patient-level approaches are recommended in situations where 
patients exposed and not exposed to the intervention of interest are expected to be reasonably 
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exchangeable on both observed and unobserved characteristics. For example, when patients 
admitted during the night with certain indications routinely receive a particular treatment while 
patients admitted during the day with similar indications do not receive this treatment, and 
differences between patients admitted during day and night can be measured and controlled for.
For many interventions, however, patients exposed and not exposed are not expected to be 
exchangeable; i.e. they may differ on various factors of which some cannot be measured and 
adjusted for (e.g. factors related to clinical intuition). These factors may subsequently confound 
the association between intervention and outcome, resulting in an invalid estimate of the 
treatment effect. For instance in panel 1, it cannot be excluded that clinicians more often provide 
written discharge information to patients with a high risk of post-concussion symptoms than to 
patients with a lower risk, based on their clinical intuition. In such a situation, a hospital-level 
approach could be considered. 
Panel 1. Example of a CER research question
Research question Does written discharge information, compared to oral discharge information and no information, 
prevent the development of post-concussion symptoms six months after sustaining mild TBI?
Rationale Persistent post-concussion symptoms are debilitating and may interfere with quality of life and 
functioning. Early information and reassurance may prevent the development of post-concussion 
symptoms, although findings from RCTs are inconclusive (Al Sayegh, 2010). 
Patients Mild TBI patients, GCS 13-15, referred home after emergency department admission. Exclude 
patients that received systematic follow-up visit by GP or specialist practitioner since it is uncertain 
if these professionals provided oral and written information
Interventions Provision of written discharge information on TBI, its possible late consequences and where to 
consult in case of difficulties
Controls Provision of oral information on TBI, its possible late consequences and where to consult in case of 
difficulties 
No discharge information provided
Outcome Primary outcome: 6-month Rivermead Post-Concussion Questionnaire (linear scale)
Secondary outcomes: Return to work / school / activities, functional outcome (GOSE), Health 
Related Quality of Life (SF-36, QOLIBRI), depression and posttraumatic stress (PCL-5 and PHQ-9)
The hospital-level approach is based on instrumental variable (IV) analysis. In IV, a substitute 
variable (‘the instrument’) is used as independent variable in the analyses with patient outcome 
as dependent variable. In multicenter observational CER studies, ‘treatment preference’ could be 
used as instrument and four different definitions can be considered (Table 1). 
IV analysis can theoretically adjust for unobserved confounders.38,39 The method however has 
several limitations warranting comment. First, IV analysis relies on strong assumptions, which are 
often violated.38,40 Some assumptions (e.g. there is no association between the instrument and 
other factors influencing outcome) can be captured by using a random effect model (Chapter 14, 
16), which is therefore recommended in multicenter observational CER studies. Nevertheless, 
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when correlations between the instrument and a confounding variable are strong, the statistical 
model might not be able to separate the effect of treatment from the effect of the confounder. 
Another limitation of multicenter observational CER studies is that they are relatively expensive 
and resource intensive since a large number of centers and a large number of participants in each 
center are necessary to obtain sufficient statistical power (Chapter 16) Lastly, the interpretation 
of CER studies using IV analysis might diverge from RCTs and traditional analytical methods for 
observational studies. Rather than estimating effectiveness of a particular intervention on the 
patient-level, CER provides information on how a change in hospital policy would affect patient 
outcomes. Caution is needed when interpreting these estimates since they might be counter-
intuitive. For example, in Chapter 16 we estimated the effectiveness of primary transfer to 
specialized neurocritical care. When we assume that neurocritical care is effective, we would 
expect a positive association between primary referral and favorable outcome on the patient 
level, but a negative association when using the percentage primary referred as an instrument; 
i.e. centers receiving predominately primary referrals are usually less specialized than centers 
also receiving secondary referrals. 
Notwithstanding, all methods for causal inference in observational data have strengths and 
limitations and are based on underlying assumptions. Therefore, we agree with Greenland41 that 
none of the methodologies should be regarded as ‘correct’ or ‘absolute’ and that data should be 
analyzed from multiple perspectives instead. For future observational CER studies, this implies 
that all statistical techniques that are reasonable for the research question of interest should be 
reported.
Researchers should determine, based on pre-specified criteria (e.g. are patients treated and not 
treated expected to be exchangeable? Is there between-center variation in treatment and case-
mix?), which analytical methods are expected to provide a valid estimate of the treatment effect 
and clinical meaningful differences in effect estimates using these different analytical methods 
should be interpreted. In addition, if ethical, practical and financial feasible, high-quality, 
pragmatic RCTs are recommended to confirm the results of observational CER studies. 
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Table 1. Different definitions of preference-based instruments in multicenter observational CER studies 
Instrument Operationalization Case-mix 
adjustment
Statistical 
efficiency
Interpretation
Instruments 
based on 
actual patient 
data from the 
observational 
study
Observed 
percentage  
treated
For each hospital, the number of patients 
treated divided by the total number of 
patients with a treatment indication is 
calculated and used as an independent 
variable in the analyses
No - -
Adjusted observed 
percentage  
treated
The random intercept for treatment, 
adjusted for case-mix is used as an 
independent variable in the analyses
Yes - - - -
Instruments 
based on other 
sources of 
information
Treatment 
preference 
according to 
provider profiling
Whether centers indicated to generally 
perform a certain treatment (1) or not (0) 
is used as an independent variable in the 
analyses 
No - - -
Treatment 
preference 
according to 
vignettes
Whether centers indicated to perform a 
certain treatment in hypothetical patients 
(1) or not (0) is used as an independent 
variable in the analyses 
Yes - - -
Living systematic reviews 
Systematic reviews aim to summarize and weight evidence and could directly inform clinicians 
and guideline developers on effectiveness of interventions. Systematic reviews are however often 
outdated42 and therefore may not present the current state-of-the-knowledge for a particular 
topic. Living systematic reviews (LSRs) have been proposed as a possible solution.43,44 Chapter 9 
presents the first LSR in TBI. With the publication of this LSR we showed that LSRs are feasible. In 
addition, the results of the LSR highlight the necessity of regular updates; in less than three years, 
13 additional studies were included, comprising 37% of the total evidence base and significantly 
changing the review conclusion. For example, two additional studies measuring the association 
between guideline adherence and outcome were included that did not report a statistically 
significant association.45,46 One of these used hospital-level analyses and was therefore judged 
as having a relatively low risk of confounding. As a consequence, the original conclusion that 
guideline adherence results in better patient outcomes became more uncertain. 
The future of LSRs might nevertheless depend on its organization and may also necessitate a 
change in research culture. The LSR in Chapter 9 was written in the context of the CENTER-TBI 
project.47 Consequently, review authors were invited to participate in review courses, an expert 
panel was constituted, arrangements with a medical journal on the publication of updates were 
arranged and review authors were reminded regularly to conduct a new update. All these steps 
might be necessary for the success of LSRs and should therefore be continued. Rather than 
including these tasks in a work package of individual research projects, it might be preferable to 
constitute one organization (e.g. the Cochrane group) warranting quality and updates of LSRs in 
medicine. 
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Next, the conduct of LSRs may necessitate a change in research culture. At this moment, 
scientific researchers are rewarded by the number of publications and their citation records.48 
LSRs however do not result in multiple publications, and therefore it might be discouraging for 
researchers to get involved in conducting LSRs. A multidimensional incentive system such as 
the ‘productivity, quality, reproducibility, sharing and translating potential (PQRST)’ developed 
by Ioannidis and Khoury49 might be promising in shifting the focus from number of publications 
towards clinical relevance.
PART III – RECOMMENDATIONS
Based on the content of this thesis and its interpretation, we formulated specific recommendations 
for research, policy and clinical practice that are summarized below. 
Recommendations for research
Research on outcome following TBI 
• Standardize the definition for mild TBI
• Standardize data collection practices (e.g. by following the recommendations of the CDE3,4)
• Include multidimensional outcome assessment, including the GOSE, SCID-5, RPQ, SF-36, 
QOLIBRI and neuropsychological tests
• Clearly describe research setting, inclusion criteria and case-mix 
• Prevent attrition in prognostic studies
• In case a patient reports a pre-injury psychiatric disorder, examine if and when the patient 
has recovered 
• Study overlap between post-concussion symptoms and psychiatric disorders and study 
whether post-concussion symptoms are unique and clinically relevant and which cut-off 
point on the RPQ is the most valid 
• Study whether a mobile phone application to track symptoms following mTBI is feasible
• Examine the etiology of psychiatric disorders following TBI in patients without a history of 
psychiatric disorders
• Perform confirmatory factor analysis with a large sample of TBI patients to confirm the SF-36 
two-factor structure
Research on prognostic models for mTBI outcome
• Consider predictors that are in line with psychological theories and focus on factors “that the 
patient brings to the injury”
• Prioritize replication of prediction modeling studies and external validation of prediction 
models, rather than testing new predictors and new models
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• Use methodology in line with recommendations (e.g. prevent statistical overfitting by using 
an adequate sample size and a limited number of candidate predictors, use internal and 
external validation)
• Study the comparative effectiveness of tracking mild TBI patients versus predicting mild TBI 
patients at high risk for persistent post-concussion symptoms 
Research on treatment effectiveness
• Use provider profiling in multicenter studies and consider the addition of vignettes
• Explore the use of large-scale multicenter CER studies to generate evidence on treatment 
effectiveness in TBI
• Consider instrumental variable analysis if patients exposed and not exposed to an intervention 
are not expected to be exchangeable 
• Use a random effect model in hospital-level analyses 
• Do not consider one particular analytical method as the most appropriate for the research 
question but report the results of all analytical methods that are considered reasonable for 
the research question of interest 
• Summarize state-of-the-knowledge for each treatment intervention in LSRs
Recommendations for policy 
• Inform the public about the potential consequences of mTBI
• Provide funding for research on studies about mTBI outcome. 
• Provide funding for large-scale observational CER studies examining treatment effectiveness 
of interventions with large between-center variation
• Obligate reporting the results of all analytical methods that are considered reasonable in 
research proposals of observational studies
• Constitute an institution (e.g. Cochrane group) that could warrant the quality of LSRs in 
medicine
• Enable a change in research culture that values LSRs
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Recommendations for clinical practice
• Inform and reassure mTBI patients about the potential sequelae 
• Examine post-concussion symptoms and psychiatric disorders during follow-up of patients 
with TBI
• Use multidimensional comprehensive assessment of post-concussion symptoms rather than 
symptom checklists
• If available, consult LSRs as a source of evidence for treatment interventions 
General discussion
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Part IV: OVERALL CONCLUSION
This thesis aimed to examine outcome and opportunities for CER in TBI from a methodological 
perspective. We first examined the prevalence and predictors of TBI sequelae. Prevalence rates 
appeared to vary widely and depended on pre-injury factors, patient population, assessment, 
analysis strategy and diagnostic criteria used. The etiology of TBI sequelae is complex and 
multifactorial and includes biological, psychological and social factors that might be difficult to 
capture in a prediction model. When studying prevalence and predictors of psychiatric disorders 
and post-concussion symptoms following TBI, the role of misattribution, research setting, 
selection bias and the overlap in symptomatology between post-concussion symptoms and 
psychiatric disorders should be taken into account. 
Our second aim was to assess to what extent CER could contribute to evidence generation in 
TBI. Current evidence underpinning TBI guidelines is weak, and consequently, there is large 
variation in policy and guideline adherence among neurotrauma centers. This variation provides 
an opportunity for CER. However, the effect estimate obtained in observational CER studies may 
depend on the analytical method used. Since all analytical methods have their strengths and 
limitations and are based on untestable assumptions, it is important that researchers do not 
consider one particular analytical method as the most appropriate. Instead, different analytical 
methods that are reasonable for the research question of interest should be used as sensitivity 
analyses. To confirm the results of observational CER studies, high-quality pragmatic RCTs are 
recommended.
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Introduction
Traumatic brain injury (TBI) is one of the leading causes of death and disability worldwide. In 
Europe, approximately 75,000 patients die each year as a consequence of TBI and many more 
patients are challenged with a range of disabilities and symptoms as a consequence of TBI that 
may drastically reduce functioning and quality of life. Although TBI has emerged as an important 
topic in medical research, research endeavors have not yet resulted in major advances in our 
understanding of TBI, nor in an improvement of patient outcomes.
Research in TBI is hampered by the heterogeneity of the patient population, the lack of 
standardized outcome instruments and the fact that secondary insults and complications are 
common and may interact with the effects of a possibly beneficial treatment. More specific 
problems in prognostic studies are that they often include too many predictors and do not use 
internal or external validation approaches. As a consequence, the evidence derived from many 
TBI studies is modest.
In this thesis we focused on two important topics in TBI research. In part I, we focused on 
outcome following TBI, including the prevalence and predictors of psychiatric disorders and 
post-concussion symptoms. In part II, we examined whether comparative effectiveness could 
contribute to evidence generation in TBI, with a focus on current guideline adherence, treatment 
variation and analytical methods. For both purposes, we followed a methodological perspective. 
The aims of this thesis were operationalized in the following two main research questions:
1. What is the prevalence and what are predictors of outcome following TBI? 
a. What is the prevalence of TBI outcome in terms of persistent post-concussion symptoms, 
psychiatric disorders and HRQoL? 
b. What are predictors of TBI outcome? 
c. Can we identify patients at greatest risk for suffering post-concussion symptoms? 
2. To what extent can CER contribute to evidence generation in TBI?
a. To what extent do clinicians adhere to current evidence from guidelines? 
b. To what extent does variation in structure and process characteristics exist among centers 
treating patients with TBI? 
c. What is the influence of analytical methods on the estimate of treatment effectiveness 
in observational studies? And which method may provide a valid estimate in case of 
confounding by indication? 
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PART I: Outcome following traumatic brain injury
In Chapter 2 we summarized the literature on post-concussion symptoms with a focus on 
definitions, epidemiology, etiology, clinical assessment and treatment. Although post-concussion 
symptoms were frequently reported following mild TBI, it is uncertain whether they represent 
a clinically relevant syndrome (the post-concussion syndrome). Prevalence of post-concussion 
symptoms varied and depended on pre-injury characteristics, patient population, assessment, 
analysis strategy, and diagnostic criteria. The etiology of post-concussion symptoms is likely 
multifactorial and complex and may include biological factors (e.g. diffuse axonal injury, repetitive 
TBI), psychological factors (e.g. pre-injury psychiatric disorders), social factors (e.g. social 
support) and personality factors (e.g. coping). In addition, post-concussion symptoms are often 
reported among patients involved in litigation and compensation procedures. Comprehensive 
multidisciplinary assessment of post-concussion symptoms using standardized instruments is 
recommended to improve early identification of post-concussion symptoms. 
In Chapter 3 we compared different classification methods for post-concussion symptoms 
in a prospective cohort study of 731 mild TBI patients from the Netherlands. Post-concussion 
symptoms were assessed with the Rivermead Post-Concussion Questionnaire (RPQ) using the 
following analysis strategies: The RPQ mapped to the ICD-10/DSM-IV criteria, the RPQ total score, 
the RPQ-3 and the RPQ three-factor model. These divergent definitions resulted in prevalence 
rates of six-month post-concussion symptoms ranging from 11% to 39%. We additionally 
found that the effect of predictors varied for the different definitions, e.g. the predictors injury 
severity score, abbreviated injury score of the head, comorbidities and hospital admission were 
significantly associated with PCS using some of the classification methods for PCS but not when 
using others.
In Chapter 4 and 5 we systematically reviewed the literature on prevalence and predictors of 
psychiatric disorders following TBI. In both reviews we focused on studies using structured 
diagnostic interviews for psychiatric disorders. In Chapter 4, a total of 34 studies were included. 
Prevalence rates of psychiatric disorders varied widely. Pooled estimates for anxiety and 
depressive disorders were 19% and 13% pre-injury and 21% and 17% in the first year post-
injury. Pooled prevalence rates appeared to increase over time, with more than 40% of the 
patients diagnosed with a psychiatric disorders after 3-10 years. In Chapter 5, 26 studies were 
included. Major depressive disorder following TBI was associated with female gender, pre-injury 
depression, TBI severity (moderate TBI vs. severe TBI), early post-injury psychiatric symptoms, 
post-injury unemployment and a lower brain volume, whereas posttraumatic stress disorder 
(PTSD) was related to shorter posttraumatic amnesia, memory of the traumatic event and early 
post-traumatic symptoms. The results of this review should however be interpreted with caution 
since predictors were predominately assessed in underpowered studies using univariable 
analyses.
385
 
In Chapter 6 and 7 we focused on prediction modeling following mild TBI. In Chapter 6, we 
used variables available at the emergency department (ED) to predict six-month post-concussion 
symptoms, using the RPQ linear scale in a prospective cohort study in the United States. A 
total of 277 mild TBI patients were included. A prediction model based on age, gender, years 
of education, pre-injury migraine and headache, pre-injury psychiatric disorders, prior TBI, 
posttraumatic amnesia and loss of consciousness explained 21% of the variance in outcome, 
which decreased to 14% after bootstrap validation. In Chapter 7, the model developed in 
Chapter 6 was externally validated in 591 mild TBI patients participating in a prospective cohort 
study in the Netherlands. The model, as well as another existing prediction model, performed 
poorly in external validation (Area Under the Curve (AUC): 0.57-0.64). A new model, based on 
female sex, symptoms at the ED (neck pain, headache, nausea or vomiting) and two-week post-
concussion symptoms and posttraumatic stress symptoms, performed reasonably (AUC: 0.77; 
AUC after bootstrap validation: 0.75).
In Chapter 8, we compared health-related quality of life (HRQoL) of Dutch and Chinese patients 
with mild and moderate TBI one year post-injury. For this purpose, we used a prospective cohort 
study from the Netherlands (447 patients) and a retrospective cohort study from Zhuhai, China 
(173 patients). There were differences among Dutch and Chinese patients on the dimensions 
general health, physical functioning, bodily pain and role limitations due to emotional problems. 
Scores on vitality were suboptimal for both patient groups. Using confirmatory factor analysis, 
we found that the vitality subscale was strongly associated with the mental health component 
and not with the physical component.
PART II: Comparative effectiveness research in traumatic brain injury
In Chapter 9, we systematically reviewed the literature on TBI guideline adherence. We included 
22 studies describing adherence to 13 guideline recommendations. Guideline adherence varied 
considerably between studies (range 18-100%) and was dependent on the invasiveness of the 
intervention, patient-related factors (age and TBI severity) and the quality of the evidence 
underpinning the guideline recommendation. Guideline adherence seemed to be associated 
with lower mortality. The systematic review was published as a living systematic review, meaning 
that updates are published when new information becomes available. The most recent update 
from June 2017 (2 years and 8 months after the initial search) revealed a total of 13 new studies 
(37% of the total evidence base). In the more recent studies, guideline adherence to intracranial 
pressure (ICP) monitoring guidelines was higher but the association between guideline adherence 
and clinical outcome became more uncertain. 
In Chapter 10-13, we presented the results of the provider profiling studies, which are part of 
the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) study, a 
large observational cohort study among 68 European neurotrauma centers. In Chapter 10, we 
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introduced the provider profiling questionnaires and reported variation in general structural 
and process characteristics. We found that the majority of participating centers were academic 
hospitals, level I trauma centers and situated in an urban location. However, the availability of 
facilities for neurotrauma care and general processes of care varied considerably. 
In Chapter 11, we describe the emergency department and hospital admission management 
across Europe. There were large differences in the definition of mild TBI across centers. In 
addition, many different guidelines were used to determine whether a patient should receive 
a computed tomography (CT) scan. Routine follow-up after ED admission was only scheduled in 
10% of the centers. Written discharge information was routinely provided in approximately half 
of the centers. 
In Chapter 12 we described monitoring and treatment policies for intracranial hypertension. 
Although the majority of centers indicated to place an ICP monitor in patients with severe TBI and 
CT abnormalities, there was no consensus on other indications or on peri-insertion precautions. 
We additionally found wide variation in the use of first- and second-tier treatments for elevated 
intracranial pressure. Approximately half of the centers were classified as having a relatively 
aggressive approach to ICP monitoring and treatment, whereas the other half was relatively 
conservative. Although the majority of participants indicated to follow TBI guidelines, the 
reported policy at the ED, hospital ward and the intensive care unit (ICU) diverged substantially 
from what is stated in the guidelines. For example, one-fifth of European neurotrauma centers 
claimed to use barbiturates as first tier therapy, while barbiturates are only recommended as 
second tier therapy. 
In Chapter 13, we examined rehabilitation policies for patients with severe TBI. An in-hospital 
multidisciplinary rehabilitation team was available in 41% of the ICUs and 49% of the wards. 
Coma stimulation was available in half of the centers and another half of the centers had an 
in-hospital rehabilitation unit. Age was reported as a major determinant of referral decisions in 
half of the centers, with younger patients usually referred to specialized rehabilitation centers, 
and patients ≥ 65 years also referred to nursing homes or local hospitals 
In Chapter 14, we performed a secondary analysis of prospectively collected data from five level 
I trauma centers in the Netherlands to examine causes and consequences of treatment variation. 
We included 503 patients and found that patient characteristics explained 12-52% of the 
variation in treatment. Treatment varied substantially among centers, even after adjustment for 
case-mix. We found that outcome was more favorable in patients treated in centers maintaining 
an aggressive approach towards ICP monitoring than in centers maintaining a less aggressive 
approach. 
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The wide variation in structure and processes of care for TBI patients found in Chapters 10-14 
provides an opportunity to study treatment effectiveness with comparative effectiveness research 
(CER). The analytical method chosen for CER analyses may however drastically influence the 
effect estimate of the treatment, which is explained in Chapter 15 and 16. Covariate adjustment 
and propensity score adjustment cannot adjust for unmeasured confounders, and therefore, 
may result in an invalid estimate of the treatment effect. Instrumental variable analysis can 
theoretically adjust for unmeasured confounders but is statistically inefficient, dependent on 
strong assumptions and difficult to interpret. 
Discussion
The aim of this thesis was to study outcome and opportunities for CER in patients with traumatic 
brain injury. We found that prevalence rates of post-concussion symptoms and psychiatric 
disorders varied widely and were dependent on pre-injury factors, patient population, 
assessment, analysis strategy and the diagnostic criteria used. Etiology of TBI sequelae is 
complex and multifactorial and includes biological, psychological and social factors that might be 
difficult to capture in a prediction model. When studying prevalence and predictors of psychiatric 
disorders and post-concussion symptoms following TBI, the role of misattribution, research 
setting, attrition and the overlap in symptomatology between post-concussion symptoms and 
psychiatric disorders should be taken into account. 
Current evidence underpinning TBI guidelines is weak, and consequently, there is large variation 
in policy and guideline adherence among neurotrauma centers. This variation provides an 
opportunity for CER. However, the effect estimate obtained in observational CER studies largely 
depends on the analytical method used. Since all analytical methods have their strengths and 
limitations and are based on untestable assumptions, it is important that researchers do not 
consider one particular analytical method as the most appropriate. Different analytical methods 
that are reasonable for the research question under study should be used as sensitivity analyses 
and the results of observational CER studies should be confirmed by high-quality RCTs. 
Based on the content of this thesis and its interpretation, we formulated specific recommendations 
for research, policy and clinical practice, including standardization of definitions for mild TBI and 
data collection practices and the prevention of attrition in prognostic studies. In addition, we 
recommend studying overlap between post-concussion symptoms and psychiatric disorders 
and examining whether a symptom track application is feasible to identify mTBI patients with 
prolonged sequelae. For research on treatment effectiveness, we recommend the use of provider 
profiling and comparative effectiveness research. Research findings on treatment effectiveness 
should subsequently be summarized into living systematic reviews. For clinical practice, we 
recommend to inform and reassure mTBI patients about the potential sequelae and to use 
multidimensional comprehensive assessment of post-concussion symptoms.  
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Introductie
‘Een dronken student loopt na een avond stappen tegen een deur aan. Ondanks dat zij niet direct 
klachten ervaart en zich alles kan herinneren heeft zij de eerste weken na het ‘ongeluk’ last van 
hoofdpijn, concentratieproblemen en vermoeidheid.’
‘Een fanatieke hockeyster botst tijdens een wedstrijd tegen haar tegenspeelster aan. Zij raakt 
bewusteloos en moet op de spoedeisende hulp worden behandeld aan een hoofdwond. Zij kan 
zich niks meer herinneren van het ongeval en heeft nog maanden last van zware hoofdpijn, 
duizeligheid, misselijkheid en prikkelbaarheid.’
‘Een automobilist raakt de macht over het stuur kwijt en rijdt tegen een boom aan. Naast een 
aantal botbreuken en kneuzingen heeft de klap op zijn hoofd geresulteerd in meerdere kleine 
bloedingen in de hersenen. Na langdurige behandeling op de intensive care volgen nog maanden 
van revalidatie. Na een jaar kan hij weer redelijk zelfstandig functioneren maar is hij als gevolg 
van concentratieproblemen, geheugenverlies en vermoeidheid niet meer in staat om zijn baan als 
docent weer op te pakken.’
Bovengenoemde drie patiënten hebben één ding gemeen: zij hebben allen een vorm van 
traumatisch hersenletsel doorgemaakt. Traumatisch hersenletsel is een vorm van niet-aangeboren 
hersenletsel waarbij een externe oorzaak, zoals een klap tegen het hoofd, resulteert in een 
verandering van de hersenfunctie. Traumatisch hersenletsel wordt vaak gecategoriseerd in licht 
(casus 1), matig-ernstig (casus 2) en ernstig (casus 3). Met name ernstig traumatisch hersenletsel 
is een van de belangrijke doodsoorzaken wereldwijd en vormt daarmee een groot probleem 
voor de volksgezondheid. Patiënten die een ernstig traumatisch hersenletsel overleefd hebben 
kunnen nog langdurige gevolgen ondervinden in het dagelijks leven (zie casus 3). Maar ook na 
een lichte vorm van traumatisch hersenletsel, ook wel hersenschudding genoemd (zie casus 1), 
zijn er patiënten die maanden, en soms jaren na het ongeval nog klachten ervaren. Deze klachten 
betreffen vaak cognitieve klachten (geheugenproblemen, concentratieproblemen), somatische 
klachten (hoofdpijn, duizeligheid) en emotionele klachten (rusteloosheid, depressie) en kunnen 
worden samengevat onder de term ‘postcommotionele symptomen’. Naast postcommotionele 
symptomen, ontwikkelt een deel van de patiënten psychiatrische stoornissen. Met name 
posttraumatische stressstoornis (PTSS) en depressie komen relatief vaak voor. 
Het is tot op heden onbekend waarom sommige patiënten na (licht) traumatisch hersenletsel 
klachten en psychiatrische stoornissen ontwikkelen en anderen binnen weken of maanden weer 
volledig herstellen. Voorgaande onderzoeken naar voorspellende factoren (‘predictoren’) hebben 
verschillende beperkingen, waardoor momenteel weinig bekend is over welke factoren wel en 
niet samenhangen met een hogere kans op langdurige klachten en psychiatrische stoornissen. In 
veel studies zijn de onderzoeksresultaten samengevat in een predictiemodel. Een predictiemodel 
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is een wiskundige formule op basis van verschillende factoren die in theorie gebruikt kan worden 
om de kans op langdurige klachten in te schatten bij patiënten met traumatisch hersenletsel. Een 
dergelijke risicoschatting kan gebruikt worden om artsen, patiënten en naasten te informeren 
over de prognose en om keuzes te maken omtrent de behandeling. Er zijn nog geen gevalideerde 
modellen die de uitkomst na licht traumatisch hersenletsel voorspellen, noch zijn er gevalideerde 
modellen voor psychiatrische stoornissen na licht, matig-ernstig en ernstig traumatisch 
hersenletsel. 
Een ander belangrijk en actueel onderwerp binnen het onderzoeksveld van traumatisch 
hersenletsel is het meten van de effectiviteit van behandelingen. Gerandomiseerd onderzoek met 
een controlegroep wordt hiervoor gezien als de ‘gouden standaard’. In gerandomiseerd onderzoek 
worden patiënten random toegewezen aan een behandelconditie en een controleconditie. Het 
verschil in uitkomst tussen behandelde en onbehandelde patiënten kan hierdoor met voldoende 
zekerheid worden toegeschreven aan de behandeling. Gerandomiseerde studies zijn echter niet 
altijd mogelijk om praktische, ethische en financiële redenen. Daarnaast hebben zij tot op heden 
niet geresulteerd in een verbetering van de zorg voor patiënten met traumatisch hersenletsel. 
Observationele studies vormen een alternatief voor gerandomiseerde studies. In observationele 
studies worden patiënten met traumatisch hersenletsel gevolgd en worden klinische gegevens 
en behandelinformatie genoteerd. De effectiviteit van behandeling kan in deze studies worden 
onderzocht door patiënten die een bepaalde behandeling hebben gekregen te vergelijken met 
patiënten die de behandeling niet hebben gekregen. Een probleem hierbij is echter dat deze 
patiënten niet altijd vergelijkbaar zijn. Of een patiënt wel of geen behandeling krijgt hangt in 
observationele studies namelijk af van allerlei factoren, zoals leeftijd en conditie van de patiënt, 
ernst van het letsel en de klinische intuïtie van de arts. Hierdoor is het onduidelijk of een verschil 
in uitkomst tussen behandelde en onbehandelde patiënten toe te schrijven is aan de behandeling 
of veroorzaakt wordt door andere factoren. Met sommige factoren, zoals bijvoorbeeld leeftijd, 
kan rekening gehouden worden in statistische analyses. Niet alle verschillen tussen patiënten 
kunnen echter gemeten worden, waardoor het onduidelijk blijft of een verschil in uitkomst 
tussen behandelde en onbehandelde patiënten veroorzaakt wordt door de behandeling of door 
andere factoren.
Een relatief nieuwe manier om met dit probleem om te gaan, is om de effectiviteit niet op patiënt-
niveau maar op ziekenhuisniveau te analyseren. Deze methode kan worden gebruikt binnen de 
zogenoemde vergelijkende effectiviteitsstudies. Dit zijn vaak grootschalige internationale studies 
waar meerdere ziekenhuizen aan meewerken. Door uitkomsten van patiënten in ziekenhuizen 
die een bepaalde behandeling vaak uitvoeren te vergelijken met uitkomsten van patiënten in 
ziekenhuizen die de behandeling weinig uitvoeren, kunnen we een schatting krijgen van de 
effectiviteit van deze behandeling. Een voorwaarde hiervoor is echter dat er voldoende variatie 
is tussen ziekenhuizen in hoe vaak de behandeling wordt toegepast. 
393
 
Onderzoeksvragen
Dit proefschrift heeft als doel om onze kennis te verdiepen met betrekking tot uitkomsten na 
traumatisch hersenletsel. Daarnaast hebben we mogelijkheden onderzocht voor vergelijkend 
effectiviteitsonderzoek. Deze doelen zijn geoperationaliseerd in de volgende hoofd- en 
deelvragen: 
1. Wat is de prevalentie van en wat zijn predictoren voor uitkomst na traumatisch hersenletsel?
a. Wat is de prevalentie van postcommotionele symptomen, psychiatrische stoornissen en 
een verminderde kwaliteit van leven?
b. Wat zijn predictoren voor uitkomst na traumatisch hersenletsel?
c. Kunnen we patiënten met het een hoog risico op postcommotionele symptomen 
identificeren? 
2. In welke mate kan vergelijkend effectiviteitsonderzoek bijdragen aan kennis over behandel-
effectiviteit bij traumatisch hersenletsel?
a. In welke mate houden clinici zich aan de huidige richtlijnen voor traumatisch hersenletsel?
b. In welke mate is er variatie tussen ziekenhuizen in de behandeling van patiënten met 
traumatisch hersenletsel?
c. Wat is de invloed van analytische methoden op de schatting van behandeleffectiviteit in 
observationele studies? En welke methode resulteert in een valide schatting?
Dit proefschrift is geschreven in het kader van de ‘Collaborative European NeuroTrauma 
Effectiveness Research in TBI (CENTER-TBI) study: een grootschalige observationele studie naar 
traumatisch hersenletsel studie in 68 Europese ziekenhuizen. 
Deel I: Uitkomst na traumatisch hersenletsel
In hoofdstuk 2 hebben we de huidige literatuur met betrekking tot postcommotionele symptomen 
samengevat. We hebben hierbij gekeken naar definities, epidemiologie, etiologie, diagnostische 
instrumenten en behandeling. Alhoewel postcommotionele symptomen vaak werden genoemd 
na licht traumatisch hersenletsel, is het tot op heden onduidelijk of deze symptomen een klinisch 
relevant syndroom vormen. De prevalentie van postcommotionele symptomen varieerde sterk 
en was afhankelijk van de patiëntpopulatie, de diagnostische criteria en de analyse strategie. 
De etiologie van postcommotionele symptomen is complex en multifactorieel en bestaat onder 
andere uit biologische factoren (onder andere diffuse axonale beschadigingen), psychologische 
factoren (onder andere positieve psychiatrische voorgeschiedenis), sociale factoren (onder 
andere sociale steun) en persoonlijkheidsfactoren (onder andere coping). Uitgebreide 
diagnostiek en het gebruik van gestandaardiseerde meetinstrumenten is sterk aanbevolen om 
postcommotionele symptomen vroeg te identificeren.
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In hoofdstuk 3 van dit proefschrift hebben we verschillende analysestrategieën voor post-
commotionele symptomen vergeleken bij 731 patiënten met licht traumatisch hersenletsel. 
Alhoewel postcommotionele symptomen vaak met een vragenlijst in kaart worden gebracht 
(bijvoorbeeld de Rivermead Post-Concussion Questionnaire, RPQ), is er geen consensus bereikt 
over hoe deze vragenlijst geanalyseerd dient te worden. Verschillende analysestrategieën 
kunnen echter tot verschillende prevalenties leiden waardoor het moeilijk is om onderzoeken 
met elkaar te vergelijken. De verschillende analysestrategieën in deze studie resulteerden in 
prevalenties in de range 11-39% Daarnaast bleek dat sommige predictoren voorspellend waren 
voor postcommotionele symptomen geanalyseerd met de ene analysestrategie maar niet met 
de andere. Uit deze studie blijkt dat het belangrijk is om de analysestrategie voor de RPQ te 
standaardiseren, zodat toekomstig wetenschappelijk onderzoek beter met elkaar vergeleken kan 
worden.
In hoofdstuk 4 en 5 hebben we door middel van literatuurstudies gekeken naar de prevalentie en 
predictoren van psychiatrische stoornissen na traumatisch hersenletsel. In hoofdstuk 4 hebben 
we 34 observationele studies geïncludeerd. De prevalenties voor angst en depressie waren 
19% en 13% vóór het ongeval en 21% en 17% gedurende het eerste jaar na het ongeval. De 
prevalentie leek toe te nemen met de tijd: drie tot tien jaar na het ongeval werden meer dan 40% 
van de patiënten gediagnosticeerd met een psychiatrische stoornis. In hoofdstuk 5 hebben we 
26 observationele studies geïncludeerd waarbij we naar predictoren hebben gekeken. Depressie 
na traumatisch hersenletsel kwam vaker voor bij vrouwen, bij patiënten met een psychiatrische 
stoornis in de voorgeschiedenis, bij patiënten met een matig-ernstig traumatisch hersenletsel, bij 
patiënten die vlak na het ongeluk psychische klachten hadden of werkloos waren en bij patiënten 
met een kleiner hersenvolume. PTSS na traumatisch hersenletsel kwam vaker voor bij patiënten 
die zich het ongeval konden herinneren, korter geheugenverlies hadden en patiënten die al 
vroeg na het ongeval stress symptomen rapporteerden.
In hoofdstuk 6 en 7 analyseerden we predictiemodellen voor uitkomst na licht traumatisch 
hersenletsel. In hoofdstuk 6 gebruikten we variabelen beschikbaar op de spoedeisende hulp 
om te voorspellen welke patiënten een grotere kans hebben op postcommotionele symptomen 
na zes maanden. Hiervoor hebben we gebruik gemaakt van een observationele studie uit de 
Verenigde Staten met 277 patiënten. Een predictiemodel gebaseerd op de variabelen leeftijd, 
geslacht, opleiding, psychiatrische voorgeschiedenis, een eerder traumatisch hersenletsel, 
geheugenverlies na het ongeval en bewustzijnsverlies na het ongeval voorspelde 14% van de 
variatie in postcommotionele symptomen. In hoofdstuk 7 hebben we dit model getest in een 
groep van 591 Nederlandse patiënten. Het model bleek slecht te functioneren. De ‘area under the 
curve (AUC)’ was 0.57, wat betekent dat het model nauwelijks beter was in het voorspellen van 
postcommotionele symptomen dan het opgooien van een munt (AUC = 0.50). Een nieuw model, 
gebaseerd op geslacht, het ervaren van klachten op de spoedeisende hulp (nekpijn, hoofdpijn, 
misselijkheid en overgeven) en symptomen na twee weken (postcommotionele symptomen en 
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stresssymptomen) was redelijk in staat om postcommotionele symptomen na zes maanden te 
voorspellen (AUC = 0.75).
In hoofdstuk 8 hebben we onderzoek gedaan naar kwaliteit van leven bij patiënten met licht en 
matig-ernstig traumatisch hersenletsel uit Nederland (447 patiënten) en China (173 patiënten). 
Nederlandse en Chinese patiënten scoorden verschillend op de dimensies algemene gezondheid, 
fysiek functioneren, pijn en rolbeperkingen door emotionele problemen. Beide populaties 
scoorden slecht op de dimensie vitaliteit, wat inhoudt dat zij een jaar na het ongeval nog 
symptomen van vermoeidheid en futloosheid hadden.
Deel II: vergelijkend effectiviteitsonderzoek bij traumatisch 
hersenletsel
In hoofdstuk 9 hebben we middels een literatuurstudie onderzocht in welke mate clinici zich aan 
de huidige richtlijnen voor traumatisch hersenletsel houden. We hebben hiervoor 22 studies 
geïncludeerd. Bij 18% tot 100% van de patiënten werden richtlijnen adequaat opgevolgd. 
Adherentie was geassocieerd met patiëntfactoren (leeftijd en ernst van het hersenletsel), de 
kwaliteit van de richtlijn en de invasiviteit van de behandeling. Patiënten die behandeld werden 
volgens de richtlijnen hadden een betere uitkomst dan patiënten die niet behandeld werden 
volgens de richtlijnen. Aangezien literatuurstudies vaak niet meer actueel zijn als ze gepubliceerd 
worden, hebben we er voor gekozen om de review regelmatig te updaten. Dit wordt ook wel 
een ‘living systematic review’ genoemd. Hoofdstuk 9 is de eerste ‘living systematic review’ 
wereldwijd. De meest recente update (Juni 2017) liet zien dat er in nog geen drie jaar na de 
originele zoekstrategie 13 nieuwe studies geïncludeerd waren, welke bijna 40% van het totaal 
aantal studies representeerden. Het toevoegen van deze 13 studies resulteerde tevens in een 
aantal aanpassingen in de conclusies en laat daarmee het belang zien van het updaten van 
literatuurstudies.
In hoofdstuk 10-13 presenteerden we de resultaten van de ‘provider profiling’ vragenlijst: een 
vragenlijst die door alle deelnemende ziekenhuizen aan de CENTER-TBI studie is ingevuld en tot 
doel had om de variatie tussen ziekenhuizen in kaart te brengen. In hoofdstuk 10 introduceerden 
we de ‘provider profiling’ vragenlijst en lieten we een aantal algemene ziekenhuisverschillen zien. 
Ondanks dat bijna alle ziekenhuizen een Academische affiliatie hadden en over een level I trauma 
center beschikten, waren er grote verschillen in de faciliteiten voor patiënten met traumatisch 
hersenletsel. Ook waren er grote verschillen in behandelbeleid. 
In hoofdstuk 11 beschreven we verschillen in de zorg op de spoedeisende hulp en tijdens opname 
in het ziekenhuis tussen de Europese centra. We lieten onder andere zien dat er verschillen zijn in 
de definitie van licht traumatisch hersenletsel. Daarnaast vonden we grote verschillen in het CT 
scan beleid tussen ziekenhuizen, waarbij sommige centra een liberaal beleid hadden (bijna alle 
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patiënten met licht traumatisch hersenletsel krijgen een scan) en andere centra meer restrictief 
handelden (alleen patiënten met een grote kans op complicaties krijgen een scan). Na het bezoek 
aan de spoedeisende hulp, had tien procent van de ziekenhuizen het beleid om de patiënt terug 
te zien op de polikliniek. Ongeveer de helft van de centra gaf schriftelijke informatie mee aan 
patiënten na het doormaken van licht traumatisch hersenletsel. 
In hoofdstuk 12 beschreven we verschillen in het monitoren en behandelen van patiënten 
met een verhoogde intracraniële druk. Een verhoogde intracraniële druk kan ontstaan doordat 
een bloeding of zwelling in de hersenen ruimte inneemt. Aangezien de hersenen niet kunnen 
uitzetten zal de druk in de hersenen op zo’n moment toenemen wat levensbedreigend kan zijn. 
Behandelingen om de druk te verlagen, zoals medicatie of een operatie kunnen echter ook weer 
complicaties geven. Bijna alle deelnemende centra gaven aan de intracraniële druk standaard 
te meten bij patiënten met ernstig traumatisch hersenletsel. De behandeling verschilde echter 
sterk, waarbij ongeveer de helft van de ziekenhuizen een relatief agressieve benadering had en de 
andere helft meer conservatief handelde. Opvallend was ook dat een deel van de centra aangaf 
een behandelbeleid te hebben dat in tegenspraak is met internationale richtlijnen. Een-vijfde van 
de centra gaf bijvoorbeeld medicijnen om het centrale zenuwstelsel te dempen (barbituraten) als 
eerste middel om de druk te verlagen, terwijl dit in verband met een hoog risico op complicaties 
alleen wordt aangeraden als andere behandelingen niet aanslaan. 
In hoofdstuk 13 hebben we de Europe centra gevraagd naar hun revalidatiemogelijkheden 
en verwijsbeleid. Ook hier vonden we veel variatie. De helft van de centra beschikte over een 
revalidatieafdeling waar patiënten met ernstig traumatisch hersenletsel behandeld konden 
worden. Met betrekking tot verwijzing vonden we dat leeftijd een belangrijke rol bleek te spelen. 
Patiënten onder de 65 jaar werden meestal verwezen naar gespecialiseerde revalidatiecentra na 
hun ziekenhuisopname, terwijl oudere patiënten vaker werden verwezen naar verpleeghuizen 
en niet-gespecialiseerde ziekenhuizen.
In hoofdstuk 14 hebben we gekeken naar oorzaken en gevolgen van behandelvariatie in 
een observationele studie met 503 patiënten afkomstig uit vijf Nederlandse Academische 
ziekenhuizen. We vonden dat variatie vooral werd bepaald door ziekenhuisfactoren en niet zozeer 
door verschil in patiëntkarakteristieken tussen ziekenhuizen. Patiënten met ernstig traumatisch 
hersenletsel die in ziekenhuizen behandeld werden met een agressieve benadering hadden een 
betere uitkomst dan patiënten die in meer conservatieve centra behandeld werden. 
De substantiële variatie in hoofdstuk 10 t/m 14 biedt kansen om behandeleffectiviteit te analyseren 
met vergelijkende effectiviteitsstudies. Het succes van zo’n vergelijkende effectiviteitsstudie is 
echter sterk afhankelijk van de statistische methode die hiervoor gebruikt wordt, wat uitgewerkt 
is in hoofdstuk 15 en 16. Conventionele methoden om te corrigeren voor patiëntkenmerken 
kunnen niet corrigeren voor factoren die niet gemeten zijn (bijvoorbeeld factoren die gerelateerd 
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zijn aan klinische intuïtie). Het analyseren van behandeleffecten op ziekenhuisniveau kan hier 
mogelijk wel voor corrigeren, maar is moeilijk te interpreteren en statistisch inefficiënt, wat 
betekent dat er veel patiënten nodig zijn om een effect aan te tonen als er een effect is. Verder is 
deze methode gebaseerd op een aantal aannames welke moeilijk te testen zijn.
Discussie
Het doel van dit proefschrift was om onze kennis met betrekking tot uitkomsten en mogelijkheden 
voor vergelijkend effectiviteitsonderzoek bij patiënten met traumatisch hersenletsel te vergroten. 
Om dit te bereiken hebben we meerdere literatuurstudies en observationele studies verricht.
 
We vonden dat de prevalentie van postcommotionele symptomen en psychiatrische stoornissen 
sterk varieerde en samenhing met de voorgeschiedenis van een patiënt, de patiëntenpopulatie, 
diagnostische criteria en analyse strategieën. De etiologie is complex en multifactorieel en 
bestaat onder andere uit biologische, psychologische en sociale factoren die moeilijk te 
integreren zijn in een predictiemodel. Bij het interpreteren van onderzoeken naar de prevalentie 
en predictoren van uitkomsten na traumatisch hersenletsel is het belangrijk om de volgende 
factoren in overweging te nemen:
• Er kan sprake zijn van misattributie waarbij symptomen na traumatisch hersenletsel worden 
toegeschreven aan het traumatisch hersenletsel terwijl ze eigenlijk een andere oorzaak 
hebben.
• De ernst van de symptomen kan samenhangen met de onderzoekssetting en hoeft dus niet 
generaliseerbaar te zijn naar alle patiënten met traumatisch hersenletsel. Het is aannemelijk 
dat patiënten met licht traumatisch hersenletsel op de spoedeisende hulp of in revalidatie 
instellingen ernstigere klachten hebben dan patiënten die zich bij de huisarts hebben gemeld 
of geen hulp hebben gezocht.
• Patiënten die deelnemen aan onderzoek kunnen verschillen van patiënten die niet willen 
deelnemen aan onderzoek of zijn uitgevallen. 
• Er kan sprake zijn van overlap tussen postcommotionele symptomen en psychiatrische 
stoornissen.
Verder hebben we gevonden dat clinici zich matig aan de huidige richtlijnen voor traumatisch 
hersenletsel houden en dat er veel variatie is in het behandelbeleid in Europa. Aan de ene kant 
is dit zorgwekkend aangezien sommige patiënten mogelijk niet de meest effectieve zorg krijgen. 
Aan de andere kant vormt de huidige variatie een mogelijkheid om de behandeleffectiviteit 
te onderzoeken met vergelijkende effectiviteitsstudies. De statistische methode is hierbij 
erg belangrijk. Veel gebruikte methoden kunnen niet corrigeren voor alle verschillen tussen 
behandelde en onbehandelde patiënten, omdat sommige verschillen, zoals klinische intuïtie, 
niet meetbaar zijn. Analyses op het niveau van het ziekenhuis kunnen dit theoretisch gezien 
wel maar zijn statistisch inefficiënt, gebaseerd op een aantal sterke aannames en zijn moeilijk 
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te interpreteren. Aangezien alle methoden voor- en nadelen hebben, is het onmogelijk om te 
stellen welke methode ‘het beste’ is. Daarom is het belangrijk dat onderzoekers verschillende 
methoden naast elkaar gebruiken bij het analyseren van de behandeleffectiviteit. Tot slot is 
het belangrijk dat de resultaten van observationele studies bevestigd worden in kwalitatief 
hoogwaardige gerandomiseerde studies met een controlegroep. 
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Beste lezer,
Na het lezen van dit proefschrift bent u waarschijnlijk meer te weten gekomen over traumatisch 
hersenletsel en onderzoek naar uitkomsten en vergelijkende effectiviteit. Nu het einde van dit 
proefschrift nadert, vraagt u zich misschien af waarom dit proefschrift begon met de beroemde 
spreuk van Forrest Gump (1994): 
“Life is like a box of chocolates, you never know what you gonna get”
In dit proefschrift heeft u kunnen lezen dat het moeilijk te voorspellen is welke patiënten met 
traumatisch hersenletsel langdurige klachten ontwikkelen (so you never know what you gonna 
get). Daarnaast heb ik laten zien dat het als patiënt met traumatisch hersenletsel moeilijk te 
voorspellen is welke behandeling je kunt verwachten, aangezien er grote verschillen zijn tussen 
ziekenhuizen (again, you never know what you gonna get).
Naast de inhoudelijke link met mijn proefschrift en het feit dat ik een fervent chocoladeliefhebber 
ben (melkchocolade met hazelnoot voor wie nog cadeau inspiratie zoekt), staat deze spreuk 
voor hoe ik mijn baan als promovendus heb ervaren. Als wetenschapper in spé ben ik in maart 
2014 gestart met het doen van onderzoek. Vele verwachtingen, of hypotheses zoals we dat in de 
wetenschap noemen, heb ik gehad. Sommige hypotheses bleken te kloppen, maar veelal bleken 
de resultaten verrassend. Als wetenschapper ben ik me er van bewust geworden dat je niet 
alles kunt voorspellen, maar dat je door te onderzoeken daadwerkelijk een bijdrage kunt leveren 
aan de kennis of de veronderstelde kennis. Daarom is de wetenschap voor mij net als ‘a box of 
chocolates’; verrassend, uitdagend en je krijgt er niet snel genoeg van. 
Chocolade eet je natuurlijk niet alleen (behalve tijdens het afronden van je proefschrift, daarom 
dank aan de AH to go in het Erasmus MC voor het op peil houden van de voorraad), noch schrijf 
je een proefschrift alleen. Daarom wil ik iedereen die heeft bijgedragen aan de totstandkoming 
van dit proefschrift hartelijk bedanken. 
Allereerst Ewout, bedankt voor de mogelijkheid om te promoveren bij de afdeling MGZ. Ik heb 
veel bewondering voor jouw intelligentie en efficiëntie, waardoor je in korte tijd noemenswaardig 
veel voor elkaar kan krijgen. Overleggen met jou waren ook altijd gezellig en er werd altijd wel 
gesproken over hardlopen (wat ik nog steeds niet doe), eten en familie. Inmiddels werk je als 
afdelingshoofd bij de afdeling klinische biostatistiek en medische besliskunde in Leiden, maar 
desondanks ben je altijd erg betrokken gebleven bij mijn promotie. 
Dan Hester en Suzanne, wat ben ik enorm blij en dankbaar dat ik jullie als copromotoren heb 
getroffen! Jullie zijn beiden betrokken, kritisch, ambitieus en hebben een goed gevoel voor 
humor. Ik kon altijd bij jullie terecht en jullie hebben mij veel vrijheid en kansen gegeven om 
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mezelf te ontwikkelen. Leuk ook om te zien hoe jullie jezelf de afgelopen jaren hebben ontwikkeld 
en inmiddels jullie eigen onderzoekslijn hebben. Hester, jouw humor en nuchterheid werken 
altijd heel relativerend en Suzanne, jouw organisatietalent en betrokken persoonlijkheid kan ik 
erg waarderen. Ik hoop in de toekomst nog veel met jullie te mogen samenwerken!
Vervolgens gaat mijn dank uit naar de leden van de promotiecommissie voor het lezen en 
beoordelen van mijn proefschrift en het zitting nemen in de commissie. En natuurlijk Jilske en 
Lea, mijn paranimfen! Met jullie ben ik in Saint Louis, Washington en New Orleans geweest, wat 
bijzondere ervaringen waren. Ook vond ik het altijd erg gezellig om met jullie te lunchen, koffie te 
drinken, sushi te eten of naar het Vroesenpark te gaan. Ik ben blij dat jullie tijdens mijn promotie 
naast mij staan.
Verder wil ik graag al mijn coauteurs bedanken. Met name Daphne, Kelly en Annemieke aangezien 
jullie de trekkende rol hebben gehad bij een aantal artikelen in dit proefschrift. Heel fijn dat ik 
jullie artikelen mocht opnemen! 
I would then like to thank all CENTER TBI investigators and participants. It has been a huge 
opportunity to be involved in such an ambitious project and to collaborate with dedicated 
researchers and clinicians. Special thanks to Andrew and David, the principle investigators of this 
project. I have learned a lot from the both of you about project management and communication 
skills and I have appreciated your feedback on my papers, which resulted in major improvements. 
Also special thanks to Nicole, Nada, Ruben and all other colleagues involved in the narrative review 
in Chapter 2. It has been an immense task to write such a comprehensive review in only a two-
month period, but it was great working with you and I have learned a lot from your dedication, 
experience and writing skills. Ook wil ik graag alle IMPACT, POCON, RUBICS, Zhuhai, TRACK-TBI 
en UPFRONT onderzoekers bedanken voor het verzamelen van de data en de mogelijkheid die 
jullie mij hebben gegeven om artikelen te schrijven op basis van de door jullie verzamelde data. 
Verder wil ik graag alle collega’s en oud collega’s van MGZ bedanken voor de gezelligheid op de 
afdeling, de wandelingen in het park, de thee- en lunch momenten en de borrels. Lea en Valerie, 
super om met jullie op de kamer te zitten en om hard werken af te wisselen met gezelligheid en 
chocolade.
Daarnaast ben ik ook mijn familie, schoonfamilie en vriendinnen dankbaar voor de interesse en 
steun tijdens het schrijven van mijn proefschrift en natuurlijk voor de gezelligheid en ontspanning 
tussendoor. Papa en mama, bedankt voor jullie onvoorwaardelijke liefde en steun. Fijn ook dat 
jullie altijd op Noah wilden passen zodat ik wat extra uurtjes in dit proefschrift kon stoppen. 
Mijn lieve gezusters Anne en Marlous, ik ben enorm blij met onze bijzondere band, ik kan met 
niemand zo lachen als met jullie! 
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Tot slot Bas  en Noah : mijn mooie gezin! Wat geniet ik er toch elke dag weer van om na een 
drukke werkdag thuis te komen. Lieve Bas, jij bent mijn grootste steun! Alle mijlpalen hebben 
we samen gevierd en jouw adviezen en nuchtere kijk op de wereld werken erg relativerend. 
Bedankt ook voor het ontwerpen van de voorpagina van dit proefschrift en je hulp bij de lay-out 
en de website. Mijn lieve Noah, wat ben ik trots op jou en wat heb ik de afgelopen 18 maanden 
genoten van al jouw grote en kleine ontwikkelingen. Ik houd ontzettend veel van jou en jij maakt 
van elke dag (en soms ook nacht) weer een feestje. 
Het was mij een groot genoegen om dit proefschrift te mogen schrijven. Alle mensen die ik 
niet bij naam heb kunnen noemen maar wel bijzondere ontmoetingen en gesprekken mee heb 
gehad of mee heb samengewerkt, wil ik bij deze ook nog van harte bedanken. Ik hoop dat dit 
proefschrift een kleine bijdrage heeft geleverd aan onze kennis over uitkomsten en vergelijkende 
effectiviteit bij patiënten met traumatisch hersenletsel. Daarnaast hoop ik dat dit proefschrift zal 
resulteren in uitgebreid vervolgonderzoek, zodat we op gegeven moment met enige zekerheid 
kunnen stellen: “you DO know what you gonna get”. 
Maryse Cnossen, Rotterdam aug. 2017
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